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The aim of the present study was to develop enzyme linked immunosorbent assays (ELISAs) for
detection of specific antibodies against Babesia bovis and B.bigemina for use in epidemiological
studies of bovine babesiosis in Brazil. These tests were developed using purified proteins of each
parasite, which were identified as species-specific in a comprehensive immunochemical
characterisation of different stocks ofBabesia parasites.
The review of the literature on bovine babesiosis covers the geographical distribution, transmission
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Methods for concentration of Babesia infected red blood cells and free parasites were then examined.
These included the use of differential hypotonic lysis, density gradient centrifugation, induction of free
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Somatic components and exoantigens of different stocks of parasites were characterised
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antigen preparations of each Babesia species and purified specific proteins. Four B.bovis stock-
conserved proteins from somatic components were electro-eluted from acrylamide gels and used to
develop an ELISA. Amongst these, a 56 kDa protein was found to be a potential candidate to replace
the crude parasite extract in immunodiagnostic assays.
Several B.bigemina specific proteins were also identified in the immunochemical analysis and four
candidates were electro-eluted from acrylamide gels. However all purified B.bigemina proteins cross-
reacted with B.bovis antisera in ELISA. The complementary use of a crude and cross-reactive
B.bigemina antigen together with the 56 kDa B.bovis-specific protein in ELISA to elucidate the
epidemiology of these diseases is recommended.
Future prospects and potential application in Brazil of these ELISA antigens for use in the detection of
anti-B.bovis and anfi-B.bigemina antibodies are discussed with particular reference to their role in
defining the epidemiology of bovine babesiosis in the dairy cattle of Minas Gerais State, Brazil.
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microplus which transmits B.bovis and B.bigemina. Brazil is located in an area with climatic
conditions favourable for the development of B. microplus and therefore its entire bovine
population (around 140 million animals) is potentially at risk from these tick-borne diseases.
Anaplasmosis, a disease of similar pathogenesis and pathogenicity caused by the rickettsial
organism Anaplasma marginale, is the third disease of a triad transmitted by this tick causing
a disease syndrome known in South America as 'tristeza parasitaria' (Fonseca & Braga,
1923).
As early as 1923 this syndrome was reported by Fonseca and Braga as being one of the major
constraints to the development of the Brazilian cattle industry, affecting calves and
genetically improved animals, which it was necessary to immunise before introducing them
into tick-infested areas (Fonseca & Braga, 1923). These two Brazilian veterinarians made the
first substantial contribution to the understanding of several aspects of these diseases
including their pathogenesis, clinical symptoms, treatment and immunisation in Brazil. They
also stressed the need for adoption of measures to control the tick vector in the face of
increased importations of Bos taurus cattle with the aim of upgrading local herds. Nowadays,
surveys carried out amongst dairy farmers in Brazil still cite tick-borne diseases as second
only in importance to diarrhoea among diseases affecting calves. Although little information
on economic losses due to each individual tick-borne disease is available, it is clear to
veterinary practitioners that babesiosis makes a substantial contribution to the reduction in
the farmer's income.
Due to the large extent of the Brazilian territory, a variety of topographic and climatic
conditions occur; consequently, diverse epidemiological situations exist which require
different control measures. As little information concerning the epidemiology of bovine
babesiosis throughout Brazil is available, it becomes difficult to propose control measures to
suit best each particular epidemiological situation. In order to propose appropriate control
measures, it is essential to understand the various factors involved in the epidemiology of
bovine babesiosis. Serological surveys are commonly used to provide relevant information
regarding infection prevalence which may make substantial contributions to decisions on
strategies to control infections in a particular area.
Despite the fact that a large number of serological tests can be used as the basis for
epidemiological surveys, there are some limitations, common to all immunodiagnostic tests
based on the detection of antibodies, that may lead to misleading results and consequently
recommendation of inappropriate control measures. One example of this is given by the
difficulty in discriminating between antibodies generated against each species of Babesia,
since there is usually cross-reactivity between B.bovis and B.bigemina in serological tests
where crude parasite preparations are used. Prediction of prevalence and incidence of disease
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based on results from serological tests may therefore not always be accurate. The reliability
of serological tests increases as the specificity and sensitivity increase. Discrimination
between the two infections in a particular area may assume great importance in cases where,
for instance, immunisation programmes are to be implemented. If live vaccines are going to
be used, it is important to define which Babesia species is needed for inclusion in the vaccine,
particularly considering that different techniques are used for attenuation of each Babesia
species. Thus, inclusion of one species unnecessarily in a vaccination programme may
represent a substantial increase in cost of such activities for the individual farmers.
Therefore there is still a need for improvement of the diagnostic tests already developed and,
as most of the cross-reactivity between related parasites is due to low specificity of antigens
used for detection of antibodies, improvements in the specificity of antigens seems to be a
sensible approach to achieve more reliable serological tests.
Thus, in the present study the main objective was to develop sensitive immunodiagnostic tests
for indirect detection of B.bovis and B.bigemina infections for epidemiological surveys in
endemic areas, using specific components of each parasite as antigens to replace crude
parasite preparations in enzyme-linked immunosorbent assay (ELISA) systems. Such tests
would be useful for a comprehensive study on the epidemiology of bovine babesiosis in areas
of Brazil, such as Minas Gerais State, where the disease is a problem faced in the
development of the cattle industry, currently with approximately 20 million animals.
The approach used to achieve this main aim was based on the identification of species-
specific parasite components through detailed immunochemical characterisation of different
stocks of each Babesia species, which would allow the identification and selection of relevant
antigenic components for use in the development of antibody detection ELISAs for each
parasite. The development of the tests was carried out in comparison with crude antigen
preparations and the assays were validated by testing with panels of experimentally produced
calf sera of known status and serum samples collected from cattle raised in areas endemic for
bovine babesiosis.
Preceding the immunochemical characterisation of Babesia stocks, it was necessary to ensure
a reliable source of both parasites. To avoid unnecessary use of experimental animals and to
obtain reliable and reproducible parasite material at the Centre for Tropical Veterinary
Medicine (CTVM), the in vitro culture systems for both B.bovis (Levy & Ristic, 1980) and
B.bigemina (Vega et al, 1985a) were seen to be the most appropriate means of providing
infected red blood cells (RBC) throughout the study. Thus a series of experiments was
designed, at the beginning of the present investigation, in which the aim was to improve the in
vitro cultivation system of B.bovis and to establish, in vitro, isolates of B.bigemina which
had not been established as continuous cultures in the past.
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Building on successful in vitro cultivation, the second stage of the study was directed towards
the enrichment of Babesia from culture suspensions, providing parasite-rich preparations for
the immunochemical analysis, in which several techniques were used for the identification of
relevant species-specific parasite components (both somatic and exoantigens) with potential
for use as immuno-diagnostic targets.
ELISA tests for detection of specific anti-B.bovis anti-B.bigemina antibodies were then
developed using purified antigens and crude antigenic preparations of each parasite, and






The babesias are intraerythrocytic protozoan parasites of mammals. The classification of
babesias has been a subject of debate for years. The Society of Protozoologists (Levine et al,







However, as the classification of the parasitic protozoa became unsatisfactory (Lee et al,
1985), a review was carried out resulting in a new classification proposed by Sleigh (1989).
The original class of sporozoans contained a heterogeneous collection of spore-forming
unicellular organisms, some of which are now classified in distinct phyla, leaving the
remaining sporozoans in a single category regarded as Phylum Sporozoa containing three
classes: Gregarina, Coccidea and Piroplasmea. The classification of the babesias in the order
Piroplasmida, family Babesiidae and genus Babesia proposed by Levine remained the same.
The systematics of parasitic protozoa comparing the classifications according to Levine
(1980) and Sleigh (1989) has recently been reviewed by Cox (1991). From this, Babesia,






2.1.2 History and geographical distribution
The babesias were first described by Babes in 1888 as Haematococcus bovis in cattle in
Rumania (Babes, 1888) and were renamed Babesia bovis by Starcovici five years latter
(Starcovici, 1893). In 1893 Smith and Kilborne proposed the name Pyrosoma bigeminum for
the parasite causing Texas fever in the southern United States and first reported the
transmission of a pathogenic protozoan by an invertebrate arthropod, the tick Boophilus
annulatus (Smith & Kilborne, 1893). In 1934 Rees reported that both B.bovis and
B.bigemina were involved with Texas fever (Rees, 1934).
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In Argentina two strains of Babesia were identified by Lignieres in blood smears from cattle
as causative agents of "tristeza"; one was large and similar to the organism described by
Smith and Kilborne, while the other was smaller and more easily seen in capillaries of the
kidneys and the meninges of the central nervous system (Lignieres, 1903). The small
organism was named Piroplasma argentina (Lignieres, 1910), later known as Babesia
argentina, until a consensus of parasitologists established that B.bovis and B. argentina were
the same parasite and that the unique designation of Babesia bovis should be used thereafter
(Brocklesby, 1978).
In 1911, M'Fadyean and Stockman reported the presence in England of a small
intraerythrocytic parasite that they named Piroplasma divergens (later Babesia divergens)
(M'Fadyean & Stockman, 1911), which was considered to be the same as B.bovis for some
years, due to morphological similarities with that parasite. Another species of Babesia, which
was morphologically very similar to B. bigemina, was first described as B. major (Sergent et
al, 1926), and was later proved to be a distinct parasite (Zwart et al, 1968, cited by Kuttler,
1988) causing only mild infections in the UK and Northern Europe. In his 1978 report,
Brocklesby proposed the existence of only four species of Babesia in cattle (B.bovis,
B. bigemina, B.major and B.divergens) (Brocklesby, 1978); however, more recently, three
additional species (B.jakimovi, B.ovata and B.occultans) have been identified by serological
methods (Minami et al, 1979; Gray & de Vos, 1981; Purnell, 1981).
The geographical distribution of Babesia species is usually correlated with the tick vector
present in the area. Thus, B.bovis and B.bigemina are the species occurring in Central and
South America, Southern Europe, North Africa, Asia and Australia, transmitted by one of the
species of Boophilus ticks, either Boophilus microplus or B.annulatus. B. bigemina occurs
throughout Sub-Saharan Africa, transmitted by Boophilus decoloratus and, in some areas,
by Boophilus geigyi or Rhipicephalus evertsi (de Vos, 1992). B.bovis only occurs in those
wetter parts of Southern, Eastern and Central Africa where B.microplus has become
established (de Vos, 1992), and in West Africa where it is presumably transmitted by
B.geigyi (Ilemobade, 1992). B.major is found in Europe and North Africa transmitted by
Haemaphysalis punctata ticks whereas B.divergens is found in Northern Europe transmitted
by Ixodes ricinus. In Northern Russia the species found is B. jakimovi which is transmitted
by 1.ricinus, in Japan B.ovata is transmitted by Haemaphysalis longicornis, and B.occultans
is found in South Africa where it is transmitted by the tick Hyalomma marginatum rufipes.
Kuttler reviewed the world-wide impact of babesiosis considering the more common Babesia
species (Kuttler, 1988) and a summary of the bovine Babesia species with their dimensions,
principal vectors and world distribution is reproduced in Table 2.1. Although seven species of
Babesia infecting cattle have been described, the majority of the cattle population of the
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world is exposed to the two most pathogenic species, B.bovis and B.bigemina, with the
greatest incidence between latitudes 32° N and 32° S, where Boophilus ticks occur. For this
reason the majority of the scientific research has been directed towards the diseases caused by
these two species. Since in Brazil and most South American countries B.bovis and
B.bigemina are the species affecting cattle, the present study will only review the aspects
involved in Babesia infections caused by these two parasites.
2.1.3 Life cycle
B.bovis and B.bigemina develop in the vertebrate host in erythrocytes (RBC) where they
multiply asexually by binary fission, with each cycle of division requiring approximately 8
hours (Mahoney, 1977) and resulting in pyriform parasites known as merozoites with a
typical apical complex (Igarashi et al, 1988). The merozoites then emerge from the host cell,
presumably by lysing it, and invade new uninfected erythrocytes. The process of entering
starts with the attachment of the merozoite to the erythrocyte membrane, with involvement of
the C3b receptor in the case of B.bigemina but not in the case of B.bovis (Igarashi et al,
1988), followed by invagination of the RBC membrane, allowing the parasite to enter with
disintegration of the invaginated part of the RBC membrane. During this process the surface
coat of the merozoite is lost and in the subsequent intracellular stages the parasite is covered
by a single plasma membrane in direct contact with the erythrocyte cytoplasm (Igarashi et al,
1988). After penetration of an erythrocyte, the merozoite is known as a trophozoite which
multiplies by binary fission or budding resulting in two merozoites.
Female ticks feeding on infected cattle ingest intraerythrocytic stages of Babesia which
remain in the host RBC for some hours in the gut of the ticks. There a sexual cycle starts with
the development of merozoites into gametocytes which divide to form four gametes. Two
gametes fuse to form a zygote (Mehlhorn & Schein, 1984). The zygotes selectively infect the
basophilic epithelial cells of the tick gut where multiple fission bodies are produced. These
release kinetes which enter the haemolymph and invade various tissue and organs, including
the developing oocytes in the ovary, to initiate cycles of multiple fission. Both B.bovis and
B.bigemina are transovarially transmitted. Kinetes from the infected oocytes subsequently
invade various organs in the embryo, larval, nymphal and adult ticks where further fission
cycles occur.
In certain cells of the salivary glands of feeding ticks a final cycle of sporogony occurs
resulting in production of sporozoites which are the forms infective for vertebrate hosts
(Friedhoff, 1988). Fig 2.1 shows a diagrammatic representation of the life cycle and routes
of transmission of B.bovis and B.bigemina parasites.
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Fig 2.1 Diagrammatic representation of the life cycle and routes of transmission of B.bovis
and B.bigemina parasites.
B.bovis and B.bigemina
1- sporozoites inoculated in saliva of feeding ticks
2- invasion of bovine erythrocytes to form trophozoites
3- binary fission of trophozoites to form merozoites
4- proliferation of parasites resulting in detectable parasitaemia and clinical disease
5- piroplasms ingested by feeding female tick develop into gametocytes (strahlenkorper) in
tick gut lumen, which fuse to form zygotes
6- growth and development of zygotes into kinetes by schizogony in tick gut epithelial cells
7- migration of kinetes throughout tissues, including ovaries, of engorged female tick
8- schizogony in developing oocytes
9- migration of kinetes throughout larval tissues
B. bovis only
10- entry of kinetes into larval salivary gland cells and subsequent sporogony during larval
feed
B. bigemina only
11- cycles of schizogony followed by kinete migration in larval/nymphal tissues
12- entry of kinetes into nymphal salivary gland cells and subsequent sporogony during
nymphal feed
13- entry of kinetes into adult salivary gland cells and subsequent sporogony during adult
feed
14- further cycles of sporogony in feeding/engorged female resulting in vertical transmission






The life cycles of the two species have distinct characteristics. B.bovis is transmitted only by
the larval stage of B.microplus or B.annulatus which then loses the infection, and vertical
transmission does not occur (Mahoney & Mirre, 1979). The infection of the tick population is
therefore based only on alimentary infection of the engorging females which will result in
infection of a low proportion of their eggs. B.bigemina, on the other hand, is transmitted by
feeding B.microplus and B.decoloratus nymphs, females and males, though transmission by
females and males of B.annulatus has not been demonstrated (Friedhoff, 1988). In addition,
persistence of infection throughout a complete life cycle and two further ecdyses occurs in
B.microplus ticks, since the adults resulting from a second generation of infected eggs are
still able to transmit the infection (Friedhoff, 1988). These particular characteristics result in
higher rates of B.bigemina infection in ticks.
2.1.4 In vitro cultivation
The in vitro cultivation of B.bovis in bovine erythrocytes was first described by Erp and co¬
workers as a short term system with slow stirring of cultures in spinner flasks (Erp et al,
1978). Later, the same group of researchers examined several variables in culture conditions
affecting parasite growth, including medium composition, pH, gas tension and storage of
serum and RBC (Erp et al, 1980). They concluded that amongst these the pH markedly
influenced growth rates and found that the optimum culture pH was 7.0. Levy and Ristic
(1980) improved this culture system to overcome some of the limitations of the original
technique, such as the lengthy manipulations necessary and slow growth rates obtained, by
culturing the parasite in a microaerophilous stationary phase (MASP), similar to the method
developed for Plasmodium falciparum (Trager & Jensen, 1976). The original MASP system
consisted of a suspension of infected erythrocytes in medium Ml99 supplemented with 15
mM HEPES and 40% normal bovine serum (NBS) with a PCV of 5 to 10% and incubated, at
a ratio of 0.62 ml to lcm^ of culture area, at 37°C under an atmosphere of 5% CO2 in air
(Levy & Ristic, 1980). The overlying medium was replaced with fresh culture medium at 24-
hour intervals with subcultures being carried out every 48 to 72 hours by diluting the culture
suspension 2 or 3-fold with fresh uninfected RBC suspension.
The MASP system has facilitated studies on many aspects of B.bovis including parasite
ultrastructure (Aikawa et al, 1985) and metabolism (Conrad, 1986; Matias et al, 1990), drug
sensitivity assays (Jasmer & Goff, 1989; Brockelman & Tan-aryia, 1991), the role of serum
factors in parasite growth (Levy et al, 1986; Tambrallo et al, 1992), immunodiagnosis and
immunoprophylaxis using either parasite soluble exoantigens released into culture
supernatants (Montenegro-James et al, 1981; 1983) or structural components
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(Goff et al, 1988; McElwain et al, 1988), and genetic and molecular characterisation of
parasite isolates (Tripp et al, 1989; Dalrymple, 1990; Brown et al, 1993).
Short term cultivation of B.bigemina has also been developed and was first described by
Timms (1980) using a method similar to that developed for human malaria parasites (Trager
& Jensen, 1976), however the infected erythrocytes could not been maintained beyond 96
hours. Vega and co-workers (Vega et al, 1985a) optimised the technique, achieving a
continuous cultivation system by washing the RBC in a phosphate-buffered saline solution
(containing CaCl2, KC1, MgSOq and dextrose) and culturing them in a stationary phase
similar to that developed for B.bovis, as a 5 to 10% RBC suspension in Ml99 supplemented
with 20 to 50% NBS at a depth of 4 mm in a 5% CO2, 2% O2, 93% N2 atmosphere. More
recently, Jorgensen and co-workers described a suspension culture system, using a PCV of
13% and gas mixtures of 2%-3% O2, 5% CO2 and 92-93% N2, which has proven more
efficient than the MASP system and is able to satisfy the present demand for B. bigemina live
vaccine in Australia (Jorgensen et al, 1992).
Following the development of a continuous in vitro culture system for B.bigemina, cultured
parasites have been used to study many aspects related to the parasite including
cryopreservation (Vega et al, 1985b), drug susceptibility assays (Brockelman & Tan-ariya,
1991), cloning (Vega et al, 1986a), concentration of erythrocytic stages (Vega et al, 1986b;
Figueroa et al, 1990a) and parasite characterisation (McElwain et al, 1987; 1991;
Montenegro-James et al, 1987; Buening et al, 1990; Figueroa et al, 1990b; Mishra et al,
1991; Tambrallo et al, 1992). Although a significant amount of work has been performed
using B.bigemina cultured parasites, only a limited number of isolates have been adapted to
continuous in vitro culture and the system has thus not advanced as far as that of B.bovis.
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2.2 The diseases
2.2.1 Clinical signs and pathogenesis
A wide variety of clinical signs caused by Babesia infections can be observed in cattle with
two important factors affecting the severity of infections. The first is the virulence of the
species and strain, with small babesias such as B.bovis being highly pathogenic, while large
babesias such as B.bigemina are generally less virulent, although variable virulence between
strains of B. bigemina has been reported with African and Israeli strains being highly virulent
while the Australian strains are of low to moderate virulence (Wright & Goodger, 1988;
Pipano, personal communication). The second factor is related to the susceptibility of the host
which is dependent on its age, breed, physiological and immunological status, and
environmental stress (Mahoney, 1977). Young animals are reported to be more resistant to
B.bovis infections than adult ones independent of the presence of colostral antibodies (Riek,
1963) and Bos indicus animals have been shown to be less susceptible than Bos taurus
breeds (Johnston et al, 1978). Splenectomy can exacerbate symptoms caused by less
pathogenic species such as B.bigemina and result in increased parasitaemias of B.bovis,
although splenectomised calves infected with B.bovis are not necessarily more severely
affected than intact calves (Wright & Goodger, 1988). The diseases are usually associated
with anaemia, fever, dehydration and enlargement of the spleen. B.bovis parasites show a
predilection for capillaries in the brain and kidney which result in damage of tissue cells by
depletion of their oxygen supply and therefore a more severe disease, whereas B.bigemina is
distributed throughout the bloodstream. Both infections are accompanied by lysis of
erythrocytes and haemoglobinaemia/haemoglobinuria followed by jaundice, the latter being
most commonly observed in B.bigemina infections.
The incubation period after tick infestation is usually between 8 and 16 days with infection by
B.bovis appearing first due to the transmission by the larval stage, and B.bigemina appearing
a few days later due to the transmission by the nymphal stage. Rectal temperature rises in
parallel with the increase in parasitaemia reaching a maximum of 41.0 to 41.5°C within two
or three days and the animal becomes listless, anorectic and weak. Haemoglobinuria occurs
followed by jaundice, particularly in B.bigemina infections, and signs of cerebral damage
such as paddling of limbs, ataxia, and coma are often seen in infection with B.bovis.
Mortality is usually high with B.bovis infections (Mahoney, 1977; Kreier & Baker, 1987).
Recovery from the acute infection is accompanied by clearance of parasites from blood with
the animals becoming immune and not normally showing recrudescence of disease.
The pathogenesis of babesiosis is complex with a multisystemic involvement, and appears to
result from the release of pharmacologically active substances and destruction of
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erythrocytes. Severe coagulation disturbance related to fibrinogen metabolism results in
hypercoagulability and rapid formation of cryoprecipitates in plasma of animals infected with
B.bovis (Goodger, 1975; Goodger & Wright, 1979). Goodger and co-workers also reported
that the B.bovis infected erythrocytes have an enhancing effect on the procoagulant activity
and that the coagulation time of normal bovine plasma was reduced by between 33 and 66%
in the presence of infected erythrocytes, depending on the strain of parasite (Goodger et al,
1987b). These authors suggested that disturbance of coagulation associated with an affinity
of fibrinogen for infected cells might be the explanation for the capillary stasis often observed
in B.bovis infections (Wright & Goodger, 1988), which appears to result from the activation
of the coagulation system in situ causing the strand-like formations reported by Wright
(1972).
During acute infection with virulent strains of B.bovis there is also an increase in circulating
activated kallikrein and a large decrease in plasma kininogen and subsequent production of
bradykinin and other vasoactive agents (Wright, 1973a, 1977), which might be associated
with falls in systolic blood pressure and correlated with haematocrit reduction (Wright &
Goodger, 1988). In addition, thrombocytopenia occurs as a result of a rise in the levels of
histamine and 5-HT (Wright, 1978), which potentiate the effect of kinins and kallikrein
(Mizuta, 1970).
Stasis induced by aggregated B.bovis infected erythrocytes in the microvascular system has
been reported to be the most deleterious lesion (Wright & Goodger, 1988), resulting from
infected cells adhering to each other and to the endothelium of the brain, kidney and skeletal
muscle (Wright, 1972, 1973a; Wright et al, 1979). The mechanism by which the stasis occurs
is probably multifactorial and cascadial involving: /) the endothelium, possibly by an
interaction between endothelial fibrin and erythrocytic fibrinogen (Goodger, 1978); ii)
changes in the erythrocyte membrane, perhaps due to the presence of babesial antigens on the
surface of the infected erythrocytes (Goodger et al, 1980) or by resultant increase in viscosity
and decrease in deformability of the erythrocytes due to lipid peroxidation (Commins et al,
1988) and Hi) increased host plasma concentrations of fibrinogen, soluble fibrin and
fibrinogen-fibrin complexes resulting in increased plasma viscosity (Goodger & Wright,
1979; Goodger et al, 1980).
2.2.2 Diagnosis
Microscopic examination of thin or thick blood smears stained with Giemsa is the usual
diagnostic procedure for confirmation of a case of acute babesiosis. For diagnosis of B.bovis,
13
thin smears are usually made from peripheral capillary blood and, if the animal is dead, from
kidney, brain, spleen and liver, where infected RBC tend to concentrate.
However, due to the difficulty of detecting parasites in blood smears from chronically infected
animals, direct microscopic examination is not applied for detection of carriers. The recent
advent of nucleic acid probes for B.bovis (McLaughlin et al, 1986) and B.bigemina (Buening
et al, 1990) and the use of the polymerase chain reaction (PCR) to enhance their sensitivity
have provided researchers with the most sensitive and specific assays for detection of
infection in carriers which are expected to become routine tests within the near future
(Palmer, 1992).
On the other hand, serological tests can be used as an indirect indication of whether or not an
animal has previously been infected with a particular parasite, and still remain the most
widely-used procedures for epidemiological surveys . The indirect diagnosis of infection by
detection of specific antibodies is appropriate for epidemiological studies of bovine
babesiosis, since animals that recover from acute infections become carriers and remain
immune for at least 4 years in the case of B.bovis, and for 2-3 years in the case of
B.bigemina infections (Mahoney et al, 1973, 1979). Evaluation of the serological status of
the animals is also useful for monitoring vaccination and chemotherapeutic programmes.
An ideal serological test should not only have high sensitivity and specificity, but it should
also be easy to perform, inexpensive and provide reliable results.
A large number of serological tests have been developed for detection of antibodies to
Babesia parasites with their sensitivity (indicated by the number of false negative results) and
specificity (indicated by the number of false positive results) depending on the antigen
preparation used. The different serological tests that have been applied for detection of anti-
Babesia antibodies have been extensively reviewed by Todorovic and Carson (1981),
Weiland and Reiter (1988) and Wright (1990). These include complement fixation (CF),
indirect haemagglutination (IHA), latex agglutination, indirect fluorescent antibody test
(IFAT), enzyme-linked immunosorbent assay (ELISA) and a modification of this (slide
ELISA), and radioimmunoassay (RIA). However, the IFAT and ELISA are the most
commonly used.
The source of antigen is either whole blood from infected animals collected during ascending
parasitaemia, or, with the development of in vitro culture systems for B.bovis (Levy & Ristic,
1980) and B.bigemina (Vega et al, 1985a), cultured parasites can also be used for
preparation of antigens for serological tests (Jones & Conrad, 1983; Woodford et al, 1990).
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2.2.2.1 IFAT
For the IFAT, whole infected erythrocytes are used to coat microscope slides, which can be
stored at low temperatures (-20°C), and are used as antigen for detection of antibodies
present in test sera. The test is based on the indirect detection of the parasite antigen - specific
antibody complex in bovine serum by its reaction with a second anti-species immunoglobulin
which has been previously conjugated to fluorescein isothiocyanate. Although the IFAT is
sensitive and easy to perform, interpretation is subjective and background fluorescence due to
non-specific binding of antibodies to host contaminants can be confused with low titre
positive serum samples (Callow et al, 1974). This, in association with the limited number of
samples that each operator can examine in one day and the requirement for ultra-violet
microscopy constitute the major limitations of the test. Cross-reactivity between B.bovis and
B.bigemina is usually observed, particularly with B.bigemina antigens (Bessenger &
Schoeman, 1983; Wright, 1990).
The use of a fluorescent antibody test was first described by Ristic and co-workers who used
it to study the development of B.caballi and B.equi in horse erythrocytes and to detect
circulating anti-Babesia antibodies in a one-step inhibition test (Ristic et al, 1964; Ristic &
Sibinovic, 1964).
In 1968, Ross and Lohr described an IFAT for detection of anti-B.bigemina antibodies in
bovine serum by which maximum titres of 1: 1280 were observed at 21 days after infection
(Ross & Lohr, 1968).
Ross and Lohr (1970) used the IFAT to study the persistence of colostral antibodies to
B.bigemina in calves and found higher titres in calves up to 1 month of age than in their
dams, which persisted for 17 weeks after birth. Based on these results the IFAT is not
considered an appropriate test for determination of Babesia infection rate in young calves.
Brocklesby and co-workers, using the IFAT to examine bovine serum, identified as B. major a
large Babesia derived from H. punctata ticks collected in two separate localities in South-
East England (Brocklesby et al, 1971).
In an attempt to facilitate epidemiological studies, Burridge and co-workers proposed the use
of blood dried on filter paper as a source of antibodies to be tested by IFAT (Burridge et al,
1973). This technique was evaluated by Todorivic and Garcia (1978) for detection of
antibodies to B.bovis and B.bigemina in blood from Colombian cattle under laboratory and
field conditions. A high correlation was found between the results obtained with serum and
dried blood, and the authors suggested that samples on filter paper could be practical for field
use in epidemiological studies since they were easy to handle and could be stored at various
temperatures.
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Comparisons between the IFAT and the CF test have shown that IFAT is more sensitive,
detecting B.bovis antibodies an average of 2 weeks earlier than CF and B.bigemina
antibodies 1.5 weeks earlier (Todorovic & Long, 1976). In that study IFAT titres rose to
levels of between 1:640 and 1:51,220 compared with CF titres ranging from trace to 1:80. A
similar comparison was carried out by Kuttler and co-workers, who found that both tests
were effective in detecting B.bigemina antibodies during the first 84 days of infection, both
showing a similar linear regression in serum titres; however after 94 days post-infection the
IFAT titre regression began to plateau while the CF titres decreased below background levels
in 60% of the samples tested (Kuttler et al, 1977).
Due to its simplicity and high sensitivity, the IFAT has been widely used in a large number of
studies, namely on antigenic relationships between Babesia species, and for epidemiological
surveys all over the world, and it still remains the test most used for serological diagnosis of
bovine babesiosis (Leeflang & Perie, 1972; Rodriguez et al, 1979; Bessenger & Schoeman,
1983; Madruga et al, 1984; Miller et al, 1984).
2.2.2.2 ELISA
The ELISA was described as a very sensitive and economical assay for detection of
antibodies by Engvall and Perlmann (1972). Tests were carried out in plastic tubes but these
were inconvenient for large scale use. The test was then adapted for performance in
disposable polystyrene microhaemagglutination plates (Voller et al, 1976), which are now
generally used as the antigen/antibody carrier. It was first shown to be suitable for detection
of Babesia antibodies by Purnell and co-workers (Purnell et al, 1976). The ELISA involves
three stages, first a reaction between the antigen and corresponding antibodies, followed by
the detection of this reaction by the use of anti-species immunoglobulin conjugated to an
enzyme. In the last stage of the assay the respective substrate for the enzyme is added and the
amount of antibody bound in the first reaction is indicated by the degree of substrate
degradation, which can be quantitatively measured on a spectrophotometer.
A number of alternative assay systems can be used for the detection and measurement of
antibodies or circulating antigens and immune complexes using antigen or antibody solid
phase coating principles. The various methods for ELISA have been reviewed by Catty and
Raykundalia (1989). However, two main types of systems are used to detect antibodies,
namely the indirect ELISA and the indirect double antibody sandwich ELISA and these are
represented diagrammatically in Fig 2.2.
So far, the assays developed for B.bovis are based on the indirect detection of antibodies
(Barry et al, 1982; Waltisbuhl et al, 1987; Bose et al, 1990).
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Fig 2.2 Schematic representation of the different stages involved in the indirect ELISA (A)


































In any of the ELISA systems there is a need to standardise all stages of the test by
determining the optimal antigen, antibody and conjugate dilutions which give the greatest
discrimination between positive and negative reference sera in a checkerboard titration (Voller
et al, 1979). The interpretation of ELISA results is also a subject which deserves great
attention. The determination of the positive-negative discrimination levels is known as the
"cut-off value" and can be calculated in different ways, as reviewed by Tijssen (1985): /') by
the mean absorbance of the negative control sera multiplied two or three times, ii) by the
mean of negative control absorbance plus two or three standard deviations, iii) by an
arbitrary value, usually between 0.15 and 0.20 absorbance. However, as demonstrated by
Beier and co-workers, positivity rates in an ELISA for determination of malaria sporozoite
infection rate in Anopheles mosquito populations could be significantly over-estimated
depending on the absorbance cut-off method applied for negative controls (Bier et al, 1988).
The original ELISA test developed for detection of B.bovis antibodies used as antigen
infected blood with 20% parasitaemia from which infected erythrocytes were concentrated by
a procedure of lysis with 0.425% potassium chloride, followed by removal of leucocytes
using CF11 cellulose, and lysis of infected cells to remove haemoglobin (Barry et al, 1982).
The conjugate used for detection of reactions was anti-IgG-alkaline phosphatase. Comparison
with IFAT showed more than 95% agreement between the two tests. The ELISA was shown
to be specific for B.bovis by the lack of significant cross reactivity with B.bigemina,
Anaplasma centrale and Theileria positive sera and to be more sensitive than the IFAT by
titration of positive sera. Antibodies in experimentally infected cattle were detected on day 14
after infection and lasted for at least 268 days.
A comparison between the ELISA, IFAT and CF for detection of antibodies in sera of cattle
experimentally infected with B.divergens and B. major was carried out by Bidwell and co¬
workers, who reported that CF detected antibodies earlier but that the CF titres were
consistently lower than those obtained with IFAT and ELISA. These authors found
agreement between the results from IFAT and ELISA. Nevertheless they suggested that the
ELISA may be preferable due to the fact that it is less subject to operator error, and therefore
more accurate, and also larger numbers of samples can be examined (Bidwell et al, 1978).
In an attempt to make the ELISA technique more economical and technically simpler, Kung'u
and Goodger developed a slide enzyme-linked immunosorbent assay (SELISA) for detection
of B.bovis antibodies, in which smears made from infected blood, fixed in acetone and stored
at -70°C, were used as the source of antigen (Kung'u & Goodger, 1990). The test was
performed in a manner similar to IFAT but using horseradish peroxidase conjugate and 4-
chloro-l-naphthol as the substrate for detection of reactions. Monoclonal antibodies were also
tested to demonstrate the cellular specificity of the test. The slides were examined using a
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light microscope and positive reactions were indicated by bluish-purple staining of the
B.bovis infected erythrocytes or the parasites, or both, whereas in negative reactions no
staining of either the infected cells or parasites occurred. The SELISA was found to be very
sensitive and detected antibodies to B.bovis for at least 36 months. Due to precise cellular
specificity obtained with different monoclonal antibodies, the test may be suitable for
screening of hybridomas (Kung'u & Goodger, 1990).
In cases where provision of parasites from infected animals is a limitation, the in vitro culture
system for B.bovis has been successfully used to provide infected erythrocytes as a source of
antigen for ELISA (Hadrill et al, 1990; Woodford et al, 1990). In these studies leucocytes
were removed from culture suspensions with parasitaemias between 4 and 10%, by column
chromatography using cellulose powder (CF11) (Melrose and Brown, 1979). The infected
erythrocytes, which are osmotically less fragile than uninfected erythrocytes, were
concentrated by selective hypotonic lysis with potassium chloride. Concentrated B.bovis
infected cells were then disrupted by sonication and the resulting soluble extract was used as
crude antigen. Some degree of cross-reactivity with B.bigemina sera was detected but it was
considered not to interfere with the interpretation of the results from the assay.
As the ELISA has proved to be a highly sensitive test, quick to perform and suitable for
surveys in which a large of samples have to be processed, attempts have been made to
improve it particularly with regard to the use as antigen of purified fractions of the parasite
instead of crude extracts. Contamination of parasite extracts with host components,
particularly erythrocyte stroma and membranes, results in binding of non-specific antibodies
which result in background absorbance values in negative sera. Attempts to reduce non¬
specific background absorbance have been made based on the use of a blocking step before
the addition of test sera, using reagents such as detergents and proteins, which occupy non¬
specific reactive sites (Spencer, 1988). In addition, non-specific binding due to presence of
anti-erythrocyte antibodies is also observed in sera from animals which had previously been
inoculated with infected erythrocytes; this can be reduced by pre-adsorption of the sera with
normal bovine erythrocytes before the test (Waltisbuhl et al, 1987 ).
Purified fractions of a lysate of B.bovis infected erythrocytes, obtained after gel filtration
using Sephadex G200, have been used as antigens in ELISA (Waltisbuhl et al, 1987 ). One
of the fractions obtained (fraction II) was selected for the development of the test since it was
found to be the most sensitive with B. bovis antisera; however it showed some cross-reactivity
when tested against Anaplasma marginale sera. In the same study four different enzyme
conjugates and their respective substrates were tested to determine the most sensitive system
for detection of B.bovis antibodies, and horseradish peroxidase was found to be the most
suitable.
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More recently, a recombinant form of an antigen from B.bovis (11C5), which had been
shown to induce immunity in cattle, was found to be sensitive and specific when used as
antigen in ELISA, although lower sensitivity was observed with some positive serum samples
(Bose et al, 1990). These authors suggested that perhaps a 'cocktail' of two or more
recombinant antigens was needed to improve the sensitivity of the test. The major advantages
of recombinant proteins as a source of antigens would be the elimination of variation between
antigen batches, and also the reduction of non-specificity due to host contamination, which
are limiting factors for the use of crude antigen. In the same study a crude antigen preparation
was used and it was reported that the use of IgG-specific monoclonal antibody conjugate
instead of conventional conjugates against bovine IgG virtually abolished non-specific
reactions. The assay was also optimised when a blocking step using PBS containing 2% horse
serum was included before the reaction with test sera (Bose et al, 1990).
The same synthetic B.bovis antigen (11C5) has been shown to be suitable for use as antigen
in an ELISA for the diagnosis of B.ovis in Turkey and successfully replaced the conventional
crude preparation (Duzgun et al, 1991).
A kit for carrying out an indirect ELISA for the detection of B.bovis antibodies has been
supplied by the Joint FAO/IAEA Division, Vienna, for serological surveys in some Latin
America countries. Recently, the kit was evaluated in Uruguay for use in serological surveys
(Cardozo et al, 1990). The test showed a sensitivity of around 98% and specificity of 97%,
although significant variability in plate to plate absorbance values was observed, and no
cross-reactions were seen when a panel of experimental sera against B.bigemina and
A.marginale were tested. The FAO/IAEA kit has also been used for a serological survey in
Mexican farms, where prevalence rates were found to be high enough to result in enzootic
stability (Vazquez et al, 1990).
Recent modifications in ELISA systems include solid phase reactions on micropegs, dip¬
sticks and beads, and the so called 'dot-ELISA' assays on protein-binding membranes such as
nitrocellulose, in which very small amounts of sample can be used (Catty & Raykundalia,
1989). A dot-ELISA system which could be read visually and gave results within three hours
has been developed for use in serodiagnosis of bovine anaplasmosis (Montenegro-James et al,
1990).
The use of ELISA has also been reported for the detection of culture-derived exoantigens of
B.bovis, in which purified anti-B.bovis IgG isolated from immune cattle was used as a
capture antibody and as an enzyme-conjugated recognising antibody (Montealegre et al,
1987). In that study 24-hour cultures showed the greatest concentration of exoantigens and
the assay was sensitive for detection of differences in species-specific antigenic activity
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between some B.bovis isolates. However cross-reactions with B.bigemina antigens were
observed.
Specific ELISA systems for serodiagnosis of B.bigemina are not as advanced as the B.bovis
system, basically due to numerous difficulties encountered in the preparation of soluble
extracts from this parasite for use as antigen. These limitations are related to the
concentration of infected erythrocytes from blood, isolation of intact parasites from RBC,
extraction of antigenic components from parasites and contamination with host material. In
addition, antigen preparations from B.bigemina usually cross-react with B.bovis antisera. In
an attempt to overcome most of these limitations, O'Donoghue and co-workers developed a
technique for purification of B.bigemina parasites from blood for use in an enzyme
immunoassay (O'Donoghue et al, 1985). The method was based on a procedure of controlled
lysis with hypotonic saline (0.06 M) by which the merozoites were freed from the
erythrocytes, and were then disrupted by sonication. The soluble extract was then subjected
to gel filtration chromatography using a Sephadex G-200 column that resulted in purification
of two antigenic fractions, which were used to monitor by ELISA the antibody response of an
infected calf. The tests using the two semi-defined fractions of B.bigemina appeared to be
sensitive, however no information concerning their specificity was given.
Schuntner and Wright also developed a serological test for B.bigemina using a
radioimmunoassay, in which a crude extract was prepared by sonication of infected blood.
The antibody response to the portion of the extract remaining after depletion by acidification,
followed by a solvent extraction, was subtracted from the response to the initial crude
preparation giving the net specific B.bigemina response (Schuntner & Wright, 1989). The
assay gave < 2% of false negative reactions, 2% false positives with negative sera, 4% false
positives with B.bovis sera and no false positives with A.marginale sera, and the specific
anti-5. bigemina antibodies were detected for at least 10 months after infection. Although the
RIA seems to be both sensitive and specific, it is a sophisticated test requiring a well-
equipped laboratory and it is unlikely that it could be widely used for field surveys in the near
future.
2.2.3 Epidemiology
The epidemiology of bovine babesiosis is a difficult subject since complex interrelationships
between the vector and the host are involved and therefore detailed analysis of the various
components of the tick-Ztoiey/o-cattle system must be considered.
The vector component Boophilus (in the case of B.bovis and B.bigemina infections) is a one-
host tick considered to be specific to cattle, with the infestation of other hosts having no
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epidemiological importance. According to Alonso and co-workers, amongst the components
of the system, Babesia is the weakest, since it depends on ticks and cattle for maintenance
and propagation, followed by Boophilus, which depends on cattle and finally the cattle which
do not depend on either, and act as a support for the other two components (Alonso et al,
1992).
Relating to the Babesia parasite the most significant factors are the percentage of mortality of
tick larvae and the ability to overcome immunological reactions from the host. Mortality of
larvae is reported to be between 74 and 90% and can be even higher when considering
Boophilus-resistant cattle (Sutherst & Utech, 1981). Climatic factors may also affect
oviposition, development of eggs and mortality of larvae (Harley, 1966) and therefore the
infection rate of ticks must be high to overcome all these barriers.
The epidemiology of bovine babesiosis has been extensively studied in Australia over the
past two decades by Mahoney and co-workers (Mahoney, 1969; 1977; Mahoney et al, 1973).
The numerical relationships between the steps in the sequence of events during infection of
the vertebrate host and transmission of the parasite from one host to another must be
calculated in order to understand the complex interactions involved and to design effective
control measures.
According to Mahoney (1977) the probability of host infection is an important parameter and
reflects the stability of the system; if this probability is high enough, the young animals
receive an initial infection before their passive immunity wanes, the situation is stable and
clinical cases do not occur, although Babesia organisms are widespread in the environment.
On the other hand, if the probability of host infection is low, a proportion of the animals do
not receive initial infection during the passive immunity period and therefore there is a risk of
them becoming clinically ill thereafter; this characterises an unstable situation. The
probability of host infection is measured by the "inoculation rate" which represents the
probability of infection of any member of the host population during 1 day, and is a product
of the number of bites received from the vector by each host per day (m), the proportion of
the vector population carrying infective forms of Babesia (a), and the proportion of infected
bites that successfully infect the host (b). Thus, estimation of the inoculation rate involves
counts of ticks on the bovine host and microscopic examination of tick smears for
determination of babesial infection rate, and is calculated by the formula:
Inoculation rate (h) = mab (1)
The rate at which young animals acquire the infection is also related to the inoculation rate
and is given by the equation:
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1=1- e"ht (2)
where I = proportion of animals infected (measured by a serological test), h = inoculation
rate, t= average age of the animals in days, and e is the natural logarithm.
Using equation 2, the inoculation rate for a determined age group can be calculated if the
proportion of infected animals (I) is known.
The range of values of the inoculation rate depends on the length of time after birth for which
the passively acquired protection is effective. If this period has been defined, the critical value
for an inoculation rate which will result in enzootic stability can be calculated by substituting
that value for t in equation 2. Inoculation rate values equal to or above this critical level will
indicate endemic stability, whereas inoculation rate values below the critical level indicate
instability, with risk of disease.
The minimum number of ticks infesting the vertebrate host which will ensure stability can
also be calculated if the infection rate of the ticks is known, using equation 1. Mahoney
(1977) reported that at least 12 larvae of B.microplns per animal (Bos taurus) per day were
required to result in a critical inoculation rate of 0.005 to maintain stability for B.bovis. The
same values have been used in epidemiological studies where no information about infection
rates of ticks are available (Vazquez et al, 1990).
When inoculation rates fall below the critical level for stability, there is a range of values
which will produce a high incidence of clinical disease in animals which did not receive
infection before passive immunity waned (zone of maximum risk); on the other hand, if the
reduction in inoculation rate falls too low, a large proportion of the population may never be
exposed to infection and the incidence of clinical disease might be very low. Knowledge and
understanding of the epizootiology of bovine babesiosis is an essential prerequisite to
proposal of effective control measures, which will vary in each situation.
It is important to emphasise that the genetic composition of cattle substantially affects the
estimation of inoculation rates, as discussed by Alonso and co-workers (Alonso et al, 1992).
B.microplus infestation is inversely proportional to the proportion of Bos indicus genes
(Lemos et al, 1985; Guglielmone et al, 1990) and parasitaemias of B.bovis are also generally
lower in Bos indicus than in Bos taurus cattle (Aguirre et al, 1990), and therefore lower
infection rates are observed in ticks feeding on Bos indicus breeds. Guglielmone and co¬
workers have reported infection rates of 28%, 23% and 5% respectively in female ticks fed on
Creole (Bos taurus), Hereford (Bos taurus) and Nelore (Bos indicus) cattle (Guglielmone et
al, 1989); these differences will affect the epizootiology of babesiosis.
In addition to the inoculation rate, host immunity will affect the stability of bovine babesiosis.
There are several aspects which affect host immunity and which should be taken into account.
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First of all, there is age resistance. Although in some situations babesiosis is considered to be
more pathogenic in calves (Madruga et al, 1984), animals below 9 months of age appear to
have a natural protection, possible related to the presence of a factor responsible for
inhibition of parasite growth (Levy et al, 1982); in addition, colostral antibodies have been
detected for many months after birth giving passive protection to calves born of immune dams
(Ross & Lohr, 1970). The second factor is the duration of immunity, which in both B.bovis
and B.bigemina infections is retained for periods of at least four years, regardless of the
infection status (Mahoney, 1974). Lastly, immunological differences between isolates may
also have an effect in the maintenance of stability depending on the frequency with which
cross infection between isolates causes recurrence of clinical disease (Mahoney, 1974).
Another important concept that involves transmission is the basic reproduction rate, which is
a hypothetical number representing the secondary cases of a disease disseminated by a single
primary case in a non-immune individual in an environment where neither the vertebrate host
nor the vector population were previously infected. The basic reproduction rate is affected by:
/) the duration of infectivity for ticks of a primary case, /'/) the number of female adult ticks
dropped per day, Hi) the number of larvae produced per tick and /V) the proportion of larvae
that bite a new host. If it is equal or greater than 1 the disease should persist, if it lower than
1 the disease should disappear. The basic reproduction rate can be calculated by the formula:
2 d n a
where d = duration of infectivity in days, n = number of female ticks dropped per day and a =
babesial infection rate of all the progeny (Mahoney, 1977). A critical level of tick infestation
(n) for maintenance of Babesia organisms in the environment can be calculated by the
equation
2 d n a = 1.
The great limitation of this equation seems to be related to the estimation of babesial infection
in ticks, which takes place during the last 24 hours of female feeding on cattle (Callow,
1968). Babesia kinetes are easier to detect in haemolymph of engorged females than in larvae.
However Mahoney and Mirre (1971) considered that this technique underestimated the
number of infected females. Moreover, the relationship between the number of kinetes seen in
haemolymph from female ticks and percentage of infective larvae is not known. Differences
between calculated and observed rates of vector infection have been reported, implying that
calculated values are not always reliable (Mahoney et al, 1981b).
There is evidence that the exposure of larvae at 14°C for three to five weeks increased their
infection rate with B.bovis and B.bigemina (Dalgliesh & Stewart, 1982). The influence of
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climatic factors has also been reported on the longevity of larvae and on the annual number of
generations of B.microplus (Sutherst & Utech, 1981), and on the transovarial transmission of
Babesia (Riek, 1964). Another aspect involved in the Boophilus-Babesia system is the
pathological effect ofBabesia on ticks, which has been reported with B. bovis and B. bigemina
experimental infections (Guglielmone et al, 1989). However, the low reliability of calculated
values of vector infections (a) does not necessarily invalidate the estimation of the inoculation
rates (h) by the proportion of animals infected (I) for a particular age group of animals (t).
On top of all the biological parameters which influence the interactions involved in the
Babesia-tick-cattle system, comes husbandry/management, which will also interfere with the
system. Thus, actions such as selection or introduction of European breeds into herds of
indigeneous cattle or vice versa can lead to changes in the enzootic stability of a herd; the use
of acaricides with long residual periods may prevent transmission of Babesia at levels high
enough to maintain stability; irrigation of pastures during dry seasons may result in an
increase in the number of tick generations during the year, and so on.
The relationships between B. bovis and its tick vector (Boophilus) have been studied by
computer simulation with an interactive BASIC program by Smith (1983), who derived the
major independent variables (host-finding success, feeding success, filial infection rate,
recovery rate) from published laboratory and field data, and calculated, during successive tick
generations, values for dependent variables (tick burden, inoculation rate, tick and bovine
infection rates). The simulation was used to predict the effects of different strategies of
disease control. Daily infestation rates of 8 to 9 engorged ticks were found to be optimum to
maintain immunity to babesiosis without significant physiological stress to the bovine host,
whereas disease outbreaks were associated with daily infestations of between 2 and 8
engorged females.
More recent studies on simulation modelling include the use of climatic matching
programmes, such as "Climex" (Sutherst & Maywald, 1985), and programmes in which all of
the features of the tick model (management of the hosts, for instance) are incorporated, such
as the TICK2 (Dallwitz, 1987).
2.2.4 Control
Bovine babesiosis is widespread in tropical and subtropical regions where, due to favourable
climatic conditions, the Boophilus tick vector can complete several generations throughout
the year. In these conditions the high rate of transmission results in most cattle becoming
infected at a young age, leading to enzootic stability.
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The epizootiological principles proposed by Mahoney (discussed in section 2.2.3) can be
applied to identify the epidemiological situation and the animals at risk, giving an indication
of whether or not control measures are necessary and what type of control would be suitable
for each case.
The inoculation rate is calculated indirectly from the proportion of animals infected, obtained
by a serological survey. In B.bovis infections, if the inoculation rate is lower than 0.0005 the
organism might disappear from the environment if the tick population is under artificial
control and there is no need for immunisation. In these situations the disease will tend to be
eradicated and an accidental reintroduction would result in outbreaks with great losses.
On the other hand, if the inoculation rate lies between 0.005 and 0.0005 only 25 to 40% of
the animals will receive infection between 9 months and 4 years of age and immunisation is
necessary to prevent clinical cases.
Inoculation rates higher than 0.005 imply that more than 75% of the calves become infected
before 9 months of age and the rest of the animals will be infected before they reach 2 years
of age. In that situation, clinical cases are not usually observed and there is no need for
control measures. According to Lawrence and de Vos (1990), however, choosing not to carry
out active control fails to keep disease at a minimal level under the following conditions,
where:
- due to ecological factors, the tick infestation is too low to maintain a critical level for
stability
- the tick infestation is too high on susceptible breeds of cattle and causes unacceptable losses
- the tick population varies from year to year due to climatic variations
- cattle are moved to and from areas with different tick populations
Under these situations the use of control programmes should be implemented in order to
prevent the occurrence of clinical disease.
Essentially, control measures rely on chemotherapy, tick control and immunisation.
A wide variety of drugs has been used for treatment of acute cases of bovine babesiosis; these
include acridine derivatives (acriflavine hydrochloride), quinoline derivatives (quinuronium
sulphate), diamidine derivatives (diminazene diaceturate), carbanilide (imidocarb
dipropionate) and tetracyclines. The aim of the treatment is to promote clinical recovery
allowing some organisms to persist in order to ensure immunity.
Anti-Babesia drugs can also be used, at sub-therapeutic doses, prior to or simultaneously
with infection to prevent clinical disease (chemoprophylaxis). Due to its slow degradation in
the body of the animal, imidocarb is the most suitable drug for use in chemoprophylaxis,
which is usually associated with immunisation programmes (Kuttler, 1988), although care
26
must be taken to correctly time application of drug and subsequent vaccination. However,
recent restrictions have been placed on the marketing of imidocarb due to toxic residues in
treated animals. Long-acting tetracycline used simultaneously with live B.bovis and
B.bigemina vaccines has been shown to reduce parasitaemia and red blood cell destruction
without inhibiting the development of immunity in the vaccinated animals (Pipano et al, 1987;
Marcovics et al, 1991). The chemotherapy of babesiosis has been reviewed by Kuttler
(1988).
Tick control is usually achieved by the use of chemical acaricides and, due to the influence of
climatic factors on the development of ticks, a comprehensive ecological study of each
situation is useful to establish any variation in subsequent recommendations for tick control
strategies that might be necessary. The various methods currently used for the control of
Boophilus ticks have been reviewed by Smith and Kakoma (1989) and Nari (1990).
Tick control may be implemented at two levels, eradication or strategic control. Eradication
programmes require the provision of effective barriers between tick-free and tick-infested
areas and may only be considered appropriate in marginal areas where survival of ticks is
tenuous. Eradication of Boophilus ticks in the mainland USA, which was completed after a 4-
decade period from its initiation in 1906, is the only case of a successful eradication
programme (Ristic & Montenegro-James, 1988). In endemic areas, eradication would be
extremely demanding in terms of costs and continuous supervision over a long period.
Examples of that are given by attempts to eradicate Boophilus sp in Mexico (Trapaga, 1989)
and in Argentina (Signorini & Mattos, 1989). A more rational action would be based on
reduction of the tick population to a level at which transmission of disease is still maintained
with perpetuation of a state of enzootic stability. Strategic control involves the application of
acaricides at predetermined times during the year when tick infestation exceeds a specific
level (Johnston et al, 1981). However, as the transmission rate of B.bovis is very low,
requiring relatively high numbers of ticks to ensure enzootic stability, the strategic control of
ticks may result in a need for concomitant immunisation programmes when B.bovis infections
are involved.
Immunisation of the animals at risk is the most appropriate method for controlling the
disease, since it allows tick control to be directed towards prevention of tick worry.
Immunisation programmes are generally implemented in situations where a rigid form of tick
control is obligatory, i.e. when infestations by Boophilus ticks reach unacceptable levels on
susceptible breeds of cattle and represent a limiting factor to beef and milk production.
Ideally, immunisation should be achieved by the use of a vaccine able to: i) prevent clinical
disease under field conditions; ii) protect against all strains of the parasite; iii) induce long-
term protection; zv) have no contaminating antigens or infection; v) be available in large
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quantities at an acceptable cost; vz) retain potency during storage and transportation; and vz'z)
be safe and easy to administer (Mahoney, 1981; de Vos et al, 1987).
A procedure for induction of protective immunity by inoculation of blood from carriers into
susceptible animals and their subsequent treatment, known as premunization, is the oldest
method of immunisation against Babesia parasites (Pound, 1897). However this method
presents serious limitations such as the risk of dissemination of other diseases, the lack of
knowledge of the number of parasites being inoculated and consequently the possible
induction of severe acute disease with a need for treatment. Furthermore, inoculation of blood
may cause deaths from haemolytic disease in calves as a result of induction of antibodies
against red blood cell stroma antigens in their mothers (Dimmock & Bell, 1970).
Vaccines against Babesia can be classified into two categories: living and non-living
vaccines.
Living vaccines were developed in Australia by altering the virulence of the organism through
serial passages of infected blood in splenectomised calves (Callow & Mellors, 1966).
Vaccines of this type have been successfully used in Australia for the past 20 years and this
technique for attenuation has been applied for production of vaccines in South Africa, and in
many countries in South America (Taylor, 1989). Vaccine strains of B.bovis are passaged,
during the acute phase of infection, from a minimum of 20 to a maximum of 30 times in
splenectomised calves. Attenuation of B.bigemina is achieved by slow serial passages in
intact calves which are splenectomised during the chronic phase of infection to produce
relapse parasitaemias (Taylor, 1989). In endemic areas where the two infections are present a
bivalent vaccine is used. These living attenuated vaccines can be stored and distributed
refrigerated (4°C) and have the advantage of being used at a standard infective dose.
However the viability of the parasite is limited to a maximum of 10 days, resulting in a very
short "shelf life" of the vaccine; another disadvantage of chilled vaccines is that the risk of
transmitting other pathogenic organisms still remains. To overcome these limitations,
vaccines frozen in liquid nitrogen have been used allowing tests to be carried out for
infectivity, immunogenicity and freedom from contaminating infections before distribution
(Jorgensen et al, 1989). The major limitation of frozen vaccines, however, is the high cost of
their storage and distribution.
The use of the in vitro culture systems for provision of cultured attenuated parasites has
overcome the problems of foreign disease agents. A recent modification of the MASP culture
system for B.bigemina has been reported which resulted in a culture suspension system that
yielded three times more parasites than the original MASP system; this technique has been
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used for vaccine production in Australia (Jorgensen et al, 1992). Nevertheless, increasing the
scale of in vitro culture systems might be a limitation if the demand for vaccine is high.
Irradiation of Babesia parasites has also been attempted for the development of vaccines
(Irvin et al, 1979; Wright et al, 1982). The principle is to use an intermediate dose of
irradiation that kills most of the parasites and, hopefully, modifies the virulence of the
survivors. However, despite the evidence of some degree of homologous and heterologous
strain protection with only mild reactions after heterologous challenge, irradiated vaccines
have not been developed further.
Non-living vaccines include parasite extracts, supernatant from cultures (exoantigens) and
synthetic vaccines developed by recombinant DNA technology.
Crude parasite extracts have been shown to confer strong immunity (Mahoney & Goodger,
1981; Mahoney et al, 1981a), but reduction of immunogenicity occurred as the preparations
were purified. Nevertheless, great efforts have been made in the identification and purification
of candidate antigens from crude parasite extracts by the use of monoclonal antibody and
affinity chromatography technologies. The identification of target antigens is reviewed in
section 2.3.3.
Based on findings that circulating antigens in the plasma from animals with acute Babesia
infections provide a degree of protection in susceptible animals (Sibinovic et al, 1967;
Mahoney & Goodger, 1972), supernatants from cultures of B.bovis and B.bigemina have
been tested for use as non-living vaccines (Smith et al, 1979; Montenegro-James et al, 1985).
These exoantigens, which are thought to be composed of three components of which one or
more originated from the merozoite surface coat (Smith et al, 1981), have been used in field
vaccination trials in some Latin American countries providing satisfactory protection.
However, protection conferred by B.bovis culture supernatant has been shown to be only
partial after challenge with heterologous strains and to be substantially lower than the
protection conferred by live parasites (Timms et al, 1983; 1984). The use of this type of
vaccine would offer several advantages over the currently used attenuated live vaccines.
These include the possibility of lyophilization which would facilitate storage and
transportation, and elimination of occurrence of neonatal haemolytic disease, since culture
supernatant is believed to be virtually free of red blood cell stromal antigens.
With the advent of recombinant DNA technology, great efforts have been made in the
development of a new generation of babesial vaccines based on the cloning of relevant genes
which express particular parasite proteins. These include studies on parasite surface proteins
(Reduker et al, 1989; McElwain et al, 1991; Suarez et al, 1991), and the sub-fractionation of
protective fractions of native proteins with the aim of identifying protective epitopes
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(Commins et al, 1985; Goodger et al, 1985b). The first trial of a vaccine for B.bovis derived
from recombinant DNA, however, showed that significant protection against challenge was
not produced (Timms & Barry, 1988). Despite that unsuccessful attempt, many workers
believe that the ideal babesiosis vaccine will require DNA technology with the most recent
approach being the combination of recombinant strain-conserved protective proteins in a
"cocktail" which may confer complete protection to susceptible cattle (Gale et al, 1992;
McElwain et al, 1992).
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2.3 Immunology
Immune responses in babesiosis are complex and involve both humoral and cell-mediated
components (de Vos et al, 1987, Zwart & Brocklesby, 1979).
2.3.1 Humoral immune response
The first evidence that antibodies play a protective role in Babesia infections was given by
the passive transfer of maternal immunity to calves by the antibodies present in colostrum
(Hall, 1960; Hall et al, 1968). However, attempts to correlate antibody levels with immune
status have failed, suggesting that not all antibodies are protective (Mahoney, 1964; Callow
et al, 1974).
On the other hand, further evidence of a protective role for antibodies was given by Mahoney,
who showed that passive transfer of immune serum to susceptible splenectomised calves
resulted in protection against B.bovis (Mahoney, 1967a). Later, it was found that protection
was due to IgG, with the target antigens appearing to be located on the surfaces of infected
red blood cells and parasites, and that the antibodies acted as opsonins with the organisms
being killed by phagocytes (Mahoney et al, 1979). However, cross-protection between
antibodies directed against heterologous strains was not observed and it was suggested that
strain-specific immunity and variant-specific serological activity during chronic infections
result from different antigen-antibody reactions (Mahoney et al, 1979).
In vitro studies of rodent babesias have shown that antibodies suppress parasite growth by
inhibition of parasite entry into erythrocytes (Bautista & Kreier, 1979). Opsonic activity
correlated with the protective function of serum has been demonstrated by the passive transfer
of immunity in B.rodhaini (Rogers, 1974). Immune serum also increased in vitro
phagocytosis of B.gibsoni by blood monocytes, and in B. microti cultures immune serum
acted together with macrophages to inhibit growth (Bautista & Kreier, 1980).
Furthermore, it has been reported that free merozoites are particularly susceptible to attack
by antibodies (Thoongsuwan & Cox, 1973; Abdalla et al, 1978; Smith et al, 1981). Ristic
and Levy suggested that antigens located on the surface coat of merozoites are the major
antigenic determinants associated with protective immunity to Babesia, and that the
antibodies to these antigens are involved in disruption and lysis of the organism (Ristic &
Levy, 1981).
In contrast, it has been reported that protective immunity is inversely related to antibody titre
when using defined protective antigens (Wright et al, 1983a; Goodger et al, 1986).
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In Babesia infections antibodies are produced, not only against a broad spectrum of parasite
antigens, both protective and non-protective, but also against host antigens as the result of an
inflammatory response (Goodger et al, 1985a). According to Goodger and co-workers, most
of the antibodies detected by serological assays are non-protective (Goodger et al, 1985a).
Non-specific factors, such as fibronectin, conglutinin and complement (C3) are involved in
immunity against babesiosis with low titres of protective antibodies being sufficient for
protection (Goodger, 1989). Complement also seems to play an important role in the invasion
of rat erythrocytes by B.rodhaini (Jack & Ward, 1980). However serum complement does
not appear to interfere with B.bovis invasion and does not facilitate invasion of bovine
erythrocytes in vitro (Levy et al, 1986).
In general, antibody levels rise to an early peak and decline during the chronic stage of
infection (Smith et al, 1978). In endemic areas, calves receive passive protection from
maternal colostral antibodies until about three months of age, by which time they have
usually become infected with the peak of antibodies occurring at 4 to 5 months of age (James
et al, 1985).
The kinetics of antibody levels in B.bigemina infections have been studied using an enzyme
immunoassay by O'Donoghue and co-workers, who reported the appearance of IgG at 7 days
after infection, with peak titres from 12 days and persistence of a plateau for 7 weeks
(O'Donoghue et al, 1985). IgM antibodies appeared 7 days after infection, peaked at 12 days,
persisted at maximum levels until day 22 and then declined to low levels by 28 days after
infection.
2.3.1.1 Antigenic heterogeneity of parasite populations
The first evidence of antigenic diversity of Babesia parasites was given by Curnow, who used
a parasitized erythrocyte agglutination test to demonstrate antigenic differences between
seven Australian isolates of B.bovis, indicating the presence of multiple strain-specific
parasite antigens (Curnow, 1968; 1973). The latter study demonstrated the emergence of
different variants of the parasite during the chronic phase of the infection, which reverted to
the basic antigenic type after transmission by the tick vector. The variant antigens appeared
at intervals of approximately three weeks resulting in recrudescence of parasitaemia. In vivo
evidence of strain differences in B.bovis and B.bigemina infections was given by studies on
cross-immunity in which animals recovered from infection were more resistant to homologous
challenge than to challenge with a heterologous strain (Callow, 1964; Uilenberg, 1970).
Studies on the protein composition of different parasite populations by 2-dimensional gel
electrophoresis of biosynthetic labelling of infected erythrocytes have demonstrated antigenic
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differences both between strains and between virulent and avirulent forms of the same strain
(Kahl et al, 1982; 1983). These studies revealed that some of the antigens which were present
or absent in different populations differed in their amino acid composition, and there was
evidence that protein differences may be correlated with virulence.
Differences between populations of B.bovis have also been demonstrated by genetic analysis.
A number of genes expressed in attenuated lines, but not in virulent lines, have been identified
and their use as probes showed that strain diversity and the selection of genetically distinct
subpopulations of parasites occurred during passage either through cattle or in vitro culture
(Cowman et al, 1984; Carson et al, 1990). Further evidence of genetic and antigenic
polymorphism among populations of B.bovis was given by the finding that cloned populations
originating from the attenuated Ka strain exhibited distinct antigenic differences, with one
clone being significantly more virulent than the others, and none of the cloned populations
being transmissible by ticks (Gill et al, 1987a). Although that study indicates that there is
considerable heterogeneity within parasite strains, it suggested that a major component of the
immunity was not parasite strain-specific, since the animals infected with cloned parasites
were immune to challenge with a different strain.
Further investigations on the virulence of cloned lines derived from the avirulent vaccinal
strain (Ka) have been reported by Timms and co-workers, who found variability in virulence,
from some clones which were completely avirulent to others which were highly virulent
(Timms et al, 1990). In that study, none of the cloned lines were transmissible by the tick
vector, neither alone nor as a combination, which is in direct contrast to the parent strain
being readily tick transmissible. The authors suggested the possibility that a gene product
required for tick transmission, perhaps an enzyme necessary for penetration of the gut
epithelial cells of the tick, had been lost in these cloned populations. They further suggested
that field strains of B.bovis contain both tick-transmissible and non-transmissible
subpopulations with the transmissible parasites being capable of supporting the transmission
of the non-transmissible parasites by provision of a factor required for transmission.
The reversion to virulence of an attenuated strain of B.bovis has been demonstrated after
mechanical passage through intact cattle or biological passage through ticks (Callow et al,
1979; Kahl et al, 1983). Timms and co-workers also reported reversion to virulence of one of
their clones after passage through an intact calf and suggested that the genes related to
virulence must still be present, but not expressed, in both the Ka and the cloned avirulent
strains (Timms et al, 1990).
The diversity of B.bovis parasites may have practical implications for vaccination
programmes (Dalrymple, 1992). In the late 1980s significant problems were observed in
Australia with the attenuated strain (Ka) of B.bovis used as a live vaccine. These problems
33
were related to an increased number of vaccinated animals showing severe reactions after
challenge. Dalrymple suggested that these problems could be attributed either to a change in
the composition of the vaccine (both phenotypic and genetic) or to the selection of some
resistant strains in the natural population, or to a combination of both factors. The selection
of parasite subpopulations that could evade the host immune system, as a result of the
intensive use of one vaccine line of parasite, has not yet been demonstrated in B.bovis.
However, if it is found to be the case, strain diversity of Babesia parasites may have even
more significant implications for the success of the development of recombinant vaccines,
which will inevitably be based on the use of a small number of parasite components.
A more comprehensive analysis of subpopulations of B.bovis has been reported recently by
Dalrymple and co-workers, who used a recombinant DNA probe specific for a tandemly
repeated gene of this parasite to analyse a number of samples from different isolates of
B.bovis (Dalrymple et al, 1992). That study revealed that five out of seven samples originally
derived from single clinical cases contained more than one distinct subpopulation of parasites,
while only one population was identified in samples from the Ka line used as the live
attenuated vaccine strain in Australia from 1979 until 1990. On the other hand, the Ta line,
which replaced the Ka line as an attenuated vaccine strain, was shown to contain two
genetically distinct subpopulations of parasites. One of the B.bovis lines analysed by
Dalrymple and co-workers, the Lismore (LP) strain which originated from the Lismore isolate
used in the present study (Timms, personal communication), was shown to comprise a
homogeneous population. Furthermore, the same subpopulation was detected after the
Lismore (LP) line was passaged through ticks, although the parasites appeared to be more
virulent. Thus, no correlation between the increase in virulence and selection of a major
distinct subpopulation of parasites was observed. The results obtained from the genetic
characterisation of the different isolates of B.bovis carried out by Dalrymple and co-workers
indicated occurrence of changes in the composition of parasite populations after passage
through splenectomised calves and in tissue culture (Dalrymple et al, 1992).
2.3.2 Cellular immune response
Lymphocytes (B and T) and natural killer cells (NK) are involved in the immune mechanisms
activated in response to Babesia infections (de Vos et al, 1987). Elimination of B.microti in
mice has been reported to be thymus-dependent (Clark & Allison, 1974; Ruebush et al,
1980a). Further evidence of a role for T-cells in the development of resistance to B.rodhaini
and B. microti was given by the transfer of immunity with lymphoid cells from infected mice
to either susceptible or irradiated mice (Roberts, 1968; Ruebush & Hanson, 1980b).
Lymphocyte transformation has also been reported in B.bovis infection with a more
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pronounced effect produced by inoculation of soluble supernatant from cultures than with live
vaccine (Timms et al, 1984). The assay showed that the cell-mediated response was short¬
lived, with a relatively low stimulation index being recorded 10 to 18 days after vaccination
with live parasites. In contrast, positive stimulation was observed throughout a 6-month
period with maximum values being observed after 18 weeks, following vaccination with
soluble exoantigens.
Machado and co-workers, evaluating the cell-mediated response to B.bovis infection using a
leucocyte migration inhibition test, reported significant inhibition of migration as early as 6
days after infection, and continuously high levels of inhibition throughout the 26-day
observation period (Machado et al, 1985).
The evidence for an antibody-dependent cell-mediated cytotoxicity (ADCC) mechanism being
involved in the resolution of B.bovis infections was given by studies of Goff and co-workers,
who demonstrated enhancement of ADCC in mononuclear effector cells isolated from the
peripheral blood of infected cattle (Goff et al, 1984a,b). The levels of activity increased
during the parasitaemic crisis (between 5 to 13 days after infection) and returned to normal
levels with the resolution of parasitaemia (19 days after infection).
The most comprehensive studies on the cell-mediated response to B.bovis infections have
been described recently by Brown and co-workers in a series of reports which started with the
examination of peripheral blood mononuclear cells (PBMC) from cattle experimentally
inoculated with tick-derived or cultured parasites tested against different parasite antigenic
fractions (Brown et al, 1991). Results from that study demonstrated that infection with
B.bovis elicited a strong cell mediated response. However, animals inoculated with tick-
derived parasites preferentially responded to an antigenic fraction from parasite membranes,
whereas inoculation of cultured merozoites elicited a vigorous response to a parasite
membrane-enriched fraction, a soluble merozoite fraction, and soluble supernatant antigens.
Furthermore, it was found that the antigens most immunogenic for T cells are parasite
membrane-enriched fractions and that monocytes appear to be required as antigen-presenting
cells in the Babesia-specific response. There was also indication that B.bovis and B.bigemina
share T-cell epitopes, since SAovA-immune PBMC responded to B.bigemina parasites.
T cells are believed to be central to both humoral and cell-mediated responses in Babesia
infections, and to be critical for activating macrophages by the elaboration of cytokines
(Brown et al, 1993). Nevertheless, studies on the cellular immune response to a protective
antigen, in both its native and recombinant forms, failed to induce interferon gamma
production by cells from vaccinated cattle when stimulated by B.bovis antigens in vitro,
suggesting that immunity is correlated most strongly with humoral rather than cell-mediated
responses (Orinda et al, 1992a).
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Further studies by Brown and colleagues on the role of T helper cells (Th) in B.bovis
infections demonstrated preferential stimulation of CD4+ T cells by unfractionated cytosolic
and merozoite membrane antigens (Brown & Logan, 1992). A panel of 11 Th clones derived
from several Babesia-specific T cell lines, which had demonstrated functional heterogeneity,
were further characterised on the basis of the patterns of proliferative responses against
merozoite fractions from different geographical isolates of B.bovis (Mexico, Texas and
Australia) and B.bigemina (Mexico) (Brown et al, 1992). In that study, at least five distinct
epitopes of B.bovis merozoite antigens were distinguished and classified according to their
differential Th cell responses. One group of four clones responded to a parasite membrane
epitope present in all B. bovis isolates, but not in B. bigemina; the remaining clones responded
to epitopes present in both parasite membrane and soluble fractions from merozoites, and
included one clone which recognised an antigenic epitope shared by all B.bovis stocks and
B.bigemina, and five clones which recognised an antigen present only in the Texan and
Mexican isolates, but not in the Australian B.bovis. These findings allowed the identification
of two Th cell epitopes on a merozoite protein (Bb-1) which appeared to be associated with
induction of protection, with further studies being directed to support its incorporation into a
recombinant vaccine (Brown et al, 1992).
2.3.2.1 The role of the spleen
In most mammalian hosts the spleen plays an important role in the development of immunity
against Babesia spp and in the suppression of infection in the chronic stage of infection
(Phillips, 1970; Mahoney, 1977). Splenectomy results in increased susceptibility and also
allows the establishment of infection in hosts that are naturally immune to infection, including
humans. In cattle with latent B.bovis infection, splenectomy rarely results in a patent relapse
parasitaemia, whereas in B.bigemina infections splenectomy usually precipitates nonfatal
parasitaemias (Carson & Phillips, 1981).
The mechanisms by which the spleen affects the infection appear to be related to three
functions: i) removal or sequestration of parasitized erythrocytes from blood as a result of
"pitting", as described for malaria parasites (Schnitzer et al, 1972), which results in reduction
of parasite numbers before the development of a specific immune response; ii)
erythrophagocytosis; and iii) production of specific antibodies, T-cells, NK cells and soluble
nonantibody mediators (Carson & Phillips, 1981; de Vos et al, 1987).
Spleen cells from immune rats transferred to susceptible rats confer protection against
B.rodhaini (Roberts, 1968). Similarly, immunity to B. microti can be transferred more
efficiently to susceptible mice with spleen cells from immune animals than with cells from
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other lymphoid organs (Allison et al, 1979). Although neither splenic microcirculation nor
mature T-cells appeared to be essential for immunity against B. microti, protection is more
rapidly established in intact than in splenectomised mice (Allison et al, 1979).
Phagocytosis of infected erythrocytes occurs in the spleen and the splenic microcirculation
appears to facilitate this function by a process of "sequestration" of infected cells from the
circulating blood (de Vos et al, 1987). It has been suggested that phagocytosis occurs after
immune complexes composed of soluble parasite antigen, antibody, complement and
immunoconglutinin have attached to infected erythrocytes (Thoongsuwan et al, 1978).
Phagocytosis of B. rodhaini infected erythrocytes and of free parasites has been demonstrated
in an in vitro model using mouse macrophages (Parrodi et al, 1991). More recently, the same
in vitro model was adapted for B.bovis infected cells in an attempt to identify the role of
protective antibodies as opsonins in B.bovis infections (Jacobson et al, 1993). The study
showed that B.bovis immune sera failed to promote phagocytosis, whereas antibodies raised
against protective fractions obtained by dextran sulphate precipitation (Goodger et al, 1990)
consistently induced phagocytosis. These findings suggested that phagocytosis induced by
opsonized particles may play an important role in the mechanism of protection. Furthermore,
NK activity increases in infected animals prior to elimination of parasites (Irvin et al, 1981).
Although it has been demonstrated that synthesis of antibodies occurs in extra-splenic sites
(Phillips, 1970), complement fixing antibodies appeared 5 to 6 days later in splenectomised
sheep than in intact animals following infection with B. ovis, suggesting that splenectomy may
reduce protective antibody production (Zwart & Brocklesby, 1979).
2.3.3 Target antigens
The definition of specific parasite antigens responsible for induction of protective immunity
has been the general approach towards the development of improved methods of
immunisation against Babesia spp. Three contrasting lines of research have been adopted to
achieve this. The first approach has focused on the identification of immunodominant parasite
surface antigens using polyclonal and monoclonal antibodies in techniques such as
immunoblotting and immunoprecipitation of radiolabeled proteins, and the subsequent
evaluation of these antigens as protective immunogens in vaccination trails (McElwain et al,
1992). The second approach has been based on indications that immunodominant antigens do
not induce a protective immune response and therefore it is necessary to evaluate the
protection conferred by parasite fractions in vaccination trials before further characterisation
37
takes place (Goodger et al, 1992b). A third approach has focused on selection of antigens
based on biological and pathophysiological parameters (Commins et al, 1985).
2.3.3.1 B.bovis antigens
Immunoprecipitation of -^S-methionine radiolabelled in vitro cultured parasites by
polyclonal sera allowed the identification of eight proteins with molecular weights from 14.5
to 200 kDa, with one of them (a 42 kDa protein) shown to be B.bovis strain-common and
species-specific (McElwain et al, 1988).
Indirect fluorescence of live B.bovis merozoites and immunoprecipitation of ^5j labelled
merozoite surface proteins by polyclonal and monoclonal antibodies resulted in identification
of four proteins with molecular weights of 37, 42, 60 and 85 kDa (Goff et al, 1988). The 37
and 42 kDa proteins were shown to be distributed over the entire surface of merozoites,
whereas the 60 kDa protein appeared to be punctate, polar and present in only about 5% of
the total viable merozoites; the exact location of the 85 kDa protein was not determined.
Later, a panel of ten monoclonal antibodies generated against five B. bovis merozoite surface
proteins (molecular weights of 16, 42, 44, 60 and 225 kDa) was used to screen a genomic
DNA library resulting in the identification of two recombinant clones that encoded a protein
recognised by a monoclonal antibody for an epitope on the native 44 kDa protein (Reduker et
al, 1989). The recombinant form of the 44 kDa protein was used to immunise cattle. Results
from the immunisation trial showed that a specific immune response was generated, however
the level of antibodies among vaccinated animals was highly variable (Reduker et al, 1989).
Further studies on immunoprecipitation of merozoite surface proteins of a cloned and
pathogenic isolate of B.bovis by polyclonal sera from protected cattle identified eight proteins
(Hines et al, 1989). Among them, a 42 kDa transmembrane protein was consistently
recognised at the highest dilution of immune sera (1: 16,000) and was identified as a potential
candidate for further studies.
A B.bovis antigen with a molecular weight of 44 kDa was also identified by
immunoadsorption with the corresponding monoclonal antibody (15B1) and was shown to
induce protective homologous immunity in splenectomised calves (Wright et al, 1983b).
Analysis of a saline eluate from sucrose washed bovine erythrocytes infected with B.bovis by
Western blotting with rabbit antiserum raised against the eluate allowed the identification of
four antigens with molecular weights of 120, 190, 280 and 380 kDa (Goodger & Wright,
1983). Immunofluorescent staining showed that the eluate contained proteins from
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membranes of non-infected erythrocytes and, in addition, proteins which were located not
only in the parasite but also in the internal matrix of infected erythrocytes.
In view of the role of esterase in the coagulation and kinin systems of the host during Babesia
infections, investigations have been directed towards determining its role in the protective
immune response (Wright et al, 1983a). Thus an esterase was isolated from a crude extract of
B.bovis by affinity chromatography and used to immunise susceptible cattle. The results from
that study showed that the vaccinated animals underwent severe reactions, after challenge
with either homologous or heterologous strains of the parasite, although a specific antibody
response was demonstrated by immunofluorescence and immunoblotting.
Protective immunity against heterologous challenge was conferred when two B.bovis
fractions, which were obtained from a lysate of infected erythrocytes by a gel filtration
procedure using Sephadex G200, were used to immunise susceptible cattle (Goodger et al,
1984). In the same study, when these fractions were analysed by Western blotting against the
corresponding antiserum, one fraction was shown to produce six reactive bands with
molecular weights between 27 and 300 kDa, whereas the second fraction produced four
bands with molecular weights of 70, 60, 44 and 27 kDa. Erythrocyte iso-antigens were also
detected by reactions of normal plasma against antigens present in both fractions, suggesting
that further fractionation was required for purification of protective parasite antigens. Further
studies carried out by Goodger and co-workers showed that the second fraction, which
contained dominant immunodiffusion antigens, failed to induce protection against B.bovis in
susceptible calves (Goodger et al, 1986).
A low molecular weight antigen (29 kDa), which was purified from a lysate of B.bovis
infected erythrocytes, was excised from acrylamide gels and used to immunise susceptible
adult cattle (Wright et al, 1985). Challenge with the homologous strain of B.bovis showed
that immunised animals were partially protected.
It has also been reported that antigenic preparations of B. bovis contain dominant components
that react in Western blotting not only with antisera to B.bovis parasites but also with sera
from naive calves recovering from an acute inflammatory reaction, indicating that some
antigens originate from the host rather than the parasite (Goodger et al, 1985a).
Two B.bovis proteinases, with molecular weights of 22 and 70 kDa, have also been identified,
and the latter was used in a vaccination trial where the immunised cattle were shown to be
protected after being challenged with the virulent strain from which the proteinases had been
isolated (Commins et al, 1985).
A heparin binding fraction of a supernatant obtained by ultracentrifugation of a lysate of
B.bovis infected erythrocytes, was used in a vaccination trial in which the immunised
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splenectomised calves were shown to be protected after challenge with the homologous strain
of the parasite (Goodger et al, 1987a). When analysed by Western blotting, this fraction was
found to contain immunodominant bands of 180 kDa, a doublet of 140 kDa, and a weak band
of 135 kDa (Goodger et al, 1987a).
Gill and co-workers used recombinant DNA techniques to produce a cDNA clone coding for
a portion of a high molecular weight antigen of B.bovis (Gill et al, 1987a). In that study, a
B.bovis cDNA library was screened with hyperimmune bovine serum and an antigen-positive
clone, which encoded a 5-10 kDa polypeptide of a 220 kDa immunodominant B.bovis native
protein localised at the apex of the parasite, was selected. Later, its recombinant form fused
to p-galactosidase was used to immunise susceptible cattle in a vaccination trial; however
protection was not observed when the immunised animals were challenged with a virulent
heterologous strain of B.bovis (Timms & Barry, 1988).
More recently, a chloroform extract from B. iovw-infected erythrocytes was used to vaccinate
susceptible cattle, which were challenged with a virulent heterologous strain, resulting in
delayed and decreased parasitaemias when compared to the control unvaccinated group of
cattle (Goodger et al, 1990). In the same study, biochemical analysis of ^C-labelled infected
erythrocytes suggested that the immune response was elicited by lipids of babesial origin
which comprised four bands of 12 to 18 kDa in Western blotting analysis.
Another lipid-enriched fraction of B. bovis was isolated from infected erythrocytes by hexane
extraction; it showed antigenic and immunogenic activity in ELISA using either bovine
antiserum to B.bovis and B.bigemina from natural infections or rabbit antiserum to the
hexane extract (Orinda et al, 1992b). Use of IFAT demonstrated that this fraction was
associated with the parasite and infected erythrocytes, and was not present in non-infected
erythrocytes; cross-reactions with B.bigemina antisera were observed, suggesting that
serological cross-reactivity in Babesia species might be due to lipid or lipid-associated
antigens.
A multifractionation procedure for B.bovis infected erythrocytes, involving selective lysis,
sonication, ultracentrifugation, gel filtration and preparative agarose gel electrophoresis,
resulted in the selection of a fraction, designated "P", which elicited protection of susceptible
cattle after challenge with a heterologous strain of the parasite (Goodger et al, 1985b). From
several monoclonal antibodies produced against this fraction, one designated W11C5 was
selected and used to extract by affinity chromatography the corresponding antigen from
B.bovis infected erythrocytes. The W11C5 monoclonal antibody was shown to react against
infected erythrocytes by IFAT and to give a large number of closely positioned reactive bands
in Western blots (Goodger et al, 1992b). The extracted antigen was then used in a vaccination
trial to test its efficacy in protecting splenectomised calves against homologous challenge; the
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vaccinated group showed significantly lower parasitacmias in comparison to the control
group (Goodger et al, 1992b). These authors suggested that the production of the B.bovis
W11C5 antigen by the use of recombinant DNA techniques would allow the evaluation of its
suitability as a commercial vaccine against B.bovis infections.
The use of antigens produced by recombinant DNA technology in vaccination against
B.bovis has recently been reviewed by Gale and co-workers, who reported that a recombinant
W11C5 fusion protein has been produced and its gene has been sequenced (Gale et al, 1992).
They also reported that the recombinant W11C5 protein induced protection in susceptible
cattle in a vaccination trial in which a heterologous strain of B.bovis was used for challenge.
In that trial the vaccinated animals developed significantly lower parasitaemias and exhibited
increased survival rates when compared to the control group.
Another antigen (12D3), which had originally been isolated from a protamine sulphate
precipitated fraction (Wright et al, 1983a), has also been targeted as a protective antigen, and
its recombinant form induced significant reduction in parasitaemia in immunised animals
upon B.bovis challenge (Gale et al, 1992). DNA hybridisation studies have revealed that the
12D3 gene is conserved in a range of different species of Babesia, with homologues of the
gene being detected in B.bigemina, B.canis, B.bovis and B.divergens. Gale and co-workers
also reported that, in a field immunisation trial, an antigen 'cocktail' of W11C5 and 12D3
induced protection in 90% of the animals, and that a third recombinant antigen (designated
T21B4), which was originally identified as a protease protective antigen (Commins et al,
1985), has been included in an attempt to further improve vaccine efficacy (Gale et al, 1992).
It was also reported that vaccination trials are currently under way to test the efficacy of the
trivalent vaccine under a range of field challenge conditions.
2.3.3.2 B.bigemina antigens
The general approach towards identification of B.bigemina antigens has been through the use
of monoclonal antibodies developed against merozoites to screen for surface reactivity.
Immunoprecipitation of -^S methionine-labelled parasite proteins by monoclonal antibodies
identified five merozoite proteins with molecular weights of 72, 58, 55, and 45 kDa
(McElwain et al, 1987).
In another report, surface reactive monoclonal antibodies identified parasite components with
molecular weights ranging from 68 to 36 kDa, including the same 58 kDa identified by
McElwain and co-workers (1987), which were conserved in at least six geographically
different B.bigemina isolates (Figueroa et al, 1990b).
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In vitro radiolabelling and immunoprecipitation studies indicate that post-translational
modification of B.bigemina proteins is common, and that at least ten parasite proteins are
post-translationally modified by incorporation of glucosamine, whereas seven are modified by
incorporation of myristic acid (McElwain et al, 1991). The p58 protein was not modified by
the incorporation of either glucosamine or myristic acid and appeared to be conserved among
B.bigemina isolates from Mexico, Puerto Rico, St. Croix and Kenya. Furthermore, it was
interpreted that calves immunised with each of three immunoaffinity purified proteins (gp45,
gp55 and p58) were able to neutralize the infectivity of merozoites as indicated by reductions
in the peak parasitaemia after challenge (McElwain et al, 1991).
Two additional monoclonal antibodies have been identified that bind to the membrane of
infected erythrocytes in acetone-fixed but not unfixed antigens in IFAT; these monoclonals
immnunoprecipitate a ^ ^ S-methioninc-label led polypeptide of > 200 kDa (McElwain et al,
1992).
Subsequently, the gene encoding the protein p58 was cloned, expressed, sequenced and
characterised (Mishra et al, 1991), and the current approach has been evaluation of the p58
protein, alone or in combination with the high molecular weight membrane protein (> 200
kDa), as an immunogen in vaccination trials, definition of the polypeptides present on the
infected erythrocyte surface, and evaluation of the efficacy of expression vectors for
presentation of antigens (McElwain et al, 1992).
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2.4 Bovine babesiosis in Brazil: current situation
Brazil, officially the Federative Republic of Brazil, with a human population of 151,381,000
(1992 estimation, Encyclopaedia Britannica, 1993) is located in South America, bordered by
Venezuela, Guyana, Surinam, and French Guyana to the north; Colombia, Peru, and Bolivia
to the west; Paraguay, Argentina, and Uruguay to the south west; and the Atlantic Ocean to
the east (see Fig 2.3). It is a federation of 23 states, three territories, and the federal district of
Brasilia. The capital is Brasilia, and principal cities include Sao Paulo, Rio de Janeiro,
Recife, Belo Horizonte, and Salvador. The largest South American country (3,286,470 sq.
miles), Brazil occupies nearly half of the continent and has a varied topography and climate,
ranging from tropical in the rain forests of the great Amazon basin in the north to temperate
in the highlands of the comparatively heavily populated east and south, which make up two
thirds of the country's land mass and contain its chief economic centres. Despite rapid
industrialisation beginning in the 1960s, Brazil still depends heavily on agriculture, which
accounts for nearly 50% of its exports. It is an important cattle producer; major commercial
crops are coffee (of which it is the world's leading producer), cocoa, cotton, sugarcane, citrus
fruit, maize, tobacco, bananas, and soybeans. Industrial production is led by motor vehicles,
steel, cotton textiles, paper, fertiliser, cement, and machinery. The country's vast mineral
wealth includes some of the finest iron resources in the world, as well as quartz, coal,
manganese, chromium, industrial diamonds, uranium, and platinum. Petroleum deposits have
not been fully developed; petroleum accounts for 26% of imports. Portuguese is the official
language and Roman Catholicism the predominant religion (Columbia Encyclopaedia, 1992).
The cattle population of Brazil is around 140 million animals, 50% of which are dairy cattle,
and the problem of tick infestation and tick-borne diseases assumes tremendous economic
proportions, in terms of lost animal protein and export earnings for Brazil.
According to Rouse (1977), cited by Primo (1992), cattle were brought to the Caribbean in
1493 by the Spanish colonisers and within 40 years the descendants of these animals had
been spread throughout the South American countries, mainly by way of Peru, Bolivia, Chile
and Paraguay. In Brazil cattle were first introduced in 1534, through Sao Paulo, Pemambuco
and Bahia; some of the animals possibly originated from the Cape Verde Islands, a
Portuguese colony in the Atlantic Ocean (Primo, 1992). Systematic importations of zebu
cattle from India began at the end of the 19th century and continued until 1930, with one
further importation in 1952. The first large scale importation of zebu cattle happened in 1906
and included Hissar, Malvi, Mewati and Mysore breeds. Between 1918 and 1921 larger
importations took place and up to 1952 over 5,800 zebu cattle had been imported, almost all
from India (Maule, 1990).
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Fig 2.3 Map of South America (A) and Brazil (B).
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Fig 2.3
The three breeds which have contributed most to the Brazilian cattle industry are Guzera,
Nelore and Gir, which gradually became adapted to Brazilian conditions.
Nowadays, Nelore is the most numerous zebu breed used for intensive beef production in the
upland states of Sao Paulo, Minas Gerais and in central Brazilian regions, while Gir cattle
have been developed more for milk production.
With the aim of improving milk production, importation of European breed (Bos taurus)
began in the 1960s in many countries of South America. These were mainly from the United
States and consisted of Holstein-Friesian and Brown Swiss, which were either maintained as
pure breeds or crossed with zebu cattle. Large numbers of animals of European breed were
imported over the past few decades and this policy is still adopted by some farmers
nowadays. However, with the introduction of Bos taurus breeds, tick infestation became one
of the most serious problems for the Brazilian cattle industry.
The main species of tick infesting cattle, Boophilus microplus, was probably introduced into
Brazil through cattle imported from Chile which entered the State of Rio Grande do Sul in the
17th century (Thiesen, 1979). Nowadays this tick is distributed all over Brazil causing
substantial economic losses; in the State of Rio Grande do Sul for instance, it was estimated
in 1974 that total losses of 30 kg per animal up to slaughtering age were due to tick
infestations (Vidor, 1975, cited by Beck, 1979).
A survey carried out by the Brazilian government in 1982 showed that commercial sales of
drugs against ectoparasites totalled around 45.8 million US dollars, representing 17.2% of all
the products marketed for veterinary use (Brazilian Agriculture Ministry, 1983).
Tick-borne diseases of cattle, mainly babesiosis and anaplasmosis, are endemic, causing
mortality and disease in livestock and therefore acting as a barrier to the improvement of
production and productivity of the herds as well as causing significant economic losses.
In order to increase productivity, most Brazilian farmers have introduced, over the past few
decades, Bos indicus x Bos taurus cattle into their herds. However it has been reported that in
Brazil, as in other tropical countries, tick infestation levels increase as the proportion of Bos
taurus "blood" increases (Gomes et al, 1989; Oliveira & Alencar, 1990). Furthermore, the
use of improved pastures has increased, allowing a higher number of animals to be mantained
per unit area . As a result, the natural equilibrium of the cattle-tick system is affected.
Therefore, management practices relating to tick and tick-borne disease control have became
increasingly important, resulting in substantial increases in costs of production.
Several studies on the tick B. microplus have been carried out in Brazil since the pioneer work
initiated with the foundation of the Oswaldo Cruz Institute, Rio de Janeiro, in 1900; these
include studies on the systematic classification (Aragao, 1911; 1917; 1936; Aragao &
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Fonseca, 1961) and on resistance of ticks to acaricides (Freitas, 1950; Queiroz & Mello,
1960). However, in the late 1970s, as a result of development of tick resistance to
organophosphate acaricides, research on B. microplus was directed towards understanding the
bio-ecological aspects which affect the interrelationship between cattle and ticks with the aim
of proposing strategic programmes to control B. microplus ticks (Arteche & Laranja, 1979;
Evans, 1979; Souza & Gonzales, 1980; Magalhaes & Lima, 1991).
The duration of each stage of the life cycle of the one host tick B. microplus is particularly
affected by climatic conditions (temperature and humidity). Under optimum climatic
conditions, B.microplus shows the following life cycle in Brazil (Arteche, 1975, cited by
Beck, 1979; Gonzales et al, 1975):
Minimum Maximum
Stage of the tick life cycle duration duration
(days) (days)
a) Non-parasitic stage:
1. from detached engorged
female to initiation of
oviposition 2 23
2. oviposition 14 44
3. pre-eclosion 14 202




from attached larva to
engorged female Ji M
total 54 501
A study on the effect of climatic conditions on B.microplus infestation of 1-2 year old
'Mantiqueira' type heifers which had been dipped with acaricide 35 days before the tick
counting, was carried out in a district of Sao Paulo State and resulted in average counts of
22, 74, 93 and 10 semi-engorged females per animal, in spring, summer, autumn and winter,
respectively (Guaragna et al, 1988).
A more comprehensive study was carried out in a district (Pedro Leopoldo) of Minas Gerais
State, in which several climatic parameters were analysed in relation to the development of
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the B.microplus life cycle under field conditions, throughout a four-year period between
November 1983 and November 1987 (Magalhaes, 1989). Pedro Leopoldo is located at 882 m
altitude, and has a dry winter with an average temperature of 16°C, and a rainy summer with
an average temperature of 25°C (Antunes, 1986). For a study of the non-parasitic stage of
the ticks, engorged females were distributed on a defined area of pasture at 14-day intervals,
and the egg incubation period and survival of larvae were registered. To study the parasitic
stages, tick-free cattle were introduced into naturally infested pastures and the number of
semi-engorged female ticks on each animal was counted at 14-day intervals. The results
obtained from that study led to the following conclusions:
- B. microplus larvae are found on the pastures throughout the year
- the longest incubation period of eggs and longest survival of larvae are observed in the
progeny from females which drop on the pasture between April and July, and March and
June, respectively; whereas the shortest incubation period of eggs and survival of larvae are
observed in the progeny from females dropping on pastures between September and March,
and October and December, respectively
- the maximum duration of the non-parasitic stage of the tick life cycle is observed in progeny
from engorged females dropping on pastures in April, May and June; whereas the minimum
duration is observed in progeny from engorged females dropping on the pasture in October,
November and December
- the maximum duration of the non-parasitic stage of the tick life cycle is 6.3 months and
occurs in May; whereas the minimum duration is 3.8 months and occurs in November
-all the non-parasitic stages of the life cycle are affected by climatic conditions, particularly
temperature; the duration of these stages is increased during the winter and decreased during
the summer
- infestations with B.microplus are detected throughout the year, with the highest rates
occurring between February and July
- the natural detachment of engorged females occurs more frequently in the afternoon and
starts on day 20 after infestation, peaking on day 22
- under natural field conditions, four generations of ticks occur per year, and the number of
ticks completing each generation is affected by climatic factors
- the time of the year most appropriate for the initiation of a control programme is during the
first tick generation which occurs in November.
In a recent report by Honer and Gomes (1992), the potential number of generations of
B.microplus ticks per year was estimated for different parts of Brazil. This was achieved by
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adapting field observations to the Climex programme. The resultant mapping indicated that in
the south of the country the conditions are appropriate for the development of up to three
generations per year, except in the extreme south (Santa Vitoria do Palmar), where ticks can
survive experimentally but are not normally found in the field. The central, southeast and
west regions have appropriate conditions for the development of up to four tick generations
per year.
The conventional and most widely used method of tick control is based on acaricide dipping
according to the intensity of engorged female B.microplus infestations. In general at least 9 to
10 dippings are required during the year. Recently Magalhaes & Lima (1991) reported a very
efficient strategic tick control regime for one farm in the State of Minas Gerais, in which the
animals were only dipped during the rainy season (October - March) using pyrethroids on six
occasions at 21 day intervals. This regime reduced tick infestation to an average of 0,29
engorged females per animal over a period of 1 year. However, such low rates of tick
infestation mean that transmission rates of Babesia spp may fall below those required to
maintain enzootic stability (Mahoney, 1977).
Tick and tick-borne disease control methods need to be considered very carefully in order to
keep tick infestation rates high enough to maintain enzootic stability and minimise the risk of
disease outbreaks, while minimising the direct damaging effects of ticks.
Despite the fact that, in some endemic situations, age resistance means that most calves
become infected and develop immunity without disease, it appears that on Brazilian farms
calves are the most likely group to suffer from clinical disease and death particularly from B.
bovis and A. marginale.
The babesias were first diagnosed in Brazil by Fajardo (1901), in blood smears taken from
imported cattle. This was followed by reports in 1908 by Dr Carini, and in 1913 by Drs
Dupont, Miranda and Horta (all cited by Fonseca & Braga, 1923). In 1914 Drs Horta and
Miranda presented a report about American babesias, during the 10th International Congress
of Veterinary Medicine in London. In 1917, Dr Dupont described a visceral form of
babesiosis responsable for high mortality rates in calves born in Brazil (cited by Fonseca &
Braga, 1923).
In a book published in 1923, Fonseca and Braga covered the various aspects involved in the
bovine babesiosis in Brazil, such as its transmission, clinical symptoms, pathogenesis,
diagnosis and prophylaxis. At that time, they had already classified the disease into two forms
according to the agent involved. The so-called Piroplasma bigeminum, which exhibited high
polymorphism, was responsible for a 'peripheral' form of disease, characterised by easily
detectable parasites in the peripheral blood, depression, constant fever, haemoglobinuria,
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tachycardia, for which treatment with Trypan Blue was effective. Piroplasma argentinum,
which was two or three times smaller than P.bigemimim, had a preference for parasitising red
blood cells of internal organs, particularly the kidneys, and was responsible for a 'visceral'
form of disease in which the parasites were rarely detected in blood smears. When
haemoglobinuria was present it occurred at a late stage of the disease and indicated an
unfavourable prognosis. Treatment with Trypan Blue was not effective against this visceral
form of babesiosis (Fonseca & Braga, 1923). These authors also reported both successes and
failures in a series of immunisations of imported cattle using inoculation of blood from
indigenous donors. In order to minimise the loss of animals due to severe clinical disease, they
proposed that the blood for inoculation should be 'attenuated' for 24 hours on ice.
The State of Minas Gerais has the largest cattle population in Brazil, with approximately 20
million animals. In a survey carried out in 30 farms in a district of Minas Gerais State, tick-
borne diseases were cited as the second most frequent disease of calves, after diarrhoea
(Leite, 1982). In blood smears from 113 calves selected randomly in those farms,
A.marginale was found in 85% and B.bigemina in 36%.
Despite the economic importance of tick-borne diseases, few serological surveys have been
carried out in Brazil. Those which have been done used the IFAT. Variable figures for
seroprevalence have been reported. In a serological survey using 315 samples from adult
cattle (> 2 years old), carried out in a region of Minas Gerais State (Zona da Mata) which
produces about 1,600,000 litres of milk per day, variable prevalence rates were found for
each micro-region sampled. The figures of seropositivity obtained for B.bovis varied from
59.5 to 88.9%, whereas for B.bigemina variation between 61.7 and 97.9% was observed
(Patarroyo-Salcedo et al, 1987).
In another serological survey carried out with samples from Zebu cattle raised in the 'cerrado'
region (State of Mato Grosso do Sul), in which a total of 667 serum samples from 3-10 year
old cows were analysed by IFAT for detection of antibodies against B.bovis and B.bigemina,
average prevalence rates of 19.0 and 12.9% were reported for B.bovis and B.bigemina
respectively. Those figures are considerably lower than in the Minas Gerais survey,
suggesting endemic instability (Madruga et al, 1983).
However the epidemiological value of the results from both studies is very limited since those
surveys tested serum samples from adult animals and no information was collected regarding
animal husbandry, breed, management, tick control, incidence of disease, mortality, etc. Also
it is well recognised that cross-reactivity between B.bovis and B.bigemina is a severe
limitation of the particular serological test used. The two infections appear to be distributed
throughout the country, and there are suggestions that B.bovis infections are more severe than
B.bigemina causing higher mortality in calves. However, more comprehensive
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epidemiological studies are needed to determine the real situation of the two infections and
their effect on cattle production. Based on these, appropriate and specific methods of control
could be proposed for each situation.
Therefore reliable, specific and sensitive tests are needed which are able to discriminate
between antibody responses to the different parasites involved, to determine the reality of the
epidemiological situation. Despite the fact that little is known about the epidemiology of
bovine babesiosis in Brazil, attempts to develop a Brazilian live attenuated vaccine were
started in 1987 in a governmental research institute (EMBRAPA - CNPGC), by Kessler and
co-workers, who isolated pure field strains of each parasite by tick infestation of
splenectomised calves (Kessler et al, 1987a). The B.bovis strain was then rapidly passaged
through 16 splenectomised calves, and the B.bigemina strain was slowly passaged through
intact calves, with the aim of producing attenuation (Kessler et al, 1987b). A preliminary test
of the pathogenicity and immunogenicity of these potentially attenuated strains showed that
the B.bovis strain was of very low virulence, since no clinical disease was observed after
vaccination. However the B.bigemina strain appeared to remain virulent, since three out of
five calves showed clinical disease after immunisation (Kessler et al, 1987b). The test also
showed that the two strains were highly immunogenic and protected the animals against
challenge with the corresponding virulent homologous strain. However, these attenuated
vaccines are not yet available on the Brazilian market.
The only commercial vaccine against bovine babesiosis available in Brazil is a chilled live
vaccine produced in the State of Rio Grande do Sul by a private laboratory (Hemopar), which
uses attenuated strains of both parasites from Uruguay (C.Arteche, personal communication).
However, the vaccine production is only enough to satisfy the local demand, with farmers in




GENERAL MATERIALS AND METHODS
3. l Origin/source of Babesia parasites
Three stocks of B.bovis were used throughout the study: i) Mexico, a Mexican isolate (Smith
et al, 1978; Erp et al, 1978) and ii) Kwanyanga, a South African isolate (Taylor & McHardy,
1979), both kindly donated to CTVM by Dr N. McHardy of Wellcome Research
Laboratories, Beckenham, England, in 1982 and 1983 respectively, and iii) Lismore, an
Australian isolate (Kahl et al, 1982b), kindly donated to CTVM by Dr S. Taylor, Stormont,
Northern Ireland, in 1987. All three stocks were maintained at CTVM as blood or culture
stabilates and had been cultured in vitro on several occasions (Conrad, 1983; L. Bell-Sakyi,
personal communication).
Three stocks of B.bigemina were used throughout the study: i) Zaria, a Nigerian isolate,
kindly donated to CTVM by Professor Uilenberg, University of Utrecht, Netherlands, in
1986; ii) Muguga, a Kenyan isolate, kindly donated to CTVM by Dr S. Williamson, National
Veterinary Research Centre, Kenya Agricultural Research Institute, Muguga, Kenya, in 1990
and iii) Mexico, a Mexican isolate (Vega et al, 1985a) kindly provided as a growing culture
by Professor E. Canning, Imperial College, London, in 1992. The Muguga and Zaria stocks
were maintained at CTVM as blood stabilates while the Mexican stock had been cultured
continuously in vitro and was maintained as culture stabilates.
3.2 In vivo infections
A series of 12 calves, some of which were splenectomised, were infected with either B.bovis
or B.bigemina and challenged one or more times, with a minimum period of 3 weeks between
inoculations, with a Babesia stock using in vitro cultured material, blood stabilates or, on one
occasion, infected ticks (see Table 3.1 and Appendix 7).
Calves to be splenectomised were anaesthetised using 3 mg/kg of alphaxolane/alphadolone
acetate (Saffan, Pitman-Moore), intubated and maintained with 1.5-2.0% halothane gas
anaesthetic (Fluothane, Imperial Chemical Industries). An approximately 20 cm long skin
incision was made on the left side, 2 cm caudal and parallel to the 13th rib. The external
abdominal oblique, internal abdominal oblique, transverse abdominus and peritoneum were
incised and the spleen exteriorized. The splenic artery and vein were ligated using No 1
chromic cat gut, the vessels were then severed and the spleen removed. The peritoneum and
abdominal musculature were sutured using No 1 cat gut in a continuous suture. The skin was
closed using No 2 nylon.
3.2.1 Splenectomy





Challenge 1 Challenge 2 Challenge 3























day 80 (BS +
CS)




Cll b * BS B.bovis
(Kwanyanga)


























U44 b * BS B.bigemina
(Zaria)
7Tb * BS B.bigemina
(Zaria)





a intact BS blood stabilate
b splenectomised CS culture stabilate
* infected in previous experiments at CTVM FB fresh blood




When blood or culture stabilates were used as inoculum, 2 x 1 ml cryopreserved vials (see
section 3.3.3) were thawed completely in a 37° C water bath and the contents of one vial was
immediately inoculated intravenously and the other subcutaneously.
When cultured infected erythrocytes were used as inoculum, 12 to 15 ml of culture
suspension, containing approximately 1.5 x 10^ RBC/ml with an average parasitaemia of
5%, was centrifuged at 1,500 x g for 15 minutes at 4°C and the pelleted red blood cells
(RBC) were washed by centrifugation with phosphate buffered saline (PBS) pH 7.2
(Appendix 1). The final pellet was resuspended in 3 volumes of PBS and half of the
suspension was inoculated subcutaneously and the other half was inoculated intravenously.
Only one of the calves (calf 634) was infected by infestation with approximately 5,000 larval
Boophilus decoloratus ticks, infected with B.bigemina (Muguga). The infected larvae were
enclosed in cloth patches glued to both sides of the calfs neck, and allowed to feed until
detachment of engorged females (21-23 days) (L Bell-Sakyi, personal communication). The
remaining feeding ticks were destroyed by spraying the calf with amitraz (Taktic, Cameo).
3.2.3 Monitoring of infection
Rectal temperature was taken daily and jugular blood was collected at least three times a
week in a 5 ml vacutainer tube with disodium edetate (Becton Dickinson) for haematological
analysis. The packed cell volume (PCV) was estimated by the microhaematocrit method
(Schalm et al, 1975), and white blood cells (WBC) and RBC were counted using an
electronic particle counter (model ZM, Coulter Electronics). For assessment of parasitaemia,
thin films were prepared from both jugular blood and peripheral capillary blood taken from
the tail tip. The smears were air dried, fixed with methanol for 2 minutes and stained in a
5%(v/v) dilution of Giemsa stock solution in Giemsa buffer, pH 7.2 (Appendix 1) for 40
minutes. The smears were then rinsed with buffer, air dried and examined under oil
immersion at x 500 or x 1000 magnification using a light microscope (Leitz Wetzlar). At
least one thousand RBC were counted in each smear and the parasitaemia (percentage
infected RBC) was calculated. Results from infection monitoring are presented in Appendix
7.
Serum samples were collected on day 0 and at two week intervals for a maximum period of
16 weeks. Blood was collected into sterile plain vacutainer tubes (Becton Dickinson) and
allowed to clot at 37° C overnight. The sera were centrifuged at 2,500 x g for 30 minutes at
4° C and stored at -20° C until required.
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3.3 IN vitro culture techniques
3.3.1 Initiation of B.bovis cultures
When the parasitemia in blood smears from infected calves had reached 0.1%, cultures were
initiated following minor modifications (L Bell-Sakyi, personal communication) of standard
techniques (Levy & Ristic, 1980; Vega et al, 1985a). Approximately 40 ml of blood were
collected aseptically by jugular puncture, defibrinated by shaking with glass beads and
centrifuged at 1,000 x g for 10 minutes at 15° C. The plasma, buffy coat and the upper 20%
RBC were discarded. The remaining RBC were used to prepare a 10% v/v suspension in
complete medium Ml99 (see Table 3.2), supplemented with additional 2 mM L-glutamine.
Culture vessels were inoculated to give a depth of 6-8 mm (i.e. 0.2 ml per well of a 96 well
flat bottomed microtitre plate (Nunc); 1.25 ml in a 2 cm^ well of a 24-well plate (Costar); 5
ml in a 25 cm^ flask (Nunclon) incubated vertically; 12-15 ml in a 25 cm^ flask incubated
horizontally and 40 ml in a 75 cm^ flask (Costar) incubated horizontally). Culture vessels
were incubated at 37° C under an atmosphere of 5% CO2 in air. In each experiment, cultures
were incubated under the same conditions unless otherwise specified.
3.3.2 Maintenance of cultures
Culture medium was changed daily by carefully removing between one half and four-fifths of
the overlying medium without disturbing the RBC layer, and replacing an equal volume of
fresh medium.
Subcultures were carried out every 2-3 days by removing approximately four-fifths of the
culture suspension and replacing the volume removed with fresh uninfected 10% RBC
suspension.
Three adult cows were used as donors of uninfected RBC and serum: Limousine/Jersey
crossbreeds No 16 (five-year-old) and No 110 (six-year-old), and Split Ear, a one year-old
pure-bred Jersey, maintained at CTVM.
For uninfected RBC suspension preparation, blood from donor animals was collected by
jugular puncture, defibrinated by shaking with glass beads and centrifuged at 1,000 x g for
10 minutes at 15° C. The plasma, buffy coat and the upper 20% RBC were discarded. The
remaining RBC were used to prepare a 10% v/v suspension as previously described in 3.3.1.
RBC suspension was stored at 4° C for up to 1 week after collection.
For serum production, blood was collected into plain sterile vacutainer tubes (Becton
Dickinson) and allowed to clot at 37 0 C overnight. The sera were separated from clotted
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blood by centrifugation at 2,500 x g for 30 minutes at 4° C and stored at 4° C for up to 1
week after collection.
Cultures of B.bigemina (Mexico) (Vega et al, 1985a), obtained as a growing culture
suspension from Imperial College, were maintained under the same conditions used for
B.bovis cultures, except that the culture medium was modified (see Table 3.2).
3.3.3 Assessment
Parasitaemia in cultures was estimated by preparing thin smears from representative samples
taken from individual cultures after mixing the RBC suspension following medium changes.
Parasite morphology was assessed from examination of Giemsa stained cytocentrifuge
smears. Smears were made by centrifuging an aliquot of approximately 30 pi of culture
suspension per well of a cytocentrifuge (Cytospin, Shandon Southern Instruments) onto
microscope slides at 1,000 x RPM for 5 minutes. The smears were fixed, stained and
examined as described in section 3.2.3.
3.3.4 Cryopreservation
Cultures, with an average parasitaemia of 5%, were centrifuged at 1500 x g for 10 min at 4°
C and the resultant RBC pellet was resuspended in 1 ml of ice-cold medium M199-H
(B.bovis) or M199-IC (B.bigemina) (as described in Table 3.2), for every 10 ml of original
culture suspension. An equal volume of an ice-cold 10% (v/v) solution of dimethyl sulphoxide
(DMSO, Analar, BDH) in culture medium was added dropwise with agitation to give a final
concentration of 5% DMSO. The cell suspension was then divided between 1 ml cryotubes
(Nunc) pre-cooled to -20°C and transferred immediately to the gas phase of a liquid nitrogen
refrigerator.
3.3.5 Resuscitation
A vial was removed from the liquid nitrogen refrigerator and immediately immersed in a 37°
C water bath until the contents had thawed completely. The contents were immediately mixed
with 15 ml of warm (37° C) M199 and centrifuged at 2500 x g for 10 min at 15° C. The
supernatant was discarded, the pellet resuspended in 1 to 5 ml of a 10% uninfected RBC
suspension (see section 3.3.1) and the resulting suspension used to inoculate culture vessels.
Cultures were incubated at 37° C under a reduced C>2 atmosphere of 4% O2, 5% CO2, 91%
N2 for the first few days after resuscitation. As soon as the parasites showed good
multiplication rates they were changed to an atmosphere of 5% CO2 in air.
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Table 3.2 - Culture Media
Medium Composition Use
complete M199-H Ml99 !, 40%NBS standard B.bovis culture
complete M199-IC M199 2, 40% NBS standard B.bigemina culture
RPMI-1640-ML RPMI-1640-^,without
methionine, 5% NBS
metabolic labelling of B.bovis
and B.bigemina
M199-HS M199 1,5%NBS harvesting of B.bovis culture
supernatant
M199-ICS M199 2 5% NBS harvesting of B.bigemina
culture supernatant
1 with Hanks balanced salt solution and 25 mM HEPES (Gibco Cat. No 041-02350H)
2 with Hanks balanced salt solution (Gibco Cat. No 041-01151H) to which 15 mM HEPES was
added
3 selectamine kit (Gibco)
NBS - normal bovine serum
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3.4 Sera and monoclonal antibodies
3.4.1 Experimental sera
Bovine sera raised experimentally against each parasite stock were used for immunological
studies. Serum samples were collected on day 0 and at specific times after primary infection
and challenge of the calves described in section 3.2 and were stored at -20° C until required.
Serum samples from calves P78, 198, P49, Cll, U44, 7T and 8T had been produced during
previous experiments carried out at CTVM and were stored at -20°C in a bank of serum
samples in the Protozoology Section.
3.4.2 Field sera
Serum samples from Brazil, kindly provided by Dr R. H. Kessler (Empresa Brasileira de
Pesquisa Agropecuaria - EMBRAPA - Centro Nacional de Pesquisa de Gado de Corte,
Brazil), were collected at a farm located in Campo Grande, Mato Grosso do Sul.
Serum samples from Mozambique, kindly provided by Mr L. Neves, Universidade Eduardo
Mondlane, Maputo, Mozambique, were collected from Xai-Xai, Chokwe and Chiango, in the
southern part of Mozambique.
Serum samples from Malawi, kindly provided by Mr M. Edelsten, Livestock Disease
Evaluation Project, Central Veterinary Laboratory, Lilongwe, Malawi, were collected from
an area within 30 km of Lilongwe.
All field serum samples were collected from cattle that had presumably been exposed to tick-
induced field infections with the respective stocks of B.bovis, B.bigemina and Anaplasma
marginale native to each country. Cattle from Malawi and Mozambique may also have been
exposed to field infections of Theileria sp and Cowdria ruminantium.
3.4.3 Monoclonal antibodies
A panel of 11 monoclonal antibodies (McAb) raised against the Kwanyanga stock of B. bovis
was kindly provided as ascites by Dr S. Crowe, Wellcome Biotechnology, Beckenham, Kent.
These were used in the immunochemical characterisation of stocks of B.bovis (described in
Chapters 6 and 7).
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3.5 Indirect fluorescent antibody test (IFAT)
For antigen slide preparation, Babesia culture suspensions were centrifuged at 1,000 x g for
10 minutes at 4° C. The supernatants were discarded and erythrocytes washed twice with
PBS by centrifugation. The volume of packed erythrocytes was estimated and approximately
2 volumes of a freshly prepared solution of 1% (w/v) bovine plasma albumin (BPA, fraction
V, Sigma) in PBS was added. After gentle mixing the RBC suspensions were kept on ice and
used to prepare antigen smears on glass microscope slides. Antigen smears were air dried,
fixed in acetone for 15 minutes, air dried again and finally wrapped in tissue paper. The
wrapped antigen slides were stored at -20° C in polythene bags containing silica gel for
periods up to 1 year.
When required, the slides were allowed to thaw out in polythene bags with silica gel for 30
minutes at 4° C and a further 30 minutes at room temperature. Three rows of six test wells
each were then drawn on each slide with a diamond pencil making 18 wells per slide. Antigen
slides were washed three times in PBS, drained and allow to dry before use.
Starting from a 1 in 40 dilution, five four-fold dilutions of each polyclonal serum in PBS
were applied to test wells and the slides were incubated for 30 minutes at room temperature in
humid chambers. In the case of each McAb only two dilutions, 1 in 10 and 1 in 100, were
tested. Each slide included three control wells, one each of positive serum, negative serum and
PBS. After the slides had been washed three times in PBS, the appropriate anti-species
fluorescein isothiocyanate labelled conjugate (FITC) (Sigma) was applied to each well, at the
manufacturer's recommended dilution in PBS, and the slides incubated for a further period of
30 minutes. The slides were then washed in PBS as before, air-dried, mounted (see Appendix
1), covered with a 22 x 64 mm coverslip and examined using a x 54 oil immersion objective
on a microscope equipped for incident excitation of FITC (Leitz-Orthoplan, Wetzlar).
3.6 Sodium dodecylsulphate-polyacrylamide gel electrophoresis
(SDS-PAGE)
3.6.1 Preparation of samples
3.6.1.1 B.bovis
Each stock of B. bovis and a negative control of uninfected RBC suspension were cultured in
vitro (section 3.3). Approximately 400 ml of each culture (10% v/v RBC suspension) were
centrifuged at 1,600 x g at 4°C for 15 minutes. The pelleted cells were washed twice by
centrifugation with PBS as described above and the packed RBC were resuspended in 2
volumes of PBS and passed through 50 cm x 4 cm glass columns containing CF-11 cellulose
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powder (Whatman) at a proportion of 1.25 g per ml of packed RBC to remove WBC
(Melrose & Brown, 1979). The columns were eluted with 200 ml PBS and fractions of
approximately 100 ml were collected. Ten pi of each fraction were applied to a plain
microscope slide, mixed with 10 pi of aO.01% (w/v) acridine orange solution in Mcllvane's
buffer (Appendix 1) and covered with a 22 x 22 mm coverslip. Slides were examined on a
microscope equipped for incident excitation of acridine orange to check for the absence of
WBC. The acridine orange stains the DNA of WBC green. WBC-depleted RBC suspensions
were then centrifuged as described above, the supernatants discarded and the volume of
packed RBC measured. Hypotonic lysis of uninfected RBC was achieved according to a
modification of the method of Kahl et al (1982a). Twenty five volumes of 0.5%(w/v) KC1 (at
4°C) were added to the packed RBC and immediately mixed thoroughly. Suspensions were
agitated briefly every 30 seconds until completion of lysis (generally 5 minutes), indicated by
the changing of colour from bright to dark red. A calculated volume (the volume of packed
RBC multiplied by the constant 1.57) of 10.9% (w/v) KC1 was added to return the solution
to normal bovine RBC isotonicity. Suspensions were then centrifuged as previously
described and pelleted infected RBC (iRBC) were washed twice by centrifugation with PBS.
The supernatants were discarded and the remaining packed iRBC were lysed by exposure to 5
volumes of 0.9%(w/v) NH4CI for 30 minutes at 4°C. The resulting free parasites and RBC
membranes were washed with 50 ml of PBS and centrifuged as previously described. The
final pellet was frozen as 200 pi aliquots until required.
3.6.1.2 B.bigemina
B. bigemina (Mexico) samples for electrophoresis were prepared by using concentrated iRBC
obtained by continuous Percoll density gradient centrifugation as described in Chapter 5. The
concentrated iRBC were washed three times with PBS by centrifugation (1,600 x g for 10
minutes at 4° C) in order to remove the Percoll solution. The final pellet was frozen as 200 pi
aliquots at -80° C until required.
3.6.2 SDS-PAGE
Separation of proteins according to their molecular weight was performed by vertical SDS-
PAGE under reducing conditions using the Laemmli buffer system (Appendix 1) (Laemmli,
1970) on either 7-20% gradient gels or homogeneous 10% gels.
Gels were prepared in vertical glass plates (160 mm x 180 mm) separated with 1.5 mm
plastic spacers. Each gradient gel was cast using a gradient mixer containing 20 ml of each
acrylamide solution (Appendix 1) and homogeneous gels were prepared with 40 ml of a 10%
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gel solution. Resolving gel solutions of 7%, 10% and 20% and stacking gel solutions of 4.5%
acrylamide (Appendix 1) were prepared and stored as 20 ml and 10 ml aliquots respectively
at -20°C. As required, one aliquot of each appropriate resolving gel solution and one aliquot
of stacking gel solution were thawed in a water bath at 37°C. To each 20 ml of resolving gel
solution, 26 pi of freshly prepared 10% (w/v) ammonium persulphate solution and 6 pi of
TEMED (BDH) were added and the gels were allowed to polymerise at room temperature for
approximately 2 hours. After polymerisation of the resolving gel, 100 pi of ammonium
persulphate and 6 pi of TEMED were added to 10 ml stacking gel solution which was
immediately overlaid. A teflon comb was inserted to produce 15 sample wells (60 pl/well)
and the gel allowed to polymerise for approximately 30 minutes.
Samples of B.bovis and B.bigemina (as described in 3.6.1) were thawed out and
approximately 50 pi of each sample were loaded per lane.
Electrophoresis was conducted overnight at room temperature, at 100 V constant voltage
which corresponded to a starting current of 18-19 mA per gel.
In some experiments the Protean II mini-gel system (Bio-Rad) was used either with pre-cast
(Bio-Rad) or home-made 10% homogeneous gels. All gels contained 10 sample wells. Twenty
five pi of sample were loaded per well and the gels were electrophoresed at a constant 200 V
for a period of 45 minutes.
To enable calculation of protein molecular weights, a sample well containing a set of low
molecular weight markers (Pharmacia or Sigma) was included in each gel.
3.6.3 Protein detection
Following electrophoresis, gels were stained with either Coomassie Brilliant Blue R-250 or
silver nitrate. All solutions were prepared with highly purified water (18 megahoms, as
described in Appendix 1).
Coomassie blue staining was performed by soaking the gels in 25% (v/v) methanol, 10%
(v/v) acetic acid, 0.1% (w/v) Coomassie blue R-250 for 1 hour. Gels were then destained in
25% (v/v) methanol, 10% (v/v) acetic acid until the background was clear (generally 2 hours
at room temperature) and then photographed through a Wratten 11 filter (Appendix 3).
Silver staining was conducted by fixing the gels in a solution of 25% (v/v) methanol, 10%
(v/v) acetic acid and then in a 5% (v/v) methanol, 7% (v/v) acetic acid solution for 30
minutes each. Gels were soaked in 10% (v/v) gluteraldehyde for 30 minutes and then either
washed with distilled water several times over a period of 2 hours or left overnight in distilled
water to remove all traces of gluteraldehyde. Gels were stained in 0.1% (w/v) silver nitrate
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for 30 minutes and, after removal of the staining solution, rinsed with developer (50 pi of
37% (w/v) formaldehyde in 100 ml 3 % (w/v) Na2C03). Fresh developer solution was added
and development continued until staining was optimal. The reaction was stopped with 10 ml
of a 2.3M citric acid solution and gels were photographed through a Wratten 61 fdter
(Appendix 3).
3.7 Western immuno-blotting
Following the method of Towbin and co-workers (Towbin et al, 1979), proteins separated by
SDS-PAGE were electrophoretically transferred to nitrocellulose membranes (blots) using a
semi-dry electroblotter (Sartorius) at a constant current of 0.8 mA/cm^ of gel. The strip of
membrane corresponding to the molecular weight markers on the gel was cut from the blot
and stained with 0.1% (w/v) amido black for approximately 15 minutes. The strip was then
destained until the bands were clearly visible (generally for 30 minutes), rinsed with distilled
water, dried and stored protected from light at room temperature until required for molecular
weight estimations.
Free binding sites on the nitrocellulose blots were blocked for 4 hours with blocking buffer
(Appendix 1). Blots were then incubated overnight with either bovine polyclonal serum or
mouse monoclonal antibody ascites fluid, both diluted 1:100 in blocking buffer. After
removing the antibody solutions, the blots were washed 7 x with PBS over a 2 hour period.
Blots were then incubated for 2 hours with appropriate dilutions of horseradish peroxidase-
conjugated anti-bovine or anti-mouse immunoglobulin (Sigma) in blocking buffer. After
removing the conjugate solutions, the blots were washed 7 x with PBS. Antigen-antibody
complexes were visualised by incubating the blots in a peroxidase substrate solution
containing 60 mg 4-chloro-l-naphthol in 20 ml of ice-cold methanol which was mixed
immediately before use with 100 ml Tris buffered saline pH 7.0 (TBS) (Appendix 1) to which
60 pi ice-cold hydrogen peroxide had been added. As bands became visible, the reaction was
stopped by removing the substrate solution and washing the blots 2 x in distilled water. The
membranes were allowed to dry before they were photographed (Appendix 3).
3.8 Enzyme linked immunosorbent assay (ELISA)
ELISAs were carried out according to Woodford and co-workers (Woodford et al, 1990) with
minor modifications. Briefly, 100 pi of antigen diluted in coating buffer (Appendix 1) were
dispensed into each well of a microELISA plate (Dynatech Ltd, M129 A), and the plates
incubated overnight at 4° C. The plates were washed for 3 x 1 minute washing cycles with
PBS containing 0.05% Tween 20 (PBST) using a commercial plate washer (Dynatech Ltd).
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Each serum sample was diluted in PBST and 100 pi of each sample was dispensed in
duplicate into the appropriate wells. Each plate had a set of 16 control wells: four wells of
B.bovis serum (taken from calf 396 on day 56 after infection), 4 wells of B.bigemina serum
(taken from calf 399 on day 57 after infection), 4 wells of a pre-infection serum (taken from
calf 634 on day 0) and 4 wells of PBST. The plates were incubated at 37° C for 30 minutes.
Unbound antibodies were removed by washing the plates as described above. One hundred pi
of anti-bovine peroxidase labelled immunoglobulin conjugate (Sigma) diluted in PBST as
recommended by the manufacturers were added to each well and the plates incubated for 30
minutes and washed as described above. Peroxidase substrate buffer was prepared by
dissolving one tablet of phosphate-citrate buffer with sodium perborate (Sigma) in 100 ml of
distilled water. One tablet of 3,3'5,5'-tetramethylbenzidine (Sigma) was dissolved in 10 ml of
substrate buffer and 100 pi were added to each well of the plate. The plate was incubated at
37° C for 10 minutes and the reactions were stopped by adding 50 pi of 2M H2SO4 to each
well. The optical density (OD) of the contents of each well was read at 450 nm using a
microELISA plate reader (Titertek Multiskan, Flow Laboratories).
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CHAPTER FOUR
IN VITRO CULTURE STUDIES
4.1 Introduction
The development of continuous in vitro culture systems for Babesia parasites allowed the
beginning of a new era of research into many aspects of bovine babesiosis such as
morphology, physiology, immunology and chemotherapy which had previously been totally
dependent on in vivo infections in experimental animals. Of the Babesia affecting cattle, only
B.divergens infects a laboratory animal, the Mongolian gerbil (Meriones unguiculatus). It
has not been possible to infect laboratory animals with B.bovis and B.bigemina-, as a
consequence, in vivo studies on these two species are limited to infection of susceptible cattle,
usually splenectomised calves.
The most significant application of the in vitro culture system has been the production of
immunogens without influence from the host immune system. Cultured parasites have been
used as source of immunogens in various parts of the world including Venezuela
(Montenegro-James et al, 1985), Mexico (Smith et al, 1981), Israel (Pipano, 1989) and
Australia (Timms et al, 1983). The in vitro culture system developed for B.canis (Molinar et
al, 1982) has been used to provide immunogens for immunisation against canine babesiosis in
France, in a commercially available vaccine ("Pirodog", Merieux, France).
In vitro cultivation has also facilitated comparative studies on characterisation of isolates
from different parts of the world and simplified cloning experiments, which in the past had
been carried out using large numbers of animals (Gill et al, 1987a).
Due to the economic constraints of experiments involving in vivo infections, particularly the
high costs of purchase and maintenance of animals and the associated labour, most of the
Babesia material used throughout this study had to be provided by in vitro culture. In
addition to economic limitations, the nature of certain experiments, in particular metabolic
labelling for immunochemical analysis, required the provision of parasites continuously over
a long period of time, making culture systems the most appropriate option as a source of
parasites.
In the past, several attempts have been made at CTVM to culture in vitro an African isolate
of B.bigemina (Zaria) without success (L.Bell-Sakyi, personal communication). This failure
to establish a continuously growing culture system was the major limitation of the
immunochemical investigation of B.bigemina isolates. Therefore, in the present study, further
attempts were made to establish a B.bigemina culture system using the existing Zaria stock, a
new isolate from Kenya (Muguga stock) and a third isolate, from Mexico, obtained from the
Imperial College, London, (described in section 3.1) that had been adapted to culture (Vega et
al, 1985a).
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Three isolates of B.bovis from different continents, Australia, Africa and South America, (as
described in section 3.1) had been grown in in vitro using the MASP system with minor
modifications and held as frozen culture stabilates at CTVM (Conrad, 1983; L.Bell-Sakyi,
personal communication), . The parasitaemias of cultures achieved at CTVM have been
comparable to the ones reported in the literature (5 to 11%). However, these figures are still
low, making the culture system expensive and often inappropriate if a large amount of
parasite material is needed.
Thus, the experiments described in this chapter were designed to investigate and optimise in
vitro culture conditions to exploit the culture systems as a reliable source of parasite material
for use in later experiments on immunochemical characterisation of the stocks available.
These included attempts to establish an in vitro culture system for B.bigemina and
optimisation of the existing B.bovis culture system. The latter involved the establishment of
cultures from low parasitaemia blood, cloning of one isolate, and incorporation of cell feeder
layers into the cultivation system. This chapter also describes a series of experiments by
which the effects on parasite growth of immune sera raised against B.bovis and B.bigemina
were investigated.
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4.2 Effect of different sera on B.bovis culture
The MASP system developed for cultivation of B.bovis (Levy & Ristic, 1980) has been
described in section 3.3.
The source of the serum component of culture medium appears to be one of the most limiting
factors in cultivation of Babesia parasites, since not all cattle provide serum that supports in
vitro growth; it has been reported in the literature that adult bovine serum is preferable to calf
serum for use in cultivation of B.bovis and that newborn and most bobby calf sera do not
support B.bovis growth in vitro (Kellermann et al, 1988). Therefore, the first step in the
establishment of a culture system has to be the identification of suitable serum donors.
Studies on passive transfer of immune serum to susceptible animals (Mahoney et al, 1979)
and passive transfer of maternal immunity (Hall, 1960; Hall et al, 1968) give indirect
evidence of a protective role of antibodies in Babesia infections. On the other hand, attempts
to correlate total antibody levels with immune status have failed (Mahoney, 1964; Callow et
al, 1974), suggesting that not all antibodies are protective.
In endemic areas where Babesia infections are widespread with most of the adult animals
having circulating specific antibodies, the identification of a serum donor which does not
carry anti-babesial antibodies may constitute the major limitation for the maintenance of in
vitro parasite growth.
With this in mind, the experiments described in this section were designed to evaluate the
effect of immune sera on in vitro growth rates of B.bovis.
4.2.1 Experimental design
Growing culture suspensions of B.bovis (Mexico and Lismore stocks), showing a
parasitaemia of 5% in thin smears, were used as source of infected erythrocytes to initiate
cultures. The culture suspensions were subcultured into a 96-well plate at a 1 in 5 dilution
with fresh 10% RBC suspensions prepared in M199-H, supplemented at 40% with one of
































6 years old negative
All serum samples were used fresh (none of them had been frozen prior to addition to the
culture medium). For serum separation, blood samples were aseptically collected by jugular
puncture, on the day before the initiation of cultures, allowed to clot at 37°C overnight,
centrifuged at 2,500 x g for 30 minutes at 4°C and stored at 4°C for up to one week.
Three replicate wells (200 pl/well) were set up for each culture medium tested and the plates
were incubated under 5% CO2 in air. The overlying medium (~ 150 pi) in each well was
replaced with the same medium daily, and smears were also made daily up to day 6.
Parasitaemias were estimated by counting 1,000 RBC in each smear and each well was
subcultured (1 in 3 dilution) with the corresponding fresh 10% RBC suspension on day three.
The medians of counts of each set of replicates were compared statistically using the Chi-
square test for homogeneous frequencies (Fowler & Cohen, 1992); this comparison was made
for the two cycles of parasite growth separately, i.e. for the first phase of exponential growth
(first three days) and for the second phase (three days after subculture).
4.2.2 Results
The counts obtained from each well of B.bovis (Mexico) culture, over the period of 6 days
are presented in Appendix 2 and the medians of each replicate set are presented in Fig 4 .1.
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There was no significant difference (p> 0.05) between the medians of parasite counts from
wells with culture media supplemented with B.bovis immune serum (from calf 396, taken at
21 days after infection) and NBS (control), suggesting that the specific antibodies against
B.bovis did not inhibit parasite growth. The lack of inhibition was observed in both cycles of
exponential growth. However, the medians of parasite counts from wells containing culture
medium supplemented with serum from calf 397 (taken at 21 days after B.bigemina
infection) were significantly lower (p< 0.001) than those obtained from control wells
(supplemented with NBS) and from the cultures supplemented with serum from calf 396.
These significant differences were observed in both cycles of parasite growth, suggesting that
serum from calf 397, taken on day 21 after infection, did not support B.bovis growth in vitro.
The counts obtained from each well of B.bovis (Lismore) are presented in Appendix 2 and the
medians of each set of replicates with each culture media are presented in Fig 4.2.
With this parasite there were no significant differences between medians of iRBC counts from
any of the sera tested and the control counts in either cycle of parasite growth, suggesting that
all the calf sera tested were as good as the NBS in supporting in vitro growth of B.bovis. In
this second experiment no inhibitory effect was observed on B.bovis growth of immune serum
(taken 69 days after infection) (Fig 4.2).
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Fig 4.1 Medians ofB.bovis (Mexico) iRBC in 1,000 cells in cultures using different sera.
























In the present study, sera from one uninfected calf and from 3 calves infected with either
B.bovis or B.bigemina were substituted for NBS in culture medium and, with only one
exception (serum from one calf taken after 21 days of infection with B.bigemina, used in the
first experiment), all calf sera were found to be suitable for use in B.bovis cultures (Fig 4.1
and 4.2). These results contradict the reports of parasite inhibition in vitro by a factor in sera
from young calves (Levy et al, 1982). However the higher inhibitory effects of young calf
sera on B.bovis cultures reported by Levy and co-workers were obtained after 3 or 4
subcultures whereas, in the present study, the growth rates of parasites were evaluated over 6
days, including only one subculture during this period. In addition, all serum samples tested
in the present study were taken from 4 to 6 month old calves and therefore it is possible that
they had already lost the inhibitory factor.
On the other hand, the observed inhibitory effect of serum from calf 397 (taken 21 days after
B.bigemina infection) on B.bovis growth in vitro (Fig 4.1) suggested an age effect, since
serum from the same calf taken 48 days later (on day 69 after infection) did not have any
inhibitory effect on parasite growth (Fig 4.2).
The inhibitory effect of calf sera on B. bovis growth has been associated with the presence of
a factor independent of antibody, and responsible for calf resistance to severe babesiosis
(Levy et al, 1982). In that report, it was demonstrated that the inhibitory factor present in calf
serum is dialyzable, has a low molecular weight (< 14,000) and is lost as the calves age,
since foetal calf serum gave the highest inhibition followed by new born calf serum (<10
days old) and bobby calf serum (10 days to 3 months old).
All post-infection serum samples used in the experiments described here had been shown by
IFAT to contain specific antibodies with titres of at least 1 in 640. However, the results
obtained here led to the conclusion that those antibodies were not able to inhibit parasite
growth in culture.
Previous studies have demonstrated the role of humoral immunity in protection against
B.bovis infections; these included the passive transfer of immune serum conferring partial
protection to susceptible calves (Mahoney et al, 1979). The subclass of antibody responsible
for protection was determined to be IgGl (Goff et al, 1982). Recently, Orinda and co-workers
reported the failure of vaccinated cattle to produce interferon gamma, reinforcing the
argument that immunity to B. bovis infection is correlated most strongly with a humoral rather
than a cell-mediated immune response (Orinda et al, 1992a). In addition, it has been
demonstrated that antibodies produced against protective antigens promote in vitro
phagocytosis of B.bovis and B.bigemina (Parrodi et al, 1990; Jacobson et al, 1993) and
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B.rodhaini (Parrodi et al, 1991); however complement did not enhance phagocytosis of
infected erythrocytes or parasites alone. Based on these findings, it was expected that the
immune sera tested in the present experiments, which had been shown to contain specific anti-
B.bovis antibodies, would inhibit parasite growth in vitro. This was not observed.
The most unexpected result was the lack of parasite inhibition by serum from calf 396 taken
on day 69 after primary infection, and after two challenges with the homologous stock of
B.bovis, which had shown to contain high titres of specific antibodies (1 in 2,560) by IFAT.
Although the serum was produced in a calf infected experimentally by inoculations of infected
blood and may differ from sera derived from naturally tick-induced infections, the results
obtained here indicate that it could be possible to use sera from sero-positive animals for in
vitro cultivation of B.bovis in endemic areas.
The effect of post-infection calf sera on B.bovis growth in vitro has been previously
examined at CTVM (L.Bell-Sakyi, personal communication), when a series of 10 frozen
serum samples taken from calves on days 0 and 28 after infection (2 with B.bovis, 1 with
B. divergens, 1 with B.bigemina and 1 with T.annulata) were tested and all of them had
performances comparable to that of the frozen NBS control. There was, however, a
significant increase in parasitaemia when the corresponding fresh NBS control was compared
with all frozen sera, suggesting that none of the frozen sera (pre or post-infection calf sera
and NBS) were as good as fresh NBS. Based on these findings, all serum samples tested in
the present study were fresh (not previously frozen), which made impossible the comparison
between the performance of pre and post-infection samples from the same animal.
The lack of parasite inhibition by calf immune sera in the present study might be related to
the fact that the two stocks of B.bovis (Lismore and Mexico) used in the present experiments
have been cultured in vitro for a considerable period of time, which may have resulted in
selection of populations of parasites very well adapted to growth in vitro and able to survive
more easily when subjected to adverse conditions.
Studies on in vitro inhibition of Babesia may be useful for understanding mechanisms related
to parasite invasion and may help to identify immunoglobulins involved in protection. In that
case however, specific immunoglobulins should be concentrated and purified before being
incorporated into the cultures. Such studies have been carried out with cultured P.falciparum
parasites, in which growth was inhibited by purified specific immunoglobulins from sera of
individuals living in endemic areas (Brown et al, 1983).
70
4.3 Use of feeder cells in b. bows cultivation
Although the in vitro culture system for B.bovis has been successfully implemented at
CTVM, the maximum parasitaemias achieved are still relatively low, usually ranging
between 5 and 8%. Moreover, on some occasions, some of the cryopreserved stabilates have
proved to be difficult to re-establish as a continuous culture (particularly Mexico and
Kwanyanga isolates).
P.falciparum has been shown to exhibit better growth rates when cultured in association with
other cells (Mazier et al, 1984; Phillips et al, 1987) and increased multiplication rates of
asexual erythrocytic stages of this parasites have been reported when either new or
established isolates were cultured in the presence of mouse peritoneal cells as a feeder cell
layer (Trenholme & Phillips, 1989).
Previous work carried out at CTVM, showed that establishment of B.bovis cultures from
infected calf blood were facilitated when bovine aortic endothelial cells (BAE) were
incorporated into culture vessels as a feeder layer (Conrad, 1983).
Therefore, the experiments described in this section were designed to evaluate the
incorporation of cell feeder layers in B.bovis cultures, with the aim of increasing
parasitaemias of established cultures and improving the technique for resuscitation of
stabilates. The study included a comparison between incorporation of mouse peritoneal wash
cells (MPWC) and BAE cells in established cultures and also an evaluation of the effect of
MPWC at different concentrations in cultures of the three stocks of B.bovis (Lismore,
Mexico and Kwanyanga), using either established cultures or cryopreserved culture stabilates
of each stock.
4.3.1 Preliminary study
A preliminary experiment was designed in which the effects of the two types of feeder cell
layers on B.bovis cultures were compared.
MPWC were aseptically collected from adult female mice by peritoneal lavage with 10 ml
ice-cold M199-H. The cells were washed twice in M199-H by centrifugation (400 x g for 5
min at 4° C) and resuspended in complete culture medium (M199-H, 40% NBS). For this
evaluation, three concentrations of MPWC were tested: 10*>, 10^ or 10^ cells/ml. The
concentration of washed cells was estimated by haemocytometer count and the suspension
was diluted with complete medium in order to give the required concentrations of MPWC.
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BAE cells were taken from a primary culture maintained at 37°C in 5 ml of MEM (Eagle's),
10% foetal calf serum (FCS) in a 25 cm^ flask under 5% CO2 in air (Gray et al, 1985).
Cells were harvested (according to A. Barns, personal communication) by adding 2 ml of a
0.1% trypsin-versene solution to the flask and incubating it at room temperature until the cell
sheet was seen to be detaching from the flask. The cells were then transferred to a sterile
centrifuge tube and washed twice with culture medium by centrifugation at 800 x g for 10
minutes. The resulting pelleted BAE cells were then resuspended in 5 ml of M199-H and
used to inoculate wells.
B.bovis (Lismore) culture suspension (as a 20% RBC suspension in M199-H, 40% NBS,
with parasitaemia of 1%) was used to initiate cultures in a 96-well plate.
Twelve wells (test wells) of a 96-wcll plate, three replicates for each condition, were set up
as described:
Day -1(100 pl/well) addition on day 0 (100 pl/well)
106 MPWC/ml B.bovis culture***
105 MPWC/ml B.bovis culture***
104 MPWC/ml B.bovis culture***
BAE culture* B.bovis culture***
CM** B.bovis culture*** (control wells)
* diluted 1:3 with complete medium (CM)
** M199-H, 40% NBS
*** a 20% RBC suspension with 1% parasitaemia
Thus, each well contained a volume of 200 pi and a PCV of 10%. In the same plate, one well
of each of the dilutions of MPWC (10^, 10^, 104/ml) and one well of BAE (200 pl/well)
were set up as control wells without the addition ofB.bovis culture.
The plate was incubated at 37° C in 5% CO2 in air. Overlying medium was changed daily
(100 pl/well) from day 0 in all wells. Parasitaemias in B.bovis culture wells were estimated
daily for 4 days after medium changes by counting 1,000 RBC in thin smears stained with
Giemsa as described in section 3.3.3. For evaluation of survival/growth of MPWC and BAE
cells, each of the control wells was examined daily using an inverted microscope (Leitz
Diavert).
Subcultures of the B.bovis wells were carried out on day 2 by gently pipetting and then
removing 150 pi of culture suspension and replacing with fresh RBC suspension.
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The medians of the counts obtained from each set of replicates of B.bovis cultures were
statistically compared by the Chi-square test for homogeneous frequencies as previously
described.
4.3.1.1 Results
There was no significant difference between the medians of counts obtained from the BAE
cell feeder wells and the B.bovis control wells. However there was a significant increase in
number of iRBC (p< 0.001) in cultures with all three concentrations of MPWC when
compared with counts from the B.bovis control wells. When the different concentrations of
MPWC were compared, no significant difference was found between them, suggesting that
the three concentrations tested had a similar effect. The counts obtained from each well are
presented in Appendix 2 and the medians of each set of replicates are presented in Fig 4.3.
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4.3.2 Effect of mouse peritoneal wash cells (MPWC) on established
cultures
For this study, two concentrations of MPWC were tested: 10^ and 1(P cells/ml, on
established cultures of all three stocks of B.bovis (Lismore, Mexico and Kwanyanga).
The MPWC were harvested and prepared as described before, and diluted with complete
medium in order to give the required concentrations.
Twelve wells of three 24-well plates (one for each stock) were set up on day -1 as described:
4 wells received 1 ml of a 10 4 MPWC suspension
4 wells received 1 ml of a 10 3 MPWC suspension
4 wells received 1 ml of medium (control)
The plates were incubated at 37°C under 5% CO2 in air.
On day 0, the overlying medium of each well was carefully removed using a Pasteur pipette
and 1.25 ml aliquots of B.bovis cultures (as 10% RBC suspensions with parasitaemia of
0.5%) were used to inoculate each well. The plates were incubated, medium changed
(lml/well) and parasitaemias estimated daily in smears from all wells by counting 1,000 RBC
as described before.
In addition to the parasite counts, a morphological analysis was also carried out. This was
done by counting the different forms (single, pair, quadruplet, pycnotic and free merozoites,
as described in Fig 4.4) present among 100 parasites in one smear from each treatment each
day.
Subcultures (1 in 10 dilution) were carried out on day 3 into 12 new wells (in the same plate),
which had previously been coated overnight with freshly collected MPWC or medium as
described for day -1. Medium was changed and smears were made daily from each well until
day 3 after subculture.
The medians of parasite counts from each set of replicates of each cycle of growth (before
and after subculture) and the counts of the different parasite forms were compared by the
Chi-square test as described before.
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The medians of parasite counts obtained in smears from wells with MPWC were significantly
higher (p< 0.001) than the control wells for all three stocks of B.bovis and no significant
differences (p> 0.05) were found between the wells which had received 10^ or 103
MPWC/ml in any of the stocks. The counts for each well are presented in Appendix 2 and the
medians of replicates are presented in Fig 4.5 A-C.
Throughout the morphological analysis, no triplet forms were seen in any of the cultures and
quadruplet forms, when seen, were very few representing a maximum of 1% of the total
counts. Thus, the counts of these two forms were not included in the figures. The culture
wells of Lismore and Mexico stocks which had received MPWC at a concentration of 10^
cells/ml contained significantly fewer (p< 0.001) pycnotic forms of B.bovis than the control
wells as shown in Fig 4.6A and 4.7A. With the Mexico stock there were also a significant
increase (p< 0.001) in the number of pair and free forms and a decrease in the number of
single forms in the wells with 10^ MPWC/ml when compared with the control wells. There
were no significant differences between counts of single forms in any of the MPWC
treatments or in control cultures (Fig 4.6 A-C and Fig 4.7 A-C). The morphological analysis
of Kwanyanga stock (Fig 4.8 A-C) showed no significant difference (p> 0.05) between the
counts of the different parasite forms observed from wells with MPWC either at 10^ or 103
cells/ml and the control wells. The counts of the different forms obtained from each stock of
B.bovis are presented in Appendix 2.
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Fig 4.5 Number of B.bovis infected cells in 1,000 RBC of established cultures of Lismore
(A), Mexico (B) and Kwanyanga (C) stocks with MPWC as feeder cells. Day 3b represents


























Fig 4.6 Proportions of different forms of B.bovis parasites (Lismore stock) in cultures with
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Fig 4.7 Proportions of different forms of B.bovis parasites (Mexico stock) in cultures with









Fig 4.8 Proportions of different forms of B.bovis parasites (Kwanyanga stock) in cultures
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4.3.3 Effect of MPWC on resuscitation
Due to the fact that no significant differences on parasite counts were observed between 104
and 1(P MPWC/ml for established cultures, MPWC were tested only at a concentration of
104 for in vitro resuscitation of each stock ofB.bovis.
On day -1, four wells of three 24-well plates (one for each stock) received 1 ml of a 104
MPWC suspension, which had been harvested and prepared as described before, and four
wells received culture medium (control wells).
On day 0, for each stock, two vials of B.bovis cryopreserved cultured parasites (see section
3.3.4) were resuscitated as described in section 3.3.5, pooled, and 1.25 ml aliquots of the
resultant 10% RBC suspension were used to inoculate each well. The plates were incubated
at 37°C under reduced O2 tension. Medium was changed and cytospin smears were made
from each well daily until day 3. Six fields of approximately 750 RBC each (4,500 RBC in
total) were examined and the number of infected erythrocytes recorded.
The medians of parasite counts from each set of replicates were compared by the Chi-square
test, as described before.
4.3.3.1 Results
No significant differences (p> 0.05) were observed between the medians of parasite counts
from the wells with MPWC and the medians of counts from the control wells in any of the
stocks tested. The counts obtained from each well are presented in Appendix 2.
4.3.4 Discussion
In the present study, the BAE cells did not affect parasite growth, whereas the MPWC, used
at concentrations of 104 or 10^ cells/ml, were shown to support an increase in the
parasitemias of established cultures of all three stocks of B.bovis tested. These findings
suggest that the MPWC might be useful in increasing parasitaemias of B.bovis isolates that
are more difficult to growth in vitro. There is also a possibility that the MPWC might be
helpful in establishment in vitro of sub-populations which are more difficult to grow, which
may be an important consideration in cloning experiments.
An increased multiplication rate of P.falciparum has also been reported when MPWC were
incorporated into cultures (Trenholme & Phillips, 1989). However the mechanism by which
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the MPWC promote this is not completely clear. It is suggested that either the cells release a
labile cysteine that acts as a promoting factor or that the adherent cells, which are mainly
macrophages, might remove toxic metabolites which inhibit parasite growth. It is possible
that the MPWC, as suggested for P.falciparum, had a positive effect on B.bovis growth by
releasing promoting factors into the culture medium or by removing from the medium toxic
metabolic products generated during parasite multiplication.
Further evidence of an effect of macrophages on growth of Babesia parasites was given by
Tambrallo and co-workers (Tambrallo et al, 1992), who reported increase of in vitro growth
of B.bovis and B.bigemina when a bovine recombinant granulocyte macrophage/colony
stimulating factor was incorporated into cultures (Tambrallo et al, 1992). However the
mechanism by which this stimulating factor affected the parasite growth was not investigated.
The same factor also enhanced promastigote growth ofLeishmania mexicana amazonensis in
mice and this was proposed that it was due to a shortening of the parasite cell cycle (Charlab
et al, 1990).
Regarding the morphological analysis, there was great variation in the results, and it was
difficult to draw substantial conclusions except that the incorporation of MPWC at 10^
cells/ml in established cultures resulted in significantly fewer pycnotic forms of Lismore and
Mexico parasites.
Pycnotic forms are usually a sign of unhealthy cultures and commonly occur as a result of
inadequate culture conditions, such as delay in medium change, delay in subculture or low
concentration of O2. The presence of pycnotic forms is therefore undesirable and in general
means that the culture conditions are not optimum. The presence of fewer pycnotic parasites
in cultures with MPWC gives support to the hypothesis that mouse macrophages may
produce better culture conditions by removing toxic metabolites from the culture medium.
The wide variation in the distribution of different forms observed throughout the examination
period can possibly be explained by the cultures being in different stages of development at
the moment of sampling. On day 2 for instance, a high proportion of free merozoites was
found particularly in Mexico and Kwanyanga stocks in all culture conditions; it may be
because at that particular moment many merozoites had been released into the culture
medium and were about to start another cycle by infecting new RBC.
In general it was clear that the Lismore stock showed consistently more pair forms and fewer
free merozoites than the other two stocks, independently of the use of MPWC. On the other
hand, parasitaemias of Mexico and Kwanyanga stock cultures were always higher than those
of Lismore stock.
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Although the MPWC promoted increases in parasitaemias of established cultures, a
concentration of 10^ MPWC/ml did not promote increase in parasitaemias when tested in in
vitro resuscitation of any of the stocks tested. Perhaps the MPWC did not produce any effect
on resuscitation because the conditions used on this occasion were quite adequate in terms of
RBC and serum supplies. This theory was supported by the finding of parasitaemias around
4% on day 3 after resuscitation, even in cultures without MPWC, which is higher than the
ones routinely obtained at this point during previous resuscitations at CTVM, which have
been 1% or less. Besides, it has to be considered that, although on some occasions stabilates
of Kwanyanga and Mexico stocks have been difficult to resuscitate (L.Bell-Sakyi, personal
communication), the three isolates used in this experiment were originally established in vitro
from infected blood quite easily, and have been cultured in vitro on a number of subsequent
occasions. Although the MPWC did not seem to improve the resuscitation of stabilates of
B.bovis stocks used in this experiment, they may be useful in establishment of new isolates
which have never been cultured in vitro.
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4.4 Cloning of B.bovis
Previous work carried out at CTVM on glucose phosphate isomerase (GPI) isoenzyme
analysis by gel electrophoresis of stocks of B. bovis found that the Lismore stock of B. bovis,
which was originally a virulent strain isolated from a clinical case (Kahl et al, 1983), showed
two bands of this enzyme, whereas the Kwanyanga and Mexico stocks had only one band
(T.R.Melrose, personal communication). The GPI pattern has shown to be useful as a
biochemical marker for characterisation of different subpopulations of Theileria parasites
(Melrose & Brown, 1979). Furthermore, analysis of B.bovis parasites at both the protein and
DNA levels has demonstrated that a high proportion of the isolates are composed of a
heterogeneous mixture of subpopulations (Kahl et al, 1982b; 1983; Cowman et al, 1984).
Therefore, at the beginning of this study, it was believed that the Lismore stock of B.bovis
might be composed of heterogeneous populations of parasites differing in antigenicity and
consequently complicating the immunochemical characterisation (described in Chapters 6 and
7). An in vitro culture procedure has been developed for cloning and establishment of
homogeneous populations of B.bovis parasites (Rodriguez et al, 1983).
Thus, a single experiment was designed with the aim of cloning the Lismore isolate by
limiting dilution in order to obtain cloned lines for immunological characterisation.
The experiment was designed to clone cultured parasites by limiting dilution in vitro in a first
stage, and then to redone the resultant lines to ensure their origin from a single parasite. For
comparative analysis of parent and cloned lines, three parameters were used: evaluation of
growth rates in vitro, morphology of the parasites and isoenzyme (GPI) profiles.
4.4.1 Cloning procedure
A vial of culture stabilate of the Lismore stock of B.bovis, passage 11, was resuscitated into
a 25 cm-^ flask (as described in section 3.3.5) and was cultured continuously in vitro for 1
week, during which time it was subcultured twice. The cloning procedure was carried out by
limiting dilution according to Rodriguez and co-workers (Rodriguez et al, 1983) with some
modifications.
The number of RBC per pi in a sample of the culture suspension, counted in an electronic
particle counter, was 1.49 x 10*> and the parasitaemia estimated in a Giemsa-stained thin
smear (see section 3.2.3), was 2.53%. Thus, 26 pi of culture suspension were mixed with 174
pi of M199-H in order to give 10^ iRBC/200 pi, which was used to make serial dilutions.
Serial 10-fold dilutions were then made in a 96-well plate (parent culture wells) to result in a
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final dilution of 200 pi that contained one infected RBC. This final dilution was divided into
four aliquots which were put into individual wells in a separate 96-well plate and constituted
a cloning set. The same procedure was carried out six times resulting in six cloning sets in
separate plates. To give a final depth of 4.0 mm (total volume of 180 pl/well), 130 pi of
10% RBC suspension (as described in 3.3.1) was added to each well. The parent culture
wells were kept as controls. The plates were incubated under reduced C>2 atmosphere. The
medium in each well was changed daily by removal and replacement of 100 pi of the
overlying medium.
The control wells were examined on day 3 by making cytocentrifuge smears (see section
3.3.3). On day 9 cytospin smears from the cloning sets were made and examined. The
contents of any cloning well showing parasites were transferred to wells of 24-well plates and
1 ml of 10% RBC suspension was added to each well. The plates were cultured for two days
and the contents of each well was transferred to 25 cm^ flasks; the volume in each flask was
adjusted to 5 ml with 10% RBC suspension. The cloned lines were cultured in flasks for two
days and were cryopreserved in 5% DMSO as described in 3.3.4. On days 12 and 15 the
remaining negative cloning wells were screened again in order to detect possible slow-
growing clones.
4.4.1.1 Results
From the 24 cloning set wells (6 cloning sets with 4 wells each) in the 96-well plate, 17
showed growth and 13 were transferred to individual wells in a 24-well plate, as described in
Table 4.1.
Screening of negative wells from the cloning sets on days 12 and 15 did not detect any slow-
growing clone.
The contents of six wells from the 24-well plate (originally well 1 of cloning set 1, well 2 of
cloning set 2, well 4 of cloning set 3, well 1 of cloning set 4, well 4 of cloning set 5 and well 2
of cloning set 6) were transferred to six individual 25 cm^ flasks, which were designated
clones 1, 2, 3, 4, 5 and 6 respectively.
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1 2 3 4
1 +++ +++
2 ++ * +++ * __
3 — — + ++ *
4 ++ * ++ * +++ * ++ *
5 ++ * ++ *
6 ++ * +++ * — ++ *
Key: — no parasites seen
++ less than 2 parasites/field
+++ 2 to 4 parasites seen/field
++++ more than 6 parasites seen/field
* contents transferred to 24-well plate wells
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4.4.2 Comparison of cloned lines
Stabilates of the parent line and of the clones 1, 3 and 4 were resuscitated into 25 cm^ flasks,
3 weeks after cryop reservation, and were compared by growth rate, morphology and
isoenzyme profiles.
4.4.2.1 Growth rate
The growth rate was evaluated by culturing the parent line and the cloned lines in 24-well
plates, starting from three different parasitemias (1%, 0.1% and 0.01%), each with four
replicates. There was no subculturing but the medium was changed daily. The parasitemia
was determined daily for 7 days by counting 2,000 RBC in Giemsa stained smears made from
each replicate well. For parasitaemias below 0.5% at least 100 fields (about 250 cells/field)
were counted.
4.4.2.2 Morphological analysis
On day 7, smears from the replicates which had started with 0.01% of parasitaemia were
used for morphological studies. At least 100 parasites were counted in each slide and were
classified according to their morphology as: single, pair, quadruplet, pycnotic and free
parasites (as described in Fig 4.4). Data obtained from growth rate evaluation and
morphological studies were statistically analysed using the Chi-square test for homogeneous
frequencies (Fowler & Cohen, 1992).
4.4.2.3 GPI analysis
The GPI analysis was done in collaboration with Mr T.R.Melrose, CTVM. Samples for
isoenzyme study of parent and cloned lines were prepared by selective lysis using KC1 as
described in section 3.6.1.1 and frozen at -80°C as a pellet. The same procedure was carried
out for uninfected RBC suspension as a negative control.
Electrophoresis was carried out according to Melrose & Brown (1979). Briefly the parasites
were lysed by freeze-thawing twice and the lysates were inserted on pieces of washed white
embroidery cotton in a plate with a layer of starch gel 0.9 mm thick. Electrophoresis was
carried out for 3 hours at 8° C with a voltage of 350 V and current of 25 mA. An electron
transfere dye system was used to locate the bands of GPI isoenzyme activity. The developer
was prepared by dissolving the substrate, the auxiliary enzyme glucose-6-phosphate
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dehydrogenase and the co-enzyme in a 0.272 M potassium phosphate buffer (pH 7.0).
Approximately 100 mg purified agar was dissolved in 10 ml distilled water by heating in a
boiling water bath, then cooled to 50° C and added to the developer solution. The agar
overlay was poured into a plastic mould resting on top of the gel and the complete plate tilted
to spread the solution over the whole area of the plate. The plate was incubated at 37° C for
1 hour and the developed gel was photographed as described in Appendix 3.
4.4.2.4 Results
The medians of parasite counts in replicate cultures of the parent and the three cloned lines
from starting parasitaemias of 1%, 0.1% and 0.01% are presented in Fig 4.9 (A), (B) and
(C) respectively.
There were no significant differences (p> 0.05) between the medians from the parent and any
of the cloned lines in cultures initiated with parasitaemias of 1% or 0.1%. However, at a
starting parasitaemia of 0.01%, clone 4 showed significantly lower parasite counts (p< 0.001)
when compared with counts of the parent and clones 1 and 3 cultures (Fig 4.9 C).
No significant differences between the cultures (parent, clone 1, 3 or 4) (p> 0.05) were found
in proportions of any of the parasite forms. The proportions of different parasite forms in
cultures of parent and cloned lines are presented in Fig 4.10.
The GPI isoenzyme banding patterns are shown in Fig 4.11. The uninfected RBC showed two
cathodic bands of activity. All B.bovis samples (parent and cloned lines) showed a single
anodic band with the same pattern of migration in every sample; however it was demonstrated
that the GPI bands observed were of B.bovis origin, since they were absent in the uninfected
RBC control.
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Fig 4.9 In vitro growth of clone 1 (—■—), clone 3 (—□—), clone 4 and parent
line (—0—) of B.bovis (Lismore) starting from a parasitaemia of 1% (A), 0.1% (B) or 0.01%
(C) over a period of 7 days in culture.
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Fig 4.9
Fig 4.10 Proportions of different forms of B.bovis parasites in cultures of parent line (H),









Fig 4.11 Zymogram of a parent and three cloned lines of B.bovis (Lismore) stained for GPI
activity.
Lysates prepared from:
Clone 1 (lane a)
Clone 2 (lane b)
Clone 4 (lane c)
Parent line (lane d)




w •« ■ . im
a b c d e
4.4.3 Recloning procedure
The comparative study of the parent and cloned lines using three parameters (growth rate,
morphology and GPI patterns) showed that all lines were very similar. However, when
cultures were initiated from low parasitaemia (0.01%), for evaluation of growth rate, a
significant difference was detected between parasitemias of clone 4 and the other cultures.
Therefore, clone 4 was selected for recloning.
A culture stabilate of clone 4 was resuscitated in vitro (section 3.3.5) and cultured for 1 week
in two 25 cm^ flasks, which provided culture suspensions for a recloning experiment.
The number of RBC per pi of culture suspension from the two flasks was 1.45 x 10^ and
1.53 x 10^, and parasitaemias were 4.8% and 4.6% respectively. Therefore, one pi of each
culture suspension contained approximately 70,000 iRBC.
The recloning procedure was based on the method described by Rosario (1981). The change
in methodology was due to the high number of positive wells obtained in the first cloning sets
(see 4.4.1.1).
The culture suspensions were diluted with M199-H to give a final concentration of 0.25
iRBC/pl and a PCV of 2% as described:
Dilution Parasite
concentration
1 10 pi of culture 690 pi of medium 105 iRBC/100 pi
2 10 pi of dilution 1 990 pi of medium 103 iRBC/100 pi
3 100 pi of dilution 2 900 pi of medium 100 iRBC/100 pi
4 100 pi of dilution 3 900 pi of 2% RBC
suspension
10 iRBC/100 pi
5 200 pi of dilution 4 1.8 ml of 2% RBC
suspension
1 iRBC/100 pi
6* 1.5 ml of dilution 5 4.5 ml of 2% RBC
suspension
0.25 iRBC/100 pi
* used to initiate 2 cloning sets (50 wells in each of two 96-well plates)
One hundred pi of the dilution 3 were placed into each of 5 wells in a 96-well plate and were
designated control A (100 parasites). The same procedure was done with dilution 4 and the
wells were designated control B (10 parasites).
One hundred pi of the dilution 6 (0.25 parasite) were then placed into each of 50 wells of two
96-well plates (cloning sets). Thus, parasite growth was expected in 12.5 wells of each plate.
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Thirty p,l of a 2% RBC suspension were added to each well (including control A and B wells)
and the plates were incubated under 4% O2 gas tension. Medium was changed in the control
wells on days 1, 3, 5 and 7. On days 2, 4, 6 and 8 100 pi of overlying medium of each
control well was replaced by 100 pi of a 2% RBC suspension, resulting in a PCV of 10% in
all wells on day 8. Each day, starting from day 6, a different well of each control set (A and
B) was screened by preparing and examining cytocentrifuge smears. The cloning set wells
also had the overlying medium (100 pi) replaced by 100 pi of a 2% RBC suspension on days
2, 4, 6 and 8, resulting in a PCV of 10% on day 8. From then, the overlying medium (100 pi)
was changed daily in the control wells and every 2 days in the cloning set wells until day 15,
when cytospin smears were made from each of the cloning set wells.
Cloning set wells showing parasites were transferred to individual wells of a 24-well plate
and 1.2 ml of 5% RBC suspension were added to each well. The plate was incubated under
5% CO2 in air and medium was changed 24 hours later. After 48 hours of incubation, 1 ml
of the overlying medium in each well was replaced by 1 ml of a 5% RBC suspension and
thereafter the medium (1 ml) was changed daily.
The 25 cm^ flasks which had been used to provide the original clone 4 cultures for initiation
of the cloning set wells were kept as control under standard conditions with daily medium
changes and subcultures every 2 days.
4.4.3,1 Results
Six wells in one plate and 8 in the other were positive on day 15 and were transferred to 14
individual wells of a 24-well plate. On day 20, a further 5 wells in the first plate were positive
and were transferred to the 24-well plate; no more positive wells were detected in the second
plate. On day 21, the first transferred wells in the 24-well plate were examined again and in
all of them very few of the parasites seen were healthy. None of the parasites in the 24 well
plate or in the control wells (A and B) in the 96-well plate survived beyond day 24 and
therefore no cloned lines were obtained after recloning.
The original clone 4 cultures (the two 25 cm^ flasks) used to initiate the cloning sets were
still healthy and attaining parasitemias of around 5% 48 hours after subcultures.
4.4.4 Discussion
The results obtained from the first cloning procedure used in this study indicated that the
culture conditions were adequate and allowed the establishment of cultures from a very low
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starting parasitaemia. However, at the end of the cloning procedure, the number of cloned
lines obtained was higher than expected (Table 4.3). All of the six cloning sets, which
theoretically had been initiated with 0.25 parasite/well and should have resulted in growth in
one single well, resulted in growth in more than one well. In two cases (cloning sets 1 and 4)
all four wells showed parasite growth, proving that the starting concentration of parasites was
at least 1 parasite/well. These results may be due to several factors. Firstly, due to a possible
inaccuracy of parasitaemia estimations in Giemsa stained smears; secondly, due to an
inaccuracy of the serial dilutions needed to obtain 1 parasite/pl, which involved six dilution
steps consequently increasing the chance of errors; thirdly, it is possible that by the time the
cloning procedure actually finished, the number of parasites/pl of culture suspension was
higher than when the cultures had been sampled. The period of time between the sampling
and the actual completion of the cloning procedure (including time required for counts of
RBC and parasitaemia, carrying out dilutions, etc.) was approximately 1 1'2 hours which may
permit substantial changes on the status of a B.bovis culture, in which doubling time in an
exponential growth phase is between 7 and 10 hours (Kellermann et al, 1988). In addition,
absence of CO2 induces release of free merozoites into the culture supernatant; the period of
time that the cultures were being manipulated in the microflow hood, deprived of CO2, before
the cloning wells were set up, may have resulted in release of some of the pair forms of
B. bovis parasites as 2 free merozoites in the culture supernatant and therefore in an increase
of the number of infective forms. One possible way to diminish the error in estimation of
starting number of infective parasites would be by washing the cells with medium before
initiation of the cloning procedure and consequently eliminating most of the free merozoites.
Although the number of parasite lines obtained after cloning was higher than expected and
the culture lines obtained did not seem to be established from a single parasite, they were
derived from very few parasites and could each represent a more homogeneous population
than the original Lismore stock, and therefore be useful for comparative studies of
immunochemical characteristics.
From the growth rate analysis, clones 1, 3 and 4 showed exponential growth very similar to
that of the parent line in cultures initiated with 0.1% or 1% parasitaemia (Fig 4.9 B and 4.9
C). When a starting parasitaemia of 0.01% was tested, clones 1 and 3 had growth rates again
very similar to that of the parent line; in contrast, clone 4 appeared to be a much slower
growing culture when compared with the parent and the other two lines (Fig 4.9 A). For this
reason, clone 4 was chosen to be recloned in a second experiment, in which some
modifications were introduced with the aim of improving the efficacy of the cloning
procedure.
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The morphological studies of the different culture lines did not show remarkable differences
in proportions of the different forms of the parasite after 7 days in culture.
The results obtained from the GPI analysis are in agreement with observations reported by
Rodriguez and co-workers, who described the presence of a single anodic band of GPI, and
also the presence of lactate dehydrogenase, glutamate dehydrogenase and hexokinase in four
Mexican isolates of B.bovis, including one cloned line (Rodriguez et al, 1986b). In that study
no variation was detected between the isolates with any of the enzymes tested. The presence
of GPI in Babesia parasites is expected as previous reports indicate that glycolysis is the
major pathway of energy production in B.rodhaini (Rickard, 1970). Similar results have been
reported for B.bigemina parasites by Vega and co-workers, who found an identical single
anodic band present in the parent and in three cloned lines of a Mexican isolate (Vega et al,
1986b).
The analysis of isoenzymes has been reported to be a useful tool in discrimination of
subpopulations of other parasites such as Plasmodium (Graves et al, 1984) and Theileria
(Melrose & Brown, 1979), which have shown polymorphism of the parasite-specific
enzymes. However it does not seem to be the case with Babesia, since polymorphism has not
been observed amongst isolates of B. bovis, which were expected to be composed of different
subpopulations as a consequence of passages through splenectomised calves, serial passages
in cultures or cloning by serial dilution (Rodriguez et al, 1986b). The lack of polymorphism
has also been reported for cloned lines of B.bigemina (Vega et al, 1986b) and different
isolates of B.microti (Momen et al, 1979). Therefore, the fact that all the lines of B.bovis
analysed in this study showed the same GPI pattern does not necessarily mean that they are
identical populations; it may be the case that the analysis of enzymatic contents is not a
suitable marker to identify polymorphism of subpopulations in Babesia parasites. On the
other hand, enzymatic characterisation can be very useful in taxonomic studies, especially in
discrimination between morphologically similar species, since inter-species enzymatic
variation between B.bovis and B.bigemina has been reported (Rodriguez et al, 1986b; Vega
et al, 1986b).
The method by which clone 4 was recloned appeared to be more accurate than the first
cloning method used, hence the numbers of positive wells obtained after cloning were similar
to that expected. Amongst the 50 wells inoculated with 0.25 parasites, one would expect to
have parasite growth in 12.5 of them; the results obtained after recloning showed 11 wells in
one plate and 8 wells in the second plate having parasite growth. Nevertheless, none of the
clones obtained after recloning of clone 4 and none of control wells survived after 24 days in
culture.
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The ability of B.bovis parasites (clone 4) which had been kept in the original 25 cm^ flasks to
survive and multiply beyond 24 days in culture, associated with the fact that the control wells
(A and B) in the 96-well plates did not survive, suggests that the culture conditions of the
recloning set wells were not appropriate to maintain established cultures continuously in
vitro. The failure to keep those recloned lines as continuously growing cultures was probably
due to the fact that they had been under reduced C>2 tension for a very long time, rather than
to unsuitability of RBC and serum supplies, which were the same used to feed the cultures in
the flasks. The cloning set wells in 96-well plates were incubated under reduced O2 tension
for 15 days before being screened, and only at that time were the contents of the first positive
wells transferred to 24-well plates and incubated under 5% CO2 in air, which is the standard
gas tension for cultures in the exponential phase of growth. The second detection of clones
was carried out 20 days after the cloning set wells had been initiated and therefore the clones
detected at this time had been under reduced O2 gas tension for 20 days. Such a long period
of reduced O2 incubation may have resulted in cultures with less healthy parasites, which
were unable to multiply continuously in vitro. From other experiments carried out at CTVM
using in vitro cultures of B.bovis, and from published data (Rodriguez et al, 1983), there is
no doubt that the use of a reduced O2 atmosphere is essential for initiation of cultures from a
low parasitaemia (particularly in resuscitation of frozen stabilates); however it is also clear
that as soon as the parasites have become established as a growing culture it is essential to
change the incubation atmosphere to 5% CO2 in air. This fact has been observed especially
with Lismore stock, which is the easiest isolate of B. bovis to re-establish as a growing culture
from frozen stabilates; it requires a shorter period of incubation under reduced O2 tension,
and can if necessary be resuscitated straight into 5% CO2 in air (L.Bell-Sakyi, personal
communication).
Two other parameters of the culture system used for the recloning were different from the
conditions used for cultures in flasks: the PCV and the medium depth. The PCV of cultures in
96-well plates was initially 2% and was increased gradually achieving the standard value of
10% only 8 days after initiation of cultures, whereas the PCV of cultures in the flasks was
always maintained at 10%. The effect of different concentrations of RBC suspensions on
B.bovis growth in vitro has been studied by Goff and Yunker (1986), who reported no
significant differences in growth rates due to variation of PCV; in addition, an increase of the
percentage of iRBC was observed when the PCV of cultures was reduced sequentially during
exponential growth even though the total number of parasites per culture remained the same
(Goff & Yunker, 1986). However in that study, the reduction of the PCV was evaluated using
a growing culture with initial PCV of 10% and a parasitaemia of 1.5%, contrary to the
present study, in which cultures had to be initiated from much lower parasitaemia using a low
initial PCV (2%). The lack of in vitro development of B.bigemina parasites when a PCV of
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2.5% was used has been reported by Vega and co-workers, who found that the optimum PCV
was between 5 and 10%, and suggested that a strong contact or pressure between the RBC is
required for B.bigemina to penetrate new RBC (Vega et al, 1986a). That study also suggests
that variation of PCV affects development particularly of cultures with low number of
parasites (parasitaemia < 0.1%). This also might be the case for B.bovis parasites. The depth
of the medium in 96-well plates was 4 mm (130 pl/well), which according to Rodriguez and
co-workers is the best fluid level to initiate cultures from a low parasitaemia (Rodriguez et al,
1983), whereas the depth of the medium in the flasks was around 7 mm (5 ml/ flask), which
is the fluid level routinely used for cultivation of all three stocks of B.bovis at CTVM. The
reduction of the PCV and medium depth in the 96-well plates could also have contributed to
the failure in maintenance of recloned lines and control wells continuously in vitro.
An analysis of the influence of different environmental conditions on genetically distinct
subpopulations of B.bovis has been published recently in which several samples were
characterised using a recombinant DNA probe specific for a tandemly repeated sequence
located within the BoVAI gene (Dalrymple et al, 1992). In that study it was concluded that
most samples derived from single animals contained more than one genetically distinct
population, although the attenuated strain (Ka), which had been used as a live vaccine for 11
years in Australia, contained only one parasite population. On the other hand the replacement
attenuated vaccine line (Ta), which is in use nowadays, contained two distinct subpopulations
of B.bovis; it was clear that changes in the ratios of subpopulations occur during attenuation
and as a result of in vitro cultivation. Amongst the isolates analysed, one designed Lismore
(W), which had been cultured in vitro, has shown to contain two subpopulations, whereas the
other designed Lismore (LP), which originated from the same field infection as the Lismore
stock used as the parent line in the present study (P.Timms, personal communication), was
shown to contain one genetically homogeneous population. Dalrymple and co-workers also
suggested that increase of virulence cannot be associated with selection of a distinct major
subpopulation of parasites, since although the Lismore (LP) isolate appeared to be more
virulent after being passaged through ticks, no genetic differences were observed. From the
genetic characterisation carried out by Dalrymple and co-workers on the Lismore isolate one
can infer that the parent line used in the present study contained one single population of
B.bovis parasites, and this could be one explanation for the similarity of the cloned lines to
the parent line when analysed by their growth rates, morphology and GPI isoenzyme patterns.
Although clone 4 was used to provide cultured parasite material for evaluation of the effect of
different media (section 4.3) and the incorporation of feeder cells on B.bovis cultivation
(section 4.4), the cloned lines were not further analysed, since it was assumed that all of them
comprised the same homogeneous population as the original isolate (parent).
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4.5 Initiation of b.bows cultures from low parasitaemia blood
During this study, one of the calves inoculated with B.bovis (Mexico) never showed
detectable parasitaemia in smears from blood taken from the jugular vein, although few
parasites (not more than 6 parasites/smear) were seen in smears from peripheral blood (ear
vein) on two occasions (days 7 and 11 after first infection).
Blood for initiation of cultures of B.bovis is usually collected when parasitaemia exceeds
0.1% (Conrad, 1983; L.Bell-Sakyi, personal communication) and the establishment of a
culture of Mexico stock from infected blood when the parasitaemia was less than 0.1% had
only been successful when a BAE feeder layer was used to initiate cultures (Conrad, 1983).
Rodriguez and co-workers have also reported that the standard method for cultivation of
B.bovis does not serve to initiate cultures from blood with a parasitaemia below 0.1% and
have modified some of the culture components, such as gas tension and fluid level in order to
allow the establishment of cultures from small numbers of parasites (Rodriguez et al, 1983).
This experiment was designed to examine the possibility of establishing of B.bovis cultures
from peripheral infected blood with parasitaemia undetectable in Giemsa stained smears,
using 4% C>2 gas tension, which is the gas tension used for resuscitation of stabilates.
4.5.1 Experimental design
Blood from calf 396 (see table 3.1) collected on day 12 after infection with B.bovis (Mexico)
was used to initiate cultures. No parasites were seen in smears made from blood collected
from the jugular vein or from peripheral blood (tail tip capillary blood). Approximately 1 ml
of heparinized blood was collected by ear vein puncture and was spun at 1,000 x g for 10
minutes at 15° C. Plasma, buffy coat and upper 10% of RBC were discarded. The pellet was
resuspended in 1 ml of complete M199-H (see table 3.2) and the suspension was divided
between 6 wells of a 96-well plate (200 plAvell) and incubated under 4% O2 gas. Medium
changes (130 plAvell) were carried out daily and smears were made daily initially from 1
well, and from day 5 onwards from all wells.
On day 5 three wells were each subcultured (1 in 2 dilution with fresh RBC suspension) into
4 additional wells in the same plate, which remained under reduced O2 gas incubation, and
three other wells were subcultured into a 24-well plate by adding the entire contents of each
well (200 pi) to 1.0 ml of fresh 10% RBC suspension. The 24-well plate was incubated under
5% CO2 in air. Medium (1.0 ml/well) was changed and smears were made daily from each
well.
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On day 7 each well in the 96-well plate was subcultured by transferring its entire contents to
wells of the 24-well plate and adding 1.0 ml of fresh RBC suspension as described for day 5.
On day 8 the contents of 3 wells from the 24-well plate were transferred to 3 flasks (25 cm^)
and 4.0 ml of fresh RBC suspension were added to each flask.
4.5.2 Results
The results from the examination of Giemsa stained smears that all six wells of the 96-well
plate contained at least 1 parasite per field 5 days after initiation of cultures, as shown in
Table 4.2.
The three flasks originated from wells in the 24-well-plate were cultured as usual with
medium changes daily and subcultures (1 in 5) with fresh RBC suspension every 2 days. On
day 14 the contents of each flask were cryop reserved (section 3.3.4).
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Table 4.2 Assessment of in vitro growth of B.bovis cultures (Mexico stock) initiated
from infected blood with undetectable parasitaemia.
DAYS
Well No 1 2 3 4 5
1 ND ND ND ND +++
2 ND ND ND ND +++
3 ND ND ND ND +++
4 ND ND ND ND +++
5 ND ND ND ND +++
6 + ++ +++ +++ +++
ND Not determined
+ 3 parasites seen in 100 fields
++ 12 parasites seen in 100 fields
+++ at least 100 parasites seen in 100 fields
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4.5.3 Discussion
In the present study it was possible to establish cultures of B.bovis from low parasitaemia
blood (undetectable by Giemsa stained smears) under an initial incubation atmosphere of 4%
O2 tension and a medium depth of 7 - 8 mm. The incubation under reduced O2 atmosphere
was the critical component for the success in establishment of the cultures, as reported by
Rodriguez and co-workers (Rodriguez et al, 1983), who also initiated cultures from carrier
cattle when no parasites had been seen in blood smears, using reduced O2 gas tension, but a
fluid level of 4 mm, whereas initiation was not possible when a higher O2 atmosphere was
used.
The fact that the blood had been collected from an ear vein might have facilitated the
establishment of the cultures, because parasites had been detected in smears made from
peripheral blood on two occasions before the initiation of cultures (days 7 and 11 after
infection), whereas no parasites had been seen in smears from jugular blood at any time after
infection. The chance of detecting B.bovis increases when smears are made from peripheral
blood rather than from jugular blood, due to the fact that parasitised RBC tend to accumulate
in peripheral veins and capillaries (Mahoney, 1977). This has been applied for the diagnosis
of acute B.bovis infections. Despite the lack of clinical disease, calf 396 developed high titres
of specific antibodies, shown by IFAT and ELISA, which increased after each challenge (as
described in Chapters 6 and 8). The fact that calf 396 had not been splenectomised probably
contributed to such low parasitaemia.
Furthermore, the lack of patent parasitaemia and clinical signs observed might be related to
low virulence of the cultured parasites used for the primary infection and subsequent
challenges. In vitro cultivation of B.bovis in the presence of horse serum has been
demonstrated to attenuate the parasite (Yunker et al, 1987), and cloning by in vitro
cultivation always results in less pathogenic lines (Pipano, personal communication). Thus,
as the Mexico stock of B. bovis used here had been maintained in culture on several occasions
since its original isolation, it is possible that less pathogenic parasite populations were
selected.
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4.6 IN VITRO CULTURE OF STOCKS OF B.BIGEMINA
4.6.1 Zaria stock
4.6.1.1 Experimental design
A series of experiments was carried out in which blood samples collected from one calf
infected with B.bigemina (Zaria) blood stabilate (calf 397, as referred in Table 3.1) were
used for initiation of cultures under several combinations of culture medium and serum
concentrations at two different gas tensions.
The culture media (GIBCO) tested in this study included:
- Ml99 with Hanks salts and 25 mM HEPES (M199-H) cat No 04102350H
- Ml99 with Earle's salts and 25 mM HEPES (M199-E) cat No 041-02340H
- Ml99 with Hanks salts (M199-IC) cat No 041-01151H
- RPMI 1640 with 25 mM HEPES (RPMI) cat No 041-02400H
Cultures were initiated on three consecutive days using jugular blood collected from day 5 to
day 7 after infection, when paras itaemias estimated in Giemsa stained smears were less than
0.1%.
For the first attempt to establish cultures (on day 5 after infection), defibrinated and
heparinized blood were collected and prior to initiation of cultures the blood was pre-treated
with PIGA buffer (Appendix 1) (Montenegro-James, personal communication) by adding one
volume of buffer to 10 volumes of blood and incubating the suspension at 37° C for 1 hour.
The blood was then spun at 1,000 x g for 10 minutes at 15°C; these centrifugation conditions
were used throughout the study, unless otherwise specified. The serum/plasma, buffy coat
and upper 20% of RBC were discarded. The erythrocytes were washed twice with M199-H
by centrifugation, under the same conditions as above, and RBC suspensions, with PCV of
both 5 and 10%, were prepared in either M199-H supplemented with 20 or 40% NBS or in
RMPI also supplemented with 20 or 40% NBS. This resulted in 8 different culture media
with defibrinated blood and 8 with heparinized blood (4 with PCV of 5% and 4 with PCV of
10% for each type of blood). Each RBC suspension was used to initiate cultures in 24-well
plates (1.2 ml/well) incubated under 4% C>2 gas tension. The overlying medium in each well
was changed daily by removal and replacement of 1 ml with fresh medium and Giemsa
stained thin smears (as described in section 3.3.3) were made daily. Fifty microscope fields
from each smear were examined at 500 x magnification for assessment of parasite growth.
For the second initiation of cultures, defibrinated blood was collected (on day 6 after
infection) and centrifiiged. The serum, buffy coat and upper 20% of RBC were discarded.
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The packed RBC were washed twice by centrifugation with PIGA buffer and cultures were
set up in 24-well plates (1 ml/well) as a 10% RBC suspension in either M199-H or RPMI
1640 supplemented with the following proportions ofNBS:









The decision to use defibrinated blood and culture media with less NBS, was based on the
results obtained from the first attempt (as described in 4.2.3). Incubation conditions and
assessment of parasite growth were identical to those previously described.
For the third and last attempt to establish Zaria stock of B.bigemina in culture, defibrinated
blood was collected (on day 7 after infection) and centrifiiged. The serum (designated
autologous serum) was kept while the buffy coat and upper 20% of RBC were discarded.
Half the packed RBC was used to prepare a 10% RBC suspension in autologous serum and
the other half was incubated with an equal volume of PIGA buffer at 37°C for 1 hour. The
resulting suspension was then centrifiiged at 1,000 x g for 10 minutes. The supernatant was
removed and the packed RBC (treated with PIGA) were used to prepare a 10% RBC
suspension in autologous serum. Each of the RBC suspensions (with and without PIGA
treatment) was then diluted with three different media: M199-E, M199-E to which 1.4 g/1 of
NaHCC>3 were added (M199-ES) and RPMI as followed:





M199-ES (0.90 ml) 0.40 ml — 28
M199-E (0.45 ml) 0.40 ml 0.45 ml 62
M199-E (0.45 ml) +
RPMI (0.45 ml)
0.40 ml — 28
RPMI (0.45 ml) 0.40 ml 0.45 ml 62
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Each aliquot of the final suspension (1.3 ml with PCV of approximately 3%) was used to
initiate a culture in a 24-well plate. The plate was incubated under 5% CO2 in air. After 24
hours of incubation, the overlying medium (~ 1 ml) of each well was removed and the same
volume of each corresponding fresh medium replaced. Giemsa stained thin smears were
prepared for parasitaemia estimation. These procedures were done over a three day period.
Fifty microscope fields of each smear were examined at 500 x magnification.
4.6.1.2 Results
From the examination of Giemsa stained smears taken 24 hours after the first initiation of
cultures, it appeared that cultures initiated from defibrinated blood in M199-H supplemented
with 20% NBS resulted in survival of higher number of parasites, as shown in Table 4.3. No
parasites were seen in cultures with 10% PCV in M199-H supplemented with 40% NBS,
whether initiated from defibrinated or heparinized blood; a few parasites survived under these
conditions with a 5% PCV. However examination of smears after a 48 hour incubation
period, showed that none of the culture media supported parasite growth, regardless of
whether heparinized or defibrinated blood with a PCV of 5 or 10% was used to initiate
cultures.
In the second attempt to initiate cultures, in which several concentrations of NBS were tested
in different combinations with M199-H, RPMI and PIGA buffer, none of the conditions
supported parasite survival after 24 hours.
Results from the third attempt to establish cultures showed that all the culture conditions
tested supported parasite survival for 24 hours. However a much lower number of parasites
were seen in cultures initiated with RBC which had been pre-treated with PIGA, suggesting
that the PIGA contributed to parasite killing. Cultures with untreated RBC in M199-ES
(Ml99 with Earle's salts supplemented with 1.4 g/1 of NaHC03) containing approximately
28% of autologous serum, contained more parasites than the other media (Table 4.4). Under
these conditions some parasites survived at least for 48 hours. However examination of
cultures at 72 hours after initiation showed that none of conditions supported parasite
survival.
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Table 4.3 Assessment of in vitro cultures of B.bigemina (Zaria stock) with a PCV of
10% or 5%, under different culture media.
PCV
Type of blood Culture medium 10% 5%
24 hours 48 hours 24 hours 48 hours
defibrinated M 199-H, 20% NBS ++ - + -
M 199-H, 40% NBS - - + -
RPMI, 20% NBS + - + -
RPMI, 40% NBS + - + -
heparinized M 199-H, 20% NBS + - + -
M 199-H, 40% NBS - - + -
RPMI, 20% NBS - - - -
RPMI, 40% NBS + - - -
Key: + at least 1 parasite seen per smear
++ at least 10 parasites seen per smear
no parasites seen
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Table 4.4 Assessment of in vitro cultures of B.bigemina (Zaria stock) under different
culture media.





Non-treated M199-ES, 28% serum +++ + -




RPMI, 62% serum + - -
Treated with PIGA M199-ES, 28% serum +/- - -




RPMI, 62% serum +/- - -
Key: +++ more than 20 parasites seen
++ 10 to 20 parasites seen
+ 5 to 10 parasites seen





Blood used for initiation of cultures of B.bigemina (Muguga stock) was collected from one
calf (calf 634, as referred in Table 3.1) which had been infested with larvae of Boophilus
decoloratus, as described in section 3.2.2. The larvae were provided by the National
Veterinary Research Centre, Kenya, and derived from females which had engorged on an
intact calf infected with B.bigemina (Muguga) 18 days after ticks were applied to the calf.
The ticks used had been shown to be free from all tick-borne diseases by feeding on
susceptible calves for two generations. Females were allowed to lay eggs at 28°C and once
the larvae had hatched they were kept at 18°C until transport to CTVM. Defibrinated jugular
blood was collected from calf 364 when the parasitaemia detected in Giemsa stained smears
was less than 0.1% (on days 19 and 20 after larval infestation). The blood was centrifuged
and the serum was kept (autologous serum). The buffy coat and upper layer of RBC were
discarded as described in previous experiments.
The pelleted RBC were used to prepare 5% RBC suspensions in either autologous serum or
in M199-ES and RPMI, both supplemented with 30% autologous serum and cultures were
set up in 24 well plates (1.3 ml/well). The plates were incubated under an atmosphere of 5%
CC>2 in air. The overlying medium of each well was changed and thin Giemsa stained smears
prepared and examined daily over a period of three days.
4.6.2.2 Results
None of the culture conditions tested supported parasite survival, since no parasites were seen
at 24 or 48 hours after initiation of cultures.
4.6.3 Mexico stock
The third isolate of B.bigemina (Mexico), originally established in culture in 1985 (Vega et
al, 1985a), was obtained in 1992 as a growing culture suspension from Imperial College
(London) and cultured using the same conditions used at Imperial College, i.e. as a 10% RBC
suspension in M199-IC, to which 15 mM HEPES were added, supplemented with 40% NBS,
under an atmosphere of 5% CO2 in air; the overlaying medium was changed daily and
subcultures were carried out every 2-3 days. An experiment was carried out at Imperial
College, by which several combinations of RBC suspensions and serum samples from three
cows maintained at CTVM (110, 16 and Split Ear) were tested in order to identify the most
108
suitable donor(s) of RBC and serum for maintenance of the cultures at CTVM. Results from
this experiment showed that all combinations of RBC and sera supported in vitro growth of
B.bigemina. However, the combination of RBC and serum taken from the two-year-old
purebred Jersey (Split Ear) resulted in slightly higher parasitaemias of cultures (A.Gunn,
personal communication). Thus, this animal was used for provision of both RBC and sera for
maintenance ofB.bigemina (Mexico) cultures at CTVM.
Typical parasitaemias observed in Giemsa stained smears from growing cultures were 2-3%
and 4-7% at respectively 24 hours and 48 hours after subculture. Subcultures were carried
out at a dilution of 1 in 5, resulting in reduction of parasitaemia to approximately 1%. Two
types of culture vessels were used: 25 cm^ flasks containing 5 ml of culture suspension,
which were incubated vertically, and 75 cm^ flasks containing 40 ml of culture suspension,
which were incubated horizontally.
4.6.4 Discussion
The Mexican isolate of B.bigemina obtained from Imperial College was successfully
maintained at CTVM as a growing culture, achieving parasitaemias of 4-7%. Cultures of
B.bigemina were bulked up on several occasions for provision of i) culture supernatant,
which was analysed by high performance liquid chromatography (HPLC) (described in
Chapter 6); ii) iRBC, which were concentrated by density gradient centrifugation (described
in Chapter 5) and used for preparation of samples for electrophoresis; Hi) infected cells for
metabolic labelling experiments; and iv) culture suspension with which conditions for
induction of free merozoites were evaluated.
Although many attempts were made to establish cultures of the two African isolates of
B.bigemina using several combinations of RBC and serum donors, culture media and gas
tensions, the conditions used did not allow the establishment of a B.bigemina culture system
for these two isolates. The source of the NBS did not appear to be a detrimental factor in the
culture system, since sera from the same two cows that did not support survival of Zaria and
Muguga parasites proved to be suitable for cultivation of the Mexican stock ofB.bigemina.
After so many unsuccessful attempts, it seems that the major limiting factor was related to the
isolates themselves, since none of the conditions tested could support survival of parasites for
more than 48 hours and in no case was there any sign of parasite multiplication.
The African isolates used in this study are naturally transmitted to cattle by Boophilus
decoloratus ticks, while the isolates which have been established in vitro so far are naturally
transmitted by Boophilus microplus (Vega et al, 1985a; Montenegro-James et al, 1987;
Jorgensen et al, 1992) or by B.annulatus (Fish et al, 1992). This fact might suggest that the
Muguga and Zaria isolates are different metabolically from those already cultured and may
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have different requirements for an in vitro cultivation system. Furthermore, the rate of
success in establishing isolates of B.bigemina from infected blood as continuous in vitro
cultures appears to be very low; in Israel, for instance, it has been reported that an average of
30 attempts are required for each successful in vitro establishment (E.Pipano, personal
communication).
The successful cultivation of the Mexican isolate of B.bigemina under conditions very similar
to those that had failed to support in vitro survival of the two African isolates, associated
with the low rates of establishment of new isolates in culture gives further evidence that
different isolates may have different requirements for an in vitro cultivation system and
points to the need for further investigations on physio/metabolic aspects of B.bigemina
parasites, which could optimise the culture system in order to make it suitable for the
establishment of more isolates from the field.
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4.7 Conclusions
The studies on the effect of calf sera on B.bovis cultivation showed that sera from calves
between 4 and 7.5 months of age, with only one exception, were able to support parasite
growth in vitro in established cultures over a period of 6 days. The serum from a 6-month-old
calf which did not support B.bovis growth in one experiment proved to support parasite
growth when the same calf was 7.5 months old. The presence of anti-Babesia antibodies in
the calf sera did not affect B.bovis growth in vitro. These results suggest that sera from
immune calves with antibodies detectable by IFAT might be of use for cultivation of B.bovis
parasites in endemic areas, where the identification of a suitable seronegative adult donor may
constitute the major limitation for the implementation of a culture system.
The attempts to increase parasitaemias of B. bovis cultures, by the incorporation of cell feeder
layers, showed that BAE, contrary to expectation, did not affect the growth of established
cultures. Mouse peritoneal wash cells (MPWC) had no effect on resuscitation of culture
stabilates. However, they promoted increase in parasitaemias of established cultures of all
three stocks of B.bovis when used at concentrations of 10^ and 10^ cells/ml. Moreover, the
incorporation of MPWC into cultures of the Lismore and Mexico stocks resulted in fewer
pycnotic parasites, which are an indication of unhealthy cultures. Nevertheless, the increase
in parasitaemias obtained with the incorporation of MPWC in established cultures was much
less proportionately than that reported for Plasmodium spp (Trenholme & Phillips, 1989) and
their use as a promoter of B.bovis growth in vitro was not considered worthwhile for the
purposes of this study. On the other hand, in the present study the MPWC did appear to have
a beneficial effect on B.bovis in vitro, suggesting that the incorporation of MPWC, as
reported for Plasmodium spp, might facilitate the establishment of field isolates of B.bovis
which may contain populations of parasites that are more difficult to grow in vitro.
The cloning by limiting dilution of the Lismore stock of B.bovis resulted in six cloned lines;
however the evaluation of their growth rates, morphology and presence of isoenzymes did not
distinguish any of them from the parent line.
The procedure by which one of the cloned lines was recloned was shown to be more accurate
than that initially used for cloning, hence the number of positive wells obtained was closer to
that expected. However, none of the recloned lines were able to multiply continuously beyond
24 days in culture. This finding indicates that in this case the culture conditions used for
initiation of cultures from a single parasite were not appropriate for support of continuous
parasite multiplication, and points to the importance of changing the culture conditions as
soon as the parasites have begun to multiply appreciably.
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Although one cloned line was used as the source of parasites in some experiments, it was
assumed on all the evidence available that the cloned lines were not different from each other
and therefore the clones were not included in the comparative immunochemical analysis.
Furthermore, a study by Dalrymple and colleagues found, by genetic analysis, that the
original Lismore isolate contained only a single parasite population (Dalrymple et al, 1992).
A culture of B.bovis (Mexico) was successfully established in vitro from blood collected
from an ear vein of an infected calf, when no parasites were detected in Giemsa stained blood
smears. Though no attempt was made to set up cultures from jugular blood at the same time,
this might suggest that the use of peripheral blood for initiation of B.bovis cultures might
facilitate the establishment of field isolates in vitro; further investigations with comparison
between the success rates for establishment of cultures from jugular and peripheral ear vein
blood would be needed to confirm this hypothesis.
The Mexico stock of B.bigemina (Vega et al, 1985a), obtained as a growing culture
suspension from Imperial College, was successfully maintained continuously in vitro at
CTVM, with parasitaemias between 4 and 7%. The ability to grow this stock of B.bigemina
continuously in vitro represented an important achievement in the provision of a reliable
source of parasites for use during the immunochemical analysis, which was the basis for the
identification of species-specific parasite components with potential use as immunodiagnostic
targets (as described in Chapters 6 and 7). Although the Mexico stock of B.bigemina was
obtained late in the present study, it was possible to use it in a series of experiments in which
different attempts were made to concentrate parasites or iRBC in order to obtain parasite-rich
preparations for use in immunochemical analyses. These attempts are described in Chapter 5.
All the attempts made in the present study to establish the two African isolates of B.bigemina
(Zaria and Muguga) as continuous cultured lines were unsuccessful, with suggestions of
remarkable differences between the Mexican and the African isolates. This was based on the
failure of Zaria and Muguga parasites to survive beyond 48 hours under culture conditions
very similar to those used for cultivation of the Mexican stock. The lack of success in
establishing the African isolates indicates that the culture system developed for B.bigemina
(Vega et al, 1985) may not be suitable for the establishment of different isolates and points to
a need for further studies on the in vitro requirements of B.bigemina parasites.
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CHAPTER FIVE
CONCENTRATION OF BABESIA PARASITES
5.1 Introduction
The in vitro culture systems developed for B.bovis (Levy & Ristic, 1980) and for B.bigemina
(Vega et al, 1985a) still provide relatively low percentages of iRBC making necessary the
development of methods of parasite concentration in order to obtain parasite-rich material
with less host contamination for use in immunochemical studies. These methods have focused
on the concentration of either free parasites, or iRBC from which the parasite can be isolated
by a lysis process.
Concentration of B.bovis iRBC has been achieved by differential lysis of non-infected RBC
with hypotonic solutions (Mahoney, 1967a; Kahl et al, 1982a). However the same method
has not been successfully applied to B.bigemina (Mahoney, 1967b; Wright, 1973b). A
procedure for differential lysis of uninfected RBC using KC1, followed by the lysis of
concentrated iRBC with NH4CI, has been routinely used at CTVM for preparation of crude
ELISA antigen of B.bovis and samples for electrophoresis analysis (see section 3.6.1.1).The
efficacy of these methods has been satisfactory, allowing concentration of parasitized cells.
However all the chemical lysis procedures will affect original characteristics of the Babesia
parasites, both structural and biochemical. Therefore, in cases where the preservation of the
original structure of the parasites is desired, such as in studies of merozoite surface
components, alternative methods based on accumulation of free merozoites in the culture
supernatant have been proposed (Levy & Ristic, 1980; Winger et al, 1987). Such methods,
which are based on deprivation of cultures of CO2, had never been tested at CTVM, and in
the present study some modifications to the method reported by Winger and co-workers for
B.divergens (Winger et al, 1987) were evaluated in an attempt to use the induction of free
merozoites as an alternative method of purification of both B.bovis and B.bigemina parasites.
Alternative methods for concentration of B.bigemina infected erythrocytes include a
procedure of filtration of infected blood through a dextran sulphate-agarose affinity column,
by which eluted suspensions contained up to 95% iRBC (Goodger et al, 1989), and the
exposure of iRBC to glycerol-enhanced osmotic shock to free the parasites, which were then
concentrated by density gradient centrifugation (Figueroa et al, 1990a).
Density gradient centrifugation has been used as a method for separation and purification of
cells, viruses and subcellular particles by exploiting differences in their density or size. The
use of colloidal silica suspensions as centrifugation media was first reported by Mateyko and
Kopac (1963); however, it was found later that those suspensions were unstable in salt
solutions at physiological pH and that they were toxic to cells (Wolff, 1975). The
development of Percoll (Pharmacia), which consists of colloidal silica particles of 15-30 nm
diameter coated with polyvinylpyrrolidone (PVP), allowed the use of modified colloidal silica
solutions to generate density gradients completely non-toxic to cells (Pertoft et al, 1978).
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Since then, density gradient centrifugation using Percoll has been used to separate different
populations of cells (Segal et al, 1980; Ellis et al, 1984) and also to concentrate parasites
such as Trypanosoma (Castanys et al, 1984), Plasmodium (Kramer et al, 1982; Saul et al,
1982), Anaplasma (Davis et al, 1978) and sporozoites of Theileria from ticks (Walker &
McKellar, 1981; 1983).
Percoll has also been used to concentrate Babesia parasites. Vega and co-workers reported
that B.bigemina iRBC were concentrated at least 20 times by Percoll and Percoll-Renografin
density gradients and that erythrocytes containing pairs of parasites were concentrated at a
density between 1.076 and 1.089 g/ml, whereas erythrocytes containing a single parasite were
concentrated at a density between 1.092 and 1.100 g/ml (Vega et al, 1986b). Later the same
method was used to concentrate B.bigemina iRBC which were then lysed by glycerol -
enhanced osmotic shock making possible the purification of erythrocytic stages of that
parasite (Figueroa et al, 1990a). A similar use of Percoll density gradient centrifugation has
been reported for concentration of B.bovis free merozoites and iRBC (Rodriguez et al,
1986a). In that study, the free merozoites were concentrated at a point corresponding to about
1.087g/ml specific density, whereas most of the iRBC were positioned between 1.121 and
1.123 g/ml. More recently, Bhushan and co-workers reported the use of Percoll gradients to
concentrate B.caballi iRBC, which were located at the interface between densities of 1.080
and 1.115 g/ml (Bhushan et al, 1991).
There are several procedures by which Percoll can be used to generate density gradients. The
two procedures used in the experiments described in this chapter were: i) a discontinuous
gradient, by which solutions of different densities are prepared and carefully layered one on
top of another, usually starting with the heaviest, and the cell preparation is then layered on
top of the gradient, followed by centrifugation at usually between 400 and 2,000 x g; and ii) a
continuous gradient formed in situ during the centrifugation, by which a solution of Percoll
with a particular density is prepared, mixed with the cell preparation and the mixture is
centrifuged in an angle-head rotor at a high speed (> 25,000 x g). The density gradient
pattern is dependent on the initial density of the solution, characteristics of the rotor and
running conditions. Usually a tube containing density markers is used to monitor the gradient
formation.
The experiments described in this chapter were designed to compare the efficiency of the
accumulation of free merozoites in culture supernatant with both discontinuous and
continuous density gradient centrifugation to concentrate RBC infected with B.bovis and
B.bigemina for provision of parasite-rich preparations for immunochemical studies.
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5.2 INDUCTION OF FREE MEROZOITES IN CULTURE SUPERNATANT
5.2.1 B.bovis
5.2.1.1 Materials and methods
Five ml of a B.bovis (Lismore) culture, as a 10% RBC suspension in complete M199-H (see
Table 3.2) with a parasitaemia of 5%, were left in air at room temperature in a glass
universal container for 4 hours. The culture was spun at 200 x g for 10 minutes at 4°C. The
pellet (PI) was retained and the supernatant (SI) was spun at 400 x g for 10 minutes at 4°C.
The upper 3 ml of the second supernatant (S2) and the second pellet (P2) were retained and
S2 was spun again at 1,000 x g for 20 minutes at 4°C. The final supernatant (S3) and final
pellet (P3) were retained. Cytospin smears (as described in section 3.3.3) were prepared from
each of the supernatants and blood smears were prepared from each of the pellets.
The final pellet (P3) was resuspended in 600 pi of a 10% RBC suspension in complete
M199-H (see Table 3.2) and divided between 3 wells of a 96-well plate (200 pi/ well) in
order to check the infectivity of the free merozoites. The plate was incubated under 5% CO2
in air and medium was changed daily (130 pl/well). From day 2 smears were made daily from
each well.
The same procedure of induction of free merozoites was repeated using 5 ml of a B.bovis
(Lismore) culture suspension which had been left in air at room temperature overnight
(approximately 16 hours).
5.2.1.2 Results
The examination of smears showed that when the culture suspension was deprived of CO2
overnight more free merozoites were released into the culture supernatant than when a 4 hour
period was used. This was inferred from the detection of fewer intact iRBC in the first pellet
(PI) from cultures left overnight without CO2 than from cultures which had been left for 4
hours.
The examination of smears from each of the supernatants and pellets after both CO2
deprivation times showed the following results:
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SI high concentration of free merozoites + RBC membranes + few
intact uninfected RBC
PI intact RBC (infected + uninfected)
S2 high concentration of free merozoites + RBC membranes
P2 some free merozoites + RBC membranes + few intact RBC
S3 RBC membranes
P3 high concentration of free merozoites + RBC membranes
The final pelleted free merozoites (P3) after both CO2 deprivations were shown to be
infective, with all three wells in each of the 96-well plates showing parasite growth after 2
days of culture.
5.2.2 B.bigemina
5.2.2.1 Materials and methods
Two 5 ml aliquots of B.bigemina (Mexico) culture suspension, as a 10% RBC suspension in
M199-IC (see Table 3.2), with a parasitaemia of 7%, were left in air in plastic bijou
containers for 6 hours either at room temperature or at 37°C. Both cultures were then
centrifuged at 200 x g for 10 minutes at 4°C. The supernatants (Sib) and the pellets (Plb)
were retained and Sib supernatants were spun at 400 x g for 5 minutes at 4°C. The upper 3
ml of each supernatant (S2b) and the pellets (P2b) were retained and S2b supernatants were
spun again at 1,500 x g for 20 minutes at 4°C. The final supernatants (S3b) and final pellets
(P3b) were retained. Cytospin smears were prepared from each of the supernatants and blood
smears were prepared from each of the pellets.
5.2.2.2 Results
The results obtained showed that when the culture suspension was deprived of CO2 at room
temperature more free merozoites were released into the culture supernatant than when it was
deprived of CO2 at 37°C. This was inferred from detection of fewer intact iRBC in the first
pellet (Plb) from cultures left at room temperature than from the culture which had been
deprived from CO2 at 37°C. However the accumulation of free merozoites of B.bigemina in
the culture supernatant after the cultures had been deprived of CO2 for a period of 6 hours
was not very efficient, since a large proportion of parasites remained inside erythrocytes after
CO2 deprivation.
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The examination of smears from each of the supernatants and pellets after both CO2
deprivation conditions showed results very similar to that obtained with B.bovis and are
presented below:
Sib high concentration of free merozoites + RBC membranes + few intact
uninfected RBC
Plb intact RBC (infected + uninfected)
S2b high concentration of free merozoites + RBC membranes
P2b RBC membranes + few intact RBC + few free merozoites
S3b RBC membranes
P3b high concentration of free merozoites + RBC membranes + few intact RBC
Cytospin smears of culture supernatants (SI and Sib) of B.bovis and B.bigemina after CO2
deprivation are shown in Fig 5.1.
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, , after CO, deprivation. A is from a B.bovls„ 5 lCy*spin smears of culture supernatant after
.iitnre. and B is from a B.&igewincr culture.
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Fig 5.1
5.3 Use of density gradients to concentrate infected red blood
cells
5.3.1 Continuous gradients
5.3.1.1 Materials and methods
a. Experiment 5.1 (B.bigemina infected blood)
A 90% (v/v) isosmotic Percoll solution (P-iso 90) was prepared by mixing 90 volumes of
stock Percoll (Pharmacia) with 10 volumes of sterile 1.5M NaCl to obtain a density of 1.123
g/ml (manufacturer's recommendation). The P-iso 90 solution was adjusted to a density of
1.095 g/ml by mixing 10 volumes of P-iso 90 with 3.146 volumes of 0.15M NaCl. The
resulting solution had a concentration of 68.46% (v/v) Percoll (P-iso 68.46). Approximately
9.5 ml of P-iso 68.46 solution were used to fill each of 4 polycarbonate tubes (15 x 75 mm).
Jugular blood from a splenectomised calf 583 taken 5 days after infection (see Table 3.1),
showing a parasitaemia of 0.6% B.bigemina (Zaria)-infected RBC, was defibrinated and
centrifuged at 1,000 x g for 10 minutes at 4° C. Serum, buffy coat and the upper 10% of
packed RBC were discarded. The remaining RBC were washed with PBS by centrifugation
as described before. Approximately 1.0 ml of the packed washed RBC was added to each of
3 tubes containing P-iso 68.46. One ml of a mixture of density marker beads (Pharmacia,
1.098, 1.087, 1.076 and 1.064 g/ml) was added to the 4th tube. The tubes were then sealed.
One each of the three RBC tubes was centrifuged, with the marker bead tube, at 30,000 x g
at 4° C for 7, 13 or 26 minutes respectively, in a Beckman L-8-60M ultracentrifiige, using a
fixed angle rotor (type 65), without braking. Representative layers were collected using a
syringe and needle and the cells were washed by centrifugation (2,000 x g for 15 minutes at
4°C) with 20 ml of PBS to remove the Percoll. Cytospin smears (as described in section
3.3.3) were made and examined.
The same procedure was repeated with blood taken 7 days after infection, when the
parasitaemia was 0.4%. Four tubes containing P-iso 68.46 (3 for B.bigemina packed RBC
and 1 for marker beads) were set up exactly as described before and were centrifuged at 8, 12
or 16 minutes under the same conditions as described before. Collection and examination of
representative layers were carried out as described above.
b. Experiment 5.2 (B.bigemina culture suspension)
For this experiment P-iso 68.46 was prepared as described in experiment 5.1 and was used to
fill 12 tubes (polyallomer tubes, 5/8" x 3", 11 ml capacity). One hundred and twenty ml of
B.bigemina (Mexico) culture suspension, with a parasitaemia of 5% and harvested at 48
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hours after subculture, were centrifuged at 1,000 x g for 10 minutes at 4°C. The culture
supernatant was discarded and 1 ml of the packed RBC was added to each of 11 tubes. One
ml of a mixture of marker beads, which included one extra density marker of 1.051 g/ml to
the ones already used in experiment 5.1, was added to the 12th tube. The RBC suspension
used for the B.bigemina cultures had previously been cleared of leucocytes aseptically by
passage through a sterile glass column containing cellulose powder (CF-11) (as described for
preparation of B.bovis samples for electrophoresis in section 3.6.1.1). The 12 tubes were
centrifuged at 30,000 x g for 13 minutes at 4°C in a Beckman ultracentrifiige, using a fixed
angle rotor (type 70 Ti), without braking. The resulting 8 bands (see Fig 5.4) from each of
the 11 tubes were collected, pooled to give 8 samples and the cells washed by centrifugation
with PBS as described before. Cytospin smears were made from each of the 8 samples.
5.3.1.2 Results
The formation of the density gradients after 7, 8, 12, 13, 16 and 26 minutes of centrifugation,
monitored by the coloured marker beads, is represented in Fig 5.2.
The appearance of the density gradients obtained after centrifugation with B.bigemina
infected blood (experiment 5.1) is represented in Fig 5.3. The results from cytospin smears
showed that under the conditions used the most suitable centrifugation time for separating
infected from uninfected RBC was 13 minutes, by which time most of the B.bigemina iRBC
were concentrated at a specific density between 1.064 and 1.076 g/ml. Cytospin smears made
from that specific density layer (shown in Fig 5.4) had a parasitaemia of approximately 90%
and a few free merozoites were present. After a centrifugation period of 16 minutes, fewer
iRBC and more free merozoites were seen in a pale layer which had a density close to 1.076
g/ml. The majority of the uninfected RBC were concentrated at densities higher than 1.087
g/ml in all centrifugation times.
The density gradients obtained from centrifugation of B.bigemina culture suspension
(experiment 5.2) are represented in Fig 5.5. The cytospin smears showed that most of the
iRBC were located in 4 layers which had densities corresponding to the layer between 1.087
and 1.098 g/ml in the marker bead tube. However, concentration of infected RBC was also
detected in other layers located at densities between 1.076 and 1.087 g/ml. Nearly all
uninfected RBC were concentrated at a density higher than 1,098g/ml.
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Fig 5.2 Development of gradients of a 68.46% Percoll solution during centrifugation at
30,000 x g for 7, 8, 12, 13, 16 and 26 minutes. Gradient densities were monitored by
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Fig 5.3 Diagrammatic representation of continuous density gradients obtained after
centrifugation of B.bigemina infected blood (starting parasitaemia of 0.6%) at 30,000 x g for
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Key: iRBC - infected red biood cells
uRBC - uninfected red blood cells
RCM - red blood cell membranes
fm - free merozoites





Fig 5.4 Cytospin smear of concentrated B.bigemina infected erythrocytes collected from a
layer corresponding to a density between 1.064 and 1.076 g/ml (layer 9 in Fig 5.2) from a




Fig 5.5 Photograph of a tube containing marker beads (A) and a tube containing B.bigemina
culture material (B) after continuous density gradient centrifugation (Experiment 5.2).
1- leucocytes
2- leucocytes + few infected RBC
3- few infected RBC












5.3.2.1 Materials and methods
a. Experiment 5.3 (B.bigemina infected blood)
Dilutions of Percoll in Hanks balanced salt solution (HBSS) (GIBCO) with bovine plasma
albumen (BPA, Sigma) were prepared as follows:
a) 0.5 g of BPA and 0.001 g of sodium bicarbonate were added to 5 ml of 10 x concentrated
HBSS. The solution (HBSS/BPA) was sterilised by filtration through a 0.22 pm filter
(Millipore)
b) a stock isotonic Percoll solution (SIP) was prepared by mixing 20 ml of sterile Percoll with
2 ml of the HBSS/BPA and the pH was adjusted to 7.2 with sterile 1M HC1
c) 2 ml of the HBSS/BPA solution were added to 18 ml sterile distilled water to give a 1 x
HBSS solution with 1% BPA (Hanks/BPA)
d) based on results obtained in experiment 5.1, a range of step dilutions were prepared by
mixing SIP and Hanks/BPA in order to give the required densities as followed:





* density of 1.121 g/ml
** density of 1.010 g/ml
Five ml of each step density were layered in each of 2 universal tubes at an angle of 45° in a
modified rack, in order of decreasing density starting with the most dense step (1.121 g/ml).
Defibrinated blood taken from calf 583 on day 5 after infection, showing a parasitaemia of
0.6%, was centrifuged and prepared as described in experiment 5.1. Two and a half ml of
packed RBC were resuspended in 2.5 ml of Hanks/BPA and were layered onto the top of
each tube containing the step gradients. The tubes were centrifuged at 4° C, one at 750 x g
for 15 minutes and the other at 1,500 x g for 30 minutes in a swing-out rotor. The bands
obtained were collected using a Pasteur pipette and the cells were washed by centrifugation
with PBS as described before. Cytospin smears were made from each band.
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b. Experiment 5.4 (B.bovis culture suspension)
A previous report on concentration of B.bovis iRBC and free merozoites by the use of Percoll
gradient centrifugations showed that they concentrated at densities ranging between 1.087 and
1.123 g/ml (Rodriguez et al, 1986a). Thus, the following step density solutions (as described
in experiment 5.3) were prepared for the present experiment:




Two ml of each density were layered in a universal tube, starting with the most dense step, as
described in experiment 5.3. Ten ml of a B.bovis culture suspension, with a parasitaemia of
5.5%, were centrifuged at 1,000 x g for 10 minutes at 4°C. The supernatant was discarded
and the packed RBC were resuspended in 1.0 ml of Hanks/BPA, and carefully layered onto
the top of the step density gradient. The tube was centrifuged at 1,500 x g for 1 hour at 4° C.
Cytospin smears were made from each resulting layer.
5.3.2.2 Results
a. Experiment 5.3 (B.bigemina infected blood)
Discontinuous gradient centrifugation at 1,500 x g for 30 minutes with B.bigemina infected
blood resulted in 3 bands, which were identified by their position from the top to the bottom
of the tube. The first one was pale and located below the least dense step (1.050 g/ml). The
second was a narrow pink band which was followed by a third red condensed band, both
located at the interface between the two most dense steps (1.095 and 1.121 g/ml) (Fig 5.6A
and 5 .6B). The examination of cytospin smears showed that the first band (1) contained a few
free merozoites, a few iRBC and a few uninfected RBC. The second band (2) contained
uninfected RBC and the third band (3) contained mainly uninfected RBC and very few
infected cells.
After centrifugation of B.bigemina infected blood at 750 x g for 15 minutes , no interfaces
were seen between any of the density steps; however two bands were located within two
intermediate density steps (1.095 and 1.070 g/ml) (Fig 5.6C). The first was red and
condensed and the second also red but less condensed. Cytospin smears from the first band
revealed the presence of uninfected RBC and some free merozoites at the top (4), and
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uninfected RBC at the bottom of the band (5). The second band contained uninfected RBC
and a few merozoites (6). Separation of B.bigemina iRBC after centrifugation at 750 x g for
15 minutes was even poorer than at 1,500 x g for 30 minutes and concentration of
B.bigemina iRBC or free merozoites was not achieved.
b. Experiment 5.4 (B.bovis culture suspension)
The results obtained from B.bovis culture suspension are presented in Fig 5.7. The results
from cytospin smears showed that a few free merozoites and some uninfected RBC were
present in the 1.060 g/ml density step (1). Most of the RBC were located at the interface
between the two most dense steps (1.121 and 1.105 g/ml). Two bands were seen at this
interface: the first (4) contained mainly iRBC with pycnotic parasites and the second (5)
contained iRBC with a parasitaemia of approximately 8% with pairs or single parasites. A
few uninfected RBC were also seen in the most dense step (6).
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Fig 5 .6 Diagrammatic representation of a discontinuous density gradient showing tubes with
B.bigemina infected blood before (A) and after centrifugation at 1,500 x g for 30 minutes(B)









1 - few free merozoites + few iRBC + few uninfected RBC
2 - uninfected RBC
3 - uninfected RBC + very few iRBC
4 - uninfected RBC + free merozoites
5 - uninfected RBC
6 - uninfected RBC + free merozoites
Fig 5.7 Diagrammatic representation of a discontinuous density gradient showing tubes with








1 - RBC membranes
2 - free merozoites + uninfected RBC
3 - uninfected RBC
4 - iRBC (-0.5% mainly pycnotic forms)
5 - iRBC (-8%) + uninfected RBC
6 - few uninfected RBC
5.4 Discussion and conclusions
The results of the present study in which merozoites were released suggested that for B.bovis
a longer period of CO2 deprivation (overnight) at a lower temperature (room temperature)
resulted in release of higher numbers of free merozoites in the culture supernatant. The
resulting merozoites successfully infected RBC cultures, indicating the likelihood that the free
merozoites survived the separation procedure. Although the possibility that intact iRBC were
present in the final merozoite pellet cannot be excluded, they were not seen in Giemsa stained
smears.
The first centrifugation of either B. bovis or B. bigemina culture supernatants at 200 x g for
10 minutes was enough to pellet most of the intact RBC leaving all the free merozoites in the
supernatant. The centrifugation of the second B.bovis supernatant (400 x g for 10 minutes)
resulted in a supernatant with a high concentration of free merozoites and RBC membranes.
However some of the free merozoites were pelleted under these centrifugation conditions. For
this reason, the length of time used for the second centrifugation of B.bigemina culture
supernatants was reduced to 5 minutes. Under these conditions, the number of free merozoites
pelleted was much lower. The last centrifugation, which was intended to pellet the free
merozoites of B.bovis (1,000 x g for 20 minutes), had also been modified to 1,500 x g for 20
minutes for B.bigemina supernatants and seemed to be adequate to pellet all free merozoites.
The induction of free merozoites of B.bovis in culture supernatant proved to be efficient,
resulting in a preparation that, although still partially contaminated with RBC membranes,
could be useful for immunochemical studies. Besides, the ability to induce free merozoites
facilitates studies on morphological, physiological and immunological aspects of this stage of
the parasites, which have been reported to contain the major antigenic determinants
associated with the induction of protective immunity (James et al, 1981; Ristic & Levy, 1981,
Ristic et al, 1981).
Deprivation of CO2, under the conditions used in the present study, appeared to be less
efficient for induction of free merozoites of B. bigemina in the culture supernatant, with a
large proportion of iRBC remaining intact at the end of the procedure. It was thought that a
longer period of CO2 deprivation was required for induction of more free merozites of
B.bigemina in the culture supernatant and therefore, on one occasion, 5 ml of B.bigemina
(Mexico stock) culture suspension was left in air at room temperature overnight. However,
after an overnight CO2 deprivation period, only a small decrease in the number of intact
iRBC was detected in smears made from the pelleted cells after centrifugation, and the
proportion of parasites that remained inside RBC was higher than that observed with B.bovis
after overnight CO2 deprivation. In addition, the free merozoites of B. bigemina obtained
from all CO2 deprivation procedures, particularly overnight, appeared fuzzy, with ill-defined
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morphology (as shown in Fig 5.1 B), suggesting that either they had suffered damage during
the process of release, or that they had subsequently died. In contrast, the free merozoites of
B.bovis obtained from all CO2 deprivation procedures appeared to be healthy and completely
free from host cell membranes. The observations on B.bigemina free merozoites were based
only on morphological examination of Giemsa stained smears and no further evaluation
concerning their viability or capability to invade other RBC was carried out. Thus, the results
obtained in the present study indicate that the induction of free merozoites by CO2
deprivation may be used as an efficient method for purification and concentration of B.bovis
parasites from cultures; however it is a less efficient method for concentration of
B.bigemina, pointing to the need for development of alternative, more efficient methods for
the provision of concentrated material from this parasite.
Density gradient centrifugation has been used for many years as a method for separation and
purification of cells and particles by which their differences in density and/or size are
exploited using a gradient medium. The following characteristics would be desired for an
ideal medium (Pharmacia, 1985): it should
- cover a sufficient density range for the particles of interest
- possess physiological ionic strength and pH
- be iso-osmotic throughout the gradient
- be of low viscosity
- be non-toxic
- be unable to penetrate biological membranes
- be supplied sterile and be resterilisable
- be able to form self-generated gradients by centrifugation at moderate g forces
- be compatible with biological materials
- have no adverse effect on assay procedures
- be easy to remove from purified materials
- have no quenching effects on radioactivity
Percoll seems to fulfil all these criteria and it has been used in a number of studies for
different purposes (Kramer et al, 1982; Walker & McKellar, 1983; Ellis et al, 1984).
Separation of particles or cells by density gradient centrifugation is based on their
sedimentation rates, which are proportional to the force applied. The sedimentation rate is
directly proportional to the size of the particle and the difference between its density and the
density of the surrounding medium. In addition, the concentration of Percoll, the length of
time of centrifugation, the rotor geometry and the size of the tubes determine the shape of the
gradient density curve, resulting in different arrangements of bands seen in the centrifuge
tubes.
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The results obtained from the experiments described in this chapter, in which density
gradients were used to concentrate iRBC, revealed that concentration of B.bigemina iRBC
was far more efficient by continuous gradient centrifugation than by using discontinuous pre¬
formed gradients. By using a 68.46% Percoll solution centrifiiged at 30,000 x g for 13
minutes in a fixed angle rotor, a parasitaemia of approximately 90% was achieved from
blood with a starting parasitaemia of 0.6%. This result represents a 150 times concentration,
which is much higher than the 20 times achieved by Vega and co-workers, who used a
continuous Percoll gradient with the same starting density to concentrate B.bigemina iRBC
(Vega et al, 1986b). In the present study all stages of the parasite were seen at a density
between 1.064 and 1.076 g/ml when infected blood with low parasitaemia (0.6%) was used,
whereas a wider and higher range of densities (1.076 to 1.098 g/ml) was found to contain
concentrated infected erythrocytes when culture suspensions (parasitaemia of 5%) were used.
The latter results were closer to that reported by Vega and co-workers, who found that the
erythrocytes containing pairs of parasites were located between densities of 1.076 and 1.089
g/ml whereas the ones containing single parasites were located between 1.092 and 1.100 g/ml
(Vega et al, 1986b). These authors used for their separation culture suspension with
parasitaemias ranging from 2 to 8%, which were comparable to that used in the present
study. However, several factors appear to affect the separation procedure; these include the
stage of development of cultures at the moment they were harvested - according to Vega and
co-workers, cultures taken less than 48 hours or more than 72 hours after subculture yielded
fewer infected erythrocytes (Vega et al, 1986b). The lack of separation of paired and single
parasite forms into bands of different density in the present study may be due to the fact that
here the culture suspension used was harvested at 48 hours after subculture, when
predominantly paired parasites were present, while Vega and co-workers used a culture
suspension harvested 72 hours after subculture. Furthermore, due to the fact that minor
changes in the conditions used resulted in different patterns of separation, one could expect
differences even if the same procedure is performed in different laboratories. Interestingly the
resulting multiple layers of parasitized RBC between densities of 1.061 and 1.103 g/ml,
reported by Vega and co-workers (Vega et al, 1986b), when the time of centrifugation was
increased to 30 minutes, were similar to that obtained in the present study using a
centrifugation time of 13 minutes (Fig 5.3), by which several layers containing concentrated
infected erythrocytes were seen between densities of 1.087 and 1.098 g/ml.
The conditions which had resulted in greatest concentration of B.bigemina iRBC in
experiment 5.1 were used for concentrating cultured iRBC in experiment 5.2. However
considerable differences were found between the band patterns obtained on the two occasions.
This may be due to several factors: first of all, although the starting density of the Percoll
solution, the speed and the time of centrifugation were the same, a different centrifuge and
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rotor were used resulting in differences in the gradient formation, as monitored by coloured
marker beads (Fig 5.2 and 5.4); secondly and perhaps the most relevant difference between
the two experiments was the origin of the RBC, since in experiment 5.1 calf blood was used
whereas in experiment 5.2 adult RBC were used and they might differ in density; thirdly, the
fact that the RBC used in experiment 5.2 had been cultured in vitro may have resulted in
substantial physiological changes which could had affected their density.
The success in separation of B.bigemina infected cells from uninfected RBC by density
gradients may be related to the preference of that parasite for invading young erythrocytes
(Wright & Kerr, 1974). Studies on separation of human RBC have shown that there is an
increase in erythrocyte density with age, probably related to a reduction in concentration of
several holoenzymes in aged RBC (Spooner et al, 1979). There is a progressive loss of
membrane and water during the cell aging process; consequently, at the end of their life span,
due to a higher concentration of solutes, RBC are heavier than the youngest cells that enters
the circulation as reticulocytes (Piomelli & Seaman, 1993).
The use of Percoll continuous gradient centrifugation has also been reported to purify
B.bigemina merozoites which had been obtained after chemical lysis of concentrated iRBC by
osmotic shock with glycerol (Figueroa et al, 1990a). By that technique only 10% of the
parasites were released from the infected erythrocytes after the glycerol treatment, but
concentration of free merozoites was obtained in a diffuse band located at a specific density
between 1.064 and 1.074 g/ml. However the resulting parasites were shown to have low
metabolic activity beyond 5 hours after purification and very low infectivity when used to
initiate new cultures (Figueroa et al, 1990a). According to the authors, although in
subsequent Western blotting analysis the free parasites were shown to retain antigenic
characteristics, the exposure of iRBC to glycerol may have osmotically damaged the parasites
and consequently decreased their ability to invade uninfected RBC.
Continuous gradient centrifugation has been also applied to concentrate free merozoites and
iRBC of B.bovis (Rodriguez et al, 1986a). In that study it was reported that a density
gradient generated from a 65% Percoll solution by centrifugation at 26,000 x g for 30
minutes allowed the best concentration of free merozoites, which had been obtained after
CC>2 deprivation (Levy et al, 1981), in a diffuse band at a specific density of approximately
1.087 g/ml. The concentrated free merozoites proved to have 89% viability when used to
initiate new cultures. In the same study the use of a 100% Percoll solution to generate density
gradients was reported, using the same previously mentioned centrifugation conditions, which
allowed concentration of infected erythrocytes at a specific density between 1.121 and 1.123
g/ml. The concentrated iRBC also proved to have a high capability for initiating new cultures
(Rodriguez et al, 1986a).
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Discontinuous gradient centrifugation under the conditions tested in the present study was
disappointing with both B.bovis and B.bigemina parasites and did not result in appreciable
concentration of iRBC. Although four density steps were used, covering a wide range of
densities (from 1.050 to 1.121 g/ml), within which the iRBC were expected to concentrate, no
concentration was achieved from B.bigemina infected blood, either after a centrifugation at
750 x g for 15 minutes or at 1,500 x g for 30 minutes (Fig 5.4). It appeared that either the g
force of 750 was too low or that a longer period of time was required for separation, since the
sample did not pass through the last two density steps and no interfaces were seen after the
centrifugation. Similar conditions have been reported by Bhushan and co-workers to be
suitable for separation of cultured equine RBC infected with B.caballi with parasitaemias
between 0.4 and 1.5% (Bhushan et al, 1991). These authors used two density steps (1.080
and 1.115 g/ml) in a discontinuous Percoll gradient subjected to centrifugation at 500 x g for
20 minutes, which resulted in a band at the interface between the two steps that contained a
high concentration of parasitized RBC (95-98%) and a large number of free merozoites,
while most of the uninfected erythrocytes passed through both density steps and settled at the
bottom of the tube.
Due to the lack of separation of B.bigemina infected blood after centrifugation at 750 x g for
15 minutes a second attempt was made in which the speed was increased to 1,500 x g and the
length of time was increased to 30 minutes. However the separation was still incomplete and
concentration of infected cells was not achieved, although one interface containing two bands
was seen between the two most dense steps (1.095 and 1.121 g/ml). Therefore it was inferred
that neither of the two discontinuous gradient conditions tested were suitable for
concentrating B.bigemina iRBC from low parasitaemia blood.
The discontinuous density gradient centrifugation designed for concentration of B.bovis
cultured RBC included three density steps which covered the range of densities in which
separation of RBC was expected (1.060 to 1.121 g/ml). Nevertheless, the concentration
achieved in one of the bands located in the interface above the most dense step (1.121 g/ml)
resulted in an increase to only 8% from the parasitaemia of 5.5% estimated in the original
culture suspension which was used for the separation. The concentration rate was 1.6 times,
which it was considered poor. Therefore, as observed for B.bigemina infected blood, the
discontinuous density centrifugation, under the conditions tested in the present study, did not
seem to be a suitable method for concentration of B.bovis iRBC, particularly considering that
this parasite could be successfully concentrated and partially purified from host cell
contamination by other methods less expensive and easier to carry out such as differential
hypotonic lysis using KC1 (as described in section 3.6.1.1), or the induction of free
merozoites by depriving cultures of CO2, as reported in this chapter.
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A comparison between the two methods used in the present study, regarding their efficiency
in concentrating B.bovis parasites, indicated that the induction of free merozoites into the
culture supernatant was more efficient than the use of density gradient centrifugation under
the conditions used here. Nevertheless, for the purposes of this study, the differential
hypotonic lysis using KC1 still appeared to be a more appropriate method for production of
bulked B.bovis antigenic preparations from cultures. Thus, it was the method used for
provision of B.bovis extracts for the immunochemical analysis (Chapter 6) and production of
crude ELISA antigen (Chapter 8).
In contrast, B.bigemina parasites are much more difficult to concentrate using conventional
methods. In the present study, the continuous gradient centrifugation using a 68.46% Percoll
solution subjected to centrifugation at 30,000 x g for 13 minutes produced high
concentrations of parasitized RBC and proved to be a very efficient method for concentration
of B.bigemina parasites from either infected blood or culture suspension. Thus, it was the
method used for provision of concentrated B.bigemina material for the experiments on
immunochemical characterisation (described in Chapter 6).
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CHAPTER SIX
IMMUNOCHEMICAL CHARACTERISATION OF STOCKS
OF B.BIGEMINA AND B.BOVIS
6.1 Introduction
Crude parasite preparations are commonly used as a source of antigen in immunodiagnostic
assays. Due to the fact that Babesia parasites develop almost exclusively inside erythrocytes,
such preparations frequently contain considerable amounts of host cell components which
affect the performance of the assays by increasing the non-specific background. Attempts to
improve specificity of immunodiagnostic assays for Babesia have therefore been directed at
replacing conventional crude extracts with purified parasite-specific antigens (Bose et al,
1990).
A preliminary step towards achieving this is the characterisation of the parasite components
present within crude preparations, using a number of biochemical methods such as gel
filtration, one and two dimensional gel electrophoresis, affinity chromatography and
isoelectric focusing. Subsequently, techniques such as immuno-blotting or
immunoprecipitation are used to identify which of the parasite components are
immunodominant antigens recognised by specific polyclonal antisera or monoclonal
antibodies. These immunodominant antigens, if parasite-specific and isolate-common, have
potential for purification and use in improved immuno-assays.
The experiments described in this chapter were designed with the aim of characterising
immunochemically both exoantigens and somatic components of geographically different
stocks of B.bovis and B.bigemina in order to identify candidate proteins for use as specific
diagnostic tools.
The analysis of somatic components included a preliminary study in which B.bovis and
B.bigemina iRBC antigens were prepared with and without the use of enzyme inhibitors to
determine the most suitable method for preparation of samples to be used in SDS-PAGE and
immuno-blotting analysis. Using somatic component preparations, a panel of eleven B.bovis
monoclonal antibodies was characterised by IFAT, ELISA and immuno-blotting analysis.
This panel of monoclonal antibodies was used as a means to identify B. bovis specific antigens
and to see whether diversity exists among B.bovis isolates.
Polyclonal and monoclonal antibodies were then both used to identify immunodominant
components present in different Babesia lysates by immuno-blotting. The polyclonal
antibodies were obtained from a panel of calf sera raised experimentally against the different
Babesia stocks, and a panel of serum samples taken from cattle naturally exposed to tick
infestation in the field in Brazil.
In order to analyse exoantigens, culture supernatants of both Babesia parasites were
concentrated and fractionated by high performance liquid chromatography (HPLC), first by
size exclusion fractionation, and followed by ion exchange fractionation. These exoantigens
were analysed using immuno-blotting techniques with the polyclonal sera described above.
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6.2 Studies on antigen preparation
6.2.1 Materials and methods
Parasite extracts of B.bovis and B.bigeminci were obtained from in vitro culture suspensions
(see section 3.3), and SDS-PAGE and immuno-blotting were performed as described
previously (see sections 3.6 and 3.7).
For this study, B.bovis iRBC (Kwanyanga stock) were prepared as described in section
3.6.1.1 and 200 pi aliquots of the resultant pellet were used to prepare B.bovis antigens
(designated bo).
B.bigemina iRBC (Mexico stock) were prepared as described in Chapter 5 (section 5.3.1)
and 200 pi aliquots of pellet were used to prepare B.bigemina antigens (designated bi).
Aliquots of bo and bi were treated as follows:
Sample Treatment with enzyme inhibitors*
bo 1 and bi 1 addition of 200 pi PBS containing 5 mM
EDTA, 0.2 mM leucopeptin and 1 mM PMSF
bo 2 and bi 2 lysis with 400 pi of TBS buffer containing 5
mM iodoacetamide, 2 mM PMSF, 5 mM
EDTA, 2 mM sodium metabisulphite, 0.1 mM
TLCK, 1% NP-40 and 1% sodium
deoxycholate
bo 3 and bi 3 none
* see list of abbreviations on page viii.
One volume of each sample (200 pi) was then mixed with an equal volume of SDS-reducing
sample buffer (see Appendix 1), boiled for 5 minutes and centrifuged at 10,000 x g for 3
minutes. Supernatants were subjected to SDS-PAGE in 10% homogeneous gels. A sample of
molecular weight markers (ranging from 21.5 to 200 kDa) was included in all gels. After
electrophoresis, separated proteins were transferred to nitrocellulose membranes by Western
immuno-blotting. For B.bovis samples, the resulting blot was probed with a pool of B.bovis
antisera (from calves 396 and P78, both taken on day 69 after infection). For B.bigemina
samples the blot was probed with a pool of B.bigemina antisera (from calves 397, 399 and
583, taken on days 69, 98 and 85 respectively).
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6.2.2 Results
Homologous sera detected antigens in all three preparations of both B.bovis and B.bigemina
samples, as shown in Fig 6.1.
A maximum of 11 antigenic bands were detected by homologous sera in B.bovis samples (bo
3). The major antigen in all three sample preparations was a protein of molecular weight 56
kDa. The greatest number of bands and the strongest reactions were detected in preparation
bo 3, followed by preparation bo 1 and the weakest bands were detected in preparation bo 2,
as shown in Fig 6.1 A.
A maximum of 16 bands were detected by homologous sera in B.bigemina samples (bi 3).
The major antigens detected in all three preparations were proteins with molecular weights 65
and 50 kDa. The greatest number of bands and the strongest reactions were detected in
preparation bi 3, followed by preparation bi 2 and bi 1, as shown in Fig 6.1 B.
It was concluded that for both B.bovis and B.bigemina, lysis of pelleted parasites with SDS
sample buffer without enzyme inhibitors was the most suitable method for preparation of
samples for use in the SDS-PAGE and immuno-blotting analysis described in this chapter.
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Fig 6.1 Western immuno-blotting analysis of B.bovis (Kwanyanga stock) and B.bigemina
(Mexico stock) antigens prepared with or without enzyme inhibitors.
Blot A (lanes bo 1-3) contains B.bovis samples tested against a pool of anti-B.bovis sera.
Blot B (lanes bi 1-3) contains B.bigemina samples tested against a pool of anti-B.bigemina
sera.
Standard molecular weight markers are indicated on the left side.
























6.3 Characterisation of monoclonal antibodies
6.3.1 Materials and methods
The panel of eleven McAbs raised against the Kwanyanga stock of B.bovis at the Wellcome
Laboratories (as described in section 3.4.3) was characterised by IFAT, ELISA and Western
immuno-blotting.
6.3.1.1 IFAT
The IFAT was carried out as described in section 3.5 except that cytospin smears were used
as antigen instead of plain smears. This was to give better visualisation of parasites allowing
the specific reactivity of an antibody against a particular component of the parasite or
infected cell to be observed. Cytospin smears (two per slide) were prepared from each stock
of B.bovis and tested against each McAb diluted 1 in 100 in PBS. Plain antigen smears of
B.bigemina (Zaria and Muguga stocks) were included in the study to evaluate the species-
specificity of the McAbs. Sera from calf 396 (see Table 3.1), taken on days 0 and 69 after
B.bovis infection, diluted 1 in 160 with PBS, were used as negative and positive controls,
respectively. A PBS control was also included on each slide.
6.3.1.2 ELISA
The ELISA was carried out using a crude B.bovis lysate from a culture suspension of the
Lismore stock as antigen (Woodford et al, 1990). Each McAb was titrated by serial doubling
dilutions from 1 in 25 to 1 in 3,200. The assay was performed as described in section 3.8; a
McAb raised against Trypanosoma evansi (McAb 2G2, IgG 1, Frame et al, 1990) was used
as a negative control. Absorbance values higher than the cut-off point 0.2, based on the OD
of the negative control, were considered positive.
6.3.1.3 Immuno-blotting
For Western immuno-blotting analysis, four pools of McAbs were tested against three stocks
of B.bovis. Pool A consisted of McAbs 4F3:1, 1C12:1 and 2C8:2; pool B consisted of
McAbs 118.672, 4D1:3 and 3D6:1; pool C consisted of McAbs 3D42 and 1C12:2; and pool
D consisted of McAbs 5G12 and 1B8:1. Each pool was tested at a dilution of 1 in 100. The




The results from the IFAT analysis are illustrated in Table 6.1 and show that, with one
exception, all B.bovis McAbs reacted with all the stocks of B.bovis parasites; only McAb
2A11 failed to react with the Lismore stock of B.bovis. For the other McAbs the strongest
reactions were seen with the Lismore antigen.
The eleven McAbs were classified into three groups according to their pattern of reactivity by
IFAT. Group 1 includes those McAbs which recognised internal parasite components (5G12,
1B8:1, 4F3:1, 3D6:1 and 2C8:2), group 2 included the McAbs which recognised parasite and
infected RBC cytoplasm/membrane components (1C12:1, 4D1:3, 118.672 and 2A11), and
group 3 included the McAbs which reacted with the parasite surface (3D42 and 1C 12:2).
In general the pattern of reactions of individual McAbs was similar for the three B.bovis
antigens, only the intensity of reactions differed between the stocks, as shown in Table 6.1.
The intensity (brightness) of reactions also varied between McAbs with 3D42, 1C12:2,
3D6:1 and 4D1:3 giving brightest reactions.
No McAbs showed cross-reactivity with any of the B.bigemina parasites. However McAbs
1B8:1, 4F3:1 and 2C8:2 (group 1), and 3D42 (group 3) reacted with erythrocyte components
(membrane or cytoplasm) of some RBC infected with B. bigemina of both Zaria and Muguga
stocks.
No reactions were seen with the negative controls (pre-infection and PBS).
6.3.2.2 ELISA analysis
Only four of the eleven McAbs reacted in ELISA with the B.bovis (Lismore) antigen. These
were 4F3:1 (end point titre of 1 in 400), 1B8:1 (end point titre 1 in 200), 2A11 and 118.672
(both with end point titres of 1 in 25).
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Table 6.1 IFAT staining patterns of a panel of eleven Kbovis McAb tested against
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cytoplasm in few iRBC
++
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parasite surface (free +
intracellular)
3D6.1 (IgG 2b) +++
only part of the parasite
++
only part of the parasite
++
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few parasites
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faint surface of free
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parasite extremity (free +
intracellular); cytoplasm
and membrane of iRBC
+++
parasite extremity (free +
intracellular); cytoplasm
and membrane of some
iRBC
118.672 (IgG 2a) ++
RBC membrane;




cytoplasm of few iRBC
+
RBC membrane;
cytoplasm of iRBC; faint
parasite extremity
Key: +++ very bright
++ bright
+ faint
— not at all
RBC uninfected red blood
cells
iRBC infected red blood
cells
* S.Crowe, personal communication
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6.3.2.3 Immuno-blotting analysis
A 195 kDa antigen was detected in all three B.bovis stocks by the four McAb pools, as
shown in Fig 6.2. Differences in staining intensity of this antigen were observed between the
pools. The antigen was recognised strongly by pools A, B and D but hardly at all by pool C.
McAb pool A also detected a 200 kDa antigen in all the three B.bovis stocks and a 58 kDa
antigen present only in the Kwanyanga stock ofB.bovis (Fig 6.2 panel A).
No reaction was observed with the negative control anti-Trypanosoma McAb (Fig 6.2, panel
E).
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Fig 6.2 Western immuno-blotting of B.bovis antigens probed with pools of McAbs.
Lane 1 is Kwanyanga stock; lane 2 is Mexico stock; and lane 3 is Lismore stock.
A is a pool of McAbs 4F3:1, 1C12:1 and2C8:2
B is a pool of McAbs 118.672, 4D1:3 and 3D6:1
C is a pool of McAbs 3D42 and 1C12:2
D is a pool of McAbs 5G12 and 1B8:1
E is an anti-Trypanosoma evansi McAb
Standard molecular weight markers are indicated on the left side.
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Fig 6.2
A B C D E
6.4 Analysis of somatic components of B.bo\is
6.4.1 Materials and methods
Samples of each B.bovis stock (Lismore, Mexico and Kwanyanga) were prepared as
described in section 3.6.1.1. The final pellet containing concentrated iRBC was mixed with 2
volumes of SDS-sample buffer (Appendix 1) and then separated by SDS-PAGE in either
homogeneous or gradient acrylamide gels (see section 3.6.2). A pellet of uninfected RBC was
included as a negative control. Protein bands were stained with Coomassie blue (as described
in section 3.6.3).
Western immuno-blotting was carried out as described in section 3.7 using homologous anti-
B.bovis serum samples (calves 396, P78, 198, P49 and C11) and heterologous anti-
B.bigemina serum samples (calves 397, 399, 583 and 8T), taken before and at different times
after infection. Calf infections from which sera were used are detailed in Table 3 .1. A pool of
6 serum samples collected from adult cattle which had been naturally exposed to tick
infestation in Brazil (field sera) was also tested against each of the B.bovis stocks.
A blot of uninfected RBC lysate was probed with a pool of anti-5. bovis sera as a negative
control.
6.4.2 Results
6.4.2.1 Total protein profiles
Protein patterns of Coomassie blue stained gels containing the three stocks of B.bovis and the
uninfected RBC sample are shown in Fig 6.3. At least 42 bands ranging from 200 to 14 kDa
were detected by Coomassie blue. There were no detectable differences between the protein
profiles of the three stocks of B.bovis and the uninfected RBC preparation.
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Fig 6.3 Coomassie blue staining of a 5-15% gradient gel containing samples of B.bovis and
uninfected RBC.
Lanes 1 Lismore stock
2 Mexico stock
3 Kwanyanga
4 uninfected RBC lysate.






Several antigenic bands were recognised by sera raised against B.bovis stocks (Figs 6.4 -6.6).
Anti-Kwanyanga sera (from calves 198 and Cll, both taken on day 28 after infection)
recognised the same number of antigenic proteins (9) in both Kwanyanga and Mexico stocks
but with different intensities (Fig 6.4 A). Fewer bands and less intensive reactions were
observed with the Lismore stock.
A pool of sera from calf P78, taken after it had been challenged twice each with Kwanyanga
and Lismore stocks, recognised approximately 20 antigenic proteins, which showed similar
molecular weights and staining intensities in both Kwanyanga and Mexico stocks (Fig 6.4 B).
In the Lismore stock some bands were detected which were absent in the other two stocks.
These occurred at molecular weights of 30, 78 and 195 kDa. In addition, some proteins which
were strongly recognised in the Kwanyanga and Mexico stocks, were not detected in the
Lismore stock. These occurred at molecular weights of 70, 68, and 37-39 kDa (Fig 6.4 B)
and corresponded to the bands which were absent in the Lismore stock when probed with
anti-Kwanyanga sera.
The homologous system (anti-Mexico serum against the Mexico stock) showed that the
number of bands increased from 5 (day 28) to 13 (day 104) (Fig 6.5, lanes 2, 5, 8 and 11).
The strongest antigenic bands occurred at molecular weights 37 and 56 kDa and, later in the
infection, at 140 kDa. Although most bands increased in intensity during the infection, there
were still only two major antigens. A similar result was obtained with the heterologous
system anti-Mexico sera/Kwanyanga stock (Fig 6.5, lanes 1, 4, 7 and 10). The heterologous
system anti-Mexico sera/Lismore stock showed only one major antigen at 56 kDa throughout
the infection (Fig 6.5, lanes 3, 6, 9 and 12). In contrast to the Kwanyanga and Mexico stocks,
the Lismore stock did not show antigenic bands at molecular weights 37-39, and only a very
faint reaction was seen against a 140 kDa antigen even 104 days after infection.
Fig 6.6 A shows that the pool of Brazilian field sera reacted more strongly against antigens in
the Kwanyanga stock than in the other two stocks. Major reactions were detected at
molecular weights 200, 140 and 56 kDa. The 200 and 56 kDa were also the major antigens
detected in the Mexico and Lismore stocks. The Brazilian field sera recognised a 37-39 kDa
protein in the Kwanyanga and Mexico stocks but not in the Lismore stock. However only in
the latter stock was a 30 kDa antigen detected. A minor antigen at 31 kDa was faintly
detected in the Kwanyanga and Mexico stocks.
The pool of anti-B.bigemina sera showed faint reactivity against four antigens present in all
three samples of B.bovis. These bands were seen at molecular weights 200, 72, 49 and 23
kDa, as shown in Fig 6.7 C (arrows). These cross-reactive bands corresponded to bands
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detected by anti-B.bovis sera as shown in Fig 6.7 A and B. However they were not the major
antigenic B.bovis bands.
Only two very faint bands (at 58 and 49 kDa) were detected when the uninfected RBC
preparation was probed with the pool of anti-fi. bovis sera, which included sera raised against
all three stocks (Fig 6.6 B).
The pool of pre-infection sera did not react against the major antigenic bands of B.bovis
samples. However a faint reaction against a band of 200 kDa was detected with this pool (Fig
6.6 C, arrow).
A summary of the B.bovis antigens detected by immuno-blotting is presented in Table 6.2.
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Fig 6.4 Western immuno-blotting analysis of B.bovis antigens probed with stock-specific
antisera.
Lanes 1 and 4 are Kwanyanga stock, lanes 2 and 5 are Mexico stock, and lanes 3 and 6 are
Lismore stock.
In A a pool of sera anti-Kwanyanga stock, taken on day 28 after infection was used.
In B a pool of sera from calf P78 infected with Lismore stock and challenged twice with
Lismore and Kwanyanga stocks was used.
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Fig 6.5 Western immuno-blotting analysis of B.bovis antigens probed with anti-Mexico stock
sera (from calf 396).
Lanes 1, 4, 7 and 10 are Kwanyanga stock; lanes 2, 5, 8 and 11 are Mexico stock; lanes 3, 6,
9 and 12 are Lismore stock, probed with:
A - serum taken on day 28 post-infection (p.i.)
B - serum taken on day 49 p.i. (21 days after the first challenge)
C - serum taken on day 77 p.i. (21 days after the second challenge)
D - serum taken on day 104 p.i. (14 days after the third challenge).
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Fig 6.6 Western immuno-blotting analysis of B.bovis and uninfected RBC antigens.
Lane 1 is Kwanyanga stock; lane 2 is Lismore stock; lane 3 is Mexico stock; and lane 4 is an
uninfected RBC lysate.
A was probed with a pool of field sera from Brazil; B was probed with a pool of anti-B.bovis
sera; and C was probed with a pool of pre-infection sera.




















Fig 6.7 Western immuno-blotting of B.bovis antigens probed with a pool of anti-B.bovis
(Lismore) sera (A); a pool of anti-B.bovis (Mexico) sera (B); and a pool of anti-B.bigemina
(Zaria) sera (C).
Lane 1 is Kwanyanga stock, lane 2 is Lismore and lane 3 is Mexico stocks.
Standard molecular weight markers are indicated on the left-hand side.
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Key: L - Lismore stock
M - Mexico stock
K - Kwanyanga stock
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6.5 Analysis of somatic components of B.bigemina
6.5.1 Materials and methods
Two stocks of B.bigemina were included in this study, Mexico and Kenya. The sample of the
Kenyan stock was obtained from the International Laboratory for Research on Animal
Diseases (ILRAD) (Kenya) and had been prepared from infected bovine blood as follows
(J.Katende, personal communication). Blood was collected in Alsever's solution and blood
cells were washed three times with PBS by centrifugation at 1,500 x g for 30 minutes at 4°C.
The buffy coat was removed after each centrifugation and the resulting pellet from the last
centrifugation was added to an equal volume of a 20% solution of DMSO in PBS. The
mixture was aliquoted into 250 ml volumes and stored in liquid nitrogen. One aliquot was
thawed in a water bath at 56°C, sonicated (40-50 relative output) for 1-2 minutes and
centrifiiged at 200 x g for 30 minutes at 4°C. The supernatant which contained most of the
merozoites was centrifuged at 500 x g for 30 minutes and pelleted merozoites were washed
three times with PBS/glucose (pH 8.0). The isolated merozoites were suspended in 2 ml of
PBS/glucose containing 0.2 M NaCl and protease inhibitors, and disrupted by sonication for
1 minute (relative output 80) on ice. The lysate was centrifuged at 4,500 x g for 30 minutes
to pellet any insoluble material and the supernatant was stored at -80°C as 100 pi aliquots
and sent to CTVM.
When required, one aliquot was thawed out and mixed with 2 volumes of SDS-PAGE
reducing buffer (Appendix 1). The suspension was boiled for 5 minutes and then centrifuged
at 10,000 x g for 3 minutes. The resulting supernatant of B.bigemina (Kenya) was used for
SDS gradient gel electrophoresis.
The Mexico stock of B.bigemina from an in vitro cultured RBC suspension was prepared as
described in Chapter 5. Concentrated B.bigemina iRBC obtained by this method were then
washed three times by centrifugation with PBS. Two volumes of SDS reducing buffer sample
were added to the final pellet; the suspension was boiled and centrifuged as described above.
The resulting supernatant of B.bigemina (Mexico) was used for SDS gel electrophoresis on
10% homogeneous acrylamide gels (as described in section 3.6.2).
Protein bands were stained with Coomassie blue (as described in section 3.6.3). Parasite
antigens were identified using serum samples from calves 8T, 397, 583 and 399 (see Table
3.1), which were used either individually or as a pool. B.bigemina antigens were also tested
against a pool of anti-B.bovis sera (from calves 396, P78 and 198) to investigate cross-
reactivity. A pool of pre-infection sera was included as a negative control. A lysate of
uninfected RBC was probed with the pool of anti-B.bigemina sera.
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6.5.2 Results
6.5.2.1 Total protein profiles
The B.bigemina (Kenya) total protein profile is presented in Fig 6.8 A. Approximately 30
protein bands were detected with molecular weights ranging from 200 to 14 kDa. Fig 6.8 B
shows the total protein profile of the Mexico stock of B. bigemina and, although poor staining
did not allow accurate quantification of the B.bigemina proteins, several groups of proteins
were detected in the molecular weight range 200 to 14 kDa.
6.5.2.2 Antigen profiles
a. Kenya stock
Fig 6.9 shows the antigenic bands of B.bigemina (Kenya stock) obtained with individual
serum samples taken at different times after infection with B.bigemina. Serum from calves
397 and 583 taken respectively on days 89 and 97 post-infection with Zaria stock showed the
greater number of antigens (13) and the highest staining intensity (Fig 6.9, lanes 2 and 3).
The antigens were seen at molecular weights ranging from 100 to 40 kDa. All sera, except
8T, recognised two major antigens at 42 and 60 kDa. Serum from calf 8T recognised two
faint antigens at 45 and 67 kDa, one of which (45 kDa) was also recognised by serum from
calf 5 83.
The pool of pre-infection sera did not react with any of the B.bigemina bands (Fig 6.9, lane
8).
The pool of anti-B.bovis sera reacted faintly against a band of molecular weight 65kDa (Fig
6.9, lane 9).
b. Mexico stock
Approximately 15 bands, molecular weights ranging from 250 to 50 kDa, were detected in
B.bigemina (Mexico stock) by anti-fi.bigemina sera (Fig 6.10 A). The major antigens
(strongest reactions) were seen at molecular weights 65 and 50 kDa. A faint reaction was
detected against two bands at 69 and 71 kDa with both the pool of pre-infection sera (Fig
6.10 B) and the pool of anti-B.bovis sera (Fig 6.10 C).
A summary of the B.bigemina antigens detected by immuno-blotting is presented in Table
6.3.
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Fig 6.8 Coomassie blue staining of acrylamide gels showing total protein profiles of
B. bigemina.
Lane 1 is a sample of the Kenya stock separated in a 7-20% gradient gel.
Lane 2 is a sample of the Mexico stock separated in a 10% homogeneous gel.





Fig 6.9 Western immuno-blotting of B.bigemina (Kenya stock) antigens probed with calf sera
taken before and at different times after B.bigemina infection:
Lanes 1 - serum from calf 8T taken on day 28 post-infection (pi)
2 - serum from calf 397 taken on day 89 pi
3 - serum from calf 583 taken on day 97 pi
4 - serum from calf 399 taken on day 29 pi
5 - serum from calf 399 taken on day 50 pi
6 - serum from calf 399 taken on day 71 pi
7 - serum from calf 399 taken on day 119 pi
8 - a pool of p re-infection sera
9 - a pool of anti-5. bovis sera
Standard molecular weight markers are indicated on the left side.
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Fig 6.9
Fig 6.10 Western immuno-blotting of B.bigemina (Mexico stock) antigens probed with a
pool of anti-it. bigemina sera (A), a pool of anti-it. bovis sera (B), and a pool of pre-infection
sera(C)
Standard molecular markers are indicated on the left side.
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6.6 ANALYSIS OF CULTURE SUPERNATANT BY HIGH PERFORMANCE LIQUID
CHROMATOGRAPHY (HPLC)
6.6.1 Introduction
Proteins may be purified on the basis of their molecular dimensions by filtration through
porous gels in a column. The rate at which a molecule moves down a gel column depends
upon the number of beads that are entered. Large proteins, above the exclusion limit of the
gel, do not enter the beads and move with the elution solution, whereas small molecules enter
the beads and must traverse this space as well as the volume around the beads. In addition to
the molecular weight of the molecules, other factors, such as the molecular shape and degree
of hydration, are important in governing the entry of molecules into the gel (Hudson & Hay,
1989). The HPLC system became operational in 1980 after the development of uniform rigid
particles for use as chromatographic supports which enable high solvent flows to be
maintained by the application of high pressure. A general system for HPLC consists of a
pump that can deliver the eluant mixture at accurate flow rates of 0.1-1.0 ml/minute, an
injection valve for application of samples, an optical flow-through cell compatible with an
ultra-violet detector, a chart-recorder and the gel columns that cover the desired molecular
weight range (Welling & Welling-Wester, 1989).
Separation of proteins may also be achieved by an ion exchange chromatography procedure,
in which proteins are bound electrostatically onto an ion exchange matrix bearing an opposite
charge. The degree of binding depends upon the protein charge density. Proteins are then
eluted differentially by either increasing the ionic strength of the medium or altering the pH
(Hudson & Hay, 1989). The high performance ion-exchange fractionation is based on these
same principles, but using a packed column of particulate material consisting of a rigid,
polymeric substrate, to which charged groups are bound (fixed charges). Proteins and
peptides (mobile ions) will attach to the fixed charges via ionic interactions. This type of
fractionation usually requires the use of a pH and/or ionic strength gradient to achieve the
best resolution (Henry, 1989).
The experiments described in this section report results obtained from fractionation of culture
supernatants of B.bovis and B.bigemina cultures with the aim of identifying relevant species-
specific exoantigens which could be used for the development of specific ELISAs.
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6.6.2 Materials and methods
6.6.2.1 Albumin removal and concentration of culture
supernatants
Prior to collection of culture supernatants, B.bovis (Kwanyanga stock) and B.bigemina
(Mexico stock) were cultured for 48 hours in M199-HS and M199-ICS, respectively (see
table 3.2), which contained 5% NBS instead of the usual concentration of 40%. This was
because, in a preliminary experiment, samples of culture supernatants containing 40% NBS
showed disturbance of protein bands, when analysed by SDS-PAGE, primarily due to the
high concentration of albumin.
An uninfected RBC suspension was cultured under the same conditions as B.bovis and
B.bigemina to provide a control of non-infected culture supernatant. Culture suspensions
were centrifuged at 1,600 x g for 10 minutes at 4° C, the supernatants collected and filtered
through a 0.22 pm filter (Millipore). One volume of each filtered supernatant was then mixed
with 5 volumes of Affigel blue (Bio-Rad) to remove serum albumin. The resulting
suspensions were mixed overnight at room temperature on a blood cell suspension mixer. The
suspensions were then processed by centrifugation as before and the resulting supernatants
filtered as described above.
The efficacy of the Affigel blue in removing serum albumin was evaluated by SDS-PAGE
and Coomassie blue staining of the samples before and after Affigel treatment.
After albumin removal, the supernatants were concentrated five fold by mixing approximately
5 ml of each supernatant with 0.92 g of Lyphogel (Gelman Instruments Company) over a
period of 4 hours at room temperature. The concentrated supernatants were centrifuged
(10,000 x g for 5 minutes), transferred to dialysis tubes (molecular cut-off 14,000 daltons)
and dialysed overnight against size exclusion buffer (Appendix 1). Culture supernatant
materials prepared in this way were used as starting material for HPLC fractionations.
6.6.2.2 Size exclusion fractionation
Concentrated culture supernatants from B.bovis, B.bigemina and uninfected RBC cultures
were fractionated according to molecular size by HPLC using isocratic conditions (Welling &
Welling-Wester, 1989). One ml of each sample was applied in column elution buffer
(Appendix 1) using an injection loop. A 7.5 x 300 mm Biosep-SEC-S 300 column
(Phenomcnex) was used throughout the analysis. Samples were eluted from the column over a
period of 30 minutes using elution buffer at a flow rate of 0.6 ml/min. The column eluate was
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collected into 1.7 ml microcentrifuge tubes at 1 minute intervals during the chromatography.
The absorbance of the column eluate was monitored continuously at 280 nni.
A sample of each fraction with absorbance greater than 0.05 was then run under reducing
conditions in gradient (8 to 25%) SDS-PAGE using the Phast-gel system (Pharmacia). Gels
were stained with silver nitrate according to the manufacture's instructions for detecting
protein bands. Standard molecular weight markers (Bio-Rad, broad range) were included in
each gel to enable estimation of molecular weights of bands.
Fractions containing protein bands detectable by silver staining were analysed by Western
immuno-blotting against pools of either species-specific antisera or pre-infection sera. The
fractions containing antigens were then further analysed by an ion exchange HPLC.
6.6.2.3 Ion exchange fractionation
Samples were subjected to ion-exchange by HPLC using a 75 x 7.5 mm Spherogel TSK
DEAE-5 PW column (Beckman). One ml of each sample was applied to the column in buffer
A (Appendix 1) using an injection loop. Proteins were eluted from the column using a
continuous gradient generated using two buffers of pH 7.0 and 8.3 (buffer A and buffer B,
Appendix 1) at a flow rate of 1 ml/min over a period of 30 minutes, as shown in Fig 6.11.
The column eluate was collected into 1.7 ml microcentrifuge tubes at 1 minute intervals
during the chromatography. The absorbance of the column eluate was monitored continuously
at 280 nm. Fractions eluted from the column with absorbance greater than 0.05 were then
analysed by SDS-PAGE, and Western immuno-blotting as previously described.
Samples of purified bovine IgG (Sigma) and NBS were separated by SDS-PAGE on the same
gel as selected fractions of B.bovis culture supernatant obtained after HPLC, blotted and
reacted with either each pool of sera (pre-infection, anti-B.bovis, B.bigemina) or with PBS in
order to detect reactions from the anti-bovine IgG conjugate against IgG and other serum
components present in fractions of culture supernatants.
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From time 0 to 5 minutes the column was eluted with 100% buffer A.
From time 5 to 20 minutes the column was elutcd with a linear gradient of 0 to 100% buffer B.
From time 20 to 25 minutes the column was elutcd with 100% buffer B.
From time 25 to 26 minutes the column was elutcd with a linear gradient of 0 to 100% buffer A.
From time 26 to 30 minutes the column was elutcd with 100% buffer A.
6.6.3 Results
6.6.3.1 Albumin removal and concentration of culture
supernatant
The treatment of culture supernatant with Affigel Blue resulted in an approximately 10 fold
reduction in concentration of the band corresponding to bovine serum albumin (66 kDa), as
shown by Coomassie blue staining of samples before and after treatment (Fig 6.12, lanes 1
and 2; 3 and 4 respectively).
Treatment of culture supernatant with Lyphogel resulted in concentration of proteins in the
samples as shown by more intensive Coomassie blue staining of bands after concentration
(Fig 6.12, lanes 5 and 6).
After albumin removal some protein bands in a range between 200-90 and 55-29 kDa were
absent. Subsequent concentration with lyphogel recovered most of the bands in the 200-90
kDa range but only some of the bands in the lower molecular range of 55-29 kDa. No
detectable differences were seen between the total protein profiles of uninfected and infected
culture supernatants.
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Fig 6.12 Coomassie blue staining of a 10% homogeneous gel showing culture supernatants
before and after treatment with Affigel and Lyphogel.
Lanes 1 - supernatant from an uninfected culture containing 5% serum.
2 - supernatant from a B.bovis culture containing 5% serum.
3 - uninfected culture supernatant after treatment with Affigel.
4 - B.bovis culture supernatant after treatment with Affigel.
5 - uninfected culture supernatant after treatment with Affigel and concentration with
Lyphogel.
6 - B.bovis culture supernatant after treatment with Affigel and concentration with
Lyphogel.
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6.6.2.2 Fractionation of li.bovis culture supernatant
Two peaks of absorbance were obtained from the fractionation of the uninfected culture
supernatant after the size exclusion procedure (Fig 6.13). The first peak (A) was detected in
fractions 9 to 13 and the second (B) in fractions 13 to 19. Fractionation of B.bovis culture
supernatant gave three peaks. The first peak (A) was detected in fractions 9 to 13, coinciding
with the uninfected supernatant; the second peak (B) was detected in fractions 13 to 17 and
was not as distinct as the one of uninfected supernatant. A third peak (C) was detected in
fractions 16 to 19 of the B.bovis supernatant and was not clearly resolved.
SDS-PAGE analysis of B.bovis supernatant showed that the starting material used for HPLC
fractionation contained at least 17 protein bands with molecular weights ranging from 200 to
6.5 kDa (Fig 6.14 A, lane 11). Fractions 21 and 20 contained protein bands of molecular
weights greater than 90 kDa (Fig 6.14 A, lanes 1 and 2); fractions 19-14 contained proteins
in a range between 200 and 20 kDa (Fig 6.14 A, lanes 3-8); and fractions 13 and 12 both
contained a band of molecular weight 60 kDa (Fig 6.14, lanes 9 and 10).
The overall SDS-PAGE pattern from the uninfected supernatant was similar to that from the
B.bovis supernatant, with minor differences. Fractions 19 and 18 contained fewer bands in
the low molecular weight range, and fewer bands in the high molecular weight region (Fig
6.14 B, lanes 3 and 4).
Western immuno-blotting analysis of nine fractions (11, 14, 15-21, as indicated in Fig 6.14
A) of B.bovis supernatant against the pool of anii-B.bovis sera showed three antigenic bands
at 120, 90 and 55 kDa in fractions 15 to 18 (Fig 6.15 A). The first immuno-blotting analysis
of these fractions showed that the 55 kDa protein in fractions 16 and 17 was reactive with the
pool of ani\-B.bovis sera but not reactive with the pool of pre-infection sera. For this reason
fractions 16 and 17 were selected for further fractionation by ion exchange. However these
results were not reproducible on other occasions and the same band (55 kDa) was reactive in
all fractions when probed with the pool of pre-infection sera, as shown in Fig 6.15 B.
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Fig 6.14 Silver staining of a 4-20% gradient gel containing fractions of supernatant of a
B.bovis culture (A) and an uninfected culture (B) obtained after HPLC fractionation by size
exclusion.
Lanes: 1 - fraction 21
2 - fraction 20
3 - fraction 19
4 - fraction 18
5 -fraction 17
6 - fraction 16
7 - fraction 15
8 - fraction 14
9 - fraction 13
10-fraction 12
11- starting culture supernatant
12- standard molecular weight markers
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Fig 6.14
Fig 6.15 Western immuno-blotting of fractions of B.bovis culture supernatant against either
a pool of anti-B.bovis sera (A) or a pool of pre-infection sera (B).
Lanes: 1 - fraction 21
2 - fraction 20
3 - fraction 19
4 - fraction 18
5 - fraction 17
6 - fraction 16
7 - fraction 15
8 - fraction 14
9 - fraction 11











The ion exchange analysis of B.bovis fractions 16 and 17 resulted in 30 sub-fractions from
each fraction. The corresponding fractions 16 and 17 from the uninfected supernatant were
also analysed by ion exchange.
Ion exchange analysis of B.bovis supernatant fraction 16 and the corresponding fraction of
the uninfected supernatant gave similar chromatography traces, as shown in Fig 6.16. Two
peaks of absorbance were detected for both the B.bovis and the uninfected fraction 16. The
first peak was detected in sub-fractions 13 to 18, and the second in sub-fractions 19 to 24.
Eleven of the B.bovis supernatant sub-fractions (4, 5, 15-17, 21-24, 27 and 28) were
analysed by SDS-PAGE and protein bands were detected in fractions 15 to 28, as shown in
Fig 6.17 (arrows on the left). Sub-fractions 22 to 28 were then selected for further analysis
by Western immuno-blotting against the pools of both pre infection and anti -B.bovis sera.
Results from this analysis showed that both pre and post-infection pools reacted with protein
bands at molecular weights 120 and 55 kDa in both sub-fractions 23 and 22 (Fig 6.18 A and
B, lanes 6 and 7), and the 55 kDa protein in sub-fractions 24 to 28 (Fig 6.18 A and B, lanes
1-5).
The second fraction selected for ion exchange sub-fractionation (fraction 17) also showed a
pattern of absorbance of sub-fractions similar to that of the corresponding fraction from
uninfected supernatant (Fig 6.19). In both samples peaks of absorbance were detected in sub-
fractions 12 to 29. However, they were not clearly resolved.
Silver staining detected protein bands in sub-fractions 18 to 26, as shown in Fig 6.20
(arrows). Sub-fractions 20 to 26 were then selected for further analysis by Western immuno-
blotting.
This analysis also resulted in detection of a reactive protein band (at 55 kDa) in all sub-
fractions, except in sub-fraction 20 (Fig 6.21 A). However the same band was also
recognised by the pool of pre-infection sera (Fig 6.21 B).
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Fig 6.17 Silver staining of a 4-20% gradient gel containing sub-fractions of fraction number
16 of B.bovis culture supernatant obtained after HPLC fractionation (ion exchange).
Lanes: 1 - sub-fraction 28
2 - sub-fraction 27
3 - sub-fraction 24
4 - sub-fraction 23
5 - sub-fraction 22
6 - sub-fraction 21
7 - sub-fraction 17
8 - sub-fraction 16
9 - sub-fraction 15
10- sub-fraction 5
11- sub-fraction 4
12- standard molecular weight markers
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Fig 6.17
Fig 6.18 Western immuno-blotting of sub-fractions of fraction number 16 of B.bovis culture
supernatant against either a pool of ani\-B.bovis sera (A) or a pool of pre-infection sera (B).
Lanes: 1 - sub-fraction 28
2 - sub-fraction 27
3 - sub-fraction 26
4 - sub-fraction 25
5 - sub-fraction 24
6 - sub-fraction 23
7 - sub-fraction 22
Standard molecular weight markers are indicated on the left.
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Fig 6.20 Silver staining of a 4-20% gradient gel containing sub-fractions of fraction number
17 of B.bovis culture supernatant obtained after HPLC fractionation (ion exchange).
Lanes: 1 - sub-fraction 26
2 - sub-fraction 25
3 - sub-fraction 22
4 - sub-fraction 21
5 - sub-fraction 20
6 - sub-fraction 18
7 - sub-fraction 17
8 - sub-fraction 16
9 - sub-fraction 6
10-sub-fraction 5
11-sub-fraction 4
12-standard molecular weight markers
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Fig 6.20
Fig 6.21 Western immuno-blotting of sub-fractions from fraction number 17 of B.bovis
culture supernatant against either a pool of anti-fi. bovis sera (A) or a pool of pre-infection
sera (B).
Lanes: 1 - sub-fraction 26
2 - sub-fraction 25
3 - sub-fraction 24
4 - sub-fraction 23
5 - sub-fraction 22
6 - sub-fraction 21
7 - sub-fraction 20
Standard molecular weight markers are indicated on the left.
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6.6.3.3 Fractionation of B.bigemina culture supernatant
Three peaks of absorbance were detected after size exclusion fractionation of B.bigemina
supernatant (Fig 6.22). The first peak (A) was detected in fractions 12 to 16, the second (B)
in fractions 16 to 23 and the third (C) in fractions 27 to 29.
Silver staining of acrylamide gels detected protein bands in fractions 14 to 26 (Fig 6.23 A and
B).
When fractions 14, 15 and 18-24 were further analysed by Western immuno-blotting against
the pool of anti-fi. bigemina sera, two reactive bands (at molecular weights 120 and 55 kDa)
were detected (Fig 6.24 A). However, the same bands were also detected by the pool of pre-
infection sera (Fig 6.24 B).
Western immuno-blotting analysis of NBS and purified IgG resulted in detection of two
bands of molecular weights corresponding to those detected in fractions of Babesia culture
supernatants suggesting that these were due to reaction of the anti-bovine IgG conjugate
against bovine IgG (Fig 6.25). With these results, no further fractionations were carried out
with B.bigemina culture supernatant.
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Fig 6.23 Silver staining of a 4-15% gradient gel containing fractions of B.bigemina culture
supernatant obtained after HPLC fractionation by size exclusion.
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Fig 6.24 Western immuno-blotting of fractions of B.bigemina culture supernatant against
either a pool of anti-B.bigemina sera (A) or a pool of pre-infection sera (B).
Lanes: 1 - fraction 24
2 - fraction 23
3 - fraction 22
4 - fraction 21
5 - fraction 20
6 - fraction 19
7 - fraction 18
8 - fraction 15
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Fig 6.25 Western immuno-blotting of NBS, purified bovine IgG and fraction 17 of B.bovis
supernatant against a pool of anti-B.bovis sera (A), a pool of anti-B.bigemina sera (B), a
pool of pre-infection sera (C) and PBS control (D).
Lanes: 1 - NBS
2 - bovine IgG
3 - fraction 17 of B.bovis supernatant
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6.7 Discussion and conclusions
In the studies described here immunodominant antigens of both B.bovis and B.bigemina
parasites were identified by immuno-blotting using immune calf sera produced by
experimental inoculation of iRBC, and sera from cattle which had undergone natural
infections under field conditions.
The study on antigen preparation showed that, for both parasites, the strongest reactions were
obtained in blots containing samples which had been prepared using either pelleted parasites
or iRBC to which no enzyme inhibitors had been added and which had not been lysed before
freezing (Fig 6.1). In such antigen preparations solubilisation of proteins was achieved with
the addition of reducing sample buffer, which contained a detergent (SDS) and a reducing
agent (mercaptoethanol).
Although samples without enzyme inhibitors were more concentrated than those to which
enzyme inhibitors were added, and therefore the stronger reactions observed with them might
simply have been due to their higher protein concentrations, it appears that there was no need
to include enzyme inhibitors in the preparation of Babesia samples for electrophoresis.
Addition of enzyme inhibitors would be of more importance if samples were to be subjected
to sequential freezing/thawing procedures which might result in degradation of proteins by
parasite proteinases. Under the conditions used here, there was little time for any protein
degradation since the parasite preparations were kept frozen until just before use and once
they were thawed, the SDS reducing sample buffer was added immediately.
The results from this study showed that solubilisation and separation of B.bovis and
B.bigemina proteins by SDS-PAGE was satisfactory when SDS-reducing sample buffer was
added directly to frozen concentrated parasites or iRBC without any previous lysis, and that
the proteins separated by this method were recognised by immune sera. This method was
therefore used for the preparation of Babesia antigens for immuno-blotting studies.
Polyclonal sera contain a mixture of different populations of antibodies that are specific for
different antigens. When such antisera are used in immunochemical characterisation of
antigens interpretation of results can be difficult. The development of techniques for
hybridoma production has allowed the preparation of McAbs which are homogeneous, have a
defined specificity and can theoretically be produced in unlimited quantities (Harlow & Lane,
1988).
It was expected that, in the present study, a panel of McAbs would be useful in identifying
B.6ov/5-specific components. Once relevant epitopes were identified, it was hoped that they
could be purified from crude parasite extracts by the use of the corresponding McAb in an
affinity purification procedure.
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The IFAT analysis of the panel of McAbs showed that all McAbs, with only one exception
(McAb 2A11), reacted against all three stocks of B.bovis. This was encouraging since
antigens conserved between isolates are necessary for diagnostic assays. Distinct patterns of
staining were observed with each of the McAbs, which allowed their classification into three
groups according to their specific reactivity against either parasite surface, parasite internal
components, or parasite and iRBC components (Table 6.1).
Despite their reactivity in IFAT, only four McAbs (4F3:1, 1B8:1, 2A1I and 118.672) reacted
in ELISA, with relatively low end point titres. All four ELISA reactive McAbs had reacted
against either parasite internal components of iRBC or cytoplasm/membrane in IFAT. None
of the McAbs that had reacted against parasite surface in IFAT reacted in ELISA. The
differences in reactivity between IFAT and ELISA might be due to substantial differences
between these two tests particularly in relation to the type of antigens used in each case. The
IFAT uses as antigen the whole iRBC after fixation and therefore reactions detected may
include ones directed against conformational components. In contrast, the ELISA uses as
antigen a soluble parasite preparation which is usually obtained by sonication and therefore
the original structure of parasite/RBC components is disrupted. This might be an explanation
for the lack of reactivity in ELISA of McAbs which reacted against the parasite surface in
IFAT. The reactivity of the McAbs in IFAT associated with the lack of reactivity of most of
them in ELISA gives support to the hypothesis that these McAbs may react specifically
against epitopes of conformational components (Harlow & Lane, 1988).
Further evidence for the lack of specific reactivity of these McAbs was observed in Western
immuno-blotting, which also uses soluble parasite extracts as antigen. In the antigen
preparations for immuno-blotting, the proteins are further reduced by mercaptoethanol
present in the sample buffer and disrupted by boiling for 5 minutes. For the immuno-blotting
analysis, the McAbs were pooled into groups of two or three. This approach was used based
on findings that a combination of multiple McAbs allows formation of stable multivalent
complexes, increasing the avidity for the antigen in question (Harlow & Lane, 1988).
The immuno-blotting analysis of four pools of McAbs showed a reaction against two protein
bands (molecular weights of 195-200 kDa) (Fig 6.2), which did not appear to be parasite-
specific components, as evidenced by their detection on several occasions by pools of pre-
infection sera (see Fig 6.6 C), although the reaction from pre-infection sera was much fainter
than those from the pools of McAbs. On the other hand, the anti-T.evansi McAb did not
detect them. Amongst the four pools of McAbs, one reacted with a band with molecular
weight of 58 kDa which was detected only in the Kwanyanga stock. Due to the fact that the
McAbs had been raised against this stock of B.bovis, these results suggest that the 58 kDa
band might be a Kwanyanga-specific epitope.
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The immuno-blotting analysis using the panel of McAbs did not identify any stock-common
antigenic determinant, thus none of the McAbs could be used to purify parasite-specific
antigenic determinants using a McAb affinity purification procedure. Nevertheless, the
McAbs which had given the strongest (brightest) reactions by IFAT (McAbs 3D42, 1C 12:2,
3D6:1 and 4D 1:3) and the ones which had resulted in highest ELISA titres (4F3:1 and 1B8:1)
were selected for further investigation by immunoprecipitation of -^S-labelled proteins as
described in Chapter 7.
The analysis of the total protein profiles of preparations of the different stocks of B.bovis
showed a large number of protein bands in Coomassie blue stained gels (Fig 6.3). The protein
profiles of the stocks were very similar and no differences were detected between the parasite
and the uninfected RBC preparations. These results could be due to presence of RBC
contamination in the parasite preparations and for this reason, an uninfected RBC lysate was
included as a negative control in immuno-blotting analysis. However, similarities between the
profiles of infected and uninfected preparations may merely reflect a limitation of one-
dimensional gel electrophoresis, which only separates the proteins according to their
molecular weight. It was therefore not possible to determine if the bands with similar
molecular weights in the uninfected and parasite preparations comprised the same proteins.
The Western immuno-blotting analysis of the B.bovis and uninfected RBC antigens, using
calf sera produced by experimental inoculation of iRBC, resulted in identification of the
major B.bovis immunodominant proteins and indicated that antigenic differences exist within
the stocks used (Fig 6.4, 6.5 and 6.6). The Kwanyanga and the Mexico stocks consistently
showed similar antigenic profiles throughout the study, whereas the Lismore stock was
different from the other two stocks in relation to some antigens. Evidence for this was the
differences found in antigen profiles when different calf sera were used to probe the three
stock preparations on the same gel (Fig 6.4). Three antigens (molecular weights of 70, 39 and
37 kDa) present in the Mexico and Kwanyanga stocks were absent in the Lismore stock (Fig
6.4 A) and two antigens (molecular weights of 78 and 30 kDa) were present only in the
Lismore stock (Fig 6.4 B). These findings give support to the belief that there is antigenic
diversity amongst the B.bovis stocks (Kahl et al, 1983; Gill et al, 1987a; Timms et al, 1990).
However, one should bear in mind, when interpreting the results of immuno-blot analysis, that
differences observed in the antigen profiles between the stocks could in part be due to
differences in the immune responses of individual calves against particular parasite
components. It was not possible to explore this further with the limited number of stock-
specific calf sera available for this study.
Further evidence of antigenic diversity amongst the stocks of B.bovis was seen when a pool of
field sera from Brazil was used to probe the three antigens. Results from this analysis again
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showed antigenic differences between the stocks, with two antigens (39-37 kDa) not being
detected in the Lismore stock while the 30 kDa antigen was only detected in Lismore. This
analysis also indicated that the Brazilian field sera reacted more strongly with the Kwanyanga
antigen (Fig 6.6, lane 1 A) than with the Mexico and Lismore antigens (Fig 6.6, lanes 2 and 3
A). This suggests that the Brazilian field stocks of B.bovis might be more antigenically
similar to this stock than to the other two stocks.
Antigenic heterogeneity of populations of Babesia parasites, as reviewed in section 2.3.1.1,
may play an important role in the generation of the immune response and should therefore be
considered in immunochemical characterisation studies. Differences between strains of
Babesia parasites have been demonstrated at the protein composition level (Kahl et al, 1982b;
1983) and at the genetic level (Dalrymple, 1992; Dalrymple et al, 1992). Rapid serial passage
of B.bovis through splenectomised calves results in its attenuation and this feature of the
parasite has been used for production of a live vaccine (Callow & Mellors, 1966). Passage
through ticks and in vitro cultivation have also been reported to result in changes in parasite
populations and their virulence (Callow et al, 1979; Dalrymple et al, 1992). With these
considerations in mind, the antigenic differences between the B.bovis stocks observed in the
present study could have appeared as a consequence of the in vitro cultivation of the three
original isolates, which might have been antigenically identical or very similar at the time of
their first isolation. Cultivation in vitro may have acted as an artificial pressure for selection
of parasite populations which were more able to survive and multiply continuously in vitro.
These populations of in vitro adapted parasites may differ antigenically from their parent
stocks.
A second explanation for the antigenic differences observed between the stocks could be that
the original isolates, which initiated the in vitro cultured parasite lines, were antigenically
different. Previous biochemical analysis of the B. bovis stocks at CTVM resulted in a different
pattern for GPI isoenzyme from the Lismore stock in comparison to identical patterns for the
Mexico and Kwanyanga stocks (T.Melrose, personal communication). The Lismore lysate
used for that analysis, however, was produced from infected blood from a calf, whereas the
other two stocks were prepared from in vitro cultured parasites. Furthermore, when the same
comparison was repeated during the present study, using in vitro cultured iRBC of each of
the three stocks of B.bovis, identical patterns were observed (data not shown). Considering
that isoenzyme analysis is a useful tool for the discrimination of sub-populations of other
protozoans, such as Theileria annulata (Melrose & Brown, 1979), these findings may give
support to the hypothesis that during in vitro cultivation of Babesia stocks there is selection
of certain populations of parasites, which express different GPI isoenzyme patterns from the
majority of the parent stocks.
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In the knowledge that antigenic diversity exists amongst the stocks of B.bovis, the
immunochemical characterisation described here was directed towards the identification of
conserved antigens for use as diagnostic tools for the development of species-specific
ELISAs.
The study showed that some protein bands detected by immune calf sera were B.bovis
species-specific and common to all three stocks studied (Table 6.2). They were therefore
potential candidates for further analysis. These proteins had molecular weights of 185, 140,
121, 95, 76, 56, 28, 27, 18 and 14 kDa. However amongst those, only some were recognised
by the pool of Brazilian field sera. These included the 185, 140, 76, 56 and 14 kDa bands
which were identified as the most appropriate candidates for use in the development of
B.bovis specific ELISAs.
B. bovis antigens with similar molecular weights have been identified by immuno-blotting by
other researchers and some of the antigens reported here might be the same or related
proteins. Goodger and Wright (1983) identified, amongst others, an antigen of 121 kDa using
a saline eluate from sucrose washed bovine RBC infected with B.bovis, which might be the
same as the 121 kDa antigen identified in the present study. However, their analysis used
rabbit antiserum raised against the eluate instead of bovine antiserum. Later, Goodger and co¬
workers identified four bands with molecular weights of 70, 60, 44 and 27 kDa from a lysate
of B.bovis iRBC after fractionation by a gel filtration procedure using Sephadex G200
(Goodger et al, 1984). These bands have molecular weights close to some of the bands
identified in the present study and may represent the same proteins.
A 29 kDa antigen, which may be the same as the 28 or the 27 kDa proteins identified in the
present study, has also been identified to be immunodominant in Western immuno-blotting
and has been used for immunisation of susceptible cattle (Wright et al, 1985). It conferred
only partial protection against challenge with the homologous strain of B.bovis, and was not
considered a suitable protective antigen.
B.bovis proteins of molecular weights of 22 and 76 kDa have also been shown to confer
partial protection against challenge with the homologous strain and have been considered to
be potential protective candidates (Commins et al, 1985). Immunodominant bands of 180 and
140 kDa, from a heparin binding fraction of a B.bovis lysate, which might be the same as the
185 and 140 kDa bands identified in the present study, have also been reported to induce
partial protection in susceptible cattle against challenge with the homologous strain (Goodger
et al, 1987a). Moreover, induction of partial protection has also been reported with proteins
of babesial origin which were shown to comprise four immunodominant bands of 12 to 18
kDa in Western immuno-blotting analysis (Goodger et al, 1990). Thus the low molecular
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weight bands (14 and 18 kDa) identified in the present study may be the same as those
reported by Goodger and co-workers.
The immuno-blotting analysis also allowed the identification of some bands which were
faintly recognised by a.nti-B. bigemina sera, and might represent epitopes shared by both
B.bovis and B.bigemina. These were 72, 49 and 23 kDa. It appeared unlikely that these
reactions had been generated against RBC components since these bands were not detected
when the uninfected control antigen was tested against a pool of anii-Babesia sera from
calves which had been challenged several times with RBC culture suspensions (Fig 6.6 B).
Furthermore one antigen (molecular weight of 200 kDa) was recognised by all sera tested, i.e.
B.bovis specific, B.bigemina specific, field sera and pre-infection sera. This suggests that
these reactions may result from cross-reactivity due to similarities between Babesia and other
agents that the animals had been previously been in contact.
The electrophoretic analysis of B. bigemina samples showed, as for B. bovis, a large number
of bands in both stocks (Kenya and Mexico) by Coomassie blue staining (Fig 6.8). The
Western immuno-blotting analysis allowed the identification of major immunodominant bands
of the Kenya stock with molecular weights of 94, 80, 79, 71, 65, 60, 59 and 42 kDa (Fig
6.9). However this analysis also indicated great variation in the intensity of reactions between
individual calf sera tested, and showed that not all the bands were recognised by all of the
serum samples. The strongest reactions were detected with serum from a splenectomised calf
(583, taken on day 97 p.i.), which had been inoculated twice with the Zaria stock of
B.bigemina, and once with the Muguga stock (Fig 6.9, lane 3). The second most intense
reactions were observed with serum from an intact calf (397, taken on day 89 p.i.), which had
been inoculated twice with the Zaria stock (Fig 6.9, lane 2). On the other hand, the weakest
reactions were observed with serum from a splenectomised calf (8T), which had been
inoculated twice with the Zaria stock (Fig 6.9, lane 1). Furthermore, the analysis indicated
that serum from an intact calf (399) detected only a few bands even after the calf had been
inoculated four times with the Zaria stock of B.bigemina (Fig 6.9, lanes 4-7). Serum samples
from this calf had been shown to contain high titres of specific antibodies in IFAT and
ELISA after the first inoculation, which were persistent throughout the study, and no
explanation for the low reactivity in Western immuno-blotting was found.
Western immuno-blotting analysis of the Mexico stock of B.bigemina resulted in
identification of several immunodominant bands (molecular weights ranging from 50 to 255
kDa), as shown in Fig 6.10. Some of them had molecular weights corresponding to those
identified in the Kenya stock and were probably the same bands. These included bands at 80,
71 and 65 kDa. The difference in the antigenic patterns of the two stocks of B. bigemina may
have been due to antigenic differences between them, but may also been resulted from the fact
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that each antigen had been prepared by different methods. The Kenya antigen was prepared
from infected calf blood and concentrated parasites were sonicated; the Mexico stock antigen
was prepared by lysis of concentrated cultured iRBC with SDS-sample buffer. It is possible
that each of these methods resulted in a different cleavage of the proteins giving distinct SDS-
PAGE separation patterns.
Only one band (molecular weight of 65 kDa) of the B.bigemina Kenya stock was faintly
recognised by the pool of anti-B.bovis sera, which may represent a cross-reactive epitope
shared by the two parasites (Fig 6.9, lane 9). However this reaction was very faint when
compared to that produced by the anti-B.bigemina sera and it was not observed in the
B.bigemina Mexico stock. The analysis of cross-reactivity using anti -B.bovis sera against the
Mexico stock of B.bigemina showed faintly stained antigens at 71 and 69 kDa (Fig 6.10).
The pool of pre-infection sera did not recognise any of the proteins in the Kenya stock (Fig
6.9, lane 8). However it did recognise faintly two antigens (molecular weights 71 and 69 kDa)
in the B.bigemina Mexico stock antigen (Fig 6.10), suggesting that these antigens may
represent epitopes with similarities to agents other than Babesia, with which the calves had
been in contact before the Babesia infections.
Therefore the summary of the immuno-blotting analysis of somatic antigens of the two stocks
of B.bigemina (presented in Table 6.3) allowed the identification of two protein bands, which
were species-specific and stock-common antigens (molecular weights of 80 and 65 kDa), as
potential candidates for use in the development of specific ELISAs. In addition to these, four
bands (molecular weights of 195, 162, 128 and 50 kDa), which had been identified as
immunodominant in the B.bigemina Mexico stock, were also considered as species-specific
for further studies, as presented in Chapter 8.
Several specific B.bigemina proteins have been identified as potential protective antigens by
other research groups. These include proteins with molecular weights of 72, 58, 45 and 36
kDa, which were common to several isolates of B.bigemina (McElwain et al, 1987; Figueroa
et al, 1990b). However, due to the fact that these studies were based on immunological
analysis by immunoprecipitation of radiolabeled parasites rather than by Western immuno-
blotting (as reviewed in section 2.3.3.2), it is probably inappropriate to make comparisons
with the antigens identified in the present study.
The second approach adopted in the present study was focused on the immunochemical
analysis of exoantigens from culture supernatants. This approach unfortunately gave
unsatisfactory results which did not allow the identification of species-specific antigens for
use in ELISAs.
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The presence of soluble antigens in serum from cattle infected with B. bovis and B. bigemina
was first reported by Mahoney (1966). The development of continuous in vitro culture
systems for both parasites (Levy & Ristic, 1980; Vega et al, 1985a) facilitated studies on the
characterisation and dynamics of production of so-called exoantigens, which are defined as
soluble proteinaceous moieties naturally released in the plasma of Babesia infected animals
and in the supernatant of in vitro cultures (Ristic & Kakoma, 1988). Biochemical
characterisation of B.bovis exoantigens has shown that at least three antigens are produced in
vitro (James et al, 1981), which are associated either with the membrane or cytoplasm of
erythrocytes or with the parasite itself (Montenegro-James et al, 1983). Exoantigens of
B. bigemina from culture supernatant have not yet been immunochemically characterised.
Nevertheless, both B. bovis and B. bigemina culture supernatants have been tested for use as a
non-living vaccine in field vaccination trials in some Latin American countries (Smith et al,
1979, Montenegro-James et al, 1985). However, protection conferred to susceptible cattle by
culture supernatants has been shown to be only partial after challenge with heterologous
strains and to be substantially lower than the protection conferred by live parasites (Timms et
al, 1983; 1984).
As the aim of the present study was to identify potential diagnostic target antigens, it was
considered that exoantigens from culture supernatant could be a suitable source of antigens
which would detect specific antibodies generated against circulating soluble parasite antigens.
If such antigens were identified, they could also be used to produce mono-specific antisera
(polyclonal or monoclonal), with which to develop an antigen-capture ELISA (Rae &
Luckins, 1984; Katende et al, 1990). Assuming that exoantigens are released into plasma of
infected animals as soon as the parasite starts to multiply, such an assay would be
appropriate for detection of infection at an early stage after primary infection, even before
antibodies have been produced. An antigen-capture ELISA could replace the conventional
microscopic examination of blood smears for diagnosis of acute infections. Moreover, such
an assay could be useful for detection of carrier animals whose antibody levels have dropped
and consequently would not be detected as reactive in an antibody detection assay.
The approach used in the present study of applying HPLC to separation of relevant soluble
exoantigens, which was based on initial fractionation by size exclusion followed by ion
exchange, was chosen with the expectation of isolating antigens from culture supernatant into
distinct fractions.
One limitation of the immunochemical analysis of Babesia sp culture supernatants appeared
to be related to the high proportion of normal serum constituents in the culture medium
(40%), which, due to the presence of serum proteins, appeared to mask the antigens of
parasite origin. In order to minimise this effect, the proportion of serum in the culture medium
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used for harvesting of exoantigens was reduced to 5%, which had been previously determined
to have little deleterious effect on parasite growth over a short period (48 hours) (data not
shown). However, SDS-PAGE analysis of culture media containing 5% serum showed that a
protein band, which was considered to be bovine serum albumin (molecular weight of 66
kDa), still caused distortions in the gel. In an attempt to achieve a better separation of the
proteins, the culture supernatants were treated with Affigel blue, which is a cross-linked
agarose gel with binding capacity of 11 mg of albumin per ml (Bio-Rad catalogue). This
treatment was shown to be effective in removing albumin from the supernatant samples, as
demonstrated in Fig 6.12 (lanes 1-4). However, as the Affigel is a suspension of beads in
PBS, it results in dilution of the sample after treatment.
Thus, following the removal of albumin, it was necessary to concentrate the culture
supernatants. An attempt was made to concentrate them by a filtration procedure using
Filtron membranes (Microsep, Microconcentrators - 10 kDa nominal molecular weight cut¬
off) by centrifugation. According to the manufacturer's recommendations, this method should
yield a 100-fold concentration after either 55 minutes of centrifugation at 3,000 x g, 40
minutes at 5,000 x g, or 25 minutes at 7,500 x g. However this was not observed; even after
increasing the time of centrifugation up to 5 hours and the speed to 3,000 x g, the volume of
supernatant that had been filtered through the membrane was very small with most of the
sample being retained by the membrane. After a few minutes of centrifugation the membrane
was completely blocked, with a brownish layer being formed around it. This may have
happened due to presence of haemoglobin in the samples as a result of lysis of RBC during in
vitro cultivation. High concentrations of IgG in the culture supernatant may also have
contributed to the blocking of the membrane. This method was therefore considered
inappropriate for concentration of Babesia culture supernatant.
The second method attempted for concentration of albumin-depleted samples was the use of
Lyphogel (Gelman), a polyacrylamide hydrogel. In aqueous solutions the lyphogel absorbs 5
times its own weight of water and low-molecular weight substances such as salts; proteins
and other substances of a molecular weight of 20 kDa or more are excluded from the gel
matrix. Treatment with Lyphogel yielded an approximately five fold concentration of the
starting albumin-depleted supernatants (Fig 6.12, lanes 3-6). This method was used
throughout the study.
The HPLC fractionation of culture supernatant by size exclusion resulted in similar fractions
from both B.bovis and uninfected supernatants, in relation to the peaks of absorbances.
Similarities in protein composition between infected and uninfected supernatants were also
seen by SDS-PAGE analysis (Fig 6.14). The fractionation by size exclusion resulted in
elution of small molecular weight proteins first, followed by the heavier ones. This was not
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expected since the heavier molecules will pass through the matrix and therefore should be
eluted first, whereas the smaller molecules will penetrate the pores of the column matrix and
therefore a longer time will be necessary to elute them.
No significant differences were detected in the protein patterns of B.bovis and uninfected
fractions, although the protein bands in the B.bovis fractions stained more intensively than the
corresponding bands in the uninfected fractions.
The first Western immuno-blotting analysis of the fractions of B.bovis supernatant revealed
that two fractions (16 and 17), both had a band of approximate molecular weight of 55 kDa
that was recognised by the pool of anti-B.bovis sera but not recognised by the pool of pre-
infection sera. For this reason these two fractions were selected for further fractionation by
ion exchange. However, the Western immuno-blotting analysis of the sub-fractions that
originated from the ion exchange fractionation resulted in reaction against the 55 kDa band
by both B.bovis and pre-infection pools of sera (Fig 6.21). Thus, it was decided to repeat the
immuno-blotting analysis using the original samples of the B.bovis fractions, including
fractions 16 and 17, before they had been fractionated by ion exchange. This analysis resulted
in detection of the 55 kDa band in fractions 15 to 18 by both pools of sera. Thus the first
detection of the 55 kDa band only by the pool of anti -B.bovis sera was not reproducible and
none of the bands appeared to be of B.bovis origin. In addition to the 55 kDa band, which
was reactive in four fractions, one additional reactive band (molecular weight of 120 kDa)
was detected in fractions 16 and 17, and one additional reactive band of 80 kDa was detected
in fractions 15 and 18 (Fig 6.15). However, all bands appeared to be reactive when either
pools of sera (anti-5. bovis and pre-infection) were tested and therefore the fractionation of
B.bovis culture supernatant did not lead to identification of parasite antigens with which to
develop specific ELISAs.
The HPLC fractionation of B.bigemina culture supernatant also resulted in fractions which
had higher absorbances than the corresponding fractions of the uninfected supernatant. These
results indicate that some fractions might have contained parasite exoantigens in addition to
serum protein components from the NBS used in the culture medium. However the Western
immuno-blotting analysis of the fractions from the size exclusion fractionation gave a similar
pattern of reactivity to that described for the B.bovis supernatant. Two reactive bands
(molecular weights of 120 and 55 kDa) were detected when either the pool of anti-B.bigemina
or the pool of pre-infection sera were tested (Fig 6.24). These bands appeared to be the same
as those observed in B.bovis supernatant and were not of parasite origin, as demonstrated by
the same pattern and intensity of reactions with both pools of sera. Therefore, it was decided
not to carry out further fractionation of B.bigemina culture supernatant since this approach
did not appear to be appropriate for identification of Babesia specific exoantigens.
The results obtained from Western immuno-blotting analyses led to the hypothesis that the
bands detected from both B.bovis and B.bigemina supernatant fractions were detected by
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reactions from the anti-IgG conjugate to IgG present in the serum used in the culture medium
rather than to parasite components. To prove this hypothesis a blot containing samples of
normal bovine serum, purified bovine IgG and fractions 16 and 17 of B.bovis culture
supernatant was reacted with the anti-bovine IgG conjugate without being previously probed
with any serum. This analysis resulted in the detection of the same size bands (120 and 55
kDa) in all samples. Therefore it was concluded that the fractions from the HPLC
fractionation in fact contained IgG present in culture media.
The whole molecule of bovine IgG has a molecular weight of 150-154 kDa, with the heavy
chain representing 54-59 kDa and the light chain 22-24 kDa (Halliwell & Gordon, 1989).
It appears that the 120 kDa band detected in some of the supernatant fractions, which was
fainter than the 55 kDa band, represented molecules of IgG which for some reason remained
unbroken after the addition of SDS-sample buffer. The 55 kDa band, which was present in all
reactive fractions, represented the heavy chains after cleavage by sample buffer, and the light
chains (25 kDa) were not detected on the blots, perhaps because they had been blocked during
the blocking step, or perhaps due to a lack of specific recognition by the conjugate.
On the other hand, it was possible that specific parasite proteins were present in those
fractions in association with IgG and that the IgG molecule may have masked their detection.
In an attempt to remove the IgG contamination, fractions 16 and 17 of B.bovis supernatant
were treated with Protein A, which has high binding affinity to IgG. However immuno-
blotting analysis of Protein A-treated fractions showed that although the protein A treatment
resulted in a decrease of reactivity against the 55 kDa band, non-specific reactions from the
conjugate were still quite strong. Thus, it appears that IgG present in normal bovine serum
used for in vitro cultivation is a major host contamination and interfered with the
identification of specific parasite exoantigens. Removal of bovine IgG should be considered
before any fractionation takes place.
The immunochemical analysis presented in this chapter led to the identification of specific
somatic proteins of both B.bovis and B.bigemina with potential use as antigens in
immunodiagnostic assays. However, in the face of several limitations regarding the
techniques used here, further characterisation of Babesia stocks was carried out using
immunoprecipitation of radiolabeled proteins as another approach for identification of
species-specific components, both somatic and exoantigens. This is presented in the next
chapter.
Some of the work reported in this chapter has been published (see Appendix 6.1):
Passos, L.M.F. & Melrose, T.R. (1991) Immunochemical and biochemical diversity in stocks
of Babesia bovis. Proceedings of the IV International Congress on Malaria and Babesiosis,
Rio de Janeiro, Brazil (Abstract).
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CHAPTER SEVEN
THE USE OF IMMUNOPRECIPITATION TO FURTHER
CHARACTERISE STOCKS OF B.BOVIS AND B.BIGEMINA
7.1 INTRODUCTION
The identification of B.bovis and B.bigemina specific antigens for use in the development of
specific ELISAs was continued using the technique of immunoprecipitation as an alternative
method for immunochemical characterisation of cultured parasites. This technique differs
from Western immuno-blotting in that the antigens are less completely denatured and thus
may retain important conformational epitopes. For this reason, it was believed that
immunoprecipitation would enable better use to be made of the McAbs in identification of
species-specific antigens.
Immunoprecipitation is a powerful method by which to analyse antigens in complex protein
mixtures. The combination of specific antigen-antibody binding and the discrimination by
SDS-PAGE separation of proteins by molecular weight permits an impressive resolution of
antigenic moieties. The protein mixture of interest is usually labelled with a radioactive amino
acid or a precursor of an amino acid by either an exogenous (surface) or endogenous
(biosynthetic) labelling technique and, if cell associated, is then solubilised by the addition of
a non-ionic detergent such as NP-40. The solubilised antigen mixture is then submitted to
high-speed centrifugation to remove insoluble material, and is then reacted with polyclonal or
monoclonal antibodies. This results in the formation of an immune complex which is
precipitated by the addition of either particles (such as protein A) with binding affinity to
IgG, or anti-immunoglobulin antibody. After thorough washing, the immune complex is
denatured by boiling in the presence of SDS and its components can be identified by SDS-
PAGE separation (Hudson & Hay, 1989).
This chapter presents the results from the immunoprecipitation analysis of -^S-methionine-
labelled components of in vitro cultures of the three stocks of B.bovis (Lismore, Mexico and
Kwanyanga), and the Mexican stock of B.bigemina. For the identification of species-specific
antigens of each parasite, two approaches were taken. One was based on the analysis of
soluble parasite components released into the culture supernatant (exoantigens), and the
second was based on the analysis of somatic parasite components. In both cases a variety of
serum samples were tested, including a panel of calf sera experimentally produced against the
different stocks of each parasite, serum samples from cattle naturally infected in the field in
Brazil and the panel of anti-B.bovis McAbs previously characterised by IFAT, ELISA and
Westen immuno-blotting (see Chapter 6).
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7.2 MATERIALS AND METHODS
7.2.1 Metabolic labelling with ^S-methionine
The method used was based on that described by Harrison and Parkhouse (1986) for labelling
secreted/excreted products of Taenia saginata. For each labelling experiment B.bovis and
B.bigemina parasites were cultured in two 2 cm^ wells of a 24-well plate (1.25 ml/well) as a
10% RBC suspension in methionine-depleted RPMI-1640-ML (as described in Table 3.2).
This analysis included all three stocks of B.bovis (Lismore, Mexico and Kwanyanga) and
B.bigemina (Mexico), the only B.bigemina stock that could be grown in vitro. Each culture
was supplemented with L--^S methionine (Amersham) to a final concentration of 50 pCi/ml
of culture, for 15-24 hours. Uninfected RBC suspensions from the same donor animals were
incubated and prepared under the same conditions as the Babesia cultures to provide negative
controls.
After incubation, the two wells were pooled and the cells were pelleted by centrifugation at
1,000 x g for 10 min at 4° C. The supernatant was removed from the cell pellet and
centrifuged at 13,000 x g for 30 minutes at 4° C. The clarified supernatant was then applied
to a 1 x 10 cm Sephadex G 25 column (Sigma), previously equilibrated and washed with 50
ml of PBS-methionine (Appendix 1). This gel filtration step was included in order to remove
the excess of free -^S-methionine which had not been incorporated by the cells. The
supernatant was eluted through the column with PBS and twenty fractions of 0.25 ml were
collected. A 10 pi aliquot was taken from every fraction, mixed with scintillation fluid (for
aqueous samples, Sigma) and counted in a liquid scintillation analyser (Packard Instruments)
to determine the ^-^-radioactivity in counts per minute (c.p.m.). Typical c.p.m. of eluted
fractions of babesial and uninfected culture supernatants are presented in Appendix 4.
Fractions containing incorporated -^S (first peak), which were usually eluted in fractions 5 to
12, were pooled and used as 'exoantigen' in subsequent immunoprecipitation reactions.
The pelleted labelled cells were washed twice in RPMI 1640 and solubilized for 1 h at 4° C
in two volumes of lysis buffer (Appendix 1). The resultant extracts were centrifiiged at
13,000 x g for 30 min at 4° C to remove insoluble material. The supernatant from this lysate
was used as 'somatic antigen' in subsequent immunoprecipitations.
To estimate the incorporation of ^S-methionine after each labelling, samples of exoantigen
and somatic antigen were precipitated with trichloroacetic acid (TCA). Aliquots of 10 pi of
each sample were mixed with 190 pi of NBS and 2 ml of 10% (w/v) TCA and allowed to
stand for 10 minutes at room temperature. The resultant precipitates were washed twice by
centrifugation at 3,000 x g for 5 minutes with NaOH, resuspended in 4 ml of scintillation
fluid and the c.p.m. measured (as previously described). The percentage of 3^-methionine
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incorporation was calculated by subtracting the c.p.m. obtained after precipitation from the
initial (total) c.p.m.. Typical percentages of incorporated -^S in exoantigens and somatic
antigens from babesial and uninfected cultures are presented in Appendix 4.
7.2.2 Immunoprecipitation
In order to minimise non-specific background, labelled parasite antigens (exo- and somatic)
were treated with serum before being used in immunoprecipitations. For this, a mixture of
200 pi of either normal bovine (in the case of precipitation with polyclonal sera) or normal
mouse (in the case of precipitation with McAbs) serum, 1.0 ml of co-precipitation diluent
(Appendix 1) and 400 pi of rabbit anti bovine or goat anti mouse Ig (Sigma), as appropriate,
was left overnight at 4° C to allow non-specific precipitation. One hundred pi of this
suspension were mixed with 100 pi of ^S-labellcd parasite extract (either exo- or somatic
antigens) and the mixtures were centrifuged at 13,000 x g for 5 min at 4° C. The
radioactivity of resultant supernatants (in c.p.m.) was estimated by scintillation counting as
previously described and the supernants (designated 'clean probe') were stored at -80° C until
required.
The panel of serum samples used throughout the analysis included calf sera produced at
CTVM by experimental inoculation of RBC infected with each parasite species and stock (as
described in Table 3.1), calf sera produced in Brazil by experimental inoculation of infected
blood, and serum samples collected from cattle which had been exposed to natural infestation
with ticks in Brazil (as described in section 3.4.2). A pool of pre-infection sera was also
included as a negative control and was prepared by mixing equal volumes of samples taken
from calves 396, 397, 399 and 583 before infection with Babesia parasites. In some
experiments pools of anti-B.bovis and anti-B.bigemina sera were used. The pool of anti-
B.bovis sera was prepared by mixing equal volumes of serum samples taken from calves 396
(days 57 and 104), P78 (day 80) and 198 (day 28); the pool of anti-JS.bigemina sera
contained serum samples from calves 397 (day 69), 399 (day 98), 583 (day 85) and 8T (day
28). In an attempt to reduce non-specific background reactions these pools of sera were pre-
adsorbed with normal RBC prior to being used in immunoprecipitations.
The anti-B.bovis McAbs used are described in section 3.4.3, and results of their
characterisation by IFAT, ELISA and Western immuno-blotting are presented in Chapter 6.
Duplicate aliquots of 5 pi of each polyclonal serum or McAb under investigation were
incubated with a volume of each clean probe containing 5 x 10^ c.p.m. at 4° C for 1 hour.
One hundred and fifty pi of anti-bovine or anti-mouse Ig diluted 1:10 with PBS were added,
and the mixtures were incubated at 4° C overnight to allow precipitation. The precipitates
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were washed 4 times by centrifugation (3,000 x g for 10 min at 4° C) in ice-cold co-
precipitation diluent and resuspended in 25 p.1 of PBS. An aliquot of 5 pi was removed for
scintillation counting and the remaining 20 pi was mixed with 10 pi of either reducing or non-
reducing electrophoresis sample buffer (Appendix 1). Samples for SDS-PAGE (total proteins
and precipitates) were boiled for 5 minutes, centrifiiged for 3 minutes (at 10,000 x g) to
remove insoluble material and run on either 7-20% gradient or 10% homogeneous gels (as
described in section 3.6.2). Radioactive ('^C) standard molecular weight markers
(Amersham) were loaded in at least one lane of each gel to enable calculation of the relative
mobility of the proteins. In addition, a sample of the corresponding clean probe (total protein)
was loaded in each gel.
7.2.3 Fluorography and autoradiography
After electrophoresis, gels containing -^S-radiolabclled samples (total proteins and/or
immune complexes) were fixed for 30 minutes in a 10% (v/v) methanol, 5% (v/v) acetic acid
solution and then washed for 2 x 30 minutes in DMSO (Sigma). Gels were then transferred
sequentially into the following solutions: a 27.5% (w/v) 2,5-Diphenyloxazole (BDH)/DMSO
solution for 3 hours; tap water overnight; and a 1% (v/v) glycerol, 10% (v/v) acetic acid
solution for 1 hour. The processed gels were dried under vacuum using a Bio-Rad apparatus
(model 224). Dried gels were then exposed to X ray films (Agfa-Curix) using fast tungstate
intensifying screens (Ilford) in metallic cassettes, and were stored at -80°C up to 6 weeks,
depending on the radioactivity of the samples (e.g. gels containing samples with counts of
2,000 c.p.m. were exposed for 4 weeks). After the appropriate exposure time the cassettes
were allowed to thaw at room temperature over a period of 2 hours and the films were
developed in a dark room. Films were soaked in developer solution (Sigma) for 4 minutes and
in fixative solution (Sigma) for 4 minutes. After being rinsed in tap water, films were allowed
to dry and were photographed through filter F61 as described in Appendix 3.
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7.3 B.BOVIS SOMATIC ANTIGENS
7.3.1 Total protein profiles
At least 35 protein bands with molecular weights ranging from 21 to 200 kDa were detected
in total protein samples of B.bovis -^S-labelled lysates, whereas no bands were detected in
samples of lysates from uninfected cultures, as shown in Fig 7.1. More numerous and clearly
resolved bands were seen in samples treated with reducing buffer (Fig 7.1, lanes 1, 3 and 5)
than in samples treated with non-reducing buffer (lanes 2, 4 and 6).
The pattern of protein separation was very similar amongst the three stocks analysed.
However the Lismore stock differed from the Mexico and Kwanyanga stocks with regard to
two bands. The former lacked a protein band (105 kDa) that was seen in the Mexico and
Kwanyanga stocks; while a distinct protein band of 195 kDa was detected only in the
Lismore stock (Fig 7.1, arrows on the left).
7.3.2 Antigen profiles
When the total lysate of B.bovis (Lismore stock) was immunoprecipitated with znii-B.bovis
sera, many bands were detected. Several of these were also detected by the pool of pre-
infection and anti-B.bigemina sera, as shown in Fig 7.2. The pattern of protein separation
obtained with reducing and non-reducing buffers was similar, except in relation to a few
protein bands. The molecular weights of bands were calculated based on the pattern obtained
under reducing conditions (rc).
The antigenic profile of the Lismore stock showed that five bands were B.bovis specific
(precipitated by anti-B.bovis sera, but not by pre-infection or anti-B.bigemina sera). These
were located at 88, 75, 65, 41 and 24 kDa (Fig 7.2).
Four bands with molecular weights corresponding to those detected in the Lismore stock,
were also identified in the Mexico stock, and, in addition to these, one extra B.bovis specific
antigenic band (46 kDa) was identified in the Mexico stock (Fig 7.3).
Five protein bands with molecular weights corresponding to those identified in the Mexico
stock (88, 75, 65, 46 and 41 kDa) were also seen in the Kwanyanga stock (Fig 7.4). In
addition to these, two extra bands (26 and 24 kDa) were identified as B.bovis specific in the
Kwanyanga stock.
Thus, results from this analysis allow the identification of four somatic antigenic components
(88, 75, 65 and 41 kDa) as being B.bovis specific and stock-conserved antigens.
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The immunoprecipitation of somatic antigen using the panel of McAbs showed that four of
the 11 McAbs precipitated proteins in the Mexico stock. Three of them (1B8:1, 118 .67.2 and
4F3:1) precipitated a 240 kDa protein (Fig 7.5, lanes 4, 13 and 14). In addition to the 240
kDa protein, McAb 1B8:1 precipitated a 49 kDa protein, and McAb 118.67.2 precipitated a
27 kDa protein. McAb 3.D6.1 precipitated a single protein of 36 kDa (Fig 7.5, lane 11).
However when the panel of McAbs was tested against the Lismore and Kwanyanga lysates,
no protein bands were detected, as shown in Fig 7.6 A and B.
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Fig 7.1 SDS-PAGE of -^S-labelled proteins of B.bovis lysates.
Lanes: 1 and 2 are Lismore stock lysate
3 and 4 are Mexico stock lysate
5 and 6 are Kwanyanga stock lysate
In 1, 3 and 5 samples were treated with reducing sample buffer; in 2, 4 and 6 samples were
treated with non-reducing sample buffer.
Lane 7 contains lysate of a ^S-labelled uninfected RBC culture (negative control).
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Fig 7.2 Immunoprecipitation of somatic antigens of the Lismore stock of B.bovis with
polyclonal sera.
rc= reducing conditions, nc= non-reducing conditions
Lanes: 1 - total protein (rc)
2 - precipitation (pp) with a pool of anti-B.bovis sera (CTVM) (rc)
3 - as in 2 (nc)
4 - pp with a pool of anti-B.bovis sera (Brazil) (rc)
5 - as in 4 (nc)
6 - pp with a pool of pre-infection sera (rc)
7 - as in 6 (nc)
8 - pp with a pool of anti-fl. bigemina sera (rc)
9 - as in 8 (nc)
10- total protein (nc)
Standard molecular weight markers are indicated on the left.
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Fig 7.3 Immunoprecipitation of somatic antigens of the Mexico stock of B.bovis with
polyclonal sera.
Lanes: 1 - total protein (rc)
2 - total protein (nc)
3 - precipitation (pp) with a pool of anti-fi. bovis sera (CTVM) (rc)
4 - as in 3 (nc)
5 - pp with a pool of anti-B.bovis sera (Brazil) (rc)
6 - as in 4 (nr)
7 - pp with a pool of pre-infection sera (rc)
8 - as in 6 (nc)
Standard molecular weight markers are indicated on the left.
Arrows on the right indicate B.bovis specific bands.
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Fig 7.3
Fig 7.4 Immunoprecipitation of somatic antigens of the Kwanyanga stock with polyclonal
sera
Lanes: 1 - total protein (rc)
2 - total protein (nc)
3 - precipitation (pp) with a pool of anti-fi. bovis sera (CTVM) (rc)
4 - as in 3 (nc)
5 - pp with a pool of anti-B.bovis sera (Brazil) (rc)
6 - as in 4 (nc)
7 - pp with a pool of pre-infection sera (rc)
8 - as in 6 (nc)
9 - pp with a pool of ant-B.bigemina sera (rc)
10- as in 9 but (nc)
Standard molecular weight markers are indicated on the left.
Arrows on the right indicate B.bovis specific bands.
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Fig 7.5 Immunoprecipitation of somatic antigens of the Mexico stock of B.bovis with McAbs
Lanes: 1 - total protein
2 - PBS control
3 - anii-Trypanosoma McAb (negative control)
4-McAb 1B8:1










Standard molecular weight markers are indicated on the right.
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Fig 7.6 Immunoprecipitation of somatic antigens of the Lismore (A) and the Kwanyanga
stocks (B) with McAbs
Lanes: 1 - total protein
2 - anti-Trypanosoma McAb (negative control)
3 - McAb 1B8:1
4 - McAb 2C8:2
5 - McAb 1C12:1
6-McAb 4D1:3
7-McAb 1C 12:2











7.4.1 Total protein profiles
Approximately 28 bands of labelled proteins (with molecular weights ranging from 200 to 14
kDa) were detected in culture supernatants of B.bovis, whereas no bands were detected in the
uninfected RBC culture supernatant (negative control), as shown in Fig 7.7. The pattern of
protein profiles was very similar between the three stocks, except in relation to a few proteins.
Two bands (200 and 185 kDa) that were clearly detected in the Kwanyanga stock were not
detected in the Lismore and Mexico stocks, and a band at 160 kDa was present only in the
Lismore stock (Fig 7.7, arrows). In addition, four low molecular weight bands (26, 25, 23
and 21.5 kDa) were seen in the supernatants of Mexico and Kwanyanga.
7.4.2 Antigen profiles
The profile of exoantigens from the Lismore stock obtained after immunoprecipitation with
polyclonal sera is presented in Fig 7.8. Many of the protein bands resulting from
immunoprecipitation with homologous B.bovis antisera (Fig 7.8, lanes 4-9) were also present,
although with less intensity, with both heterologous B.bigemina antisera (Fig 7.8, lane 2) and
pre-infection sera (Fig 7.8, lane 3). Five bands, which were not clearly resolved, were
detected in immunoprecipitates from anti-B.bovis sera but not detected, or only very faintly
detected, in immunoprecipitates from both anti-B.bigemina and pre-infection sera. These
were seen at molecular weights 250, 169, 80, 29 and 22 kDa, as shown in Fig 7.8 (arrows).
The profile of exoantigens of the Mexico stock of B. bovis revealed that at least 8 bands were
strongly precipitated by anti-B.bovis sera and not precipitated by either anti-B.bigemina or
pre-infection sera (Fig 7.9). These were seen at molecular weights 80, 79, 72, 58, 38, 34, 24
and 22 kDa, as indicated by arrows in Fig 7.9.
The immunoprecipitation analysis of the Kwanyanga stock exoantigens resulted in a profile
similar to that observed with the Mexico stock. Ten antigens, many with molecular weights
corresponding to those identified as B. bovis specific in the Mexico stock culture supernatant
(80, 72, 58, 38, 34, 24 and 22 kDa) were also immunoprecipitated in the Kwanyanga culture
supernatant (Fig 7.10). In addition to these, three extra antigens were detected as B.bovis
specific in the Kwanyanga supernatant. These were seen at molecular weights 120, 44 and 42
kDa.
When immunoprecipitates from culture supernatants of each of the B.bovis stocks were
separated on the same gel, 6 antigens were identified as B.bovis specific and common to the
three stocks analysed (Fig 7.11). These were seen at molecular weights 80, 72, 58, 38, 34 and
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24 kDa, and therefore these were identified as exoantigens which were B.bovis specific and
present in all three stocks.
None of the McAbs immunoprecipitated any of the exoantigens of the Lismore and
Kwanyanga stocks of B.bovis. However two faint bands at 120 and 40 kDa were seen in
precipitates of each McAb tested against the Mexico stock, as shown in Fig 7.12.
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Fig 7.7 Total protein profiles of •^S-labelled supernatants of B.bovis and uninfected RBC
cultures.
Lanes: 1 - Lismore stock
2 - Mexico stock
3 - Kwanyanga stock
4 - uninfected RBC
Standard molecular weight markers are indicated on the right.
Arrows on the left indicate differences in protein profiles between stocks.
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Fig 7.7
Fig 7.8 Immunoprecipitation of exoantigens of the Lismore stock of B.bovis using pooled
polyclonal sera.
Lanes: 1 - total exoantigens
2 - precipitation (pp) with a pool of anii-B.bigemina sera
3 - pp with a pool of pre-infection sera
4 - pp with calf 396 serum (day 104)
5 - pp with calf P78 serum (day 96)
6 - pp with calf P78 serum (day 42)
7 - pp with calf P78 serum (day 21)
8 - pp with calf CI 1 serum (day 28)
9 - pp with calf 198 serum (day 28)
Standard molecular weight markers are indicated on the left.





Fig 7.9 Immunoprecipitation of exoantigens of the Mexico stock of B.bovis using polyclonal
sera.
Lanes: 1 - pp with a pool of anti-£.Zjovzs sera
2 - pp with a pool of pre-infection sera
3 - pp with a pool of anti-S. bigemina sera
4 - pp with distilled water
5 - pp with foetal calf serum
6 - pp with a pool of calf P78 sera (days 21, 42and 96)
7 - pp with calf 396 serum (day 28)
8 - pp with calf 396 serum (day 56)
9 - pp with calf 396 serum (day 84)
10-pp with calf 396 serum (day 104)
11 -pp with a pool of anti-5. bovis (Brazilian) sera
12-total exoantigens
Standard molecular weight markers are indicated on the left.
Arrows on the right indicate B.bovis specific bands.
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Fig 7.10 Immunoprecipitation of exoantigens of the Kwanyanga stock of B.bovis using
polyclonal sera.
Lanes: 1 - pp with a pool of anti-B.bovis sera
2 - pp with a pool of pre-infection sera
3 - pp with a pool of anti-B.bigemina sera
4 - pp with distilled water
5 - pp with a pool of calves 198 and CI 1 sera (day 28)
6 - pp with calf P78 serum (day 21)
7 - pp with calf P78 serum (day 42)
8 - pp with calf P78 serum (day 96)
9 - pp with calf 396 serum (day 104)
10-pp with a pool of ?a\i\-B.bovis (Brazilian) sera
11 -total exoantigens
Standard molecular weight markers are indicated on the right.
Arrows on the left indicate B.bovis specific bands.
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Fig 7.10
Fig 7.11 Immunoprecipitation of exoantigens of stocks of B.bovis using polyclonal sera.
Lanes 1, 4, 7 and 10 are Lismore stock; lanes 2, 5, 8 and 11 are Mexico stock; lanes 3, 6, 9
and 12 are Kwanyanga stock.
A shows pp with a pool of anti-5. bovis sera
B shows pp with a pool of Brazilian field sera
C shows pp with a pool of ani\-B.bigemina sera
D shows pp with a pool of pre-infection sera.
Standard molecular weight markers are indicated on the left.
Arrows on the right indicate B.bovis specific bands.
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Fig 7.12 Immunoprecipitation of B.bovis (Kwanyanga stock) exoantigens using McAbs.
Lanes: 1 - pp with McAb 1B8:1
2 - pp with McAb 2C8:2
3 - pp with McAb 1C12:1
4 - pp with McAb 4D1:3
5 - pp with McAb 1C12:2
6 - pp with McAb 3D4:2
7 - pp with McAb 5G12
8 - pp with McAb 3D6.1
9 - pp with McAb 2A11
10-pp with McAb 118.67.2
11-pp with McAb 4F31
12-pp with McAb PBS
13-pp with McAb anti-Trypanosoma
14-total exoantigens
Standard molecular weight markers are indicated on the left.




7.5.1 Total protein profiles
Approximately 40 labelled protein bands (with molecular weights ranging from 200 to 14
kDa) were seen in the lysate of B.bigemina (Mexico stock), as shown in Fig 7.13, A; and at
least 23 bands were detected in the culture supernatant (Fig 7.13, B).
7.5.2 Somatic antigen profiles
At least 30 bands were seen in precipitates resulting from the reaction between B.bigemina
lysate and anti-B.bigemina sera (Fig 7.14, lanes 2-11). However many of these were also
seen in precipitates using either pre-infection sera (Fig 7.14, lane 1) or anti-B.bovis sera (Fig
7.14, lane 13). Twelve bands were detected in precipitates of homologous sera and were not
detected in precipitates from either pre-infection or anti-5. bovis sera. These were seen within
the range from 210 to 21 kDa and are indicated by arrows in Fig 7.14.
7.5.3 Exoantigen profiles
Immunoprecipitation analysis of exoantigens of the Mexico stock of B.bigemina revealed that
four bands were precipitated by anti-B.bigemina sera but not by pre-infcction sera (Fig 7.15).
These were seen at molecular weights 240, 112, 50 and 29 kDa as indicated by arrows in Fig
7.15. These bands were not seen in precipitates using anti-B.bovis sera (data not shown) and
therefore were identified as B.bigemina specific exoantigens.
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Fig 7.13 SDS-PAGE of -^S-Iabelled proteins of B.bigemina (Mexico stock).
Panel A contains a lysate of iRBC and panel B contains culture supernatant.
In A the standard molecular weight markers are indicated on the left and in B on the right.
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Fig 7.13
Fig 7.14 Immunoprecipitation of somatic antigens of B.bigemina (Mexico stock) using
polyclonal sera.
Lanes: 1 - pp with a pool of pre-infection sera
2 - pp with calf 399 serum (day 29)
3 - pp with calf 399 serum (day 71)
4 - pp with calf 399 serum (day 119)
5 - pp with calf 397 serum (day 28)
6 - pp with calf 397 serum (day 89)
7 - pp with calf 583 serum (day 28)
8 - pp with calf 583 serum (day 64)
9 - pp with calf 583 serum (day 97)
10-pp with a pool of anti-B.bigemina sera (CTVM)
11 -pp with a pool of anti-B.bigemina sera (Brazil)
12-pp with a pool of Brazilian field sera
13-pp with a pool of and-B.bovis sera
Standard molecular weight markers are indicated on the left and right.








Fig 7.15 Immunoprecipitation of exoantigens of B.bigemina (Mexico stock) using polyclonal
sera.
Lanes: 1 - total exoantigens
2 - pp with a pool of pre-infection sera
3 - pp with calf 399 serum (day 29)
4 - pp with calf 399 serum (day 71)
5 - pp with calf 397 serum (day 87)
6 - pp with calf 583 serum (day 28)
7 - pp with calf 583 serum (day 97)
Standard molecular weight markers are indicated on the left.
Arrows on the right indicate specific exoantigens of B.bigemina.
 
7.6 Discussion and conclusions
The results presented in this chapter show that immunoprecipitation of -^S-labelled
components is an appropriate tool for the identification of babesial antigens. This technique
was found to be very sensitive and allowed the identification of several B.bovis and
B.bigemina antigens in both somatic and extracellular components from culture supernatants.
Proteins metabolically labelled with -^-methionine were detected in both lysates and
supernatants of Babesia infected cultures but not in lysates or supernatants of uninfected
cultured RBC, proving that the components labelled were of parasite origin. The level of
incorporation of ^s-methionine by iRBC was consistently high in all labelling experiments,
with an average of 70% and 90% precipitatable proteins (TCA) in somatic components and
exoantigens respectively (Appendix 4A and B). These indicate that the culture conditions
used for the metabolic labelling were adequate and allowed good parasite metabolism.
Although measures were taken to preclear the labelled protein mixtures prior to adding
specific antibodies, high background was observed in the SDS gels throughout the analysis.
Background problems may come from several different sources and can be either specific as
when antigens are recognised directly by spurious antibodies or non-specific occurring due to
contaminant proteins that either bind to particulate matter in the preparation or aggregate and
are precipitated with the immune complex (Harlow & Lane, 1988). In the present study the
observed background appeared to be non-specific. This was inferred because similar
background reactions were observed when distilled water or PBS were used instead of serum
to precipitate labelled proteins, and also by unsuccessful attempts to minimise background by
pre-incubating the test sera with normal RBC. In order to minimise the non-specific
background, an alternative protocol was attempted in which protein A was used to precipitate
the immune complex. However this was found to be no better than the co-precipitation
protocol with similar non-specific background still being detected with pre-infection sera and
PBS. In spite of this non-specific background, the inclusion of negative controls (pre-infection
sera and PBS or distilled water) throughout the analysis permitted the identification of
specific antigens without difficulty.
As expected, separation of immune complexes under reducing conditions resulted in better
resolution and a greater number of protein bands than under non-reducing conditions
(ilustrated in Fig 7.2-7.4). This was probably due to complete cleavage of polypeptides by the
reducing agent mercaptoethanol present in the reducing sample buffer (Hames & Rickwood,
1990). Thus the subsequent identification of target antigens was based on separation under
reducing conditions.
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The present study showed antigenic diversity between the three stocks of B.bovis at the two
levels analysed (somatic and exoantigens). As discussed in Chapter 6, where antigenic
diversity between the stocks was also indicated by Western immuno-blotting, this may be
related to specific differences in the protein profiles amongst the stocks, which originated
from different isolates. Thus, the present analysis was focused on the identification of stock-
common components which could be used as target antigens for the development of specific
ELISAs. The results obtained here confirm that, although the Mexico and the Kwanyanga
stocks differed in some proteins, their protein profiles showed greater similarity to each other
than to that of the Lismore stock. In immunoprecipitation, as in Western immuno-blotting, the
Brazilian field sera reacted more strongly against antigens of the Kwanyanga and Mexico
stocks than against those of the Lismore stock. This supports the hypothesis, presented in
Chapter 6, that Brazilian isolates of B.bovis may be more antigenically similar to the
Kwanyanga stock than to the Lismore; however, in contrast to the Western immuno-blotting
results, immunoprecipitation suggested that the Brazilian isolates also had similarities to the
Mexico stock of B.bovis.
Four B.bovis somatic antigens fulfilled the criteria of being species-specific, present in all
three stocks, and recognised by both experimentally raised sera and field sera in
immunoprecipitations. These antigens had molecular weights of 88, 75, 65 and 46 kDa and
were identified as potential candidates for further analysis. Other workers have identified
somatic B.bovis proteins by immunoprecipitation of labelled components. These include a 42
kDa protein which was found to be species-specific and stock-conserved (McElwain et al,
1988) and a 44 kDa merozoite surface protein (Reduker et al, 1989). The 46 kDa protein
identified in the present study might be the same as one of these.
The B.bovis somatic proteins identified here had different molecular weights from those
identified by Western immuno-blotting (Chapter 6) and only the 75 kDa might be the same as
the 76 kDa protein previously identified as species-specific and conserved amongst stocks in
Chapter 6. The identification of different proteins in the present study was probably related to
differences in the two techniques used. Western immuno-blotting detects antigens which have
been denatured by the action of boiling with SDS-reducing buffer, whereas in
immunoprecipitation the antigen mixture is reacted with the serum without previous
denaturation of the polypeptides (Harlow & Lane, 1988). Furthermore, the
immunoprecipitation detects labelled components which might be present in minute amounts
and therefore may not be detected by Western immuno-blotting. Thus, antigens resulting from
immunoprecipitation arc not expected to be the same as those detected by Western immuno-
blotting.
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The panel of McAbs which had been raised against B.bovis (Kwanyanga) was included in
this analysis in the hope of being able to use them in an affinity column procedure to purify
specific antigens from a crude mixture of B.bovis components. In the present analysis four
McAbs precipitated proteins in the Mexico stock lysate. These were seen at molecular
weights 200, 49, 36 and 27 (Fig 7.5). The four reactive McAbs had previously been found to
recognise internal parasite components by IFAT and three of them were also reactive in
ELISA (as described in Chapter 6). These findings suggest that McAbs 1B8:1, 118.67.2 and
4F3:1 recognise B.bovis epitopes which may be related to internal parasite components.
Despite reacting in IFAT against all three stocks of B.bovis, none of the McAbs
immunoprecipitated proteins in the Lismore and Kwanyanga stocks and therefore the
approach of using them in an affinity purification column was not pursued.
The somatic antigens which were thus considered to be the most promising potential
candidates for the development of B.bovis specific ELISAs were those identified by
polyclonal sera in Western immuno-blotting (molecular weights ranging from 185 to 14 kDa,
as described in Chapter 6) and immunoprecipitation (88, 75, 65 and 46 kDa, described in the
present chapter). As affinity column purification could not be used, an alternative method of
purification of the proteins of interest was attempted by electro-elution of protein bands from
acrylamide gels. To use this approach it was necessary to visualise the bands of interest
needed to be visualised by conventional staining methods to enable their excision from the gel.
Coomassie blue staining of acrylamide gels containing total lysates of B.bovis showed well
defined protein bands at molecular weights corresponding to four candidate proteins (121, 75,
56 and 46 kDa). Thus, these were selected for the development of B.bovis specific ELISAs
(Chapter 8).
The analysis of B.bigemina somatic antigens was limited to the only stock (Mexico) that
could be grown in vitro. As observed for the three B.bovis stocks, a wide range of labelled
proteins was detected in the total lysate of B.bigemina. High non-specific background was
observed and the more intense bands detected in precipitates from anti-B.bigemina sera were
also seen in precipitates from anti-5. ^ovis and pre-infection sera. However several weak
bands were detected as being B.bigemina specific antigens (Fig 7.14). Similar protein profiles
were seen with serum samples taken from three calves infected with B. bigemina (Zaria stock)
regardless of the length of time after primary infection and number of challenges. In contrast,
serum taken from a fourth calf (583) showed much more intense bands after challenge with
the Muguga stock in comparison to the antigenic profiles obtained from sera taken after
challenges with the Zaria stock (Fig 7.14, lanes 9 and 8). This suggests that the Mexico and
Muguga stocks may have more antigenic similarities than the Mexico and Zaria stocks of
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B.bigemina. However, as 583 was the only calf challenged with the Muguga stock it was not
possible to make any conclusive comparison between stock-specific sera.
The precipitated proteins identified as B.bigemina specific antigens were minor components
and none of them had molecular weights corresponding to those previously identified by
Western immuno-blotting (Chapter 6). The identification of B.bigemina proteins by
immunoprecipitation of ^-^-labelled components using McAbs has been reported by other
authors. These include several proteins (molecular weights ranging from 72 to 36) found to
be located on the surface of merozoites (McElwain et al, 1987; Figueroa et al, 1990a). More
recent studies have been focused on the characterisation and synthesis of a 58 kDa protein
(Mishra et al, 1991) and its use as an immunogen alone or in combination with a high
molecular weight (> 200 kDa) protein, also identified by McAbs in immunoprecipitation of
^S-labelled components (McElwain et al, 1992). The latter protein has been shown to be
associated with the membrane of infected erythrocytes (McElwain et al, 1992) and may be the
same as the 210 kDa protein identified in the present study.
As the present study did not have access to McAbs against B.bigemina for use in an
immunoaffinity purification, the candidate somatic proteins for the development of
B.bigemina specific ELISAs were those identified by polyclonal sera in either Western
immuno-blotting (molecular weights ranging from 195 to 50 kDa, as described in Chapter 6)
or immunoprecipitation, described in the present chapter (Fig 7.14). The next step to
determine the applicability of these antigens in a diagnostic test was to purify the B.bigemina
proteins by electro-elution from acrylamide gels and use them in B.bigemina specific
ELISAs. Coomassie blue staining of acrylamide gels containing total B.bigemina lysate
detected four well-defined bands with molecular weights corresponding to some of the
candidate proteins (210, 80, 65 and 50). These were then selected for use in the development
of B.bigemina specific ELISAs.
In the search for exoantigens, a wide range of protein bands were detected in labelled
supernatants of both B.bovis and B.bigemina cultures. It was assumed that these were
secreted or excreted parasite components, as no labelled proteins were detected in supernatant
of uninfected cultures. Several species-specific proteins were identified in both B.bovis and
B.bigemina labelled culture supernatants. However, in order to utilise these proteins it was
necessary to purify parasite components from culture supernatant and this emerged as a
factor limiting further progress in the present study. Due to the use of high proportion of NBS
in Babesia culture media a large number of protein bands are seen in acrylamide gels making
it difficult to identify bands that are of parasite origin. It was expected that HPLC
fractionation of culture supernatants would enable separation of the complex mixture of
proteins into fractions containing certain ranges of molecular weight components, which
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would facilitate location of parasite components in acrylamide gels. However this approach
was not found to be appropriate for purification of Babesia exoantigens from culture
supernatants (Chapter 6). The electro-elution of exoantigens from acrylamide gels was not
found to be an appropriate approach either, since the parasite components, which were
present in minor amounts, were masked by protein components present in high concentrations
in the NBS. Thus, the methods attempted for purification of exoantigens did not allow
purification of supernatant components and for this reason it was not possible to use any of
the exoantigens identified as candidate antigens in the development of species-specific
ELISAs (Chapter 8). Perhaps better results would be achieved if, prior to attempts to purify
exoantigens, most of the contaminating serum components were removed by an affinity
column. In addition, it appeared from results of the present analysis that in order to have clear
visualisation of Babesia exoantigens in acrylamide gels, culture supernatants would need to
be concentrated considerably (Chapter 6). Exoantigens from culture supernatant have been
purified and characterised for P.falciparum (Thelu et al, 1985), used in experimental
vaccination against B.divergens (Valentin et al, 1993), and form the basis of the commercial
vaccine "Pirodog" (Merieux) against B.canis (Molinar et al, 1982). Although it was hoped
that exoantigens would play a major role in the development of discriminatory diagnostic
assays for bovine babesiosis, the lack of success in purifying exoantigens from cultures
points to the need for improvement and adaptation of the methods used in the present study,
and the need for development of other methods for purification of babesial exoantigens from
culture supernatants.
Some of the work reported in this chapter has been published (see Appendix 6.2):
Passos, L.M.F. (1993) Identification of immunodominant Babesia bovis exoantigens. Trans
R Soc Trop Med Hyg 87, 122.
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CHAPTER EIGHT
DEVELOPMENT OF ELISAs FOR DETECTION OF
ANTIBODIES AGAINST B.BOVIS AND B.BIGEMINA
8.1 INTRODUCTION
Due to difficulties in the detection of Babesia parasites in the blood of animals with chronic
infections using conventional methods, epidemiological investigations are usually based on
results from immunodiagnostic techniques designed to detect antibodies against Babesia
species. These methods have been reviewed in section 2.2.2. Each assay has both advantages
and disadvantages depending on its sensitivity, specificity, simplicity and the costs involved.
The ELISA system is considered to be a very sensitive and economical assay, ideal for use in
epidemiological surveys where a large number of samples need to be tested. Since its first
application for detection of antibodies against Babesia species (Purnell et al, 1976) the aim
has been primarily to improve the quality of reagents in order to obtain more reliable tests for
epidemiological studies in the field. Particular problems with Babesia arise from the fact that
the parasite develops almost exclusively inside erythrocytes, making it difficult to obtain pure
parasite antigen preparations. Crude antigens contain host components, such as erythrocyte
stroma and membrane, which result in non-specific antibody binding. These non-specific
reactions usually contribute to high background absorbance values in sera from animals
which have not been infected with Babesia parasites (Bose et al, 1990).
In order to improve the quality of antigen preparations, the aim has been to identify parasite
fragments or soluble exoantigens that react with specific antibodies. However, due to
similarities between species of Babesia, cross-reactions are commonly observed in most
serological tests. Cross-reactivity between B.bovis and B.bigemina becomes a problem in
discrimination of the two infections in endemic areas where they usually occur in association,
having a common vector in B.microplus. Furthermore, antigenic diversity among different
strains of B.bovis has also been described (Kahl et al, 1982b; Kahl et al, 1983; McElwain et
al, 1988) and these antigenic differences between isolates may have important roles in
determining the extent and specificity of the immune response. Such factors must be
considered in any attempt to select parasite components to be used as antigens for diagnostic
or immunogenic purposes.
Thus, work has been directed towards the identification of specific antigens of B.bovis and
B.bigemina for use as diagnostic tools.
Through the immunochemical characterisation of stocks of B.bovis and B.bigemina described
in Chapters 6 and 7, several candidate proteins were identified that might be of use as
antigens for immunodiagnostic purposes.
This chapter describes attempts to develop specific ELISAs based on the use of these proteins
as antigens for species-specific antibody detection. The proteins selected for this purpose had
been shown to be species-specific when analysed by other immunological techniques as
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described in previous chapters. The approach used here was based on the elution of the
proteins of interest from acrylamide gels containing crude parasite antigen preparations.
The assays using eluted parasite proteins were developed on a comparative basis with assays
using crude antigen preparations of each Babesia species as reference.
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8.2 ELISAS USING CRUDE PARASITE ANTIGENS
8.2.1 Materials and methods
8.2.1.1 Crude antigen preparations
A crude B.bovis (Lismore stock) antigen was used as the reference preparation. This had
been prepared from culture suspensions with a parasitaemia of 7% by Woodford and co¬
workers (Woodford et al, 1990). Briefly, iRBC from culture suspensions (as described in
3.3.2) were concentrated by differential hypotonic lysis with KC1 and lysed with NH4CI, as
described for SDS-PAGE samples in 3.6.1.1. The final lysate was then sonicated for 3 x 30
seconds at maximum amplitude in a 100-W ultrasonic disintegrator (MSE, Crawley, U.K.),
and the supernatant obtained after centrifugation at 10,000 x g for 5 minutes was stored as
100 pi aliquots at -80° C until required for ELISAs.
A crude B.bigemina antigen lysate which had been produced at the ILRAD, Kenya, from
B.bigemina (Kenya stock) was used as a reference antigen. Parasites had been obtained from
blood taken from a calf during ascending B.bigemina parasitaemia, concentrated after
cryopreservation in DMSO, and disintegrated by sonication (as described in 6.5.1, J.
Katende, personal communication). This antigen was received at CTVM as 100 pi aliquots
frozen in liquid nitrogen and was stored at -80°C until required for ELISAs.
8.2.1.2 Standardisation of assays
The ELISA procedure used throughout this study was as described in section 3.8.
The crude B.bovis antigen was used at a dilution of 1 in 1,000 and test sera were diluted 1 in
100. These dilutions had been judged as optimal after checkerboard titration against standard
control sera (Woodford et al, 1990).
Throughout the study the anti-bovine IgG peroxidase conjugate (Sigma) was used at a
dilution of 1 in 6,000, according to the manufacturer's recommendation.
The crude B. bigemina antigen was used at a dilution of 1 in 1,000 and test sera were diluted
1 in 100, based on a checkerboard titration previously carried out at ILRAD (J. Katende,
personal communication).
Each crude antigen was tested against a panel of calf sera of known provenance, including 15
samples taken before infection, 13 samples taken at specific periods after infection with
B.bovis, and 19 samples taken at specific periods after B.bigemina infection (details of calf
infections are given in Table 3.1).
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All serum samples were tested in duplicate and their means calculated. The standard
deviation (SD) of mean readings from the group of negative sera was calculated and used for
the calculation of positive-negative discrimination levels (cut-off values), according to
Richardson and co-workers (Richardson et al, 1983). Absorbance values higher than the
mean of negative sera plus twice their SD were considered as positive, while values lower
were considered as negative.
The sensitivity of each assay was defined as the proportion of known positive serum samples




The absorbance values obtained from each pair of wells tested against the panel of calf serum
samples are presented in Appendix 5.1 and are summarised in Table 8.1. The mean
absorbance value from the anti-B.bovis serum group was approximately 2.8 times greater
than that obtained with pre-infection sera. An anti-#. bovis.ax\i\-B. bigemina absorbance ratio
of 2.2:1 was obtained with the B.bovis crude antigen assay. The greatest variation in
absorbance values was observed amongst anti-#.bovis sera (SD = 0.190), whereas the groups
of pre-infection and anti-#.bigemina sera showed lower variations (SD = 0.061 and 0.080,
respectively).
The calculated cut-off point was 0.310. This gave the assay a sensitivity of 0.85, since only
11 of the 13 known anti-#Aov/5 sera were detected as positive (Table 8.2). All 15 samples of
pre-infection sera were negative. Two of the 19 anti-B.bigemina sera were detected as
positive for B.bovis, giving the assay a specificity of 0.94.
The absorbance readings obtained from the anti-#. bovis sera were distributed over a wide
range of values (Fig 8.1 A); whereas absorbance values obtained from anti-B.bigemina and
pre-infection sera were each distributed in a more limited range, resembling a normal
distribution curve (Fig 8.1 B and C, respectively).
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Table 8.1 Absorbance values in experimentally raised sera and pre-infection sera tested
against crude B.bovis antigen in ELISA.
Sera (No of Mean Standard No of
samples) deviation positives/
total
anti-B.bovis (13) 0.522 0.190 11/13
anti-B. bigeminal 19) 0.233 0.080 2/19
pre-infection (15) 0.188 0.061 0/15
Table 8.2 Sensitivity and specificity of ELISA using crude B.bovis antigen.
Status of samples Proportion
True positives (sensitivity) 0.85 (11/13)
True negatives (specificity) 0.94 (32/34)
False positives 0.06 (2/34)
False negatives 0.15 (2/13)
227
Fig. 8.1 Frequency distribution of absorbance values obtained with experimentally raised
sera and pre-infection sera tested against B.bovis crude antigen in ELISA.
A is anti-fi. bovis sera
B is anti-B.bigemina sera
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8.2.2.2 B. bigemina assay
The absorbance values obtained from each duplicate well with the panel of calf serum
samples tested against crude B.bigemina antigen are presented in Appendix 5.2 and are
summarised in Table 8.3. The mean of absorbance values from the anti-B. bigemina serum
group was approximately 3 times greater than that obtained with pre-infection sera. An anti-
B.bigemina\ani\-B.bovis absorbance ratio of 1.8:1 was obtained with the crude B.bigemina
antigen assay. The greatest variation in absorbance values was observed amongst anti-
B.bigemina sera (SD = 0.345), followed by the anti-B.bovis serum group (SD = 0.201). The
pre-infection sera showed the lowest variation (SD = 0.071).
The calculated cut-off point was 0.689. This gave the assay a sensitivity of 0.63, since only
12 amongst 19 known anti-B.bigemina sera were detected as positive (Table 8.3). All 15
samples of pre-infection sera were negative. However, as 3 amongst the 13 anti-B. Aom sera
were detected as positive, 25 amongst 28 samples were detected as true negatives, giving the
assay a specificity of 0.89.
The absorbance readings obtained from the anti-B.bigemina sera showed that although the
majority of the samples had absorbance values higher than 0.900, they were distributed over
a wide range of values (Fig 8.2 A). A wide range of values was also observed with anti-
B.bovis sera (Fig 8.2 B). In contrast, the group of pre-infection sera were distributed in a
more limited range (Fig 8.2 C).
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Table 8.3 Absorbance values in experimentally raised sera and pre-infection sera tested
against crude B.bigemina antigen in ELISA.
Sera (No of Mean Standard No of
samples) deviation positives/
total
anti-B. bigeminal 19) 0.848 0.345 12/19
anti-B.bovis (13) 0.465 0.201 3/13
pre-infection (15) 0.287 0.071 0/15
Table 8.4 Sensitivity and specificity of ELISA using crude B.bigemina antigen.
Status of samples Proportion
True positives (sensitivity) 0.63 (12/19)
True negatives (specificity) 0.89 (25/28)
False positives 0.11 (3/28)
False negatives 0.37 (7/19)
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Fig. 8.2 Frequency distribution of absorbance values obtained with experimentally raised
sera and pre-infection sera tested against B.bigemina crude antigen in ELISA.
A is anti-B. bigemina sera
B is znh-B.bovis sera
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Discrimination between sera from infected and uninfected animals was achieved with both
assays using crude antigens, with mean absorbance values showing homologous
positive:negative serum ratios of at least 2.8.
However, cross-reactivity with heterologous sera was observed with both crude antigen
preparations. This was more pronounced with the crude B.bigemina antigen, since a higher
proportion of anti-B.bovis sera were detected as positive by the B.bigemina antigen than of
anti-B.bigemina sera detected as positive by the B.bovis antigen. Furthermore, the assay
using B. bovis crude antigen was found to be more sensitive than the assay using B. bigemina
crude antigen. The observation of two false negative samples with the B.bovis crude antigen
assay may be related to the fact that the samples had been collected only 17 and 21 days after
primary infection, and possibly the level of antibodies was too low to be detected by the
assay. Evidence for this hypothesis was given by seroconversion of one of those calves (P78)
on day 42 after primary infection. It was not possible to have the same evidence for the other
false negative calf (P49), since no sera were collected beyond day 21 after infection.
With the crude B.bovis antigen the highest absorbance reading variation between samples
(SD) was observed with the anti-B.bovis serum group. This was expected since samples had
been taken at different times after infection and challenge, and could also be due to individual
differences in levels of immune response. For instance, one calf serum (C11) contained a
relatively high level of antibodies at 21 days after infection, while two other calves were
negative when tested at about the same time after infection. In contrast, low variation in
absorbance readings was observed in both anti-B. bigemina and pre-infection serum groups,
which appeared to be distributed normally. These findings gave support to the decision to
calculate a cut-off value based on the mean plus 2 SD.
Defining the positive/negative discrimination level is a crucial element in the design of a
serological assay and several methods have been used for this purpose (de Savigny & Voller,
1980). When large numbers (>10) of negative reference sera are available the method most
commonly applied is that used in the present study (the mean plus 2 SD). This method
assumes that the values are normally distributed and therefore the probability of negative
values being below that cut-off point is 95%; however there is a 5% probability of obtaining
false positive reactions.
In the present study, the calculated cut-off point value for the B.bovis crude antigen assay
was considerably higher than that applied by Woodford and co-workers, using the same batch
of antigen (Woodford et al, 1990). These authors reported a calculated cut-off point of 0.211,
which was also calculated as the mean of absorbance readings from negative reference sera
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plus 1.96 times its SD. However, for that calculation Woodford and co-workers used a pool
of negative serum samples tested on several occasions (P.Rae, personal communication),
whereas in the present study results from mean and SD of individual serum samples from 15
uninfected calves were used to calculate the cut-off point. Obviously, the larger the sample of
negative sera, the better approximation it gives of the situation in an unexposed population.
Furthermore, the ELISA method used in the present study did not include the step of blocking
with 5% normal goat serum in PBS used by Woodford and co-workers. The decision to
exclude this blocking stage was based on subsequent work at CTVM which showed that it
was not necessary (R.Boid, personal communication). However the absence of that blocking
step in the present study may have contributed to increased non-specific background
absorbance in the negative serum group, which increased the mean value and consequently
resulted in a higher cut-off value than that reported by Woodford and co-workers (Woodford
etal, 1990).
The results obtained with the assay using crude B.bigemina antigen revealed higher non¬
specific background readings with negative serum samples than those obtained with the crude
B.bovis antigen assay. This resulted in a considerably higher cut-off value to enable
discrimination between positive and negative samples. However, as the pre-infection serum
absorbances were not normally distributed, calculation of the cut-off point by the mean plus 2
SD did not appear to be the most appropriate method for the crude B.bigemina antigen assay.
Thus, an alternative method for calculation of a cut-off value was attempted based on the use
of the mean of the pre-infection serum group multiplied by two. The cut-off point calculated
by this method (0.574) would give the assay a sensitivity of 0.74, since 14 amongst 19 anti-
B.bigemina sera would be detected as positive. Therefore, in order to increase the sensitivity
of the crude B. bigemina antigen assay, the cut-off point calculated as twice the mean value of
negative sera (0.574) was applied in subsequent tests (section 8.4).
However, as several anti-B.bovis sera were distributed in a range of absorbances which
coincided with some anti -B.bigemina sera (as shown in Fig 8.2 A and B), the assay using the
B.bigemina antigen had a specificity 0.86. These findings indicate that the cross-reactivity
between B.bovis and B.bigemina was more pronounced with the crude B.bigemina antigen
than with the B.bovis antigen. As a consequence, in the present study, neither of the
calculated cut-off points for the crude B.bigemina antigen assay allowed complete
discrimination between anti -B.bovis and anti-B.bigemina sera. Observation of cross-
reactivity higher with B.bigemina antigens than with B.bovis has also been reported by
Wright (1990).
Cross-reactivity between related species of Babesia has been demonstrated in other
serological tests and very often complicates discrimination of mixed infections in areas where
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more than one species is involved (Leeflang & Perie, 1972; Wright et al, 1987; McElwain et
al, 1988). Cross-reactivity between B.bovis and B.bigemina is a particular limitation for
epidemiological surveys in endemic areas where both diseases occur. Discrimination between
the two infections becomes important for elucidation of particular epidemiological situations
and subsequent determination of appropriate methods of control. Cross-reactions between the
two species can lead to inaccurate predictions about incidence and prevalence of each disease
and, consequently, may result in adoption of inappropriate control measures.
The results from the experiments described in this section point to the need for improvements
in specificity of crude Babesia antigens, particularly the B.bigemina antigen.Therefore the
approach of using species-specific Babesia proteins to replace crude antigen preparations
(described in the next section) was taken with the aim of developing reliable, specific and
sensitive tests which would enable discrimination between antibody responses to each species
of parasite.
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8.3 Development of ELISAs using proteins eluted from acrylamide
gels
8.3.1 Materials and methods
8.3.1.1 Protein elution from gels
Four proteins of B.bovis and four of B.bigemina, which had been identified as potential
candidates for the development of specific ELISAs (as described in Chapters 6 and 7), were
selected for elution from acrylamide gels containing parasite antigens. The B.bovis proteins
had approximate molecular weights of 121, 75, 56 and 46 kDa, and the B.bigemina proteins
selected for elution had approximate molecular weights of 210, 80, 65 and 50 kDa.
A B.bovis lysate (Kwanyanga stock) was prepared from cultured iRBC concentrated by
differential hypotonic lysis as described in 3.6.1.
A B.bigemina (Mexico stock) lysate was prepared using concentrated cultured iRBC
generated after continuous gradient centrifugation with Percoll (as described in Chapter 5).
Crude lysates of B.bovis and B.bigemina iRBC and reference lanes containing standard
molecular weight markers were separated by SDS-PAGE, under reducing conditions, in
individual 10% homogeneous gels using the mini-gel system Protean II (Bio-Rad) as
described in 3.6.2.
After electrophoresis, the whole gels were stained in Coomassie blue R-250 for 1 hour and
destained (as described in section 3.6.3) until the bands were clearly resolved. The bands of
interest for each lysate were cut from the gels using a scalpel, and proteins contained in the
bands were eluted using the model 422 Electro-Eluter (Bio-Rad). The electroelution was
carried out at a constant current of 10 mA/sampIe for a minimum of 4 hours using electro¬
elution buffer (Appendix 1). The eluate (approximately 600 pi) recovered from each
acrylamide gel slice was then transferred to dialysis tubes (with cut-off level 12 kDa, Sigma)
and dialysed against a large volume of ELISA coating buffer (Appendix 1) overnight. The
purity and immunogenicity of dialysed proteins were determined by SDS-PAGE (Silver
staining) and Western immuno-blotting (as described in sections 3.6.3 and 3.7, respectively)
against each respective homologous anti-serum. Elutcd proteins were then stored as 100 pi
aliquots at -20° C until required for use as antigen in ELISAs.
8.3.1.2 Standardisation of assays
In order to determine the appropriate working dilutions of test sera to be used in ELISAs, the
eluted B.bovis and B.bigemina proteins were tested by ELISA in checkerboard titrations
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against an anti-B.bovis serum (from calf 396 taken on day 56 after infection), an anti-
B.bigemina serum (from calf 399 taken on day 57 after infection) and a pre-infection serum
(from calf 634 taken on day 0).
Eluted fractions were diluted in coating buffer (Appendix 1) at 1 in 100 dilution and used to
coat ELISA plates. Five doubling dilutions (starting from 1 in 100) of each serum sample in
PBST were tested in duplicate against each eluted protein. Control wells containing PBS
instead of serum were included as a PBS control.
The results from the checkerboard titration were used as the basis for selection of fractions
for further development of ELISAs.
The same panel of calf serum samples used for standardisation of crude antigens (as
described in 8.2.1.2) were tested in duplicate wells against selected fractions.
The cut-off point for the assay using eluted proteins was calculated as the mean absorbance
of the negative sera plus 2 SD.
8.3.2 Results
8.3.2.1 Elution of B.bovis proteins
The four B. bovis protein bands were successfully eluted from the gel slices, as demonstrated
by silver staining of a gel containing samples of each eluted protein (Fig 8.3). Western
immuno-blotting analysis showed that the eluted proteins remained antigenic, as demonstrated
by detection of reactive bands with molecular weights corresponding to those of the original
bands (Fig 8.4). However, after elution, extra antigenic components of proteins 75 and 46
kDa which had not been detected in silver stained gels were recognised by the anti-B.bovis
serum in immuno-blotting. The protein which showed the strongest reaction in immuno-
blotting (56 kDa) was seen to contain a single band.
In ELISA the 56 kDa protein was the only protein which gave B.bovis:B.bigemina ratios of
at least 2.5:1, and absorbance values obtained with anti -B.bovis serum 5 times greater than
those obtained with the pre-infection serum (results presented in Appendix 5.3). The
checkerboard titration indicated that the highest discriminatory ratio between positive and
pre-infection sera were obtained with sera diluted at 1 in 200. Titrations of the other three
eluted proteins (121, 75 and 46 kDa) did not result in discrimination between pre and post¬
infection sera (see Appendix 5.3). Therefore, the 56 kDa protein was selected to be used as
antigen for the development of a B. 6ov/s-specific antibody detection ELISA.
In the subsequent tests, the 56 kDa eluted protein was used to coat plates at a dilution of 1 in
100 and test sera were diluted at 1 in 200.
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8.3.2.2 ELISA using the eluted B.bovis 56 kDa protein
The absorbance values obtained from each duplicate well with the 56 kDa B.bovis protein
tested against the panel of calf sera are presented in Appendix 5.5 and are summarised in
Table 8.5. Positive:negative as well as B.bovis.B.bigemina absorbance ratios of only 1.5:1
were obtained with the assay using the 56 kDa protein as antigen. The greatest variation in
absorbance values was observed amongst anti-S.ftovw sera (SD = 0.132), whereas anti-
B.bigemina and pre-infection sera showed little variation (SD = 0.059 and 0.049,
respectively).
The calculated cut-off point was 0.352, which gave the assay a sensitivity of 0.61, since only
8 of 13 known ani\-B.bovis sera were detected as positive (Tables 8.5 and 8.6). All 15
samples of pre-infection sera were negative. The specificity of this assay was 0.94, since two
ax\i\-B.bigemina serum were detected as positive.
The absorbancc readings obtained from the anti-B.bovis sera showed that the majority were
distributed within a wide range of absorbance (Fig 8.5 A). In contrast, the anti-B.bigemina
and pre-infection sera were distributed with in a more limited range of values, resembling a
normal distribution (Fig 8.5 B and C).
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Fig 8.3 Silver staining of a 10% homogeneous gel containing B.bovis eluted proteins from gel
slices.
Lane 1 contains the crude lysate of B.bovis, lane 2 contains the 121 kDa band, lane 3




Fig 8.4 Western immuno-blotting of B.bovis eluted protein bands against antt-B.bovis serum.
Lane 1 contains the crude lysate of B.bovis, lane 2 contains the 46 kDa band, lane 3 contains
the 56 kDa band, lane 4 contains the 75 kDa band and lane 5 contains the 121 kDa band.
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Fig 8.4
Table 8.5 Absorbance values in experimentally raised sera and pre-infection sera tested







anti-fi.6ov/s (13) 0.372 0.132 8/13
anti-S. bigeminal 19) 0.275 0.059 2/19
pre-infection (15) 0.254 0.049 0/15
Table 8.6 Sensitivity and specificity of ELISA using an eluted Ii.bovis 56 kDa protein as
antigen.
Status of samples Proportion
True positives (sensitivity) 0.61 (8/13)
True negatives (specificity) 0.94 (32/34)
False positives 0.05 (2/34)
False negatives 0.38 (5/13)
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Fig 8.5 Frequency distribution of absorbance values obtained with experimentally raised sera
and pre-infection sera tested against B.bovis 56 kDa protein.
A is anti-B.bovis sera
B is anti-fi. bigemina sera










8.3.2.3 Elution of B.bigemina proteins
The four target proteins were successfully eluted from gel slices, as demonstrated by silver
staining of a gel containing samples of each eluted protein (Fig 8.6 ). However, Western
immuno-blotting analysis of the eluted proteins showed that only two proteins (65 and 50
kDa) remained antigenic after elution, demonstrated by detection of reactive bands with
molecular weights corresponding to those of the original bands (Fig 8.7). The reaction
detected against the 65 kDa was weaker than that detected against the 50 kDa protein.
However, ELISA checkerboard titrations showed no discrimination between homologous,
heterologous and pre-infection sera with any of the eluted proteins (results presented in
Appendix 5.4).
Therefore, it was not possible to develop a B.bigemina specific-ELISA test using the proteins
eluted from acrylamide gels.
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Fig 8.6 Silver staining of a 10% homogeneous gel containing B.bigemina eluted proteins
from gel slices.
Lane 1 contains the 50 kDa band, lane 2 contains the 65 kDa band, lane 3 contains the 80
kDa band and lane 4 contains the 210 kDa.
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Fig 8.6
Fig 8.7 Western immuno-blotting of B.bigemina eluted proteins against anti-B.bigemina
serum.
Lane 1 contains the crude lysate of B.bigemina, lane 2 contains the 50 kDa band, lane 3





Purification of parasite components was successfully achieved by electroelution of particular
protein bands from crude preparations, as demonstrated by SDS-PAGE analysis (Fig 8.3).
Silver staining was used to determine the purity of eluted proteins due to its high sensitivity in
detecting small amounts of proteins. Silver staining is up to 100 times more sensitive than
Coomassie blue, and is able to detect as little as 0.38 ng/mm^ of bovine serum albumin
(Hames & Rickwood, 1990). Although single bands were seen in each of the eluted fractions
of B.bovis, Western immuno-blotting analysis (Fig 8.4) showed the presence of more than one
band in two fractions (75 and 46 kDa). This might be due to cleavage of the protein into
smaller molecular weight units as a result of the reducing effect of the sample buffer. Only
one fraction of B.bovis (56 kDa) showed a single band by both silver staining and Western
immuno-blotting.
Results from ELISA checkerboard titrations showed that only the 56 kDa eluted protein
resulted in acceptable discrimination between ?u\i\-B.bovis, anti-B.bigemina and pre-infection
sera, with B.bovis.B.bigemina absorbance ratios of at least 2.5:1, and B.bovis.negative
absorbance ratios of 5:1. None of the other eluted proteins showed discrimination between pre
and post-infection sera. Results from the titrations indicated that the three B.bovis fractions
(121, 75 and 46 kDa) reacted equally against anti -Babesia sera and uninfected serum and
therefore the reactions were non-specific. This may be due to a loss of antigenicity of B.bovis
specific epitopes during the extensive purification procedure, which involved denaturing of
the proteins by the addition of sample buffer and electroelution over a relatively long period
of time (minimum of 4 hours). Thus, although antigenic bands were detected in Western
immuno-blotting, the antigenicity of these three B. bovis components was not preserved in the
ELISA. Furthermore, it is also possible that, after the various steps of the purification
procedure, the specific epitopes had lost their ability to bind to ELISA plates, despite the fact
that the eluted fractions had been dialysed against coating buffer before being used in
ELISAs.
Purification of B.bigemina protein components was also successfully achieved by
electroelution, as demonstrated by silver staining of acrylamide gels (Fig 8.6). However the
Western immuno-blotting analysis demonstrated that only two fractions (65 and 50 kDa)
remained antigenic, with the strongest reaction being detected against the 50 kDa fraction.
The absence of detectable immuno-reaction against the other fractions may have been related
to either low protein concentration in these fractions, since their protein bands were weakly
detected in silver staining, or loss of antigenicity during the elution procedure. Results from
ELISAs showed discrimination between pre and post-infection sera but not between anti-
B. bovis and anti-B. bigemina sera. This was seen with all of the fractions, suggesting that all
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four proteins may have epitopes shared by the two parasites and thus none of them was
B.bigemina specific. These findings reinforce the theory that B.bigemina has more epitopes
cross-reactive with B.bovis than vice-versa, as indicated by the ELISAs carried out using
crude parasite preparations (section 8.2).
As the 56 kDa B.bovis protein was the only one that remained antigenic in ELISA after the
purification procedure, and showed good discrimination between anti-B.bovis and anti-
B.bigemina sera, it was tested against the panel of known sera. Results from these ELISAs
showed lower mean absorbance ratios of both anti-fi.6ovw:negative sera (1.5:1) and anti-
B.bovis.anti-B.bigemina sera (1.5:1) than those obtained with single samples of each type of
serum in the checkerboard titrations, which showed 5:1 and 2.5:1, respectively. High
background readings were obtained for the negative serum group, in contrast to low
absorbance values obtained from the pre-infection serum in the checkerboard titration.
Thus, applying the calculated cut-off value to determine the status of known calf sera resulted
in a sensitivity of 0.61 and a specificity of 0.94 for the assay using the B.bovis 56 kDa
protein. The sensitivity of the assay was lower than expected, with a large proportion of
infected calves (5/13) not being detected as positives. However, these false negative samples
had been collected relatively early after primary infection (on average 27 days p.i.). It is
possible that the immune response against this particular B.bovis component (56 kDa)
develops later after infection and that sera from early stages of infection did not contain
antibodies against it. This could be due to, for instance, a small proportion of the 56 kDa
component in relation to other B.bovis immunogenic components being responsible for
induction of immune responses at an early stage after primary infection. Therefore, the 56
kDa might be useful to differentiate between chronic and early infections. Furthermore, two
anti -B.bovis samples which were falsely negative in the assay using the 56 kDa protein, were
also falsely negative in the assay using crude B.bovis antigen. This suggested that inherent
characteristics of these calves, such as reduced responsiveness to Babesia infections, or
development of immune response later than in the other calves, could have been responsible
for the lack of detection of anti-Babesia specific antibodies in these samples.
The two false positive samples in the assay using the B.bovis 56 kDa protein were from a
single calf (397), taken at different stages after B.bigemina infection. This may be related to
an immune response developed in this animal against other unrelated antigens that may have
similar epitopes to that of the 56 kDa protein of B.bovis. It appeared that the reactions were
due to an individual characteristic of that calf rather than to cross-reactivity between B. bovis
and B.bigemina, since none of the sera from the other calves infected with B.bigemina cross-
reacted with the B.bovis 56 kDa protein.
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Overall, one has to consider that sera produced experimentally against Babesia parasites,
such as the ones used in the present study, very often do not represent the reality observed in
the field, and therefore are not the ideal reference sera. There are several factors related to the
initiation and subsequent course of a babesial infection that certainly will affect the
development of the immune response. The most relevant is probably related to the source and
nature of parasite immunogens. For the calf immunisations carried out in the present study,
almost all Babesia material used was blood-derived. The immunisation of calves was
achieved using as inoculum cryopreserved Babesia-va£oc\eA RBC, either derived from
infected blood or from culture suspensions originating from infected blood. This
immunisation scheme is quite different from what happens under natural field conditions,
where the animals are infected through inoculation by infected ticks of infective sporozoite
stages of Babesia. The use of infected ticks for immunisation of calves was not possible at
CTVM, since this would involve maintainance of Boophilus tick colonies with pure Babesia
infections (both the tick and Babesia being species exotic to Britain) over a long period of
time, and a large number of calves would be necessary. In the present study, a B.bigemina
calf infection was carried out by infestation with infected ticks on only one occasion, when
B.decoloratus larvae had been brought from Kenya. However, that infected calf was
destroyed during ascending parasitaemia (day 23 p.i.), before the development of specific
antibodies. In all the other immunised calves, the immune response must have been directed
against blood stages of the parasite (trophozoites and merozoites), which were the only forms
present in the inoculum. The development of differential cellular immune responses to B.bovis
according to the source of inoculum used (tick-derived parasites or cultured merozoites) has
been reported recently (Brown et al, 1991). Thus, it is possible that development of
differential humoral immune responses according to the type of inoculum used also occurs in
Babesia infections.
Another difference between the artificial infections of the present study and natural infections
in the field is that in endemic areas the animals are under constant natural tick challenge,
which may contribute to the development of stronger immune responses than those produced
artificially by needle inoculations at particular intervals.
Furthermore, under natural field conditions the animals are usually exposed to a variety of
other agents, which stimulate the immune system and may interact with immunogens of
babesial origin. Although the animals used in the present study were not kept isolated from
other agents, they were exposed to a much more limited range of agents (both pathogens and
non-pathogens) than animals in tropical Babesia-endemic areas, where a large number of
organisms are present in the environment, and capable of stimulating the immune system.
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With all these considerations in mind, the B.bovis 56 kDa protein was considered to be
species-specific and a further experiment was designed to validate its use as a B.bovis
specific antigen in an antibody detection ELISA for use in Babesia endemic areas.
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8.4 Comparative analysis of ELISAs using crude antigens and
eluted proteins
8.4.1 Materials and methods
For this analysis a panel of serum samples collected from cattle exposed to natural tick
infestation under field conditions (as described in section 3.4.2) was tested against both
B.bovis and B.bigemina crude antigens, and the B.bovis 56 kDa eluted protein. The panel
included 33 samples collected in Mozambique, 49 samples collected in Malawi and 7 samples
collected in Brazil.
Both crude antigens were tested at a dilution of 1 in 1,000 with test sera diluted at 1 in 100,
whereas the B.bovis 56 kDa eluted protein was tested at a dilution of 1 in 100 with test sera
diluted 1 in 200. In both assays (crude antigen and 56 kDa protein) anti-bovine IgG
peroxidase conjugate was used at a dilution of 1 in 6,000; all test serum samples were tested
in duplicate wells. A serum sample was considered positive if its mean calculated from the
duplicate wells was greater than the respective cut-off points for each assay.
In order to minimise plate-to-plate variations between assays performed at different times, the
means of absorbance values were adjusted using a factor which was calculated from readings
of control wells of each plate, as described below:
Factor (F) = Po - No
Pt-Nt
Adjusted value = F (St - Nt) + No
Po = Mean of 4 positive control wells in first plate
No = Mean of 4 negative control wells in first plate
Pt = Mean of 4 positive control wells in subsequent test plate
Nt = Mean of 4 negative control wells in subsequent test plate
St = Mean of 2 wells of test sample
Based on the standardisation of each assay, the values considered positive were absorbance
values > 0.310 for the assay using crude B.bovis antigen, > 0.352 for the assay using the
B.bovis 56 kDa protein, and > 0.574 for the assay using crude B.bigemina antigen.
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The two assays for detection of ant\-B.bovis antibodies (using crude antigen or the 56 kDa
protein) were compared using correlation analysis (Fowler & Cohen, 1990) considering the
mean absorbance readings obtained from each field serum sample in each assay.
8.4.2 Results
8.4.2.1 B.bovis assays
The absorbance values from each duplicate well and the means and adjusted values obtained
from the panels of field serum samples tested against the crude B.bovis antigen and against
the 56 kDa protein are presented in Appendix 5.6 and 5.8 respectively, and are summarised in
Table 8.7.
All 33 samples from Mozambique and all 7 from Brazil were positive by both assays (crude
antigen and the 56 kDa protein), resulting in agreement of 100% between the two tests. The
agreement between the two tests was 95.6% in relation to the Malawi sera. Amongst the 5
samples detected as negative by the crude antigen assay, 3 were also negative in the assay
using the 56 kDa protein. However the other two samples detected as negative in the crude
antigen assay were detected as positive in the assay using the 56 kDa protein. The
disagreement of 4.4% between the two tests was not significant when the results were
compared by the Chi-square test.
The analysis of correlation between the mean absorbances obtained for each sample in each
assay resulted in a calculated correlation coefficient of 0.44, which for the number of
observations (89) means that there is modest positive linear correlation between the results
from the two tests. This is represented in Fig 8.8.
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Table 8.7 Number of positive field serum samples in ELISAs using either crude B.bovis
antigen or the 56 kDa eluted protein as antigen.





Mozambique 33 0 33 0 100.0
Malawi 44 5 46 3 95.6
Brazil 7 0 7 0 100.0
Key: +ve = positive
-ve = negative
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Fig 8.8 ELISA absorbance values obtained with field sera tested against both crude B.bovis
antigen and the 56 kDa protein.














8.4.2.2 Crude B.bigemina antigen assay
The assay using the crude B.bigemina antigen detected as positive 25 (78.8%) serum samples
from Mozambique out of 33 tested, 47 (95.9%) out of 49 serum samples from Malawi, and 6
(85.7%) out of 7 samples from Brazil. The absorbance values of each pair of wells, the
means and the adjusted values obtained from field serum samples against crude B.bigemina
antigen are presented in Appendix 5.7. Only one serum sample, from Malawi (L243), was
detected as negative by all of the tests (B.bovis and B.bigemina crude antigens and the 56
kDa purified protein).
The mean absorbances obtained from each field serum sample with both crude antigen assays
(B.bovis and B.bigemina) were compared and the calculated correlation coefficient was 0.37,
which for the number of observations (89), indicates that there is a moderate positive linear
correlation between results obtained in the two tests.
Fig 8.9 summarises the results obtained with both crude antigens (B.bovis and B.bigemina)
and shows that the vast majority of the field samples tested were detected as positive by both
assays; however amongst the samples detected as negative, a larger number were negative
with the B.bigemina antigen than with B.bovis.
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Fig 8.9 ELISA absorbance values obtained with field sera tested against crude antigens of
B.bovis and B.bigemina.
Overlying lines represent the calculated cut-off points for each assay.
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8.5 General discussion and conclusions
The antibody detection ELISA developed using the B.bovis 56 kDa antigen gave results
comparable to that obtained with the assay using the reference crude antigen.
The standardisation of the assay using the panel of known calf sera resulted in relatively low
sensitivity (0.61) in relation to that achieved with the crude antigen assay (0.85). However,
the validation of the developed test using a panel of bovine field sera originating from three
different countries proved that the purified 56 kDa protein was as good as the crude parasite
preparation in detecting reactive sera and that it could replace the latter in sero-
epidemiological studies in endemic areas. Although the quantitative correlation between
absorbance values obtained by each assay was low, an overall qualitative agreement of
97.8% was observed between the assays.
The vast majority of the field sera tested were positive to both of the crude antigens and the
56 kDa B.bovis protein, with only one animal being detected as negative to all three antigenic
preparations. This was not surprising as they originated from endemic areas, where a high
inoculation rate of Babesia is expected under natural conditions, and consequently a high
proportion of the animals should produce specific antibodies.
Considering that the field sera tested here had been taken from animals older than 12 months,
and therefore probably chronic carriers, the results obtained with the 56 kDa antigen assay
give support to indications that it may be useful in detecting chronic infections. Although the
assay using the 56 kDa antigen was shown to be less sensitive than the crude antigen assay
during standardisation (see Tables 8.2 and 8.6), it detected a higher number of positive field
samples than did the crude antigen assay, and indicated that this antigen was conserved
between strains. Detection of a higher number of positive samples by the 56 kDa antigen was
not expected, since crude antigenic preparations, which contain numerous parasite antigens,
would be expected to detect at least as many positive samples as a pure antigen. Only two
samples (2.2% of the total tested) that were detected as negative by the crude antigen were
positive by the 56 kDa antigen assay; these can be regarded as within the expected percentage
of false negatives with the crude antigen assay (15%). Thus, although the panel of known
experimental sera indicated low sensitivity (0.61) for the 56 kDa antigen assay, a higher
number of positive field sera were detected using this test. This may be due to the presence of
higher titres in sera collected from cattle naturally exposed to Babesia infections in the field
than in experimentally infected animals, since in natural field conditions the animals are under
constant challenge.
In addition, as reported by Jacobson (1992), when the disease in question has a high expected
prevalence, as in the case of Babesia infections in endemic areas, negative results are usually
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good indicators of non-infected animals even if the sensitivity and specificity of the test are
not very high. However, in situations were prevalence is low, a test with a sensitivity of 99%
and a specificity of 99% becomes a poor predictor of infection. In this situation with a disease
prevalence of 0.1%, a positive result would be wrong 91% of the time (Jacobson, 1992).
A purified parasite specific antigen would be preferable to crude antigenic preparations for
sero-diagnostic tests in many ways. Common limitations related to the use of crude
preparations, which it is hoped to overcome with the use of species-specific components, are
the cross-reactivity between related species and non-specific reactions with host
contaminants. Another limitation of crude antigens is the potentially large batch-to-batch
variation, which relates to the parasitaemia of infected blood or culture suspension used,
amongst other factors such as efficiency of concentration and purification procedures. This
limitation could also be overcome with the use of pure parasite fractions, which would be
produced reproducibly either as a recombinant fusion protein by recombinant DNA
technology or by artificial synthesis once its amino acid composition had been sequenced.
Furthermore, the use of synthetic antigens would eliminate the need to sacrifice experimental
cattle for the preparation of crude antigens.
Since the first use of the ELISA system for detection of antibodies against B.bovis (Barry et
al, 1982) efforts have been made to improve the quality of crude antigenic preparations, in
order to increase sensitivity and specificity of assays. Recently, Bose and co-workers reported
for the first time an ELISA test using a recombinant B.bovis antigen (11C5) expressed in
Escherichia coli, which was shown to be both sensitive and specific as compared with a
native antigen preparation (Bose et al, 1990). Later, the same 11C5 recombinant antigen was
found to have a high degree of cross-reactivity with B.ovis and, as a result, the ELISA
developed for detection of anti-B.bovis antibodies was found to be useful for
immunodiagnosis of B.ovis (Duzgun et al, 1991). The native antigen 11C5 was identified by
a monoclonal antibody that reacted against a large number of closely positioned bands in
Western immuno-blotting (Goodger et al, 1992a) and therefore it appears to be distinct from
the B.bovis 56 kDa used in the present study. As described here for the 56 kDa antigen, the
11C5 recombinant antigen showed lower sensitivity when compared with a crude antigen
preparation in ELISAs using known status sera, and there was a suggestion that the use of a
cocktail of two or more purified antigens could overcome the possible low sensitivity of a
single antigen (Bose et al, 1990). Thus, the 56 kDa antigen used in the present study
constitutes an appropriate candidate for further investigation in association with other well
defined antigens.
The high background absorbance readings, which are commonly observed with crude
antigenic preparations due to the presence of contaminants, were also observed with the 56
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kDa antigen assay. This was not expected from a purified antigen. It may be regarded as a
consequence of the extensive purification procedure, which may have contributed to a loss of
the specificity of the antigen. However, even with the non-specific background reading it was
possible to discriminate between positive/negative sera, and this did not appear to interfere
with the interpretation of results from the field sera. Nevertheless, a decrease of the non¬
specific background is desirable and might be achieved with further purification of the 56
kDa antigen by conventional methods such as precipitation, immuno-affinity and dialysis.
Unfortunately it was not possible to develop a B.bigemina-specific ELISA using eluted
proteins. This would be useful for discrimination between B.bovis and B.bigemina infections
in areas endemic for both parasites. The need for the development of a B.bigemina-specific
ELISA was evident from the poorer performance of the B.bigemina crude antigen in
comparison to that of B.bovis. This was inferred by higher cross-reactivity and non-specific
background obtained with the crude antigenic preparation of B.bigemina than with the
B.bovis crude antigen. The lack of an assay with a B.bigemina purified antigen limited the
validation of the B.bovis 56 kDa using field serum samples, in relation to determination of
cross-reactivity.
As observed with both B.bovis antigens, the majority of the field sera were positive when
tested against the B.bigemina crude antigen. However the proportion of negative animals was
slightly higher than that obtained with B.bovis antigens. This was not expected, since in an
endemic situation where the two infections occur together, inoculation rates of B.bigemina
are usually higher than those of B.bovis (Miller et al, 1984). This is due to the particular
nature of each parasite's life cycle in the vector tick. B.bovis is transmitted only by the larval
stage which then loses the infection and vertical transmission does not occur (Mahoney &
Mirre, 1979). The infection of the tick population with B.bovis is therefore based only on
alimentary infection of the engorging females which will produce a low proportion of infected
eggs. B.bigemina, on the other hand, is transmitted by feeding nymphs, females and males,
and in addition to the alimentary infection, there is also vertical transmission which results in
maintenance of the infection over two or more generations of the tick without alimentary
reinfection (Friedhoff, 1988). These particular characteristics result in higher rates of
B.bigemina infection in ticks. However, the slightly higher prevalence of anti-B.bovis
antibodies may have been observed because the number of samples tested was small and
probably do not fully represent the epidemiological situation in each area where the samples
originated.
In conclusion, the ELISA developed for detection of antibodies against B.bovis using a
purified 56 kDa antigen was shown to be appropriate for use in epidemiological studies.
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Further studies on this antigen regarding its composition, origin and dynamics during B. bovis
infections should be carried out with the aim of producing it synthetically for large scale use.
Some of the work reported in this chapter has been published (see Appendix 6.3):
Passos, L.M.F.; Brown, C.G.D.; Jones,T.W.; Bell-Sakyi, L.; Boid, R. (1993) The
development of specific ELISAs for use in epidemiological studies of bovine babesiosis in
Brazil. Proceedings of the Nth International Conference of the World Association for the




The aim of the present study was to develop ELISAs using purified proteins for detection of
specific antibodies against B.bovis and B.bigemina, with which to discriminate between the
two infections in endemic areas. Such discrimination would contribute to more effective
targeting of control measures against bovine babesiosis. The approach used here for
identification of potential candidate proteins of each species was based on immunochemical
characterisation of different stocks of these Babesia species.
Two constraints were faced in the present study on immunochemical characterisation of
Babesia stocks. The first was related to the provision of parasites on a regular basis, for
which in vitro culture systems were considered to be the most appropriate source of material
to be used at CTVM, and the second was related to the low parasitaemias usually obtained in
both infected blood and culture suspensions, from which concentration of either parasites or
iRBC was necessary in order to obtain parasite-rich preparations. In order to use the in vitro
culture systems as a reliable source of parasite material, the initial work of the present study
concentrated on attempts to optimise the culture system used for already-established stocks of
B.bovis and to establish in vitro isolates of B.bigemina, some of which had not previously
been established as continuously growing cultures in the past.
The attempts to increase parasitaemias of B.bovis in vitro were based on the incorporation of
feeder cells into cultures. Unexpectedly, BAE cells did not improve parasitaemias of B.bovis
cultures. In contrast, incorporation of MPWC into growing cultures resulted in increases of
parasitaemia, although it did not improve resuscitation of cryopreserved stabilates. However,
the increase achieved, although significant, was not substantial in practical terms in
comparison to the results obtained with the conventional culture system used for B.bovis at
CTVM. It appears that there is a limit for growth of B.bovis in vitro, beyond which it is not
possible to increase the parasitaemia. Therefore the approach to increasing parasitaemias in
culture by the use of feeder cells was not pursued. Thus, all material for the immunochemical
characterisation of B.bovis stocks was obtained from iRBC cultured using minor
modifications of the microaerophilous stationary phase (MASP) technique (Levy & Ristic,
1980), and further efforts were directed to achieving a method by which iRBC could be
efficiently concentrated. Nevertheless, the encouraging results obtained from experiments in
which MPWC were incorporated into cultures suggest they might be useful in attempts to
establish new isolates from field infections.
Further achievements from the experiments on the in vitro cultivation of B.bovis described in
this thesis include the re-establishment of the Mexico stock in vitro from peripheral blood
taken from a calf when the parasitaemia was so low that no parasites were detected in Giemsa
stained smears, and the replacement of NBS with immune calf sera to supplement culture
media without inhibition of parasite growth. The success in re-establishing B.bovis in cultures
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from blood with low parasitaemia can be seen as an indication that the B. bovis culture system
used in the present study is well standardised and reliable. The lack of inhibition of B.bovis
growth in vitro by sera taken from calves after infection with either B. bovis or B.bigemina
(sero-positive by IFAT) shows that the stocks of B.bovis used in the present study are well
adapted to grow in vitro, and also indicates that sero-positive animals in endemic areas might
be suitable for provision of serum to supplement culture media. Moreover, these results
indicate that the B.bovis culture systems might be unreliable for evaluating aspects of the
bovine immune response in vitro.
It was more difficult to achieve a continuous supply of B.bigemina parasites than of B. bovis,
since none of the culture conditions tested in the present study resulted in the establishment of
the two African isolates (Zaria and Muguga) as continuous cultures. This was a severe
constraint to comparisons between the antigenic profiles of different stocks of B.bigemina.
The majority of the immunochemical studies were performed using the only available stock of
B.bigemina (Mexico) that had previously been established in vitro (Vega et al, 1985a).
Surprisingly, the Mexican stock of B.bigemina was successfully grown continuously in vitro
for more than two months under culture conditions very similar to those which failed to even
maintain parasites of the other two stocks of B.bigemina alive beyond 48 hours. These
results, in association with many unsuccessful attempts to establish the African stocks in
vitro prior to the present study and further recent unsuccessful attempts using different
culture conditions (L.Bell-Sakyi, E.Posnett, personal communications), led to the conclusion
that the two African stocks have different requirements from those of the Mexican stock of
B.bigemina, and pointed to the need for further investigations into the in vitro cultivation
system of B.bigemina parasites. Thus, the only reproducible source of B.bigemina parasites
to which one could return regularly was the cultured Mexican stock; however, as for B. bovis,
the B.bigemina culture system provided maximum parasitaemias around 5-7%, which was
lower than desirable for production of parasite samples for use in the immunochemical
analysis. Therefore, it was necessary to develop efficient methods for concentration of either
iRBC or free parasites in order to obtain parasite-rich extracts.
The methods attempted for concentration of Babesia parasites in the present study showed
that each species of Babesia should be considered separately, since techniques for
concentration of B. bovis will not necessarily be appropriate for concentration of B.bigemina.
For instance, the release of free merozoites into culture supernatant after CO2 deprivation of
cultures was considered to be an appropriate method for concentration of B. bovis but it was
not found to be so efficient for B.bigemina. For this parasite it was found that smaller
proportions of merozoites are released into the culture supernatant and, although no
investigation was carried out to evaluate viability of free merozoites of B.bigemina, their
260
appearance was not as healthy as those of B.bovis, suggesting that they may have suffered
damage during the CO2 deprivation. The free merozoites of B.bovis released after CO2
deprivation of cultures were viable, as indicated by their ability to infect new RBC in
cultures. However, as differential lysis of uninfected RBC (Kahl et al, 1982a) yielded a good
concentration of parasites, it was decided to use this technique to concentrate B.bovis for
preparation of crude ELISA antigens and samples for protein electrophoresis. Differential
lysis of uninfected RBC has not been successfully applied to concentration of B.bigemina
iRBC, since they are more fragile than uninfected RBC and are lysed first (Mahoney, 1967a;
Wright, 1973b). Thus, alternative techniques for concentration of iRBC using density
gradient centrifiigation were attempted in the present study. Amongst these the continuous
density gradient generated after centrifugation at 30,000 x g for 13 minutes using a Percoll
solution with density of 1.095 g/ml (68.48% of Percoll) yielded the best concentration of
B.bigemina iRBC and therefore it was the method used for provision of parasite-rich material
for the immunochemical characterisation of this parasite.
Once the techniques for concentration of each species of Babesia had been defined, the work
was directed towards the immunochemical characterisation of both somatic components
(resulting from lysis of either whole iRBC or freed parasites) and soluble exoantigens
released into culture supernatants. This approach was taken hoping that specific somatic
components of each parasite would be useful for the development of ELISAs for detection of
antibodies produced against whole parasites. Moreover, antibodies produced against
exoantigens would be useful for the development of an ELISA for detection of circulating
antigens in serum of infected animals. Such a test, if highly sensitive, would be more
appropriate than the detection of antibodies for identification of carrier animals with low
levels of antibodies.
Prior to initiating the immunochemical analysis of Babesia stocks, studies were carried out
with the aim of identifying the most appropriate methods for preparation of samples for
electrophoresis. As far as somatic antigens were concerned, results from the present study
showed that there is no need to use enzyme inhibitors for the preparation of both B.bovis and
B.bigemina samples if the lysis with SDS-sample buffer is carried out immediately after
harvesting iRBC or free parasites. Lysates prepared in this way remained antigenic and the
antigens did not degrade when preserved at -80°C.
Regarding the immunochemical analysis of exoantigens, two steps were considered to be
essential before preparation of samples for electrophoresis. The first was the removal of
albumin present in the bovine serum used to supplement culture media which, due to its high
concentration, disturbed the protein bands with approximately similar molecular weight when
separated by SDS-PAGE. This was successfully achieved by the use of Afftgel Blue, which
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binds to serum albumin allowing its removal. However, results obtained from the Western
immuno-blotting analysis of culture supernatants showed that perhaps more important than
removal of albumin would be the removal of IgG which reacts with the anti-bovine IgG
conjugate, and in the present study, appeared to be the major contaminating serum component
in the culture media. The second step judged to be necessary to precede the SDS-PAGE
analysis of culture supernatants, was the concentration of parasite exoantigens, enabling their
detection by the usual gel staining techniques. Attempts to concentrate culture supernatant
using a centrifugal concentration procedure were unsuccessful under the conditions used here.
Concentration of culture supernatant was easily achieved by a simple technique based on
removal of water by the use of Lyphogel.
The immunochemical analysis of both somatic components and exoantigens, which included
the use of sera experimentally raised against individual stocks of Babesia, McAbs which had
been raised against B.bovis and sera collected from animals in endemic areas, was based on
two major techniques: Western immuno-blotting and immunoprecipitation of 3\S-labelled
proteins. The aim of the characterisation was to identify relevant species-specific antigens
present in all stocks of each Babesia species, which were then targeted for purification and
the development of ELISAs. As a panel of McAbs produced against B.bovis was available, it
was hoped that some of them would recognise relevant specific epitopes and therefore be
useful for purification of specific antigens in an affinity chromatography procedure.
As the culture supernatants comprised complex mixtures of proteins (both parasite
secreted/excreted products and serum contaminants), after albumin removal and
concentration, culture supernatants were subjected to fractionation by HPLC, hoping that the
proteins could be separated according to their size and iso-electric points into fractions
containing less complex mixtures of proteins. This, it was hoped, would facilitate the
purification of particular proteins of known molecular weight. However, results from the
HPLC fractionation were disappointing and did not permit the identification of either B. bovis
or B.bigemina exoantigens for use as diagnostic tools. At the end of the fractionation
procedure, it was found that IgG, originating from the bovine serum component of culture
media, was the major serum contaminant present in the resultant fractions, making it
impossible to identify specific parasite exoantigens released into culture supernatants.
The first conclusion drawn from the immunochemical characterisation of somatic antigens of
B.bovis stocks described in this thesis was that antigenic diversity exists amongst the stocks.
Antigenic diversity of somatic antigens was observed by the two techniques used here -
Western immuno-blotting and immunoprecipitation - and reinforced the need for selection of
species-specific antigens which are common to all stocks of the parasite for the development
of immunodiagnostic tests designed to be used in epidemiological studies world-wide.
262
The immunochemical analysis of B.bovis components included three stocks which had been
originally isolated from three different continents. These were an Australian isolate
(Lismore), a Mexican isolate (Mexico), and a South African isolate (Kwanyanga).
Throughout the present study, the Kwanyanga and Mexico stocks showed similar antigenic
profiles, whereas the Lismore stock was different from the other two with regard to some
antigens. The Western immuno-blotting analysis showed that three antigens (molecular
weights of 70, 39 and 37 kDa) that were present in the Kwanyanga and Mexico stocks were
absent in the Lismore stock of B.bovis. In contrast, a 30 kDa antigen was identified as being
Lismore specific, since it was not detected in the other two stocks. Thus, these antigens were
not considered not to be appropriate candidates for the development of ELISAs.
It was hypothesised that antigenic differences between B.bovis stocks already reported by
other workers (Kahl et al, 1982b; 1983; Dalrymple et al, 1992) could be due to differences in
the proportions of distinct sub-populations of parasites within each stock. With this in mind,
the Lismore stock was cloned in vitro by limiting dilution in order to compare
immunochemically cloned and uncloned lines. However, no evidence of differences between
the parent and cloned lines could been detected when cultured parasites were compared by in
vitro growth rates, morphology and GPI isoenzyme patterns and, at the end of the experiment,
it was assumed that the Lismore stock maintained in culture at CTVM comprises a
homogeneous population of B.bovis parasites. This was confirmed in a recent report by
Dalrymple and co-workers, who found in a molecular analysis at the DNA level that the
particular Lismore isolate, from which the CTVM culture originated, comprises a
homogeneous population of parasites (Dalrymple et al, 1992).
Despite the antigenic diversity observed amongst the stocks of B. bovis in immuno-blotting, a
large number of the identified antigens fulfilled the criteria of being species-specific yet
common amongst all stocks. These were identified as potential candidates for use in the
development of ELISAs. These were seen at molecular weights of 185, 140, 121, 95, 76, 56,
28, 27, 18 and 14 kDa. Throughout the Western immuno-blotting analysis, the 56 kDa
protein was identified as the major immunodominant antigen recognised by both
experimentally raised anti-B.bovis sera and field sera and therefore was a potential candidate
for use as an immunodiagnostic target.
The technique for immunoprecipitation of ^^-methionine labelled proteins used in the
present study was found to be very sensitive, and useful for identification of Babesia antigens
both in the lysates and culture supernatants. All of the labelled material was of parasite
origin, as illustrated by the lack of incorporation of ^ ^-methionine in both lysates and
supernatant of uninfected RBC cultures. However, it was found in the present study that all
the steps involved in the immunoprecipitation technique needed to be carefully standardised in
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order to make it a reliable tool for identification of specific Babesia antigens. The major
constraint to this technique appeared to be related to the high non-specific background
observed throughout the analysis. Thus, the inclusion of negative controls (pre-infection sera,
PBS or distilled water) throughout the analysis was judged to be essential.
Four B.bovis species-specific somatic antigens were identified by immunoprecipitation (88,
75, 65 and 46 kDa). However they were seen at molecular weights different from those
identified by Western immuno-blotting. Although some antigens had molecular weights close
to some identified by Western immuno-blotting and therefore might be the same protein,
results from the present study showed that antigens identified by one technique could not
necessarily be correlated with those identified by the other. Thus, the four B.bovis species-
specific somatic antigens identified by immunoprecipitation, plus many identified by Western
immuno-blotting, were all candidate antigens for use in the development of B.bovis specific
antibody detection ELISAs.
Unfortunately, none of the B. bovis candidate antigens were recognised by any of the McAbs
when tested in either Western immuno-blotting or immunoprecipitation, despite the fact that
all the McAbs reacted with B.bovis parasites in IFAT. Thus the approach of using one or
more McAbs in an affinity column to purify relevant antigens was not pursued. The low
reactivity of the McAbs in Western immuno-blotting, ELISA and immunoprecipitation,
contrasting with their good reactivity in IFAT was interpreted as possibly being related to
their specificity for conformational epitopes (Harlow & Lane, 1988).
Regarding the identification of B.bigemina antigens, the present analysis faced more
limitations than for B.bovis stocks, particularly as a consequence of the failure to maintain
continuously more than one stock of B.bigemina in vitro. Even that stock (Mexico) was only
acquired late in the study. The only possible comparison was performed between two stocks
of B.bigemina (Kenya and Mexico) by Western immuno-blotting. This allowed identification
of two somatic antigens (80 and 65 kDa) as common to both stocks of B.bigemina yet absent
from B.bovis and therefore potential candidates for use as specific immunodiagnostic targets.
The analysis by immunoprecipitation of ^S-Iabelled somatic antigens, which was performed
with the only B.bigemina stock that could be grown in vitro (Mexico), allowed identification
of specific antigens with a wide range of molecular weights (210 to 21 kDa) and these were
also seen as potential candidates for use in the development of specific ELISAs.
In the search for exoantigens in supernatants of B.bovis and B.bigemina cultures, the
immunoprecipitation of -^S-Iabelled products proved to be an appropriate method, allowing
identification of a wide range of species-specific antigens. Six B.bovis exoantigens (80, 72,
58, 38, 34 and 24 kDa) were shown to be common amongst the three stocks and four
B.bigemina exoantigens (240, 112, 50 and 29 kDa) were identified as species-specific. These
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were therefore potential candidates for use as immunodiagnostic targets. However, the great
limitation in the use of exoantigens for the development of ELISAs, was related to the
purification of relevant components from the mixture of proteins (most of which were serum
contaminants) present in supernatants from cultures. The lack of success of the HPLC
fractionation used in the present study in identifying Babesia exoantigens from culture
supernatant made it difficult to purify the relevant exoantigens identified by
immunoprecipitation, and therefore it was not possible to develop ELISAs with specific
exoantigens.
Electroelution of proteins from acrylamide gels appeared to be an appropriate method for
purification of B.bovis and B.bigemina antigens since immuno-affinity purification was not
possible using the McAbs available in the present study. Some candidate somatic antigens of
each Babesia species were therefore selected for elution and used for the development of
ELISAs. Four protein bands of B.bovis (121, 75, 56 and 46 kDa) and four of B.bigemina
(210, 80, 65 and 50 kDa) were successfully eluted from SDS gels. All four B.bovis proteins
remained antigenic after elution in Western immuno-blotting; however only one (56 kDa) was
found to discriminate between anti-5. ftovis and anti-B.bigemina sera in ELISA and therefore
it was selected for the development of a B.bovis specific antibody detection ELISA.
Due to the fact that none of the B.bigemina proteins were able to discriminate between anti-
B.bigemina and anti-B.bovis sera in ELISA, although two amongst the four eluted remained
antigenic in Western immuno-blotting, it was not possible to develop a B.bigemina specific
ELISA using eluted proteins. These findings were interpreted as being possibly due to more
B.bigemina epitopes being cross-reactive with B.bovis than vice-versa. Nevertheless, as
results obtained from the immunochemical analysis and the ELISA checkerboard titration
gave strong indications that the 56 kDa protein is a B.bovis-specific antigen, its use alongside
a crude B.bigemina antigen in ELISAs should permit discrimination between the two
infections in endemic areas.
The purified B.bovis 56 kDa protein was found to have potential in replacing crude antigenic
preparations in antibody detection ELISAs, as demonstrated by the high level of agreement
(at least 95%) between the two antigens in detecting B.bovis reactive field serum samples.
Furthermore, the ability of the 56 kDa protein to detect high proportions of positive sera from
cattle from three different countries (Malawi, Mozambique and Brazil) suggests that this
protein is conserved amongst different isolates of B.bovis and therefore could be used world¬
wide.
The ELISA developed here using the B.bovis 56 kDa protein as antigen for detection of
B.bovis specific antibodies has considerable potential for use in epidemiological studies on
bovine babesiosis in Brazil, where the assay should be implemented in the near future. In
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order to make it viable, the 56 kDa protein should be produced by recombinant DNA
technology. The assay would then have advantages over conventional antigen preparations in
several ways. In addition to eliminating cross-reactions due to anti-fi.bigemina antibodies
present in sera from cattle in endemic areas, due to concurrent infections with B. bigemina,
the 56 kDa protein would be produced artificially, therefore eliminating batch-to-batch
variations. Furthermore, there would be no need to sacrifice experimental cattle for the bulk
preparation of crude antigens.
9.1 FUTURE PROSPECTS
The experiments described in this thesis report relevant achievements related to the in vitro
cultivation, concentration and immunochemical characterisation of B.bovis and B. bigemina
parasites and open new prospects for a better understanding of bovine babesiosis in tropical
countries where the two diseases are endemic.
Future work should include further investigations on the 56 kDa B.bovis protein, used here to
develop a specific antibody detection ELISA with potential for sero-epidemiological surveys.
Further work should be carried out in order to produce its recombinant form, enabling its use
on a large scale. A detailed investigation regarding its composition, origin and dynamics
during B.bovis infections may reveal other features and further potential uses for this
component, for instance as a protective immunogen.
Moreover, of particular relevance would be the production of antibodies against the 56 kDa
protein. These antibodies could them be used to develop ELISAs for detection of either
circulating antigens or immune complexes, as developed for Trypanosoma sp (Rae &
Luckins, 1984) and Theileria mutans (Katende et al, 1990), which, in association with the
antibody detection ELISA developed here, would probably allow more reliable detection of
carrier animals than with the use of a single test. Specific antibodies produced against the 56
kDa protein would also be necessary for screening a B.bovis genomic library with a view to
identifying the gene encoding it and subsequent production of its recombinant form.
As the major constraint of the present effort to characterise stocks of B.bigemina was the
lack of an in vitro culture system which enabled continuous growth of all available
B. bigemina isolates, future work should primarily be directed towards the improvement of the
present in vitro culture system for B.bigemina. This should include investigations on the use
of atmosphere with a wider range of O2 tension and PCVs than those used in the present
study to initiate cultures.
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In the search for B.bigemina specific antigens, future work should include the use of more
powerful techniques, such as two-dimensional gel electrophoresis, to resolve immune
complexes which would allow more precise identification of specific antigens.
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APPENDICES
APPENDIX 1 Reagents and solutions
Giemsa Stain Solution
Glycerol (Analar) 540 ml
Methanol 840 ml
Giemsa powder (Merck) 10 g
Azur II (0.2 g/100 ml) 2.75 g
The Giemsa powder was dispensed into a large glass mortar. Some of the glycerol was added
and ground throughly. The mixture was poured into a large flat-bottomed flask. Gradually the
rest of the glycerol was added and the flask was heated in a 60° C water bath for 1 hour, with
intermittent shaking, and then cooled to room temperature. The methanol was added and the
solution stirred overnight. The Azur II was added followed by another overnight stirring. The
solution was then filtered (Whatmans No 4) and stored in a dark bottle.
Giemsa Buffer (pH 7.2)
1 tablet GURR (cat No 33201) per litre of distilled water
IFAT mountant (66% glycerol)




citric acid 6.46 g
The solution was made up to 1 litre with distilled water and pH adjusted to 6.4 with HC1.
PIGA buffer





The solution was made up in 0.9%(w/v) NaCl and pH adjusted to 7.2 with HCL.
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SDS-PAGE solutions
SDS reducing sample buffer
solution a) Tris 45 nig
EDTA(disodium) 223 mg
distilled water 10 ml
solution b) SDS 1.0 g
2-mercaptoethanol 0.45 ml
glycerol 5 ml
A spatula tip of bromophenol blue was added and the solution made up to 10 ml with distilled
water.
Equal volumes of a) and b) were mixed.




Ponceau-S to colour to 10 ml in distilled water
Gel Solutions
Solutions Concentration of gel solutions
required (ml) 20% 10% 7% 4.5%
Stock acrylamide (40%) 100 50 35 11.25
x 4 lower Tris 50 50 50 —
x 4 upper Tris — — — 25
sucrose (g) 30 — — —
distilled water 20 100 115 63.75
Total volume 200* 200* 200* 100**
* frozen at -20° C as 20-ml aliquots
** frozen at -20° C as 10-ml aliquots
x 4 lower Tris
Tris 36.4 g
SDS 0.8 g
distilled water to 200 ml
pH adjusted to 8.8 with conc. HC1
295
x 4 upper Tris
Tris 12.12 g
SDS 0.8 g
distilled water to 200 ml
pH adjusted to 6.8 with cone. HC1




Made up to 1 litre in distilled water







electrode buffer 100 ml
methanol 100 ml
dist.water 300 ml







made up to 1 litre and pH adjusted to 7.4 with cone. HC1. Before use, the solution was diluted
1:10 with distilled water and 5% (w/v) of dried skimmed milk (Marvel) was added.
Tris buffered saline (TBS)
Tris 20 mM
NaCl 0.5 M
made up to 2 litres and pH adjusted to 7.5 with cone. HC1.
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Highly purified water
The water was first deionised in a MILI RO 60 water purification system (Millipore) and at
the same time purified by reverse osmosis. The water was then given a final polishing with a
MILLI Q water purification system (Millipore). The final product had a resistivity of 18
megahoms, indicating a high degree of purity.
Metabolic labelling and immunoprecipitation solutions
PBS-methionine (for washes of Sephadex column)
PBS 199 ml







the solution was made up in distilled water and pH adjusted to 7.8 with HC1. To this solution












Solution was made up in distilled water and pH was adjusted to 8.0
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HPLC buffers




pH adjusted to 7.0 with HC1
Buffer A
Tris 20 mM




pH adjusted to 8.3 with HC1
298
APPENDIX 2 IN VITRO CULTURE RESULTS
Number of B.bovis infected cells in 1,000 RBC in cultures of Mexico stock with different
sera (Fig 4.1).
serum well No days
1 2 3 4 5 6
calf 396 1 1 7 22 32 21 19 8
2 8 16 34 24 32 10
3 5 15 31 19 23 11
calf 397 2 4 6 18 13 6 9 2*
5 11 19 17 9 6 2*
6 5 12 22 10 5 3*
NBS 7 14 18 30 10 19 14
8 7 15 43 20 20 19
9 10 13 35 15 16 11
Key: * 50 fields(~250 RBC/field) counted
' 21 days after B.bovis infection
2 21 days after B.bigemina infection
Number of B.bovis infected cells in 1,000 RBC in cultures of Lismore stock with different
calf sera (Fig 4.2).
serum well No days
1 2 3 4 5 6
NBS 1 10 30 49 27 18 37
2 11 24 43 30 38 36
calf 396 1 3 9 21 41 29 32 40
4 12 19 45 27 33 38
calf 397 2 5 8 29 44 30 30 41
6 11 24 42 19 26 43
calf 3 99 3 7 9 25 46 15 28 38
8 14 28 49 17 25 43
calf 5 90 4 9 8 30 48 16 25 32
10 9 24 49 20 29 35
Key: 1 day 69 after B.bovis infection (IFAT titre 1 in 2560)
2 day 69 after B.bigemina infection (IFAT titre 1 in 640)
3 day 36 after B.bigemina infection (IFAT titre 1 in 2560)
4 uninfected
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Number of B.bovis infected cells in 1,000 RBC in cultures with MPWC or BAE as feeder
cells (Fig 4.3).
condition well n° days
1 2* 3 4
A 1 39 59 17 26
2 38 54 16 30
3 40 68 19 28
B 4 44 63 22 36
5 41 64 19 40
6 39 79 14 34
C 7 45 82 29 42
8 43 72 17 27
9 40 68 24 36
D 10 37 48 14 24
11 29 47 11 18
12 34 48 8 25
E 13 30 47 16 12
14 35 58 7 18
15 36 52 11 16
Key: A - 106 MPWC B - 105 MPWC
C - 104 MPWC D - no feeder cells
E - BAE cells
* all wells were subcultured at lin 5 dilution with fresh RBC suspension
Number of B.bovis infected cells in 1,000 RBC of established cultures of Lismore stock with




days 1 2 3 4 1 2 3 4 1 2 3 4
1 5 5 5 5 5 5 5 5 5 5 5 5
2 35 29 30 26 23 28 34 26 19 18 17 15
3 64 53 48 47 60 60 58 44 37 38 34 33
3b* 4 4 4 4 5 5 5 5 5 5 5 5
4 33 31 27 26 32 37 30 31 19 25 21 26
5 52 59 64 64 60 58 57 53 48 54 49 50
6 60 85 70 79 71 78 69 89 54 60 52 42
* after subculture
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Number of B.bovis infected cells in 1,000 RBC of established cultures of Mexico stock with
MPWC as feeder cells (Fig 4.5 B).
MPWC/ml
lays 104 103 none
1 2 3 4 1 2 3 4 1 2 3 4
1 6 6 6 6 6 6 6 6 6 6 6 6
2 34 37 30 30 31 35 38 36 19 16 21 15
3 52 71 63 49 65 52 50 47 26 48 36 33
3b* 8 8 8 8 9 9 9 9 8 8 8 8
4 45 50 49 56 55 59 45 50 30 34 43 26
5 79 101 102 109 101 85 81 93 57 79 89 50
6 80 94 81 82 81 86 101 95 80 78 82 42
* after subculture
Number of B.bovis infected cells in 1,000 RBC of established cultures of Kwanyanga stock
with MPWC as feeder cells (Fig 4.5 C).
MPWC/ml
lays 104 103 none
1 2 3 4 1 2 3 4 1 2 3 4
1 6 6 6 6 6 6 6 6 6 6 6 6
2 34 40 37 37 38 38 39 37 29 24 26 22
3 53 51 50 48 52 39 58 59 38 40 43 34
3b* 11 11 11 11 10 10 10 10 10 10 10 10
4 46 40 43 37 44 33 42 40 28 25 32 37
5 88 104 111 92 101 98 95 89 55 46 56 72
6 91 115 95 78 101 122 118 87 65 67 78 80
* after subculture




form 104 103 Ctr 104 103 Ctr 104 103 Ctr 104 103 Ctr 104 103 Ctr
pair 78 64 63 80 91 71 73 81 64 85 73 88 22 25 20
single 17 27 30 13 6 14 26 19 27 15 27 12 57 58 51
quadr 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0
picn 0 4 4 0 0 4 0 0 4 0 0 0 8 15 24
free 5 5 3 6 2 11 1 0 5 0 0 0 13 2 5
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Proportions of different forms of B.bovis parasites (Mexico stock) in cultures with MPWC
(Fig 4.7).
Days
1 2 3 4 5
form 104 103 Ctr 104 103 Ctr 104 103 Ctr 104 103 Ctr 104 103 Ctr
pair 62 68 62 11 13 47 68 23 20 87 28 26 24 17 13
single 36 27 34 50 50 36 29 75 77 13 72 53 54 47 46
quadr 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
picn 0 0 3 4 2 4 0 2 3 0 9 18 16 35 41
free 2 5 1 35 35 13 3 0 0 0 0 3 6 1 0
Proportions of different forms of B.bovis parasites (Kwanyanga stock) in cultures with
MPWC (Fig 4.8).
Days
1 2 3 4 5
form 104 103 Ctr 104 103 Ctr 104 103 Ctr 104 103 Ctr 104 103 Cti
pair 60 56 51 3 11 6 63 39 29 12 36 28 23 17 27
single 35 36 45 69 54 33 35 51 65 73 63 59 54 65 50
quadr 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
picn 1 4 4 4 1 9 0 0 2 12 1 11 23 15 22
free 4 4 0 24 34 52 1 10 4 3 0 2 0 3 1
Number of B.bovis infected cells in 4,500
using MPWC as feeder cells.
Days 104
1 2 3 4 1
1 18 11 17 17 6
2 35 40 54 39 37
3 216 133 179 174 145







Number of B.bovis infected cells in 4,500 RBC of cultures of Mexico stock resuscitated
using MPWC as feeder cells.
MPWC/ml
Days 104 none
1 2 3 4 1 2 3 4
1 10 16 6 10 4 8 7 9
2 37 36 49 47 33 29 22 33
3 177 276 200 140 227 130 176 206
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Number of B.bovis infected cells in 4,500 RBC in cultures of Kwanyanga stock resuscitated
using MPWC as feeder cells.
MPWC/ml
Days 104 none
1 2 3 4 1 2 3 4
1 4 8 5 5 5 4 5 6
2 179 54 34 23 8 20 30 20
3 159 150 146 157 148 128 154 125
Number of B.bovis infected cells in 2,000 RBC in cultures of clone 1 (growth rate evaluation
of cloned lines - Fig 4 .9).
Starting parasitaemia 1%
replicates
days 1 2 3 4
1 45 68 35 42
2 76 66 73 86
3 98 61 41 90
4 91 74 88 60
5 63 60 52 42
6 45 48 29 36
7 31 29 34 37
Starting parasitaemia 0.1%
replicates
days 1 2 3 4
1* 6.2 6.6 5.9 6
2 18 34 36 14
3 54 66 41 48
4 57 61 77 60
5 57 106 102 54
6 25 71 52 62
7 85 46 21 42
Starting parasitacmia 0.01%
replicates
days 1 2 3 4
1* 0.6 0.6 1.1 0.6
2* 2.6 2.5 2.2 2
3 5 4 5 8
4 16 14 12 22
5 21 34 16 22
6 51 63 44 62
7 58 63 47 90
* 100 fields counted (250 cells/field) and the number of infected cells was adjusted to a total of
2,000 RBC
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Number of B.bovis infected cells in 2,000 RBC in cultures of clone 3.
Starting parasitaemia 1%
replicates
days 1 2 3 4
1 54 73 82 54
2 76 70 72 80
3 84 80 78 75
4 78 72 69 87
5 33 63 53 81
6 41 58 36 39
7 70 41 71 39
Starting parasitaemia 0.1%
replicates
days 1 2 3 4
1* 6.3 5 5.9 7.6
2 36 26 34 30
3 59 46 37 44
4 81 46 44 73
5 75 87 96 92
6 82 101 90 74
7 78 84 29 61
Starting parasitaemia 0.01%
replicates
days 1 2 3 4
1* 1.3 1.1 1.5 0.7
2* 2.8 0.6 2.9 2
3 10 10 12 5
4 17 8 19 10
5 35 24 30 25
6 54 31 53 37
7 60 43 61 76
* 100 fields counted (250 cells/field) and the number of infected cells was adjusted to a total of
2,000 RBC
Number of B.bovis infected cells in 2,000 RBC in cultures of clone 4.
Starting parasitaemia 1%
replicates
days 1 2 3 4
1 30 21 42 23
2 92 78 74 69
3 116 98 108 76
4 67 56 73 63
5 67 129 114 53
6 37 73 64 59




days 1 2 3 4
1* 5.5 4.6 5.9 3.2
2 18 20 22 14
3 32 44 40 36
4 44 52 63 62
5 69 58 49 72
6 76 57 39 71
7 50 55 49 33
Starting parasitaemia 0.01%
replicates
days 1 2 3 4
1* 0.9 0.4 0.6 0.6
2* 1.9 1.4 1.9 1
3 10 5 4 6
4 12 5 8 9
5 18 8 11 9
6 12 5 8 7
7 16 14 20 12
* 100 fields counted (250 cells/field) and the number of infected cells was adjusted to a total
2,000 RBC
Number of B.bovis infected cells in 2,000 RBC in cultures of the Lismore parent line.
Starting parasitaemia 1%
replicates
days 1 2 3 4
1 26 46 32 44
2 49 52 58 53
3 93 83 68 59
4 65 79 60 63
5 44 56 60 61
6 60 68 59 57
7 50 52 46 47
Starting parasitaemia 0.1%
replicates
days 1 2 3 4
1 11 12 8 9
2 15 16 24 17
3 33 48 44 46
4 64 67 52 50
5 86 51 46 66
6 73 60 75 76




days 1 2 3 4
1 8 5 11 9
2 14 18 17 20
3 13 9 7 10
4 16 12 13 19
5 32 20 21 31
6 53 46 56 48
7 71 76 80 88
Proportions of different forms ofB.bovis cloned lines in cultures.
Parent line
Forms replicates
1 2 3 4
pair 75 78 82 77
single 9 13 10 12
pycnotic 9 3 3 5
free 6 4 5 4
Clone 1
replicates
Forms 1 2 3 4
pair 73 75 65 68
single 16 13 15 20
triplet 0 2 0 1
quadrup 2 1 0 4
pycnotic 2 5 6 2
free 7 4 14 5
Clone 3
replicates
Forms 1 2 3 4
pair 75 70 75 72
single 19 14 11 14
triplet 2 3 1 0
quadrup 1 0 1 2
pycnotic 2 2 9 1
free 1 11 4 10
Clone 4
replicates
Forms 1 2 3 4
pair 72 63 62 58
single 17 17 16 21
triplet 1 0 1 1
quadrup 5 2 3 2
pycnotic 4 10 6 9
free 1 8 12 9
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APPENDIX 3 Photography
Gels stained with Coomassie blue or silver stain, nitrocellulose membranes and X-ray fdms
were photographed using a Polaroid MP4 camera (Polaroid) with type 55 POS-NEG 5x4
sheet film.
Coomassie blue stained gels were photographed using Wratten 11 filter, 1 sec exposure F11
and silver stained gels were photographed using Wratten 61 filter, 4 sec exposure F16, both
using transmitted light. Nitrocellulose membranes were photographed using Wratten 23 filter,
0.5 sec exposure F16 using reflected light. X-ray films were photographed using Wratten 61
filter, 5 sec exposure F16, using transmitted light.
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Appendix 4 Results from metabolic labelling
4.1 Typical counts of radioactivity (c.p.m.) in 10 pi aliquots of fractions from -^S-labelled
supernatant of B.bovis, B.bigemina and uninfected RBC cultures obtained after filtration
through Sephadex G25.
Counts per minute (c.p.m.)
Fraction B.bovis culture B.bigemina culture uninfected culture
number supernatant supernatant supernatant
1 77 47 23
2 90 276 32
3 101 171 21
4 928 638 51
5 13,576 1,846 439
6 45,753 7,244 1,513
7 54,954 26,602 766
8 59,974 43,251 281
9 56,609 63,762 97
10 56,932 63,888 64
11 35,522 55,934 62
12 10,238 19,705 127
13 3,521 13,722 390
14 21,972 5,239 1,460
15 55,798 33,566 8,956
16 89,544 92,697 47,127
17 122,345 476,262 102,464
18 339,562 450,394 366,903
19 470,267 236,892 459,892
20 302,129 167,233 545,273
4.2 Typical counts (c.p.m.) of samples of -^S-labclled exoantigens and somatic antigens
before and after TCA precipitation (pp.), and calculated percentages of incorporation.
Culture Type of antigen Initial counts After TCA pp. % incorporation
B.bovis exoantigens 30,913 27,821 90.0
somatic 324,561 227,193 70.0
B.bigemina exoantigens 20,608 19,289 93.0
somatic 335,802 239,144 71.0
uninfected RBC exoantigens 1,499 29 2.0
somatic 34,243 1,004 2.9
308
APPENDIX 5 ELISA RESULTS






Days P.I. Well 1 Well 2 Mean Status
c.p.= 0.310
1 198(K) 28 0.314 0.440 0.377 P
1 C11(K) 21 0.719 0.533 0.626 P
1 396(M) 28 0.541 0.507 0.524 P
1 396(M) 56 0.583 0.661 0.622 P
1 396(M) 77 0.737 0.726 0.732 P
1 396(M) 103 0.784 0.785 0.785 P
1 P49(L) 17 0.174 0.212 0.193 N
1 P78(L) 21 0.191 0.244 0.218 N
1 P78(L) 42 0.429 0.438 0.434 P
1 P78(L) 70 0.544 0.552 0.548 P
1 P78(L) 90 0.744 0.715 0.730 P
1 71X(Br) n.k. 0.369 0.471 0.420 P
1 3334X(Br) n.k. 0.695 0.461 0.578 P
X= 0.522 SD= 0.190
2 399(Z) 14 0.391 0.256 0.324 P
2 399(Z) 29 0.293 0.290 0.292 N
2 399(Z) 57 0.301 0.228 0.265 N
2 399(Z) 68 0.341 0.271 0.306 N
2 399(Mug) 112 0.302 0.398 0.350 P
2 583(Z) 14 0.295 0.276 0.286 N
2 583(Z) 28 0.153 0.214 0.184 N
2 583(Z) 49 0.172 0.201 0.187 N
2 583 (Mug) 104 0.284 0.250 0.267 N
2 1255(Br) n.k. 0.226 0.269 0.248 N
2 1258(Br) n.k. 0.230 0.242 0.236 N
2 1268(Br) n.k. 0.286 0.278 0.282 N
2 1269(Br) n.k. 0.310 0.274 0.292 N
2 397(Z) 28 0.259 0.165 0.212 N
2 397( Z) 49 0.238 0.201 0.220 N
2 397( Z) 83 0.172 0.184 0.178 N
2 U44 (Z) 28 0.117 0.184 0.151 N
2 7 T (Z) 34 0.088 0.082 0.085 N
2 8 T (Z) 42 0.078 0.072 0.750 N
X= 0.233 SD= 0.080
3 396 0 0.189 0.197 0.193 N
3 399 0 0.127 0.109 0.118 N
3 583 0 0.180 0.162 0.171 N
3 397 0 0.253 0.258 0.256 N
3 Pll 0 0.177 0.200 0.189 N
3 T57 0 0.255 0.256 0.256 N
3 634 0 0.255 0.175 0.215 N
3 539 0 0.178 0.165 0.172 N
3 929 0 0.123 0.130 0.127 N
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Continuation
Type of Calf No Days P.I. Well 1 Well 2 Mean Status
serum (stock) c.p.= 0.310
3 S126 0 0.205 0.285 0.245 N
3 37 0 0.107 0.114 0.111 N
3 V56 0 0.069 0.099 0.084 N
3 P58 0 0.167 0.264 0.215 N
3 P45 0 0.299 0.254 0.276 N
3 M13 0 0.191 0.210 0.200 N
X= 0.188 SD= 0.061
PBS 0.070 0.089 0.080
Key: 1 anti- B.bovis serum
2 anti-B.bigemina serum
3 pre-infection serum
K-Kwanyanga L-Lismore M-Mexico Br-Brazil
n.k. not known P.I. post-infection P- positive















1 198(K) 28 0.304 0.254 0.279 N N
1 C11(K) 21 0.464 0.475 0.470 N N
1 396(M) 28 0.410 0.438 0.424 N N
1 396(M) 56 0.599 0.557 0.578 N P
1 396(M) 77 0.727 0.709 0.718 P P
1 396(M) 103 0.878 0.783 0.831 P P
1 P49(L) 17 0.227 0.229 0.228 N N
1 P78(L) 21 0.249 0.231 0.240 N N
1 P78(L) 42 0.263 0.268 0.266 N N
1 P78(L) 70 0.327 0.343 0.335 N N
1 P78(L) 90 0.592 0.531 0.562 N N
1 71X(Br) n.k. 0.372 0.423 0.398 N N
1 3334X(Br) n.k. 0.834 0.605 0.720 P P
X= 0.465 SD=0.201
2 399(Z) 14 1.169 0.992 1.081 P P
2 399(Z) 29 1.005 0.893 0.949 P P
2 399(Z) 57 1.19 1.024 1.107 P P
2 399(Z) 68 1.289 1.265 1.277 P P
2 399(Mug) 112 1.351 1.251 1.301 P P
2 583(Z) 14 0.604 0.584 0.594 N P
2 583(Z) 28 0.546 0.500 0.523 N N
2 583(Z) 49 0.641 0.489 0.565 N N
2 583 (Mug) 104 1.392 1.367 1.380 P P
2 1255(Br) n.k. 1.052 0.880 0.966 P P
2 1258(Br) n.k. 1.147 1.010 1.079 P P
2 1268(Br) n.k. 1.157 1.065 1.111 P P
2 1269(Br) n.k. 0.969 0.943 0.956 P P
2 397 (Z) 28 0.577 0.596 0.587 N P
2 397 (Z) 49 0.885 0.913 0.899 P P
2 397 (Z) 83 0.803 0.836 0.820 P P
2 U44 (Z) 28 0.260 0.247 0.254 N N
2 7 T (Z) 34 0.343 0.394 0.369 N N
2 8 T (Z) 42 0.291 0.295 0.293 N N
X= 0.848 SD=0.345
3 396 0 0.235 0.320 0.278 N N
3 399 0 0.425 0.437 0.431 N N
3 583 0 0.258 0.244 0.251 N N
3 397 0 0.339 0.334 0.337 N N
3 Pll 0 0.398 0.348 0.373 N N
3 T57 0 0.491 0.396 0.444 N N
3 634 0 0.277 0.263 0.270 N N
3 539 0 0.297 0.284 0.291 N N
3 929 0 0.239 0.218 0.229 N N











3 37 0 0.293 0.226 0.260 N N
3 V56 0 0.200 0.203 0.202 N N
3 P58 0 0.239 0.297 0.268 N N
3 P45 0 0.236 0.236 0.236 N N
3 M13 0 0.279 0.236 0.258 N N
X= 0.290 SD=0.076
PBS 0.141 0.168 0.155
Key: 1 anti- B.bovis serum
2 anti-B.bigemina serum
3 pre-infection serum
K-Kwanyanga L-Lismore M-Mexico Br-Brazil
n.k. not known P.I. post-infection P- positive





5.3 Results of checkerboard titrations of anti-B.bovis, anti-B.bigemina and negative sera
against eluted B.bovis protein bands (section 8.3.2.1).
121 kDa protein
Serum dilution anti-B.bovis anti-B. bigemina pre-infection
1:100 0.325 0.330 0.287 0.271 0.260 0.230
1:200 0.215 0.231 0.197 0.204 0.180 0.164
1:400 0.137 0.162 0.136 0.149 0.142 0.141
1:800 0.108 0.119 0.108 0.107 0.105 0.117
1:1,600 0.100 0.103 0.091 0.096 0.099 0.102
75 kDa protein
Serum dilution anti-B. 6ov/'s anti -B. bigemina pre-infection
1:100 0.283 0.296 0.234 0.242 0.210 0.187
1:200 0.182 0.189 0.173 0.174 0.142 0.160
1:400 0.146 0.144 0.140 0.127 0.128 0.132
1:800 0.125 0.115 0.106 0.116 0.129 0.122
1:1,600 0.137 0.111 0.115 0.101 0.135 0.189
56 kDa protein
Serum dilution anti-B. bovis anti-B. bigemina pre-infection
1:100 0.325 0.522 0.172 0.165 0.058 0.107
1:200 0.404 0.369 0.119 0.123 0.037 0.035
1:400 0.248 0.252 0.078 0.085 0.021 0.024
1:800 0.179 0.152 0.049 0.052 0.010 0.016
1:1,600 0.100 0.109 0.033 0.036 0.009 0.005
46 kDa protein
Serum dilution anti-jB.bovis anti-B. bigemina pre-infection
1:100 0.325 0.312 0.290 0.298 0.241 0.265
1:200 0.202 0.210 0.199 0.202 0.188 0.172
1:400 0.139 0.165 0.137 0.152 0.149 0.137
1:800 0.109 0.111 0.109 0.105 0.100 0.112
1:1,600 0.100 0.102 0.100 0.095 0.101 0.100
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5.4 Results of checkerboard titrations of anti-5.bovis, cait\-B.bigemina and negative sera
against eluted B.bigemina protein bands (section 8.3.2.2).
210 kDa protein
Serum dilution anti-B.bigemina anti -B. bovis pre-infection
1:100 0.148 0.167 0.168 0.149 0.044 0.050
1:200 0.099 0.106 0.086 0.082 0.020 0.026
1:400 0.062 0.066 0.056 0.057 0.009 0.013
1:800 0.040 0.033 0.039 0.031 0.004 0.008
1:1,600 0.025 0.026 0.019 0.020 0.001 0.004
80 kDa protein
Serum dilution anti -B.bigemina anti -B. bovis pre-infection
1:100 0.280 0.296 0.308 0.301 0.095 0.099
1:200 0.176 0.188 0.330 0.289 0.062 0.070
1:400 0.142 0.154 0.151 0.130 0.048 0.040
1:800 0.089 0.102 0.101 0.106 0.041 0.042
1:1,600 0.067 0.076 0.075 0.080 0.032 0.025
65 kDa protein
Serum dilution anti -B.bovis anti-B.bigemina pre-infection
1:100 0.507 0.499 0.462 0.422 0.164 0.127
1:200 0.350 0.363 0.320 0.308 0.122 0.119
1:400 0.231 0.222 0.256 0.222 0.084 0.087
1:800 0.156 0.152 0.156 0.143 0.065 0.059
1:1,600 0.109 0.105 0.115 0.111 0.056 0.051
50 kDa protein
Serum dilution ai\\i-B.bigeniina anti -B. bovis pre-infection
1:100 0.345 0.315 0.306 0.298 0.102 0.105
1:200 0.230 0.223 0.215 0.212 0.078 0.082
1:400 0.164 0.162 0.161 0.154 0.056 0.059
1:800 0.103 0.111 0.102 0.101 0.046 0.039
1:1,600 0.074 0.079 0.076 0.089 0.037 0.035
314






Days P.I. Well 1 Well 2 Mean Status
c.p.= 0.352
1 198(K) 28 0.213 0.212 0.213 N
1 C11(K) 21 0.418 0.390 0.404 P
1 396(M) 28 0.328 0.326 0.327 N
1 396(M) 56 0.434 0.408 0.421 P
1 396(M) 77 0.600 0.593 0.597 P
1 396(M) 103 0.599 0.564 0.582 P
1 P49(L) 17 0.188 0.197 0.193 N
1 P78(L) 21 0.180 0.184 0.182 N
1 P78(L) 42 0.304 0.282 0.293 N
1 P78(L) 70 0.391 0.420 0.410 P
1 P78(L) 90 0.495 0.499 0.497 P
1 71X(Br) n.k. 0.352 0.359 0.355 P
1 3334X(Br) n.k. 0.370 0.359 0.365 P
X= 0.372 SDK). 132
2 399(Z) 14 0.289 0.266 0.278 N
2 399(Z) 29 0.250 0.254 0.252 N
2 399(Z) 57 0.212 0.217 0.215 N
2 399(Z) 68 0.275 0.259 0.267 N
2 399(Mug) 112 0.324 0.314 0.319 N
2 583(Z) 14 0.221 0.237 0.229 N
2 583(Z) 28 0.232 0.235 0.234 N
2 583(Z) 49 0.208 0.209 0.208 N
2 583(Mug) 104 0.249 0.256 0.253 N
2 1255(Br) n.k. 0.253 0.232 0.243 N
2 1258(Br) n.k. 0.279 0.293 0.286 N
2 1268(Br) n.k. 0.285 0.277 0.281 N
2 1269(Br) n.k. 0.300 0.329 0.315 N
2 397(Z) 28 0.370 0.359 0.365 P
2 397( Z) 49 0.338 0.333 0.336 N
2 397( Z) 83 0.445 0.413 0.429 P
2 U 44 (Z) 28 0.247 0.304 0.276 N
2 7 T (Z) 34 0.237 0.209 0.223 N
2 8 T (Z) 42 0.209 0.187 0.198 N
X= 0.275 SDK).059
3 396 0 0.239 0.268 0.254 N
3 399 0 0.330 0.348 0.339 N
3 583 0 0.236 0.271 0.253 N
3 397 0 0.256 0.247 0.252 N
3 Pll 0 0.249 0.251 0.250 N
3 T57 0 0.245 0.282 0.264 N
3 634 0 0.187 0.206 0.197 N
3 539 0 0.209 0.207 0.208 N
3 929 0 0.244 0.256 0,250 N
3 S126 0 0.271 0.257 0.264 N







Days P.I. Well 1 Well 2 Mean Status
c.p.=
0.352
3 V56 0 0.162 0.170 0.166 N
3 P58 0 0.267 0.268 0.268 N
3 P45 0 0.390 0.345 0.368 N
3 M13 0 0.265 0.24 0.253 N
X= 0.254 SD=0.049
PBS 0.036 0.045 0.041
Key: 1 anti- B.bovis serum
2 anti-6. bigemina serum
3 pre-infection serum
K-Kwanyanga L-Lismore M-Mexico Br-Brazil
n.k. not known P.I. post-infection P- positive





5.6 Absorbance values from field serum samples tested against crude B.bovis antigen (section
8.4.2.1).
Origin serum well 1 well 2 mean adj.v. status
A 1 0.785 0.779 0.782 0.782 P
A 2 1.079 0.937 1.008 1.008 P
A 3 0.674 0.644 0.659 0.659 P
A 4 1.013 0.803 0.908 0.908 P
A 6 0.722 0.767 0.744 0.744 P
A 8 0.903 0.838 0.871 0.871 P
A 9 0.682 0.668 0.675 0.675 P
A 10 0.669 0.605 0.637 0.637 P
A 11 0.991 0.943 0.967 0.967 P
A 12 0.780 0.746 0.763 0.763 P
A 13 0.440 0.462 0.451 0.451 P
A 14 0.591 0.628 0.610 0.610 P
A 15 0.683 0.672 0.677 0.677 P
A 16 0.900 0.758 0.829 0.829 P
A 17 1.018 0.950 0.984 0.984 P
A 18 0.707 0.608 0.658 0.658 P
A 19 0.949 1.065 1.007 1.007 P
A 20 0.961 1.008 0.985 0.985 P
A 21 1.145 1.118 1.132 1.132 P
A 22 0.936 0.952 0.944 0.944 P
A 23 0.695 0.684 0.690 0.690 P
A 24 0.562 0.586 0.574 0.574 P
A 25 1.046 1.025 1.036 1.036 P
A 26 0.851 0.814 0.833 0.833 P
A 27 0.957 0.948 0.953 0.953 P
A 28 1.032 1.023 1.028 1.028 P
A 29 1.110 1.134 1.122 1.122 P
A 30 0.632 0.628 0.630 0.630 P
A 31 1.006 0.933 0.970 0.970 P
A 32 0.917 0.899 0.908 0.908 P
A 33 0.541 0.580 0.561 0.561 P
A 34 1.039 1.076 1.058 1.058 P
A 35 0.558 0.590 0.574 0.574 P
B L210 1.460 1.455 1.458 1.069 P
B L272 1.101 1.159 1.130 0.838 P
B L281 0.767 0.724 0.745 0.567 P
B L20 0.926 0.850 0.888 0.667 P
B L244 1.032 1.003 1.018 0.759 P
B L250 1.099 1.350 1.225 0.905 P
B L246 1.367 1.315 1.341 0.987 P
B L252 1.360 1.281 1.320 0.973 P
B L270 1.098 1.108 1.103 0.819 P
B L271 0.461 0.477 0.469 0.469 P
B L210 1.054 1.284 1.169 1.169 P
B L256 1.450 1.078 1.264 1.264 P
B L190 1.366 1.507 1.437 1.437 P
B L269 0.423 0.434 0.429 0.429 P
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Continuation
Origin serum well 1 well 2 mean adj.v. status
B L49 1.328 1.418 1.373 1.010 P
B T200 0.518 0.513 0.516 0.404 P
B T411 1.203 1.176 1.190 0.880 P
B T395 1.388 1.509 1.449 1.063 P
B T416 0.953 0.851 0.902 0.677 P
B T387 0.998 1.004 1.001 0.747 P
B T412 0.559 0.574 0.567 0.440 P
B T406 1.603 1.505 1.554 1.138 P
B T415 1.250 1.297 1.273 0.940 P
B T413 1.094 1.071 1.083 0.805 P
B T329 0.881 1.000 0.941 0.704 P
B T418 0.431 0.463 0.447 0.356 N
B L269 0.629 0.616 0.623 0.480 P
B L45 1.412 1.251 1.331 0.980 P
B L252 1.499 1.459 1.479 1.085 P
B L244 0.229 0.130 0.180 0.186 N
B L243 0.283 0.403 0.343 0.303 N
B L278 1.133 1.202 1.168 0.889 P
B L274 0.440 0.377 0.409 0.349 N
B L276 1.013 1.138 1.075 0.823 P
B T391 1.080 1.133 1.107 0.845 P
B T409 0.532 0.428 0.480 0.400 P
B T308 0.897 0.878 0.888 0.690 P
B T403 0.944 0.959 0.952 0.735 P
B T416 1.243 1.161 1.202 0.913 P
B T414 0.292 0.253 0.273 0.253 N
B T417 0.746 0.522 0.634 0.510 P
B T385 1.078 1.038 1.058 0.811 P
B T387 1.194 1.209 1.202 0.913 P
B T389 1.663 1.568 1.616 1.207 P
B T407 1.506 1.510 1.508 1.131 P
B T406 1.273 1.277 1.275 0.965 P
B T402 1.497 1.425 1.461 1,098 P
B T405 1.313 1.423 1.368 1.031 P
B T408 1.432 1.535 1.484 1.114 P
C 8655 0.665 0.675 0.670 0.963 P
C 4260 0.962 0.751 0.857 1.248 P
C 4320 0.522 0.616 0.569 0.809 P
C 3406 0.727 0.511 0.619 0.885 P
C 2980 0.879 1.048 0.964 0.964 P
C 7294 1.205 1.278 1.242 1.242 P
C 3334 0.695 0.755 0.725 0.725 P
Key: A - serum sample from Mozambique
B - serum sample from Malawi
C - serum sample from Brazil




5.7 Absorbance values from field serum samples tested against B.bigemina crude antigen
(section 8.4,2.2).
Origin serum well 1 well 2 mean adj.v. status
A 1 0.726 0.539 0.633 0.539 N
A 2 0.729 0.720 0.725 0.616 P
A 3 0.404 0.458 0.431 0.372 N
A 4 0.683 0.740 0.712 0.605 P
A 6 0.778 0.855 0.817 0.692 P
A 8 0.887 0.917 0.902 0.763 P
A 9 0,709 0.727 0.718 0.610 P
A 10 0.681 0.728 0.705 0.599 P
A 11 0.858 0.810 0.834 0.706 P
A 12 0.809 0.869 0.839 0.711 P
A 13 0.485 0.480 0.483 0.415 N
A 14 0.613 0.555 0.584 0.499 N
A 15 0.519 0.501 0.510 0.438 N
A 16 0.854 0.835 0.845 0.715 P
A 17 0.866 0.821 0.844 0.714 P
A 18 0.519 0.715 0.617 0.526 N
A 19 0.870 0.734 0.802 0.690 P
A 20 0.838 0.774 0.806 0.683 P
A 21 1.106 1.004 1.055 0.890 P
A 22 0.918 0.911 0.915 0.773 P
A 23 0.522 0.553 0.538 0.460 N
A 24 0.565 0.627 0.596 0.509 N
A 25 0.931 0.832 0.882 0.746 P
A 26 0.847 0.934 0.891 0.753 P
A 27 0.861 0.853 0.857 0.726 P
A 28 0.873 0.927 0.900 0.761 P
A 29 1.028 1.091 1.060 0.894 P
A 30 0.782 0.780 0.781 0.662 P
A 31 0.814 0.834 0.824 0.698 P
A 32 0.857 0.978 0.918 0.776 P
A 33 0.806 0.791 0.799 0.677 P
A 34 1.087 1.100 1.094 0.922 P
A 35 0.869 0.884 0.877 0.742 P
B L210 0.994 0.980 0.987 0.833 P
B L272 1.080 1.096 1.088 0.917 P
B L281 0.849 0.848 0.849 0.718 P
B L20 1.192 1.172 1.182 0.995 P
B L244 1.920 1.083 1.502 1.260 P
B L250 0.928 0.945 0.937 0.791 P
B L246 1.127 1.137 1.132 0.954 P
B L252 1.254 1.268 1.261 1.061 P
B L270 1.111 1.078 1.095 0.923 P
B L271 0.783 0.782 0.783 0.664 P
B L239 0.865 0.903 0.884 0.748 P
B L256 1.061 1.058 1.060 0.894 P
B L190 1.025 0.979 1.002 0.846 P
B L269 1.046 1.027 1.037 0.874 P
B L49 1.208 1.153 1.181 0.994 P
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Continuation
Origin serum well 1 well 2 mean adj.v. status
B T200 1.281 1.245 1.263 1.062 P
B T411 0.984 1.008 0.996 0.841 P
B T395 0.916 0.960 0.938 0.793 P
B T416 0.965 0.932 0.949 0.801 P
B T387 1.076 1.108 1.092 0.921 P
B T412 0.853 0.872 0.863 0.730 P
B T406 1.264 1.288 1.276 1.073 P
B T415 1.157 1.105 1.131 0.953 P
B T413 0.507 0.529 0.518 0.444 N
B T329 0.752 0.758 0.755 0.641 P
B T418 0.924 0.908 0.916 0.774 P
B L269 0.616 0.580 0.598 0.511 N
B L45 1.072 1.085 1.079 0.909 P
B L252 1.040 1.053 1.047 0.883 P
B L244 0.610 0.626 0.618 0.618 P
B L243 0.324 0.322 0.323 0.323 N
B L278 1.062 1.067 1.065 1.065 P
B L274 1.109 1.092 1.101 1.101 P
B L276 0.897 0.865 0.881 0.881 P
B T391 1.060 1.079 1.070 1.070 P
B T409 0.607 0.672 0.640 0.640 P
B T308 1.173 1.262 1.218 1.218 P
B T403 0.784 0.799 0.792 0.792 P
B T416 0.891 1.029 0.960 0.960 P
B T414 0.901 0.922 0.912 0.912 P
B T417 1.093 1.135 1.114 1.114 P
B T385 0.917 0.925 0.921 0.921 P
B T387 1.315 1.340 1.328 1.328 P
B T389 1.461 1.516 1.489 1.489 P
B T407 1.454 1.460 1.457 1.457 P
B T406 1.401 1.337 1.369 1.369 P
B T402 1.364 1.362 1.363 1.363 P
B T405 0.929 0.896 0.913 0.913 P
B T408 1.429 1.546 1.488 1.488 P
C 8655 1.706 1.710 1.708 1.708 P
C 4260 1.577 1.536 1.557 1.557 P
C 4320 1.351 1.302 1.327 1.327 P
C 3406 1.257 1.132 1.195 1.195 P
C 2980 1.062 1.083 1.073 1.073 P
C 7294 0.576 0.549 0.563 0.563 P
C 3334 0.333 0.554 0.444 0.444 N
Key: A - serum sample from Mozambique
B - serum sample from Malawi
C - serum sample from Brazil




5.8 Absorbance values from field serum samples tested against B.bovis 56 kDa protein
(section 8.4.2.1),
Origin serum well 1 well 2 mean adj.v. status
A 1 0.533 0.556 0.545 0.545 P
A 2 0,882 0.806 0.844 0.844 P
A 3 0.435 0.428 0.432 0.432 P
A 4 0.650 0.647 0.649 0.649 P
A 6 1.163 1.630 1.397 1.397 P
A 8 0.589 0.602 0.596 0.596 P
A 9 0.533 0.590 0.562 0.562 P
A 10 0.735 0.817 0.776 0.776 P
A 11 0.883 0.825 0.854 0.854 P
A 12 1.130 1.096 1.113 1.113 P
A 13 0.607 0.622 0.615 0.615 P
A 14 0.595 0.569 0.582 0.582 P
A 15 0.470 0.454 0.462 0.462 P
A 16 0.573 0.582 0.578 0.578 P
A 17 0.916 0.979 0.948 0.948 P
A 18 0.745 0.759 0.752 0.752 P
A 19 0.762 0.791 0.777 0.777 P
A 20 0.585 0.553 0.569 0.569 P
A 21 0.772 0.805 0.789 0.789 P
A 22 0.984 0.956 0.970 0.970 P
A 23 0.514 0.491 0.503 0.503 P
A 24 0.550 0.615 0.583 0.583 P
A 25 1.148 0.584 0.866 0.866 P
A 26 0.773 0.75 0.762 0.762 P
A 27 0.965 0.924 0.945 0.945 P
A 28 0.616 0.615 0.616 0.616 P
A 29 1.031 1.017 1.024 1.024 P
A 30 0.781 0.767 0.774 0.774 P
A 31 1.187 1.223 1.205 1.205 P
A 32 1.022 1.007 1.015 1.015 P
A 33 0.624 0.623 0.624 0.624 P
A 34 0.841 0.845 0.843 0.843 P
A 35 0.649 0.665 0.657 0.657 P
B L210 1.346 1.303 1.325 1.132 P
B L272 0.779 0.776 0.778 0.692 P
B L281 0.401 0.402 0.402 0.389 P
B L20 0.769 0.781 0.775 0.690 P
B L244 0.87 0.852 0.861 0.759 P
B L250 0.707 0.683 0.695 0.625 P
B L246 1.007 0.995 1.001 0.872 P
B L252 0.741 0.787 0.764 0.681 P
B L270 0.696 0.699 0.698 0.627 P
B L271 0.799 0.877 0.838 0.74 P
B L239 0.579 0.576 0.578 0.531 P
B L256 0.849 0.903 0.876 0.771 P
B L190 0.901 0.943 0.922 0.808 P
B L269 0.574 0.546 0.560 0.517 P
B L49 0.933 0.88 0.907 0.796 P
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Continuation
Origin serum well 1 well 2 mean adj.v. status
B T200 0.710 0.709 0.710 0.637 P
B T411 0.950 0.926 0.938 0.821 P
B T395 0.986 0.799 0.893 0.784 P
B T416 0.550 0.615 0.583 0.535 P
B T387 0.515 0.545 0.530 0.492 P
B T412 0.592 0.622 0.607 0.554 P
B T406 0.904 0.941 0.923 0.808 P
B T415 0.726 0.753 0.740 0.661 P
B T413 0.719 0.709 0.714 0.641 P
B T329 1.145 1.088 1.117 0.965 P
B T418 0.833 0.872 0.853 0.752 P
B L269 0.392 0.358 0.375 0.368 P
B L45 0.537 0.572 0.555 0.512 P
B L252 0.587 0.575 0.581 0.534 P
B L244 0.224 0.231 0.228 0.253 N
B L243 0.317 0.271 0.294 0.322 N
B L278 0.893 0.726 0.810 0.869 P
B L274 0.684 0.686 0.685 0.739 P
B L276 0.503 0.785 0.644 0.687 P
B T391 0.748 0.638 0.693 0.738 P
B T409 0.592 0.333 0.463 0.498 P
B T308 1.049 0.933 0.991 1.049 P
B T403 0.558 0.779 0.669 0.713 P
B T416 1.258 1.403 1.331 1.403 P
B T414 0.285 0.298 0.292 0.320 N
B T417 0.748 0.749 0.749 0.796 P
B T385 0.582 0.443 0.513 0.550 P
B T387 0.805 0.628 0.717 0.763 P
B T389 1.311 1.182 1.247 1.316 P
B T407 0.904 0.841 0.873 0.926 P
B T406 1.067 1.016 1.042 1.102 P
B T402 0.780 0.769 0.775 0.823 P
B T405 0.559 0.605 0.582 0.623 P
B T408 0.577 0.565 0.571 0.611 P
C 8655 0.478 0.464 0.471 0.774 P
C 4260 0.430 0.541 0.486 0.803 P
C 4320 0.337 0.374 0.356 0.540 P
C 3406 0.390 0.432 0.411 0.652 P
C 2980 0.802 0.843 0.823 0.823 P
C 7294 0.652 0.632 0.642 0.642 P
C 3334 0.578 0.603 0.591 0.591 P
Key: A - serum sample from Mozambique
B - serum sample from Malawi
C - serum sample from Brazil
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Isomerase(GPI) isoenzyme patternt
proteins were identified(relative
128, 56, 25 and 20 kDa). Sera rai
and Mexican stocks did not recogi
the Australian stock. A 37 kDa ]
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Identification of immunodominant Babesia bovis exoan¬
tigens
L. Passos Centre for Tropical Veterinary Medicine, University of
Edinburgh, Easter Bush. Roslin, Midlothian, EH25 9RG. UK
Bovine babesiosis caused by Babesia bovis and B. bi-
gemina is one of the most common cattle tick-borne dis¬
eases in tropical and sub-tropical regions of the world
and causes serious production losses.
With the objective of identifying species-specific im¬
munodominant proteins for diagnostic purposes, 3 stocks
of B. bovis from Australia, Mexico and South Africa were
cultured in vitro and analysed by immunoprecipitation of
35S-radiolabelled proteins present in supernatants. Using
bovine immune sera experimentally raised against B.
bovis and B. bigemina stocks and field sera from Brazil,
where both infections are endemic, 4 specific and immu¬
nodominant proteins were identified (molecular masses
of 72, 58, 38 and 24 kDa). The supernatants are also
being analysed by Western blotting and the proteins will
be purified and used to develop a B. bovis specific
enzyme-linked immunosorbent assay.
324
6.3 Passos, L.M.F.; Brown, C.G.D.; Jones,T.W.; Bell-Sakyi, L.; Boid, R. (1993) The
development of specific ELISAs for use in epidemiological studies of bovine babesiosis in
Brazil. Proceedings of the Nth International Conference of the World Association for the
Advancement ofVeterinary Parasitology, Cambridge.
The development of specific elisas for use in
epidemiological studies of bovine babesiosis
in Brazil
L_ M. F. PASSOS, C. G. D. BROWN, T. W. JONES, L BELL-SAKYI AND R. BOID
Centre for Tropical Veterinary Medicine, Easter Bush, Rostin, Midlothian, Scotland
abesia bouis and B. bigemina, the causative agents of bovine
babesiosis in tropical areas where the tick vector (Boophilus
microplus) occurs, are responsible for important economic
losses in both milk and beef production in Brazil.
Following previous work on the identification of B. bouis and B.
bigem'tna specific antigens using immunoblotting and
immunoprecipitation of biosynthetically labelled parasite components
(Passos, L.M.F. 1992 Trans. R. Soc. Trop. Med. Hyg. 87, 122), the
present study reports the purification of selected parasite proteins from
acrylamide gels and their use in the development of antibody-detection
ELISAs for these two protozoans to use in epidemiological studies in
Brazil. Crude antigen extracts of each parasite were compared in
ELISAs with one candidate purified protein from each parasite to test
against a panel of calf sera experimentally raised to three
geographically different isolates of B. bouis and three of B. bigemina. In
addition, these ELISA antigens were tested against a panel of sera from
cattle in Brazil, Malawi and Mozambique which had been infected
naturally by ticks in the field.
The purified B. bouis protein detected specific antibodies and is a
potential candidate to replace the crude parasite extract in
immunodiagnostic assays. However the purified B. bigemina protein
cross-reacted with B. bouis antisera and other candidate proteins will
need to be assessed.
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